#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia
#Text=A core feature of schizophrenia (SCZ) is impairment in intrinsic motivation.
1-1	0-8	Impaired	_	
1-2	9-19	prefrontal	_	
1-3	20-28	activity	_	
1-4	29-31	to	_	
1-5	32-40	regulate	_	
1-6	41-44	the	_	
1-7	45-54	intrinsic	_	
1-8	55-72	motivation-action	_	
1-9	73-77	link	_	
1-10	78-80	in	_	
1-11	81-94	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-12	95-96	A	_	
1-13	97-101	core	_	
1-14	102-109	feature	_	
1-15	110-112	of	_	
1-16	113-126	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-17	127-128	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-18	128-131	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-19	131-132	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-20	133-135	is	_	
1-21	136-146	impairment	_	
1-22	147-149	in	_	
1-23	150-159	intrinsic	_	
1-24	160-170	motivation	_	
1-25	170-171	.	_	

#Text=Although intrinsic motivation plays an important role in enhancing improvement of the social functioning, its neural mechanisms of impairment have yet to be clarified.
2-1	172-180	Although	_	
2-2	181-190	intrinsic	_	
2-3	191-201	motivation	_	
2-4	202-207	plays	_	
2-5	208-210	an	_	
2-6	211-220	important	_	
2-7	221-225	role	_	
2-8	226-228	in	_	
2-9	229-238	enhancing	_	
2-10	239-250	improvement	_	
2-11	251-253	of	_	
2-12	254-257	the	_	
2-13	258-264	social	_	
2-14	265-276	functioning	_	
2-15	276-277	,	_	
2-16	278-281	its	_	
2-17	282-288	neural	_	
2-18	289-299	mechanisms	_	
2-19	300-302	of	_	
2-20	303-313	impairment	_	
2-21	314-318	have	_	
2-22	319-322	yet	_	
2-23	323-325	to	_	
2-24	326-328	be	_	
2-25	329-338	clarified	_	
2-26	338-339	.	_	

#Text=We hypothesized that abnormal function of the frontostriatal loop consisting of the striatum and lateral prefrontal cortex (LPFC) may be related to impaired intrinsic motivation in SCZ.
3-1	340-342	We	_	
3-2	343-355	hypothesized	_	
3-3	356-360	that	_	
3-4	361-369	abnormal	_	
3-5	370-378	function	_	
3-6	379-381	of	_	
3-7	382-385	the	_	
3-8	386-400	frontostriatal	_	
3-9	401-405	loop	_	
3-10	406-416	consisting	_	
3-11	417-419	of	_	
3-12	420-423	the	_	
3-13	424-432	striatum	_	
3-14	433-436	and	_	
3-15	437-444	lateral	_	
3-16	445-455	prefrontal	_	
3-17	456-462	cortex	_	
3-18	463-464	(	_	
3-19	464-468	LPFC	_	
3-20	468-469	)	_	
3-21	470-473	may	_	
3-22	474-476	be	_	
3-23	477-484	related	_	
3-24	485-487	to	_	
3-25	488-496	impaired	_	
3-26	497-506	intrinsic	_	
3-27	507-517	motivation	_	
3-28	518-520	in	_	
3-29	521-524	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-30	524-525	.	_	

#Text=We tested this by comparing the brain activity measured by functional magnetic resonance imaging and behavioral parameters associated with movement, motivation, and cognitive control between 18 stable SCZ patients and 17 healthy control (HC) participants during a task that elicits intrinsic motivation.
4-1	526-528	We	_	
4-2	529-535	tested	_	
4-3	536-540	this	_	
4-4	541-543	by	_	
4-5	544-553	comparing	_	
4-6	554-557	the	_	
4-7	558-563	brain	_	
4-8	564-572	activity	_	
4-9	573-581	measured	_	
4-10	582-584	by	_	
4-11	585-595	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[2]	
4-12	596-604	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[2]	
4-13	605-614	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[2]	
4-14	615-622	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[2]	
4-15	623-626	and	_	
4-16	627-637	behavioral	_	
4-17	638-648	parameters	_	
4-18	649-659	associated	_	
4-19	660-664	with	_	
4-20	665-673	movement	_	
4-21	673-674	,	_	
4-22	675-685	motivation	_	
4-23	685-686	,	_	
4-24	687-690	and	_	
4-25	691-700	cognitive	_	
4-26	701-708	control	_	
4-27	709-716	between	_	
4-28	717-719	18	_	
4-29	720-726	stable	_	
4-30	727-730	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-31	731-739	patients	_	
4-32	740-743	and	_	
4-33	744-746	17	_	
4-34	747-754	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-35	755-762	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-36	763-764	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-37	764-766	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-38	766-767	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-39	768-780	participants	_	
4-40	781-787	during	_	
4-41	788-789	a	_	
4-42	790-794	task	_	
4-43	795-799	that	_	
4-44	800-807	elicits	_	
4-45	808-817	intrinsic	_	
4-46	818-828	motivation	_	
4-47	828-829	.	_	

#Text=We also compared the functional connectivity during resting-state and the fractional anisotropy using diffusion tensor imaging analysis between the two groups.
5-1	830-832	We	_	
5-2	833-837	also	_	
5-3	838-846	compared	_	
5-4	847-850	the	_	
5-5	851-861	functional	_	
5-6	862-874	connectivity	_	
5-7	875-881	during	_	
5-8	882-895	resting-state	_	
5-9	896-899	and	_	
5-10	900-903	the	_	
5-11	904-914	fractional	_	
5-12	915-925	anisotropy	_	
5-13	926-931	using	_	
5-14	932-941	diffusion	_	
5-15	942-948	tensor	_	
5-16	949-956	imaging	_	
5-17	957-965	analysis	_	
5-18	966-973	between	_	
5-19	974-977	the	_	
5-20	978-981	two	_	
5-21	982-988	groups	_	
5-22	988-989	.	_	

#Text=We adopted an enjoyable timing task to stop a stopwatch at an exact time, which in our previous study has demonstrated to elicit intrinsic motivation.
6-1	990-992	We	_	
6-2	993-1000	adopted	_	
6-3	1001-1003	an	_	
6-4	1004-1013	enjoyable	_	
6-5	1014-1020	timing	_	
6-6	1021-1025	task	_	
6-7	1026-1028	to	_	
6-8	1029-1033	stop	_	
6-9	1034-1035	a	_	
6-10	1036-1045	stopwatch	_	
6-11	1046-1048	at	_	
6-12	1049-1051	an	_	
6-13	1052-1057	exact	_	
6-14	1058-1062	time	_	
6-15	1062-1063	,	_	
6-16	1064-1069	which	_	
6-17	1070-1072	in	_	
6-18	1073-1076	our	_	
6-19	1077-1085	previous	_	
6-20	1086-1091	study	_	
6-21	1092-1095	has	_	
6-22	1096-1108	demonstrated	_	
6-23	1109-1111	to	_	
6-24	1112-1118	elicit	_	
6-25	1119-1128	intrinsic	_	
6-26	1129-1139	motivation	_	
6-27	1139-1140	.	_	

#Text=Although the performance level in general was not different between groups, the SCZ group performed worse than the HC group in trials following “overshoot” errors (i.e., the response was too late).
7-1	1141-1149	Although	_	
7-2	1150-1153	the	_	
7-3	1154-1165	performance	_	
7-4	1166-1171	level	_	
7-5	1172-1174	in	_	
7-6	1175-1182	general	_	
7-7	1183-1186	was	_	
7-8	1187-1190	not	_	
7-9	1191-1200	different	_	
7-10	1201-1208	between	_	
7-11	1209-1215	groups	_	
7-12	1215-1216	,	_	
7-13	1217-1220	the	_	
7-14	1221-1224	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
7-15	1225-1230	group	_	
7-16	1231-1240	performed	_	
7-17	1241-1246	worse	_	
7-18	1247-1251	than	_	
7-19	1252-1255	the	_	
7-20	1256-1258	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
7-21	1259-1264	group	_	
7-22	1265-1267	in	_	
7-23	1268-1274	trials	_	
7-24	1275-1284	following	_	
7-25	1285-1286	“	_	
7-26	1286-1295	overshoot	_	
7-27	1295-1296	”	_	
7-28	1297-1303	errors	_	
7-29	1304-1305	(	_	
7-30	1305-1308	i.e	_	
7-31	1308-1309	.	_	
7-32	1309-1310	,	_	
7-33	1311-1314	the	_	
7-34	1315-1323	response	_	
7-35	1324-1327	was	_	
7-36	1328-1331	too	_	
7-37	1332-1336	late	_	
7-38	1336-1337	)	_	
7-39	1337-1338	.	_	

#Text=SCZ participants showed lower intrinsic motivation to the task than the HC group in an inventory report.
8-1	1339-1342	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-2	1343-1355	participants	_	
8-3	1356-1362	showed	_	
8-4	1363-1368	lower	_	
8-5	1369-1378	intrinsic	_	
8-6	1379-1389	motivation	_	
8-7	1390-1392	to	_	
8-8	1393-1396	the	_	
8-9	1397-1401	task	_	
8-10	1402-1406	than	_	
8-11	1407-1410	the	_	
8-12	1411-1413	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
8-13	1414-1419	group	_	
8-14	1420-1422	in	_	
8-15	1423-1425	an	_	
8-16	1426-1435	inventory	_	
8-17	1436-1442	report	_	
8-18	1442-1443	.	_	

#Text=The striatal activity during the prediction at the task cue period was consistently lower in SCZ participants than in HC.
9-1	1444-1447	The	_	
9-2	1448-1456	striatal	_	
9-3	1457-1465	activity	_	
9-4	1466-1472	during	_	
9-5	1473-1476	the	_	
9-6	1477-1487	prediction	_	
9-7	1488-1490	at	_	
9-8	1491-1494	the	_	
9-9	1495-1499	task	_	
9-10	1500-1503	cue	_	
9-11	1504-1510	period	_	
9-12	1511-1514	was	_	
9-13	1515-1527	consistently	_	
9-14	1528-1533	lower	_	
9-15	1534-1536	in	_	
9-16	1537-1540	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
9-17	1541-1553	participants	_	
9-18	1554-1558	than	_	
9-19	1559-1561	in	_	
9-20	1562-1564	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
9-21	1564-1565	.	_	

#Text=The LPFC activity at the task cue period positively correlated with intrinsic motivation and also with the rate of success following overshoot errors in the HC group, but not in the SCZ group.
10-1	1566-1569	The	_	
10-2	1570-1574	LPFC	_	
10-3	1575-1583	activity	_	
10-4	1584-1586	at	_	
10-5	1587-1590	the	_	
10-6	1591-1595	task	_	
10-7	1596-1599	cue	_	
10-8	1600-1606	period	_	
10-9	1607-1617	positively	_	
10-10	1618-1628	correlated	_	
10-11	1629-1633	with	_	
10-12	1634-1643	intrinsic	_	
10-13	1644-1654	motivation	_	
10-14	1655-1658	and	_	
10-15	1659-1663	also	_	
10-16	1664-1668	with	_	
10-17	1669-1672	the	_	
10-18	1673-1677	rate	_	
10-19	1678-1680	of	_	
10-20	1681-1688	success	_	
10-21	1689-1698	following	_	
10-22	1699-1708	overshoot	_	
10-23	1709-1715	errors	_	
10-24	1716-1718	in	_	
10-25	1719-1722	the	_	
10-26	1723-1725	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
10-27	1726-1731	group	_	
10-28	1731-1732	,	_	
10-29	1733-1736	but	_	
10-30	1737-1740	not	_	
10-31	1741-1743	in	_	
10-32	1744-1747	the	_	
10-33	1748-1751	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-34	1752-1757	group	_	
10-35	1757-1758	.	_	

#Text=The LPFC activity at the task cue period was also positively correlated with the striatal activity in both groups.
11-1	1759-1762	The	_	
11-2	1763-1767	LPFC	_	
11-3	1768-1776	activity	_	
11-4	1777-1779	at	_	
11-5	1780-1783	the	_	
11-6	1784-1788	task	_	
11-7	1789-1792	cue	_	
11-8	1793-1799	period	_	
11-9	1800-1803	was	_	
11-10	1804-1808	also	_	
11-11	1809-1819	positively	_	
11-12	1820-1830	correlated	_	
11-13	1831-1835	with	_	
11-14	1836-1839	the	_	
11-15	1840-1848	striatal	_	
11-16	1849-1857	activity	_	
11-17	1858-1860	in	_	
11-18	1861-1865	both	_	
11-19	1866-1872	groups	_	
11-20	1872-1873	.	_	

#Text=The striatal activity during the feedback period was not significantly different between groups.
12-1	1874-1877	The	_	
12-2	1878-1886	striatal	_	
12-3	1887-1895	activity	_	
12-4	1896-1902	during	_	
12-5	1903-1906	the	_	
12-6	1907-1915	feedback	_	
12-7	1916-1922	period	_	
12-8	1923-1926	was	_	
12-9	1927-1930	not	_	
12-10	1931-1944	significantly	_	
12-11	1945-1954	different	_	
12-12	1955-1962	between	_	
12-13	1963-1969	groups	_	
12-14	1969-1970	.	_	

#Text=These results suggest that, unlike HC, the neural activity in the LPFC fails to mediate between prediction of hedonic events and cognitive control of action plans in SCZ, whereas the hedonic response is retained.
13-1	1971-1976	These	_	
13-2	1977-1984	results	_	
13-3	1985-1992	suggest	_	
13-4	1993-1997	that	_	
13-5	1997-1998	,	_	
13-6	1999-2005	unlike	_	
13-7	2006-2008	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
13-8	2008-2009	,	_	
13-9	2010-2013	the	_	
13-10	2014-2020	neural	_	
13-11	2021-2029	activity	_	
13-12	2030-2032	in	_	
13-13	2033-2036	the	_	
13-14	2037-2041	LPFC	_	
13-15	2042-2047	fails	_	
13-16	2048-2050	to	_	
13-17	2051-2058	mediate	_	
13-18	2059-2066	between	_	
13-19	2067-2077	prediction	_	
13-20	2078-2080	of	_	
13-21	2081-2088	hedonic	_	
13-22	2089-2095	events	_	
13-23	2096-2099	and	_	
13-24	2100-2109	cognitive	_	
13-25	2110-2117	control	_	
13-26	2118-2120	of	_	
13-27	2121-2127	action	_	
13-28	2128-2133	plans	_	
13-29	2134-2136	in	_	
13-30	2137-2140	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
13-31	2140-2141	,	_	
13-32	2142-2149	whereas	_	
13-33	2150-2153	the	_	
13-34	2154-2161	hedonic	_	
13-35	2162-2170	response	_	
13-36	2171-2173	is	_	
13-37	2174-2182	retained	_	
13-38	2182-2183	.	_	

#Text=Highlights
#Text=The neural basis of impaired motivation in schizophrenia is examined using fMRI.
14-1	2184-2194	Highlights	_	
14-2	2195-2198	The	_	
14-3	2199-2205	neural	_	
14-4	2206-2211	basis	_	
14-5	2212-2214	of	_	
14-6	2215-2223	impaired	_	
14-7	2224-2234	motivation	_	
14-8	2235-2237	in	_	
14-9	2238-2251	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
14-10	2252-2254	is	_	
14-11	2255-2263	examined	_	
14-12	2264-2269	using	_	
14-13	2270-2274	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
14-14	2274-2275	.	_	

#Text=The hedonic response to a feedback in the striatum is retained in schizophrenia.
15-1	2276-2279	The	_	
15-2	2280-2287	hedonic	_	
15-3	2288-2296	response	_	
15-4	2297-2299	to	_	
15-5	2300-2301	a	_	
15-6	2302-2310	feedback	_	
15-7	2311-2313	in	_	
15-8	2314-2317	the	_	
15-9	2318-2326	striatum	_	
15-10	2327-2329	is	_	
15-11	2330-2338	retained	_	
15-12	2339-2341	in	_	
15-13	2342-2355	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
15-14	2355-2356	.	_	

#Text=Translating hedonic events to action plans is impeded by poor cognitive control.
16-1	2357-2368	Translating	_	
16-2	2369-2376	hedonic	_	
16-3	2377-2383	events	_	
16-4	2384-2386	to	_	
16-5	2387-2393	action	_	
16-6	2394-2399	plans	_	
16-7	2400-2402	is	_	
16-8	2403-2410	impeded	_	
16-9	2411-2413	by	_	
16-10	2414-2418	poor	_	
16-11	2419-2428	cognitive	_	
16-12	2429-2436	control	_	
16-13	2436-2437	.	_	

#Text=The cognitive control impairment is associated with altered prefrontal function.
17-1	2438-2441	The	_	
17-2	2442-2451	cognitive	_	
17-3	2452-2459	control	_	
17-4	2460-2470	impairment	_	
17-5	2471-2473	is	_	
17-6	2474-2484	associated	_	
17-7	2485-2489	with	_	
17-8	2490-2497	altered	_	
17-9	2498-2508	prefrontal	_	
17-10	2509-2517	function	_	
17-11	2517-2518	.	_	

#Text=Introduction
#Text=People with schizophrenia (SCZ) show marked cognitive deficits that are closely related to deficits in social functioning, and cognitive remediation therapies have been shown to moderately improve cognitive impairments and social functioning.
18-1	2519-2531	Introduction	_	
18-2	2532-2538	People	_	
18-3	2539-2543	with	_	
18-4	2544-2557	schizophrenia	_	
18-5	2558-2559	(	_	
18-6	2559-2562	SCZ	_	
18-7	2562-2563	)	_	
18-8	2564-2568	show	_	
18-9	2569-2575	marked	_	
18-10	2576-2585	cognitive	_	
18-11	2586-2594	deficits	_	
18-12	2595-2599	that	_	
18-13	2600-2603	are	_	
18-14	2604-2611	closely	_	
18-15	2612-2619	related	_	
18-16	2620-2622	to	_	
18-17	2623-2631	deficits	_	
18-18	2632-2634	in	_	
18-19	2635-2641	social	_	
18-20	2642-2653	functioning	_	
18-21	2653-2654	,	_	
18-22	2655-2658	and	_	
18-23	2659-2668	cognitive	_	
18-24	2669-2680	remediation	_	
18-25	2681-2690	therapies	_	
18-26	2691-2695	have	_	
18-27	2696-2700	been	_	
18-28	2701-2706	shown	_	
18-29	2707-2709	to	_	
18-30	2710-2720	moderately	_	
18-31	2721-2728	improve	_	
18-32	2729-2738	cognitive	_	
18-33	2739-2750	impairments	_	
18-34	2751-2754	and	_	
18-35	2755-2761	social	_	
18-36	2762-2773	functioning	_	
18-37	2773-2774	.	_	

#Text=To design more effective therapies, it is necessary to be aware of the mediators linking them such as motivation, particularly intrinsic motivation, which is distinct from extrinsic motivation in that it is based on internal value such as interest and enjoyment.
19-1	2775-2777	To	_	
19-2	2778-2784	design	_	
19-3	2785-2789	more	_	
19-4	2790-2799	effective	_	
19-5	2800-2809	therapies	_	
19-6	2809-2810	,	_	
19-7	2811-2813	it	_	
19-8	2814-2816	is	_	
19-9	2817-2826	necessary	_	
19-10	2827-2829	to	_	
19-11	2830-2832	be	_	
19-12	2833-2838	aware	_	
19-13	2839-2841	of	_	
19-14	2842-2845	the	_	
19-15	2846-2855	mediators	_	
19-16	2856-2863	linking	_	
19-17	2864-2868	them	_	
19-18	2869-2873	such	_	
19-19	2874-2876	as	_	
19-20	2877-2887	motivation	_	
19-21	2887-2888	,	_	
19-22	2889-2901	particularly	_	
19-23	2902-2911	intrinsic	_	
19-24	2912-2922	motivation	_	
19-25	2922-2923	,	_	
19-26	2924-2929	which	_	
19-27	2930-2932	is	_	
19-28	2933-2941	distinct	_	
19-29	2942-2946	from	_	
19-30	2947-2956	extrinsic	_	
19-31	2957-2967	motivation	_	
19-32	2968-2970	in	_	
19-33	2971-2975	that	_	
19-34	2976-2978	it	_	
19-35	2979-2981	is	_	
19-36	2982-2987	based	_	
19-37	2988-2990	on	_	
19-38	2991-2999	internal	_	
19-39	3000-3005	value	_	
19-40	3006-3010	such	_	
19-41	3011-3013	as	_	
19-42	3014-3022	interest	_	
19-43	3023-3026	and	_	
19-44	3027-3036	enjoyment	_	
19-45	3036-3037	.	_	

#Text=However, the neural mechanisms of intrinsic motivation in SCZ have yet to be clarified.
20-1	3038-3045	However	_	
20-2	3045-3046	,	_	
20-3	3047-3050	the	_	
20-4	3051-3057	neural	_	
20-5	3058-3068	mechanisms	_	
20-6	3069-3071	of	_	
20-7	3072-3081	intrinsic	_	
20-8	3082-3092	motivation	_	
20-9	3093-3095	in	_	
20-10	3096-3099	SCZ	_	
20-11	3100-3104	have	_	
20-12	3105-3108	yet	_	
20-13	3109-3111	to	_	
20-14	3112-3114	be	_	
20-15	3115-3124	clarified	_	
20-16	3124-3125	.	_	

#Text=A negative symptom is one of the major symptoms in SCZ.
21-1	3126-3127	A	_	
21-2	3128-3136	negative	_	
21-3	3137-3144	symptom	_	
21-4	3145-3147	is	_	
21-5	3148-3151	one	_	
21-6	3152-3154	of	_	
21-7	3155-3158	the	_	
21-8	3159-3164	major	_	
21-9	3165-3173	symptoms	_	
21-10	3174-3176	in	_	
21-11	3177-3180	SCZ	_	
21-12	3180-3181	.	_	

#Text=Although it has been thought that the hedonic response is impaired in SCZ (‘anhedonia’), recent studies report that patients exhibit a hedonic response that is similar to healthy controls (HC) at the subjective and neurophysiological level.
22-1	3182-3190	Although	_	
22-2	3191-3193	it	_	
22-3	3194-3197	has	_	
22-4	3198-3202	been	_	
22-5	3203-3210	thought	_	
22-6	3211-3215	that	_	
22-7	3216-3219	the	_	
22-8	3220-3227	hedonic	_	
22-9	3228-3236	response	_	
22-10	3237-3239	is	_	
22-11	3240-3248	impaired	_	
22-12	3249-3251	in	_	
22-13	3252-3255	SCZ	_	
22-14	3256-3257	(	_	
22-15	3257-3258	‘	_	
22-16	3258-3267	anhedonia	_	
22-17	3267-3268	’	_	
22-18	3268-3269	)	_	
22-19	3269-3270	,	_	
22-20	3271-3277	recent	_	
22-21	3278-3285	studies	_	
22-22	3286-3292	report	_	
22-23	3293-3297	that	_	
22-24	3298-3306	patients	_	
22-25	3307-3314	exhibit	_	
22-26	3315-3316	a	_	
22-27	3317-3324	hedonic	_	
22-28	3325-3333	response	_	
22-29	3334-3338	that	_	
22-30	3339-3341	is	_	
22-31	3342-3349	similar	_	
22-32	3350-3352	to	_	
22-33	3353-3360	healthy	_	
22-34	3361-3369	controls	_	
22-35	3370-3371	(	_	
22-36	3371-3373	HC	_	
22-37	3373-3374	)	_	
22-38	3375-3377	at	_	
22-39	3378-3381	the	_	
22-40	3382-3392	subjective	_	
22-41	3393-3396	and	_	
22-42	3397-3415	neurophysiological	_	
22-43	3416-3421	level	_	
22-44	3421-3422	.	_	

#Text=However, SCZ patients seem less motivated to be engaged in goal-directed behavior, suggesting that the apparent reduction of motivation may not be based on deficits in the hedonic response itself but on impairments in linking expectation of hedonic events to action plans.
23-1	3423-3430	However	_	
23-2	3430-3431	,	_	
23-3	3432-3435	SCZ	_	
23-4	3436-3444	patients	_	
23-5	3445-3449	seem	_	
23-6	3450-3454	less	_	
23-7	3455-3464	motivated	_	
23-8	3465-3467	to	_	
23-9	3468-3470	be	_	
23-10	3471-3478	engaged	_	
23-11	3479-3481	in	_	
23-12	3482-3495	goal-directed	_	
23-13	3496-3504	behavior	_	
23-14	3504-3505	,	_	
23-15	3506-3516	suggesting	_	
23-16	3517-3521	that	_	
23-17	3522-3525	the	_	
23-18	3526-3534	apparent	_	
23-19	3535-3544	reduction	_	
23-20	3545-3547	of	_	
23-21	3548-3558	motivation	_	
23-22	3559-3562	may	_	
23-23	3563-3566	not	_	
23-24	3567-3569	be	_	
23-25	3570-3575	based	_	
23-26	3576-3578	on	_	
23-27	3579-3587	deficits	_	
23-28	3588-3590	in	_	
23-29	3591-3594	the	_	
23-30	3595-3602	hedonic	_	
23-31	3603-3611	response	_	
23-32	3612-3618	itself	_	
23-33	3619-3622	but	_	
23-34	3623-3625	on	_	
23-35	3626-3637	impairments	_	
23-36	3638-3640	in	_	
23-37	3641-3648	linking	_	
23-38	3649-3660	expectation	_	
23-39	3661-3663	of	_	
23-40	3664-3671	hedonic	_	
23-41	3672-3678	events	_	
23-42	3679-3681	to	_	
23-43	3682-3688	action	_	
23-44	3689-3694	plans	_	
23-45	3694-3695	.	_	

#Text=Many studies suggest that the expectation of rewards or hedonic events is processed in the striatum and the prefrontal regions, and the lateral prefrontal cortex (LPFC) in particular is the core region for planning actions on the basis of expectation of goal attainment.
24-1	3696-3700	Many	_	
24-2	3701-3708	studies	_	
24-3	3709-3716	suggest	_	
24-4	3717-3721	that	_	
24-5	3722-3725	the	_	
24-6	3726-3737	expectation	_	
24-7	3738-3740	of	_	
24-8	3741-3748	rewards	_	
24-9	3749-3751	or	_	
24-10	3752-3759	hedonic	_	
24-11	3760-3766	events	_	
24-12	3767-3769	is	_	
24-13	3770-3779	processed	_	
24-14	3780-3782	in	_	
24-15	3783-3786	the	_	
24-16	3787-3795	striatum	_	
24-17	3796-3799	and	_	
24-18	3800-3803	the	_	
24-19	3804-3814	prefrontal	_	
24-20	3815-3822	regions	_	
24-21	3822-3823	,	_	
24-22	3824-3827	and	_	
24-23	3828-3831	the	_	
24-24	3832-3839	lateral	_	
24-25	3840-3850	prefrontal	_	
24-26	3851-3857	cortex	_	
24-27	3858-3859	(	_	
24-28	3859-3863	LPFC	_	
24-29	3863-3864	)	_	
24-30	3865-3867	in	_	
24-31	3868-3878	particular	_	
24-32	3879-3881	is	_	
24-33	3882-3885	the	_	
24-34	3886-3890	core	_	
24-35	3891-3897	region	_	
24-36	3898-3901	for	_	
24-37	3902-3910	planning	_	
24-38	3911-3918	actions	_	
24-39	3919-3921	on	_	
24-40	3922-3925	the	_	
24-41	3926-3931	basis	_	
24-42	3932-3934	of	_	
24-43	3935-3946	expectation	_	
24-44	3947-3949	of	_	
24-45	3950-3954	goal	_	
24-46	3955-3965	attainment	_	
24-47	3965-3966	.	_	

#Text=Furthermore, the prefrontal regions and the striatum are interconnected through the frontostriatal loops, which are involved in functions including generation of goal-directed, motivated behaviors.
25-1	3967-3978	Furthermore	_	
25-2	3978-3979	,	_	
25-3	3980-3983	the	_	
25-4	3984-3994	prefrontal	_	
25-5	3995-4002	regions	_	
25-6	4003-4006	and	_	
25-7	4007-4010	the	_	
25-8	4011-4019	striatum	_	
25-9	4020-4023	are	_	
25-10	4024-4038	interconnected	_	
25-11	4039-4046	through	_	
25-12	4047-4050	the	_	
25-13	4051-4065	frontostriatal	_	
25-14	4066-4071	loops	_	
25-15	4071-4072	,	_	
25-16	4073-4078	which	_	
25-17	4079-4082	are	_	
25-18	4083-4091	involved	_	
25-19	4092-4094	in	_	
25-20	4095-4104	functions	_	
25-21	4105-4114	including	_	
25-22	4115-4125	generation	_	
25-23	4126-4128	of	_	
25-24	4129-4142	goal-directed	_	
25-25	4142-4143	,	_	
25-26	4144-4153	motivated	_	
25-27	4154-4163	behaviors	_	
25-28	4163-4164	.	_	

#Text=Moreover, several studies have reported reduced ventral striatum activity in the expectation of rewards in SCZ.
26-1	4165-4173	Moreover	_	
26-2	4173-4174	,	_	
26-3	4175-4182	several	_	
26-4	4183-4190	studies	_	
26-5	4191-4195	have	_	
26-6	4196-4204	reported	_	
26-7	4205-4212	reduced	_	
26-8	4213-4220	ventral	_	
26-9	4221-4229	striatum	_	
26-10	4230-4238	activity	_	
26-11	4239-4241	in	_	
26-12	4242-4245	the	_	
26-13	4246-4257	expectation	_	
26-14	4258-4260	of	_	
26-15	4261-4268	rewards	_	
26-16	4269-4271	in	_	
26-17	4272-4275	SCZ	_	
26-18	4275-4276	.	_	

#Text=There are many reports about the behavioral deficits and altered neural activity during cognitive control tasks mediated by the LPFC in SCZ.
27-1	4277-4282	There	_	
27-2	4283-4286	are	_	
27-3	4287-4291	many	_	
27-4	4292-4299	reports	_	
27-5	4300-4305	about	_	
27-6	4306-4309	the	_	
27-7	4310-4320	behavioral	_	
27-8	4321-4329	deficits	_	
27-9	4330-4333	and	_	
27-10	4334-4341	altered	_	
27-11	4342-4348	neural	_	
27-12	4349-4357	activity	_	
27-13	4358-4364	during	_	
27-14	4365-4374	cognitive	_	
27-15	4375-4382	control	_	
27-16	4383-4388	tasks	_	
27-17	4389-4397	mediated	_	
27-18	4398-4400	by	_	
27-19	4401-4404	the	_	
27-20	4405-4409	LPFC	_	
27-21	4410-4412	in	_	
27-22	4413-4416	SCZ	_	
27-23	4416-4417	.	_	

#Text=These findings led us to hypothesize that SCZ patients may show reduced intrinsic motivation and also difficulty in translating information about potentially rewarding events into action plans due to cognitive control impairments associated with altered LPFC function.
28-1	4418-4423	These	_	
28-2	4424-4432	findings	_	
28-3	4433-4436	led	_	
28-4	4437-4439	us	_	
28-5	4440-4442	to	_	
28-6	4443-4454	hypothesize	_	
28-7	4455-4459	that	_	
28-8	4460-4463	SCZ	_	
28-9	4464-4472	patients	_	
28-10	4473-4476	may	_	
28-11	4477-4481	show	_	
28-12	4482-4489	reduced	_	
28-13	4490-4499	intrinsic	_	
28-14	4500-4510	motivation	_	
28-15	4511-4514	and	_	
28-16	4515-4519	also	_	
28-17	4520-4530	difficulty	_	
28-18	4531-4533	in	_	
28-19	4534-4545	translating	_	
28-20	4546-4557	information	_	
28-21	4558-4563	about	_	
28-22	4564-4575	potentially	_	
28-23	4576-4585	rewarding	_	
28-24	4586-4592	events	_	
28-25	4593-4597	into	_	
28-26	4598-4604	action	_	
28-27	4605-4610	plans	_	
28-28	4611-4614	due	_	
28-29	4615-4617	to	_	
28-30	4618-4627	cognitive	_	
28-31	4628-4635	control	_	
28-32	4636-4647	impairments	_	
28-33	4648-4658	associated	_	
28-34	4659-4663	with	_	
28-35	4664-4671	altered	_	
28-36	4672-4676	LPFC	_	
28-37	4677-4685	function	_	
28-38	4685-4686	.	_	

#Text=To test the above hypothesis, we used a timing task called the stopwatch (SW) task, which requires subjects to stop a stopwatch by pressing a button as close as possible to the 5-s time point.
29-1	4687-4689	To	_	
29-2	4690-4694	test	_	
29-3	4695-4698	the	_	
29-4	4699-4704	above	_	
29-5	4705-4715	hypothesis	_	
29-6	4715-4716	,	_	
29-7	4717-4719	we	_	
29-8	4720-4724	used	_	
29-9	4725-4726	a	_	
29-10	4727-4733	timing	_	
29-11	4734-4738	task	_	
29-12	4739-4745	called	_	
29-13	4746-4749	the	_	
29-14	4750-4759	stopwatch	_	
29-15	4760-4761	(	_	
29-16	4761-4763	SW	_	
29-17	4763-4764	)	_	
29-18	4765-4769	task	_	
29-19	4769-4770	,	_	
29-20	4771-4776	which	_	
29-21	4777-4785	requires	_	
29-22	4786-4794	subjects	_	
29-23	4795-4797	to	_	
29-24	4798-4802	stop	_	
29-25	4803-4804	a	_	
29-26	4805-4814	stopwatch	_	
29-27	4815-4817	by	_	
29-28	4818-4826	pressing	_	
29-29	4827-4828	a	_	
29-30	4829-4835	button	_	
29-31	4836-4838	as	_	
29-32	4839-4844	close	_	
29-33	4845-4847	as	_	
29-34	4848-4856	possible	_	
29-35	4857-4859	to	_	
29-36	4860-4863	the	_	
29-37	4864-4865	5	_	
29-38	4865-4866	-	_	
29-39	4866-4867	s	_	
29-40	4868-4872	time	_	
29-41	4873-4878	point	_	
29-42	4878-4879	.	_	

#Text=The control task required the subjects to passively view a stopwatch and simply press a button when it automatically stopped (watch-stop, WS).
30-1	4880-4883	The	_	
30-2	4884-4891	control	_	
30-3	4892-4896	task	_	
30-4	4897-4905	required	_	
30-5	4906-4909	the	_	
30-6	4910-4918	subjects	_	
30-7	4919-4921	to	_	
30-8	4922-4931	passively	_	
30-9	4932-4936	view	_	
30-10	4937-4938	a	_	
30-11	4939-4948	stopwatch	_	
30-12	4949-4952	and	_	
30-13	4953-4959	simply	_	
30-14	4960-4965	press	_	
30-15	4966-4967	a	_	
30-16	4968-4974	button	_	
30-17	4975-4979	when	_	
30-18	4980-4982	it	_	
30-19	4983-4996	automatically	_	
30-20	4997-5004	stopped	_	
30-21	5005-5006	(	_	
30-22	5006-5016	watch-stop	_	
30-23	5016-5017	,	_	
30-24	5018-5020	WS	_	
30-25	5020-5021	)	_	
30-26	5021-5022	.	_	

#Text=Although the main aim of the study by was to detect the undermining effects of monetary reward on intrinsic motivation in healthy populations, the authors also found that subjects without monetary reward were clearly more engaged in the SW task than in the WS task during the free choice period, which suggests that they were intrinsically motivated by the SW task.
31-1	5023-5031	Although	_	
31-2	5032-5035	the	_	
31-3	5036-5040	main	_	
31-4	5041-5044	aim	_	
31-5	5045-5047	of	_	
31-6	5048-5051	the	_	
31-7	5052-5057	study	_	
31-8	5058-5060	by	_	
31-9	5061-5064	was	_	
31-10	5065-5067	to	_	
31-11	5068-5074	detect	_	
31-12	5075-5078	the	_	
31-13	5079-5090	undermining	_	
31-14	5091-5098	effects	_	
31-15	5099-5101	of	_	
31-16	5102-5110	monetary	_	
31-17	5111-5117	reward	_	
31-18	5118-5120	on	_	
31-19	5121-5130	intrinsic	_	
31-20	5131-5141	motivation	_	
31-21	5142-5144	in	_	
31-22	5145-5152	healthy	_	
31-23	5153-5164	populations	_	
31-24	5164-5165	,	_	
31-25	5166-5169	the	_	
31-26	5170-5177	authors	_	
31-27	5178-5182	also	_	
31-28	5183-5188	found	_	
31-29	5189-5193	that	_	
31-30	5194-5202	subjects	_	
31-31	5203-5210	without	_	
31-32	5211-5219	monetary	_	
31-33	5220-5226	reward	_	
31-34	5227-5231	were	_	
31-35	5232-5239	clearly	_	
31-36	5240-5244	more	_	
31-37	5245-5252	engaged	_	
31-38	5253-5255	in	_	
31-39	5256-5259	the	_	
31-40	5260-5262	SW	_	
31-41	5263-5267	task	_	
31-42	5268-5272	than	_	
31-43	5273-5275	in	_	
31-44	5276-5279	the	_	
31-45	5280-5282	WS	_	
31-46	5283-5287	task	_	
31-47	5288-5294	during	_	
31-48	5295-5298	the	_	
31-49	5299-5303	free	_	
31-50	5304-5310	choice	_	
31-51	5311-5317	period	_	
31-52	5317-5318	,	_	
31-53	5319-5324	which	_	
31-54	5325-5333	suggests	_	
31-55	5334-5338	that	_	
31-56	5339-5343	they	_	
31-57	5344-5348	were	_	
31-58	5349-5362	intrinsically	_	
31-59	5363-5372	motivated	_	
31-60	5373-5375	by	_	
31-61	5376-5379	the	_	
31-62	5380-5382	SW	_	
31-63	5383-5387	task	_	
31-64	5387-5388	.	_	

#Text=In addition, they also reported that the anterior striatum and the LPFC were more activated by the SW task compared to the WS task using functional MRI, suggesting that the task may reveal a the neural mechanism related to intrinsic motivation in SCZ.
32-1	5389-5391	In	_	
32-2	5392-5400	addition	_	
32-3	5400-5401	,	_	
32-4	5402-5406	they	_	
32-5	5407-5411	also	_	
32-6	5412-5420	reported	_	
32-7	5421-5425	that	_	
32-8	5426-5429	the	_	
32-9	5430-5438	anterior	_	
32-10	5439-5447	striatum	_	
32-11	5448-5451	and	_	
32-12	5452-5455	the	_	
32-13	5456-5460	LPFC	_	
32-14	5461-5465	were	_	
32-15	5466-5470	more	_	
32-16	5471-5480	activated	_	
32-17	5481-5483	by	_	
32-18	5484-5487	the	_	
32-19	5488-5490	SW	_	
32-20	5491-5495	task	_	
32-21	5496-5504	compared	_	
32-22	5505-5507	to	_	
32-23	5508-5511	the	_	
32-24	5512-5514	WS	_	
32-25	5515-5519	task	_	
32-26	5520-5525	using	_	
32-27	5526-5536	functional	_	
32-28	5537-5540	MRI	_	
32-29	5540-5541	,	_	
32-30	5542-5552	suggesting	_	
32-31	5553-5557	that	_	
32-32	5558-5561	the	_	
32-33	5562-5566	task	_	
32-34	5567-5570	may	_	
32-35	5571-5577	reveal	_	
32-36	5578-5579	a	_	
32-37	5580-5583	the	_	
32-38	5584-5590	neural	_	
32-39	5591-5600	mechanism	_	
32-40	5601-5608	related	_	
32-41	5609-5611	to	_	
32-42	5612-5621	intrinsic	_	
32-43	5622-5632	motivation	_	
32-44	5633-5635	in	_	
32-45	5636-5639	SCZ	_	
32-46	5639-5640	.	_	

#Text=There is also supporting evidence for using a timing task to investigate the neural mechanism of motivation from animal studies. reported that schizophrenic model mice that selectively overexpress striatal dopamine D2 receptors showed both timing and motivational deficits, which suggests a common neural basis underlying both functions.
33-1	5641-5646	There	_	
33-2	5647-5649	is	_	
33-3	5650-5654	also	_	
33-4	5655-5665	supporting	_	
33-5	5666-5674	evidence	_	
33-6	5675-5678	for	_	
33-7	5679-5684	using	_	
33-8	5685-5686	a	_	
33-9	5687-5693	timing	_	
33-10	5694-5698	task	_	
33-11	5699-5701	to	_	
33-12	5702-5713	investigate	_	
33-13	5714-5717	the	_	
33-14	5718-5724	neural	_	
33-15	5725-5734	mechanism	_	
33-16	5735-5737	of	_	
33-17	5738-5748	motivation	_	
33-18	5749-5753	from	_	
33-19	5754-5760	animal	_	
33-20	5761-5768	studies	_	
33-21	5768-5769	.	_	
33-22	5770-5778	reported	_	
33-23	5779-5783	that	_	
33-24	5784-5797	schizophrenic	_	
33-25	5798-5803	model	_	
33-26	5804-5808	mice	_	
33-27	5809-5813	that	_	
33-28	5814-5825	selectively	_	
33-29	5826-5837	overexpress	_	
33-30	5838-5846	striatal	_	
33-31	5847-5855	dopamine	_	
33-32	5856-5858	D2	_	
33-33	5859-5868	receptors	_	
33-34	5869-5875	showed	_	
33-35	5876-5880	both	_	
33-36	5881-5887	timing	_	
33-37	5888-5891	and	_	
33-38	5892-5904	motivational	_	
33-39	5905-5913	deficits	_	
33-40	5913-5914	,	_	
33-41	5915-5920	which	_	
33-42	5921-5929	suggests	_	
33-43	5930-5931	a	_	
33-44	5932-5938	common	_	
33-45	5939-5945	neural	_	
33-46	5946-5951	basis	_	
33-47	5952-5962	underlying	_	
33-48	5963-5967	both	_	
33-49	5968-5977	functions	_	
33-50	5977-5978	.	_	

#Text=Although a free-choice behavior is useful for detecting intrinsic motivation directly, a self-report measure of intrinsic motivation based on cognitive evaluation theory, such as the Intrinsic Motivation Inventory (IMI) has been developed as a multidimensional self-report and used widely to assess motivational structures for targeted activities such as sports, school, medical procedures, and laboratory tasks.
34-1	5979-5987	Although	_	
34-2	5988-5989	a	_	
34-3	5990-6001	free-choice	_	
34-4	6002-6010	behavior	_	
34-5	6011-6013	is	_	
34-6	6014-6020	useful	_	
34-7	6021-6024	for	_	
34-8	6025-6034	detecting	_	
34-9	6035-6044	intrinsic	_	
34-10	6045-6055	motivation	_	
34-11	6056-6064	directly	_	
34-12	6064-6065	,	_	
34-13	6066-6067	a	_	
34-14	6068-6079	self-report	_	
34-15	6080-6087	measure	_	
34-16	6088-6090	of	_	
34-17	6091-6100	intrinsic	_	
34-18	6101-6111	motivation	_	
34-19	6112-6117	based	_	
34-20	6118-6120	on	_	
34-21	6121-6130	cognitive	_	
34-22	6131-6141	evaluation	_	
34-23	6142-6148	theory	_	
34-24	6148-6149	,	_	
34-25	6150-6154	such	_	
34-26	6155-6157	as	_	
34-27	6158-6161	the	_	
34-28	6162-6171	Intrinsic	_	
34-29	6172-6182	Motivation	_	
34-30	6183-6192	Inventory	_	
34-31	6193-6194	(	_	
34-32	6194-6197	IMI	_	
34-33	6197-6198	)	_	
34-34	6199-6202	has	_	
34-35	6203-6207	been	_	
34-36	6208-6217	developed	_	
34-37	6218-6220	as	_	
34-38	6221-6222	a	_	
34-39	6223-6239	multidimensional	_	
34-40	6240-6251	self-report	_	
34-41	6252-6255	and	_	
34-42	6256-6260	used	_	
34-43	6261-6267	widely	_	
34-44	6268-6270	to	_	
34-45	6271-6277	assess	_	
34-46	6278-6290	motivational	_	
34-47	6291-6301	structures	_	
34-48	6302-6305	for	_	
34-49	6306-6314	targeted	_	
34-50	6315-6325	activities	_	
34-51	6326-6330	such	_	
34-52	6331-6333	as	_	
34-53	6334-6340	sports	_	
34-54	6340-6341	,	_	
34-55	6342-6348	school	_	
34-56	6348-6349	,	_	
34-57	6350-6357	medical	_	
34-58	6358-6368	procedures	_	
34-59	6368-6369	,	_	
34-60	6370-6373	and	_	
34-61	6374-6384	laboratory	_	
34-62	6385-6390	tasks	_	
34-63	6390-6391	.	_	

#Text=According to the cognitive evaluation theory, events leading to greater perceived self-determination or perceived competence increase intrinsic motivation, whereas events that decrease perceived self-determination or competence lessen intrinsic motivation. developed an adapted version of the IMI for SCZ patients.
35-1	6392-6401	According	_	
35-2	6402-6404	to	_	
35-3	6405-6408	the	_	
35-4	6409-6418	cognitive	_	
35-5	6419-6429	evaluation	_	
35-6	6430-6436	theory	_	
35-7	6436-6437	,	_	
35-8	6438-6444	events	_	
35-9	6445-6452	leading	_	
35-10	6453-6455	to	_	
35-11	6456-6463	greater	_	
35-12	6464-6473	perceived	_	
35-13	6474-6492	self-determination	_	
35-14	6493-6495	or	_	
35-15	6496-6505	perceived	_	
35-16	6506-6516	competence	_	
35-17	6517-6525	increase	_	
35-18	6526-6535	intrinsic	_	
35-19	6536-6546	motivation	_	
35-20	6546-6547	,	_	
35-21	6548-6555	whereas	_	
35-22	6556-6562	events	_	
35-23	6563-6567	that	_	
35-24	6568-6576	decrease	_	
35-25	6577-6586	perceived	_	
35-26	6587-6605	self-determination	_	
35-27	6606-6608	or	_	
35-28	6609-6619	competence	_	
35-29	6620-6626	lessen	_	
35-30	6627-6636	intrinsic	_	
35-31	6637-6647	motivation	_	
35-32	6647-6648	.	_	
35-33	6649-6658	developed	_	
35-34	6659-6661	an	_	
35-35	6662-6669	adapted	_	
35-36	6670-6677	version	_	
35-37	6678-6680	of	_	
35-38	6681-6684	the	_	
35-39	6685-6688	IMI	_	
35-40	6689-6692	for	_	
35-41	6693-6696	SCZ	_	
35-42	6697-6705	patients	_	
35-43	6705-6706	.	_	

#Text=The IMI for SCZ has been shown to be responsive to manipulations made to a specific task or activity, and a target of intervention when modifying activity parameters to encourage greater engagement for that activity.
36-1	6707-6710	The	_	
36-2	6711-6714	IMI	_	
36-3	6715-6718	for	_	
36-4	6719-6722	SCZ	_	
36-5	6723-6726	has	_	
36-6	6727-6731	been	_	
36-7	6732-6737	shown	_	
36-8	6738-6740	to	_	
36-9	6741-6743	be	_	
36-10	6744-6754	responsive	_	
36-11	6755-6757	to	_	
36-12	6758-6771	manipulations	_	
36-13	6772-6776	made	_	
36-14	6777-6779	to	_	
36-15	6780-6781	a	_	
36-16	6782-6790	specific	_	
36-17	6791-6795	task	_	
36-18	6796-6798	or	_	
36-19	6799-6807	activity	_	
36-20	6807-6808	,	_	
36-21	6809-6812	and	_	
36-22	6813-6814	a	_	
36-23	6815-6821	target	_	
36-24	6822-6824	of	_	
36-25	6825-6837	intervention	_	
36-26	6838-6842	when	_	
36-27	6843-6852	modifying	_	
36-28	6853-6861	activity	_	
36-29	6862-6872	parameters	_	
36-30	6873-6875	to	_	
36-31	6876-6885	encourage	_	
36-32	6886-6893	greater	_	
36-33	6894-6904	engagement	_	
36-34	6905-6908	for	_	
36-35	6909-6913	that	_	
36-36	6914-6922	activity	_	
36-37	6922-6923	.	_	

#Text=These findings indicate that the IMI for SCZ is a valid measure of intrinsic motivation to perform a given task.
37-1	6924-6929	These	_	
37-2	6930-6938	findings	_	
37-3	6939-6947	indicate	_	
37-4	6948-6952	that	_	
37-5	6953-6956	the	_	
37-6	6957-6960	IMI	_	
37-7	6961-6964	for	_	
37-8	6965-6968	SCZ	_	
37-9	6969-6971	is	_	
37-10	6972-6973	a	_	
37-11	6974-6979	valid	_	
37-12	6980-6987	measure	_	
37-13	6988-6990	of	_	
37-14	6991-7000	intrinsic	_	
37-15	7001-7011	motivation	_	
37-16	7012-7014	to	_	
37-17	7015-7022	perform	_	
37-18	7023-7024	a	_	
37-19	7025-7030	given	_	
37-20	7031-7035	task	_	
37-21	7035-7036	.	_	

#Text=Behavioral task, performance, and IMI scores.
38-1	7037-7047	Behavioral	_	
38-2	7048-7052	task	_	
38-3	7052-7053	,	_	
38-4	7054-7065	performance	_	
38-5	7065-7066	,	_	
38-6	7067-7070	and	_	
38-7	7071-7074	IMI	_	
38-8	7075-7081	scores	_	
38-9	7081-7082	.	_	

#Text=(A) In the stopwatch (SW) task, participants were presented with a SW that starts automatically, and the goal is to press a button with the right thumb as close as possible to the 5-s time point.
39-1	7083-7084	(	_	
39-2	7084-7085	A	_	
39-3	7085-7086	)	_	
39-4	7087-7089	In	_	
39-5	7090-7093	the	_	
39-6	7094-7103	stopwatch	_	
39-7	7104-7105	(	_	
39-8	7105-7107	SW	_	
39-9	7107-7108	)	_	
39-10	7109-7113	task	_	
39-11	7113-7114	,	_	
39-12	7115-7127	participants	_	
39-13	7128-7132	were	_	
39-14	7133-7142	presented	_	
39-15	7143-7147	with	_	
39-16	7148-7149	a	_	
39-17	7150-7152	SW	_	
39-18	7153-7157	that	_	
39-19	7158-7164	starts	_	
39-20	7165-7178	automatically	_	
39-21	7178-7179	,	_	
39-22	7180-7183	and	_	
39-23	7184-7187	the	_	
39-24	7188-7192	goal	_	
39-25	7193-7195	is	_	
39-26	7196-7198	to	_	
39-27	7199-7204	press	_	
39-28	7205-7206	a	_	
39-29	7207-7213	button	_	
39-30	7214-7218	with	_	
39-31	7219-7222	the	_	
39-32	7223-7228	right	_	
39-33	7229-7234	thumb	_	
39-34	7235-7237	as	_	
39-35	7238-7243	close	_	
39-36	7244-7246	as	_	
39-37	7247-7255	possible	_	
39-38	7256-7258	to	_	
39-39	7259-7262	the	_	
39-40	7263-7264	5	_	
39-41	7264-7265	-	_	
39-42	7265-7266	s	_	
39-43	7267-7271	time	_	
39-44	7272-7277	point	_	
39-45	7277-7278	.	_	

#Text=The control task was a watch-stop (WS) task, in which participants passively viewed a SW and were asked to simply press a button when it automatically stopped.
40-1	7279-7282	The	_	
40-2	7283-7290	control	_	
40-3	7291-7295	task	_	
40-4	7296-7299	was	_	
40-5	7300-7301	a	_	
40-6	7302-7312	watch-stop	_	
40-7	7313-7314	(	_	
40-8	7314-7316	WS	_	
40-9	7316-7317	)	_	
40-10	7318-7322	task	_	
40-11	7322-7323	,	_	
40-12	7324-7326	in	_	
40-13	7327-7332	which	_	
40-14	7333-7345	participants	_	
40-15	7346-7355	passively	_	
40-16	7356-7362	viewed	_	
40-17	7363-7364	a	_	
40-18	7365-7367	SW	_	
40-19	7368-7371	and	_	
40-20	7372-7376	were	_	
40-21	7377-7382	asked	_	
40-22	7383-7385	to	_	
40-23	7386-7392	simply	_	
40-24	7393-7398	press	_	
40-25	7399-7400	a	_	
40-26	7401-7407	button	_	
40-27	7408-7412	when	_	
40-28	7413-7415	it	_	
40-29	7416-7429	automatically	_	
40-30	7430-7437	stopped	_	
40-31	7437-7438	.	_	

#Text=(B) Numbers of success trials in the SW task were not significantly different between groups (SCZ: 11.9, HC: 15.2, z = 1.58, p = 0.11, Mann-Whitney U test).
41-1	7439-7440	(	_	
41-2	7440-7441	B	_	
41-3	7441-7442	)	_	
41-4	7443-7450	Numbers	_	
41-5	7451-7453	of	_	
41-6	7454-7461	success	_	
41-7	7462-7468	trials	_	
41-8	7469-7471	in	_	
41-9	7472-7475	the	_	
41-10	7476-7478	SW	_	
41-11	7479-7483	task	_	
41-12	7484-7488	were	_	
41-13	7489-7492	not	_	
41-14	7493-7506	significantly	_	
41-15	7507-7516	different	_	
41-16	7517-7524	between	_	
41-17	7525-7531	groups	_	
41-18	7532-7533	(	_	
41-19	7533-7536	SCZ	_	
41-20	7536-7537	:	_	
41-21	7538-7542	11.9	_	
41-22	7542-7543	,	_	
41-23	7544-7546	HC	_	
41-24	7546-7547	:	_	
41-25	7548-7552	15.2	_	
41-26	7552-7553	,	_	
41-27	7554-7555	z	_	
41-28	7555-7556	 	_	
41-29	7556-7557	=	_	
41-30	7557-7558	 	_	
41-31	7558-7562	1.58	_	
41-32	7562-7563	,	_	
41-33	7564-7565	p	_	
41-34	7565-7566	 	_	
41-35	7566-7567	=	_	
41-36	7567-7568	 	_	
41-37	7568-7572	0.11	_	
41-38	7572-7573	,	_	
41-39	7574-7586	Mann-Whitney	_	
41-40	7587-7588	U	_	
41-41	7589-7593	test	_	
41-42	7593-7594	)	_	
41-43	7594-7595	.	_	

#Text=(C) The differences in IMI between SW and WS tasks showed a significant between-group difference suggesting that intrinsic motivation was lower in SCZ than in HC (SCZ: 2.9 ± 1.2, HC: 8.9 ± 2.1, z = 2.14, p = 0.03, Mann-Whitney U test, error bar: SEM). *: p < 0.05.
42-1	7596-7597	(	_	
42-2	7597-7598	C	_	
42-3	7598-7599	)	_	
42-4	7600-7603	The	_	
42-5	7604-7615	differences	_	
42-6	7616-7618	in	_	
42-7	7619-7622	IMI	_	
42-8	7623-7630	between	_	
42-9	7631-7633	SW	_	
42-10	7634-7637	and	_	
42-11	7638-7640	WS	_	
42-12	7641-7646	tasks	_	
42-13	7647-7653	showed	_	
42-14	7654-7655	a	_	
42-15	7656-7667	significant	_	
42-16	7668-7681	between-group	_	
42-17	7682-7692	difference	_	
42-18	7693-7703	suggesting	_	
42-19	7704-7708	that	_	
42-20	7709-7718	intrinsic	_	
42-21	7719-7729	motivation	_	
42-22	7730-7733	was	_	
42-23	7734-7739	lower	_	
42-24	7740-7742	in	_	
42-25	7743-7746	SCZ	_	
42-26	7747-7751	than	_	
42-27	7752-7754	in	_	
42-28	7755-7757	HC	_	
42-29	7758-7759	(	_	
42-30	7759-7762	SCZ	_	
42-31	7762-7763	:	_	
42-32	7764-7767	2.9	_	
42-33	7767-7768	 	_	
42-34	7768-7769	±	_	
42-35	7769-7770	 	_	
42-36	7770-7773	1.2	_	
42-37	7773-7774	,	_	
42-38	7775-7777	HC	_	
42-39	7777-7778	:	_	
42-40	7779-7782	8.9	_	
42-41	7782-7783	 	_	
42-42	7783-7784	±	_	
42-43	7784-7785	 	_	
42-44	7785-7788	2.1	_	
42-45	7788-7789	,	_	
42-46	7790-7791	z	_	
42-47	7791-7792	 	_	
42-48	7792-7793	=	_	
42-49	7793-7794	 	_	
42-50	7794-7798	2.14	_	
42-51	7798-7799	,	_	
42-52	7800-7801	p	_	
42-53	7801-7802	 	_	
42-54	7802-7803	=	_	
42-55	7803-7804	 	_	
42-56	7804-7808	0.03	_	
42-57	7808-7809	,	_	
42-58	7810-7822	Mann-Whitney	_	
42-59	7823-7824	U	_	
42-60	7825-7829	test	_	
42-61	7829-7830	,	_	
42-62	7831-7836	error	_	
42-63	7837-7840	bar	_	
42-64	7840-7841	:	_	
42-65	7842-7845	SEM	_	
42-66	7845-7846	)	_	
42-67	7846-7847	.	_	
42-68	7848-7849	*	_	
42-69	7849-7850	:	_	
42-70	7851-7852	p	_	
42-71	7852-7853	 	_	
42-72	7853-7854	<	_	
42-73	7854-7855	 	_	
42-74	7855-7859	0.05	_	
42-75	7859-7860	.	_	

#Text=Fig. 1
#Text=In the present study, we explored the neural mechanism of intrinsic motivation, which is a key element in psychiatric rehabilitation to enhance social functioning in SCZ.
43-1	7861-7864	Fig	_	
43-2	7864-7865	.	_	
43-3	7866-7867	1	_	
43-4	7868-7870	In	_	
43-5	7871-7874	the	_	
43-6	7875-7882	present	_	
43-7	7883-7888	study	_	
43-8	7888-7889	,	_	
43-9	7890-7892	we	_	
43-10	7893-7901	explored	_	
43-11	7902-7905	the	_	
43-12	7906-7912	neural	_	
43-13	7913-7922	mechanism	_	
43-14	7923-7925	of	_	
43-15	7926-7935	intrinsic	_	
43-16	7936-7946	motivation	_	
43-17	7946-7947	,	_	
43-18	7948-7953	which	_	
43-19	7954-7956	is	_	
43-20	7957-7958	a	_	
43-21	7959-7962	key	_	
43-22	7963-7970	element	_	
43-23	7971-7973	in	_	
43-24	7974-7985	psychiatric	_	
43-25	7986-8000	rehabilitation	_	
43-26	8001-8003	to	_	
43-27	8004-8011	enhance	_	
43-28	8012-8018	social	_	
43-29	8019-8030	functioning	_	
43-30	8031-8033	in	_	
43-31	8034-8037	SCZ	_	
43-32	8037-8038	.	_	

#Text=We recruited a population of SCZ patients who were clinically stable and were ready to participate in rehabilitation such as cognitive remediation therapy.
44-1	8039-8041	We	_	
44-2	8042-8051	recruited	_	
44-3	8052-8053	a	_	
44-4	8054-8064	population	_	
44-5	8065-8067	of	_	
44-6	8068-8071	SCZ	_	
44-7	8072-8080	patients	_	
44-8	8081-8084	who	_	
44-9	8085-8089	were	_	
44-10	8090-8100	clinically	_	
44-11	8101-8107	stable	_	
44-12	8108-8111	and	_	
44-13	8112-8116	were	_	
44-14	8117-8122	ready	_	
44-15	8123-8125	to	_	
44-16	8126-8137	participate	_	
44-17	8138-8140	in	_	
44-18	8141-8155	rehabilitation	_	
44-19	8156-8160	such	_	
44-20	8161-8163	as	_	
44-21	8164-8173	cognitive	_	
44-22	8174-8185	remediation	_	
44-23	8186-8193	therapy	_	
44-24	8193-8194	.	_	

#Text=To test whether the intrinsic motivation impairment in SCZ is associated with frontostriatal loop dysfunction, we focused on activity in the striatum and LPFC during a stopwatch task as described in (Fig. 1A).
45-1	8195-8197	To	_	
45-2	8198-8202	test	_	
45-3	8203-8210	whether	_	
45-4	8211-8214	the	_	
45-5	8215-8224	intrinsic	_	
45-6	8225-8235	motivation	_	
45-7	8236-8246	impairment	_	
45-8	8247-8249	in	_	
45-9	8250-8253	SCZ	_	
45-10	8254-8256	is	_	
45-11	8257-8267	associated	_	
45-12	8268-8272	with	_	
45-13	8273-8287	frontostriatal	_	
45-14	8288-8292	loop	_	
45-15	8293-8304	dysfunction	_	
45-16	8304-8305	,	_	
45-17	8306-8308	we	_	
45-18	8309-8316	focused	_	
45-19	8317-8319	on	_	
45-20	8320-8328	activity	_	
45-21	8329-8331	in	_	
45-22	8332-8335	the	_	
45-23	8336-8344	striatum	_	
45-24	8345-8348	and	_	
45-25	8349-8353	LPFC	_	
45-26	8354-8360	during	_	
45-27	8361-8362	a	_	
45-28	8363-8372	stopwatch	_	
45-29	8373-8377	task	_	
45-30	8378-8380	as	_	
45-31	8381-8390	described	_	
45-32	8391-8393	in	_	
45-33	8394-8395	(	_	
45-34	8395-8398	Fig	_	
45-35	8398-8399	.	_	
45-36	8400-8402	1A	_	
45-37	8402-8403	)	_	
45-38	8403-8404	.	_	

#Text=We also examined the neural correlates of the control of action accelerated by motivation, through detailed analyses of behavioral data in SCZ versus HC subjects during a SW task that elicits motivation.
46-1	8405-8407	We	_	
46-2	8408-8412	also	_	
46-3	8413-8421	examined	_	
46-4	8422-8425	the	_	
46-5	8426-8432	neural	_	
46-6	8433-8443	correlates	_	
46-7	8444-8446	of	_	
46-8	8447-8450	the	_	
46-9	8451-8458	control	_	
46-10	8459-8461	of	_	
46-11	8462-8468	action	_	
46-12	8469-8480	accelerated	_	
46-13	8481-8483	by	_	
46-14	8484-8494	motivation	_	
46-15	8494-8495	,	_	
46-16	8496-8503	through	_	
46-17	8504-8512	detailed	_	
46-18	8513-8521	analyses	_	
46-19	8522-8524	of	_	
46-20	8525-8535	behavioral	_	
46-21	8536-8540	data	_	
46-22	8541-8543	in	_	
46-23	8544-8547	SCZ	_	
46-24	8548-8554	versus	_	
46-25	8555-8557	HC	_	
46-26	8558-8566	subjects	_	
46-27	8567-8573	during	_	
46-28	8574-8575	a	_	
46-29	8576-8578	SW	_	
46-30	8579-8583	task	_	
46-31	8584-8588	that	_	
46-32	8589-8596	elicits	_	
46-33	8597-8607	motivation	_	
46-34	8607-8608	.	_	

#Text=Materials and methods
#Text=Participants
#Text=Subjects and demographics.
47-1	8609-8618	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
47-2	8619-8622	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
47-3	8623-8630	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
47-4	8631-8643	Participants	_	
47-5	8644-8652	Subjects	_	
47-6	8653-8656	and	_	
47-7	8657-8669	demographics	_	
47-8	8669-8670	.	_	

#Text=Table 1\t \t
#Text=\tSCZ\tHC\t \tNumbers\t18\t17\t \tSex (males)\t11\t10\t \tAge (mean ± SD)\t33.6 ± 7.7\t33.7 ± 8.3\t \tNumbers of left-handed\t2\t2\t \tEducated years⁎\t13.8 ± 1.8\t16.8 ± 1.6\t \tJART\t102.2 ± 6.8\t104.2 ± 10.1\t \tDuration of illness (year)\t8.7 ± 4.7\t\t \tDaily dosage (CP equivalent, mg/day)\t455.0 ± 251.7\t\t \tPANSS score\t\t\t \t Total\t43.4 ± 8.0\t\t \t Positive\t10.3 ± 3.7\t\t \t Negative\t12.1 ± 3.5\t\t \t General\t21.1 ± 3.4\t\t \tGAF score\t68.9 ± 12.4\t\t \t
#Text=Abbreviation: SCZ: schizophrenia; HC: healthy control; JART: Japanese Adult Reading Test; PANSS: Positive and Negative Syndrome Scale.
48-1	8671-8676	Table	_	
48-2	8677-8678	1	_	
48-3	8683-8686	SCZ	_	
48-4	8687-8689	HC	_	
48-5	8692-8699	Numbers	_	
48-6	8700-8702	18	_	
48-7	8703-8705	17	_	
48-8	8708-8711	Sex	_	
48-9	8712-8713	(	_	
48-10	8713-8718	males	_	
48-11	8718-8719	)	_	
48-12	8720-8722	11	_	
48-13	8723-8725	10	_	
48-14	8728-8731	Age	_	
48-15	8732-8733	(	_	
48-16	8733-8737	mean	_	
48-17	8737-8738	 	_	
48-18	8738-8739	±	_	
48-19	8739-8740	 	_	
48-20	8740-8742	SD	_	
48-21	8742-8743	)	_	
48-22	8744-8748	33.6	_	
48-23	8748-8749	 	_	
48-24	8749-8750	±	_	
48-25	8750-8751	 	_	
48-26	8751-8754	7.7	_	
48-27	8755-8759	33.7	_	
48-28	8759-8760	 	_	
48-29	8760-8761	±	_	
48-30	8761-8762	 	_	
48-31	8762-8765	8.3	_	
48-32	8768-8775	Numbers	_	
48-33	8776-8778	of	_	
48-34	8779-8790	left-handed	_	
48-35	8791-8792	2	_	
48-36	8793-8794	2	_	
48-37	8797-8805	Educated	_	
48-38	8806-8811	years	_	
48-39	8811-8812	⁎	_	
48-40	8813-8817	13.8	_	
48-41	8817-8818	 	_	
48-42	8818-8819	±	_	
48-43	8819-8820	 	_	
48-44	8820-8823	1.8	_	
48-45	8824-8828	16.8	_	
48-46	8828-8829	 	_	
48-47	8829-8830	±	_	
48-48	8830-8831	 	_	
48-49	8831-8834	1.6	_	
48-50	8837-8841	JART	_	
48-51	8842-8847	102.2	_	
48-52	8847-8848	 	_	
48-53	8848-8849	±	_	
48-54	8849-8850	 	_	
48-55	8850-8853	6.8	_	
48-56	8854-8859	104.2	_	
48-57	8859-8860	 	_	
48-58	8860-8861	±	_	
48-59	8861-8862	 	_	
48-60	8862-8866	10.1	_	
48-61	8869-8877	Duration	_	
48-62	8878-8880	of	_	
48-63	8881-8888	illness	_	
48-64	8889-8890	(	_	
48-65	8890-8894	year	_	
48-66	8894-8895	)	_	
48-67	8896-8899	8.7	_	
48-68	8899-8900	 	_	
48-69	8900-8901	±	_	
48-70	8901-8902	 	_	
48-71	8902-8905	4.7	_	
48-72	8909-8914	Daily	_	
48-73	8915-8921	dosage	_	
48-74	8922-8923	(	_	
48-75	8923-8925	CP	_	
48-76	8926-8936	equivalent	_	
48-77	8936-8937	,	_	
48-78	8938-8940	mg	_	
48-79	8940-8941	/	_	
48-80	8941-8944	day	_	
48-81	8944-8945	)	_	
48-82	8946-8951	455.0	_	
48-83	8951-8952	 	_	
48-84	8952-8953	±	_	
48-85	8953-8954	 	_	
48-86	8954-8959	251.7	_	
48-87	8963-8968	PANSS	_	
48-88	8969-8974	score	_	
48-89	8979-8980	 	_	
48-90	8980-8985	Total	_	
48-91	8986-8990	43.4	_	
48-92	8990-8991	 	_	
48-93	8991-8992	±	_	
48-94	8992-8993	 	_	
48-95	8993-8996	8.0	_	
48-96	9000-9001	 	_	
48-97	9001-9009	Positive	_	
48-98	9010-9014	10.3	_	
48-99	9014-9015	 	_	
48-100	9015-9016	±	_	
48-101	9016-9017	 	_	
48-102	9017-9020	3.7	_	
48-103	9024-9025	 	_	
48-104	9025-9033	Negative	_	
48-105	9034-9038	12.1	_	
48-106	9038-9039	 	_	
48-107	9039-9040	±	_	
48-108	9040-9041	 	_	
48-109	9041-9044	3.5	_	
48-110	9048-9049	 	_	
48-111	9049-9056	General	_	
48-112	9057-9061	21.1	_	
48-113	9061-9062	 	_	
48-114	9062-9063	±	_	
48-115	9063-9064	 	_	
48-116	9064-9067	3.4	_	
48-117	9071-9074	GAF	_	
48-118	9075-9080	score	_	
48-119	9081-9085	68.9	_	
48-120	9085-9086	 	_	
48-121	9086-9087	±	_	
48-122	9087-9088	 	_	
48-123	9088-9092	12.4	_	
48-124	9097-9109	Abbreviation	_	
48-125	9109-9110	:	_	
48-126	9111-9114	SCZ	_	
48-127	9114-9115	:	_	
48-128	9116-9129	schizophrenia	_	
48-129	9129-9130	;	_	
48-130	9131-9133	HC	_	
48-131	9133-9134	:	_	
48-132	9135-9142	healthy	_	
48-133	9143-9150	control	_	
48-134	9150-9151	;	_	
48-135	9152-9156	JART	_	
48-136	9156-9157	:	_	
48-137	9158-9166	Japanese	_	
48-138	9167-9172	Adult	_	
48-139	9173-9180	Reading	_	
48-140	9181-9185	Test	_	
48-141	9185-9186	;	_	
48-142	9187-9192	PANSS	_	
48-143	9192-9193	:	_	
48-144	9194-9202	Positive	_	
48-145	9203-9206	and	_	
48-146	9207-9215	Negative	_	
48-147	9216-9224	Syndrome	_	
48-148	9225-9230	Scale	_	
48-149	9230-9231	.	_	

#Text=Data in both groups are not significantly different except for the educated years (z = 3.84, p = 0.0001, Mann-Whitney U test).
49-1	9232-9236	Data	_	
49-2	9237-9239	in	_	
49-3	9240-9244	both	_	
49-4	9245-9251	groups	_	
49-5	9252-9255	are	_	
49-6	9256-9259	not	_	
49-7	9260-9273	significantly	_	
49-8	9274-9283	different	_	
49-9	9284-9290	except	_	
49-10	9291-9294	for	_	
49-11	9295-9298	the	_	
49-12	9299-9307	educated	_	
49-13	9308-9313	years	_	
49-14	9314-9315	(	_	
49-15	9315-9316	z	_	
49-16	9316-9317	 	_	
49-17	9317-9318	=	_	
49-18	9318-9319	 	_	
49-19	9319-9323	3.84	_	
49-20	9323-9324	,	_	
49-21	9325-9326	p	_	
49-22	9326-9327	 	_	
49-23	9327-9328	=	_	
49-24	9328-9329	 	_	
49-25	9329-9335	0.0001	_	
49-26	9335-9336	,	_	
49-27	9337-9349	Mann-Whitney	_	
49-28	9350-9351	U	_	
49-29	9352-9356	test	_	
49-30	9356-9357	)	_	
49-31	9357-9358	.	_	

#Text=Eighteen patients with SCZ diagnosed in accordance with the DSM-IV-TR criteria with mild symptomatology were recruited from outpatients of National Center Hospital, National Center of Neurology and Psychiatry (NCNP).
50-1	9359-9367	Eighteen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-2	9368-9376	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-3	9377-9381	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-4	9382-9385	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
50-5	9386-9395	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-6	9396-9398	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-7	9399-9409	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-8	9410-9414	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-9	9415-9418	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-10	9419-9428	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-11	9429-9437	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-12	9438-9442	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-13	9443-9447	mild	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-14	9448-9462	symptomatology	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-15	9463-9467	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-16	9468-9477	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-17	9478-9482	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-18	9483-9494	outpatients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-19	9495-9497	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-20	9498-9506	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-21	9507-9513	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-22	9514-9522	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-23	9522-9523	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-24	9524-9532	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-25	9533-9539	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-26	9540-9542	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-27	9543-9552	Neurology	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-28	9553-9556	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-29	9557-9567	Psychiatry	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-30	9568-9569	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-31	9569-9573	NCNP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-32	9573-9574	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
50-33	9574-9575	.	_	

#Text=All patients gave written informed consent.
51-1	9576-9579	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-2	9580-9588	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-3	9589-9593	gave	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-4	9594-9601	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-5	9602-9610	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-6	9611-9618	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
51-7	9618-9619	.	_	

#Text=The mean PANSS total score was 43.4 ± 8.0 and the mean duration of illness was 8.7 ± 4.7 years suggesting that the patients were clinically stable and treatment responsive considering the relatively short duration of illness.
52-1	9620-9623	The	_	
52-2	9624-9628	mean	_	
52-3	9629-9634	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale	
52-4	9635-9640	total	_	
52-5	9641-9646	score	_	
52-6	9647-9650	was	_	
52-7	9651-9655	43.4	_	
52-8	9655-9656	 	_	
52-9	9656-9657	±	_	
52-10	9657-9658	 	_	
52-11	9658-9661	8.0	_	
52-12	9662-9665	and	_	
52-13	9666-9669	the	_	
52-14	9670-9674	mean	_	
52-15	9675-9683	duration	_	
52-16	9684-9686	of	_	
52-17	9687-9694	illness	_	
52-18	9695-9698	was	_	
52-19	9699-9702	8.7	_	
52-20	9702-9703	 	_	
52-21	9703-9704	±	_	
52-22	9704-9705	 	_	
52-23	9705-9708	4.7	_	
52-24	9708-9709	 	_	
52-25	9709-9714	years	_	
52-26	9715-9725	suggesting	_	
52-27	9726-9730	that	_	
52-28	9731-9734	the	_	
52-29	9735-9743	patients	_	
52-30	9744-9748	were	_	
52-31	9749-9759	clinically	_	
52-32	9760-9766	stable	_	
52-33	9767-9770	and	_	
52-34	9771-9780	treatment	_	
52-35	9781-9791	responsive	_	
52-36	9792-9803	considering	_	
52-37	9804-9807	the	_	
52-38	9808-9818	relatively	_	
52-39	9819-9824	short	_	
52-40	9825-9833	duration	_	
52-41	9834-9836	of	_	
52-42	9837-9844	illness	_	
52-43	9844-9845	.	_	

#Text=Seventeen HC subjects, matched on age and sex and without any history of psychiatric and neurological illness, also consented to participate in the study.
53-1	9846-9855	Seventeen	_	
53-2	9856-9858	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
53-3	9859-9867	subjects	_	
53-4	9867-9868	,	_	
53-5	9869-9876	matched	_	
53-6	9877-9879	on	_	
53-7	9880-9883	age	_	
53-8	9884-9887	and	_	
53-9	9888-9891	sex	_	
53-10	9892-9895	and	_	
53-11	9896-9903	without	_	
53-12	9904-9907	any	_	
53-13	9908-9915	history	_	
53-14	9916-9918	of	_	
53-15	9919-9930	psychiatric	_	
53-16	9931-9934	and	_	
53-17	9935-9947	neurological	_	
53-18	9948-9955	illness	_	
53-19	9955-9956	,	_	
53-20	9957-9961	also	_	
53-21	9962-9971	consented	_	
53-22	9972-9974	to	_	
53-23	9975-9986	participate	_	
53-24	9987-9989	in	_	
53-25	9990-9993	the	_	
53-26	9994-9999	study	_	
53-27	9999-10000	.	_	

#Text=The study was approved by the ethical committee of NCNP.
54-1	10001-10004	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-2	10005-10010	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-3	10011-10014	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-4	10015-10023	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-5	10024-10026	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-6	10027-10030	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-7	10031-10038	ethical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-8	10039-10048	committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-9	10049-10051	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-10	10052-10056	NCNP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
54-11	10056-10057	.	_	

#Text=The demographic and clinical characteristics in both groups are shown in Table 1 and Supplementary Methods.
55-1	10058-10061	The	_	
55-2	10062-10073	demographic	_	
55-3	10074-10077	and	_	
55-4	10078-10086	clinical	_	
55-5	10087-10102	characteristics	_	
55-6	10103-10105	in	_	
55-7	10106-10110	both	_	
55-8	10111-10117	groups	_	
55-9	10118-10121	are	_	
55-10	10122-10127	shown	_	
55-11	10128-10130	in	_	
55-12	10131-10136	Table	_	
55-13	10137-10138	1	_	
55-14	10139-10142	and	_	
55-15	10143-10156	Supplementary	_	
55-16	10157-10164	Methods	_	
55-17	10164-10165	.	_	

#Text=Experimental task
#Text=In the stopwatch (SW) task, a SW depicted in the screen started automatically, and the goal was to press a button with the right thumb within 50 ms of the 5-s time point (Fig. 1A).
56-1	10166-10178	Experimental	_	
56-2	10179-10183	task	_	
56-3	10184-10186	In	_	
56-4	10187-10190	the	_	
56-5	10191-10200	stopwatch	_	
56-6	10201-10202	(	_	
56-7	10202-10204	SW	_	
56-8	10204-10205	)	_	
56-9	10206-10210	task	_	
56-10	10210-10211	,	_	
56-11	10212-10213	a	_	
56-12	10214-10216	SW	_	
56-13	10217-10225	depicted	_	
56-14	10226-10228	in	_	
56-15	10229-10232	the	_	
56-16	10233-10239	screen	_	
56-17	10240-10247	started	_	
56-18	10248-10261	automatically	_	
56-19	10261-10262	,	_	
56-20	10263-10266	and	_	
56-21	10267-10270	the	_	
56-22	10271-10275	goal	_	
56-23	10276-10279	was	_	
56-24	10280-10282	to	_	
56-25	10283-10288	press	_	
56-26	10289-10290	a	_	
56-27	10291-10297	button	_	
56-28	10298-10302	with	_	
56-29	10303-10306	the	_	
56-30	10307-10312	right	_	
56-31	10313-10318	thumb	_	
56-32	10319-10325	within	_	
56-33	10326-10328	50	_	
56-34	10328-10329	 	_	
56-35	10329-10331	ms	_	
56-36	10332-10334	of	_	
56-37	10335-10338	the	_	
56-38	10339-10340	5	_	
56-39	10340-10341	-	_	
56-40	10341-10342	s	_	
56-41	10343-10347	time	_	
56-42	10348-10353	point	_	
56-43	10354-10355	(	_	
56-44	10355-10358	Fig	_	
56-45	10358-10359	.	_	
56-46	10360-10362	1A	_	
56-47	10362-10363	)	_	
56-48	10363-10364	.	_	

#Text=The accumulated number of successful trials in the SW task was continuously presented at the upper right corner of the screen and was updated 1.5 s after the button press only when the participant succeeded in stopping the SW display between 4.95 s and 5.05 s.
57-1	10365-10368	The	_	
57-2	10369-10380	accumulated	_	
57-3	10381-10387	number	_	
57-4	10388-10390	of	_	
57-5	10391-10401	successful	_	
57-6	10402-10408	trials	_	
57-7	10409-10411	in	_	
57-8	10412-10415	the	_	
57-9	10416-10418	SW	_	
57-10	10419-10423	task	_	
57-11	10424-10427	was	_	
57-12	10428-10440	continuously	_	
57-13	10441-10450	presented	_	
57-14	10451-10453	at	_	
57-15	10454-10457	the	_	
57-16	10458-10463	upper	_	
57-17	10464-10469	right	_	
57-18	10470-10476	corner	_	
57-19	10477-10479	of	_	
57-20	10480-10483	the	_	
57-21	10484-10490	screen	_	
57-22	10491-10494	and	_	
57-23	10495-10498	was	_	
57-24	10499-10506	updated	_	
57-25	10507-10510	1.5	_	
57-26	10510-10511	 	_	
57-27	10511-10512	s	_	
57-28	10513-10518	after	_	
57-29	10519-10522	the	_	
57-30	10523-10529	button	_	
57-31	10530-10535	press	_	
57-32	10536-10540	only	_	
57-33	10541-10545	when	_	
57-34	10546-10549	the	_	
57-35	10550-10561	participant	_	
57-36	10562-10571	succeeded	_	
57-37	10572-10574	in	_	
57-38	10575-10583	stopping	_	
57-39	10584-10587	the	_	
57-40	10588-10590	SW	_	
57-41	10591-10598	display	_	
57-42	10599-10606	between	_	
57-43	10607-10611	4.95	_	
57-44	10611-10612	 	_	
57-45	10612-10613	s	_	
57-46	10614-10617	and	_	
57-47	10618-10622	5.05	_	
57-48	10622-10623	 	_	
57-49	10623-10624	s	_	
57-50	10624-10625	.	_	

#Text=The control task was a watch-stop (WS) task, in which participants passively viewed a SW and were asked to simply press a button when it automatically stopped.
58-1	10626-10629	The	_	
58-2	10630-10637	control	_	
58-3	10638-10642	task	_	
58-4	10643-10646	was	_	
58-5	10647-10648	a	_	
58-6	10649-10659	watch-stop	_	
58-7	10660-10661	(	_	
58-8	10661-10663	WS	_	
58-9	10663-10664	)	_	
58-10	10665-10669	task	_	
58-11	10669-10670	,	_	
58-12	10671-10673	in	_	
58-13	10674-10679	which	_	
58-14	10680-10692	participants	_	
58-15	10693-10702	passively	_	
58-16	10703-10709	viewed	_	
58-17	10710-10711	a	_	
58-18	10712-10714	SW	_	
58-19	10715-10718	and	_	
58-20	10719-10723	were	_	
58-21	10724-10729	asked	_	
58-22	10730-10732	to	_	
58-23	10733-10739	simply	_	
58-24	10740-10745	press	_	
58-25	10746-10747	a	_	
58-26	10748-10754	button	_	
58-27	10755-10759	when	_	
58-28	10760-10762	it	_	
58-29	10763-10776	automatically	_	
58-30	10777-10784	stopped	_	
58-31	10784-10785	.	_	

#Text=The SW task was considered more motivating than the WS task.
59-1	10786-10789	The	_	
59-2	10790-10792	SW	_	
59-3	10793-10797	task	_	
59-4	10798-10801	was	_	
59-5	10802-10812	considered	_	
59-6	10813-10817	more	_	
59-7	10818-10828	motivating	_	
59-8	10829-10833	than	_	
59-9	10834-10837	the	_	
59-10	10838-10840	WS	_	
59-11	10841-10845	task	_	
59-12	10845-10846	.	_	

#Text=A session consists of 30 SW and 30 WS trials, which were pseudorandomly intermixed and both tasks were preceded by a cue that indicates which of the two tasks will be displayed (Supplementary Methods).
60-1	10847-10848	A	_	
60-2	10849-10856	session	_	
60-3	10857-10865	consists	_	
60-4	10866-10868	of	_	
60-5	10869-10871	30	_	
60-6	10872-10874	SW	_	
60-7	10875-10878	and	_	
60-8	10879-10881	30	_	
60-9	10882-10884	WS	_	
60-10	10885-10891	trials	_	
60-11	10891-10892	,	_	
60-12	10893-10898	which	_	
60-13	10899-10903	were	_	
60-14	10904-10918	pseudorandomly	_	
60-15	10919-10929	intermixed	_	
60-16	10930-10933	and	_	
60-17	10934-10938	both	_	
60-18	10939-10944	tasks	_	
60-19	10945-10949	were	_	
60-20	10950-10958	preceded	_	
60-21	10959-10961	by	_	
60-22	10962-10963	a	_	
60-23	10964-10967	cue	_	
60-24	10968-10972	that	_	
60-25	10973-10982	indicates	_	
60-26	10983-10988	which	_	
60-27	10989-10991	of	_	
60-28	10992-10995	the	_	
60-29	10996-10999	two	_	
60-30	11000-11005	tasks	_	
60-31	11006-11010	will	_	
60-32	11011-11013	be	_	
60-33	11014-11023	displayed	_	
60-34	11024-11025	(	_	
60-35	11025-11038	Supplementary	_	
60-36	11039-11046	Methods	_	
60-37	11046-11047	)	_	
60-38	11047-11048	.	_	

#Text=Behavioral measures
#Text=To measure the participants' behavioral response properties, we obtained the reaction time (RT) in the WS task.
61-1	11049-11059	Behavioral	_	
61-2	11060-11068	measures	_	
61-3	11069-11071	To	_	
61-4	11072-11079	measure	_	
61-5	11080-11083	the	_	
61-6	11084-11096	participants	_	
61-7	11096-11097	'	_	
61-8	11098-11108	behavioral	_	
61-9	11109-11117	response	_	
61-10	11118-11128	properties	_	
61-11	11128-11129	,	_	
61-12	11130-11132	we	_	
61-13	11133-11141	obtained	_	
61-14	11142-11145	the	_	
61-15	11146-11154	reaction	_	
61-16	11155-11159	time	_	
61-17	11160-11161	(	_	
61-18	11161-11163	RT	_	
61-19	11163-11164	)	_	
61-20	11165-11167	in	_	
61-21	11168-11171	the	_	
61-22	11172-11174	WS	_	
61-23	11175-11179	task	_	
61-24	11179-11180	.	_	

#Text=The RT in the WS trial was the period from the time that the stopwatch automatically stopped to when the participant pressed the button (always positive because button press was not allowed before the stopwatch stopped).
62-1	11181-11184	The	_	
62-2	11185-11187	RT	_	
62-3	11188-11190	in	_	
62-4	11191-11194	the	_	
62-5	11195-11197	WS	_	
62-6	11198-11203	trial	_	
62-7	11204-11207	was	_	
62-8	11208-11211	the	_	
62-9	11212-11218	period	_	
62-10	11219-11223	from	_	
62-11	11224-11227	the	_	
62-12	11228-11232	time	_	
62-13	11233-11237	that	_	
62-14	11238-11241	the	_	
62-15	11242-11251	stopwatch	_	
62-16	11252-11265	automatically	_	
62-17	11266-11273	stopped	_	
62-18	11274-11276	to	_	
62-19	11277-11281	when	_	
62-20	11282-11285	the	_	
62-21	11286-11297	participant	_	
62-22	11298-11305	pressed	_	
62-23	11306-11309	the	_	
62-24	11310-11316	button	_	
62-25	11317-11318	(	_	
62-26	11318-11324	always	_	
62-27	11325-11333	positive	_	
62-28	11334-11341	because	_	
62-29	11342-11348	button	_	
62-30	11349-11354	press	_	
62-31	11355-11358	was	_	
62-32	11359-11362	not	_	
62-33	11363-11370	allowed	_	
62-34	11371-11377	before	_	
62-35	11378-11381	the	_	
62-36	11382-11391	stopwatch	_	
62-37	11392-11399	stopped	_	
62-38	11399-11400	)	_	
62-39	11400-11401	.	_	

#Text=On the other hand, in the SW task, we calculated the Timing Error (TE).
63-1	11402-11404	On	_	
63-2	11405-11408	the	_	
63-3	11409-11414	other	_	
63-4	11415-11419	hand	_	
63-5	11419-11420	,	_	
63-6	11421-11423	in	_	
63-7	11424-11427	the	_	
63-8	11428-11430	SW	_	
63-9	11431-11435	task	_	
63-10	11435-11436	,	_	
63-11	11437-11439	we	_	
63-12	11440-11450	calculated	_	
63-13	11451-11454	the	_	
63-14	11455-11461	Timing	_	
63-15	11462-11467	Error	_	
63-16	11468-11469	(	_	
63-17	11469-11471	TE	_	
63-18	11471-11472	)	_	
63-19	11472-11473	.	_	

#Text=The TE in the SW trial was defined as the time from 5.00 s (ideal time to be stopped) to when the participant pressed the button to stop the stopwatch (positive TE for stopped time of > 5.00 s, and negative TE for stopped time of < 5.00 s).
64-1	11474-11477	The	_	
64-2	11478-11480	TE	_	
64-3	11481-11483	in	_	
64-4	11484-11487	the	_	
64-5	11488-11490	SW	_	
64-6	11491-11496	trial	_	
64-7	11497-11500	was	_	
64-8	11501-11508	defined	_	
64-9	11509-11511	as	_	
64-10	11512-11515	the	_	
64-11	11516-11520	time	_	
64-12	11521-11525	from	_	
64-13	11526-11530	5.00	_	
64-14	11530-11531	 	_	
64-15	11531-11532	s	_	
64-16	11533-11534	(	_	
64-17	11534-11539	ideal	_	
64-18	11540-11544	time	_	
64-19	11545-11547	to	_	
64-20	11548-11550	be	_	
64-21	11551-11558	stopped	_	
64-22	11558-11559	)	_	
64-23	11560-11562	to	_	
64-24	11563-11567	when	_	
64-25	11568-11571	the	_	
64-26	11572-11583	participant	_	
64-27	11584-11591	pressed	_	
64-28	11592-11595	the	_	
64-29	11596-11602	button	_	
64-30	11603-11605	to	_	
64-31	11606-11610	stop	_	
64-32	11611-11614	the	_	
64-33	11615-11624	stopwatch	_	
64-34	11625-11626	(	_	
64-35	11626-11634	positive	_	
64-36	11635-11637	TE	_	
64-37	11638-11641	for	_	
64-38	11642-11649	stopped	_	
64-39	11650-11654	time	_	
64-40	11655-11657	of	_	
64-41	11658-11659	>	_	
64-42	11659-11660	 	_	
64-43	11660-11664	5.00	_	
64-44	11664-11665	 	_	
64-45	11665-11666	s	_	
64-46	11666-11667	,	_	
64-47	11668-11671	and	_	
64-48	11672-11680	negative	_	
64-49	11681-11683	TE	_	
64-50	11684-11687	for	_	
64-51	11688-11695	stopped	_	
64-52	11696-11700	time	_	
64-53	11701-11703	of	_	
64-54	11704-11705	<	_	
64-55	11705-11706	 	_	
64-56	11706-11710	5.00	_	
64-57	11710-11711	 	_	
64-58	11711-11712	s	_	
64-59	11712-11713	)	_	
64-60	11713-11714	.	_	

#Text=Also, to measure how quickly or slowly the participants pressed the button in erroneous SW trials, we classified the erroneous SW trials into two types: Undershoot for the trial with TE < − 0.05 s (i.e. the stopped time < 4.95 s) and Overshoot for the trial with TE > + 0.05 s (i.e. the stopped time > 5.05 s), and averaged the TE s for Undershoot and Overshoot trials separately.
65-1	11715-11719	Also	_	
65-2	11719-11720	,	_	
65-3	11721-11723	to	_	
65-4	11724-11731	measure	_	
65-5	11732-11735	how	_	
65-6	11736-11743	quickly	_	
65-7	11744-11746	or	_	
65-8	11747-11753	slowly	_	
65-9	11754-11757	the	_	
65-10	11758-11770	participants	_	
65-11	11771-11778	pressed	_	
65-12	11779-11782	the	_	
65-13	11783-11789	button	_	
65-14	11790-11792	in	_	
65-15	11793-11802	erroneous	_	
65-16	11803-11805	SW	_	
65-17	11806-11812	trials	_	
65-18	11812-11813	,	_	
65-19	11814-11816	we	_	
65-20	11817-11827	classified	_	
65-21	11828-11831	the	_	
65-22	11832-11841	erroneous	_	
65-23	11842-11844	SW	_	
65-24	11845-11851	trials	_	
65-25	11852-11856	into	_	
65-26	11857-11860	two	_	
65-27	11861-11866	types	_	
65-28	11866-11867	:	_	
65-29	11868-11878	Undershoot	_	
65-30	11879-11882	for	_	
65-31	11883-11886	the	_	
65-32	11887-11892	trial	_	
65-33	11893-11897	with	_	
65-34	11898-11900	TE	_	
65-35	11900-11901	 	_	
65-36	11901-11902	<	_	
65-37	11902-11903	 	_	
65-38	11903-11904	−	_	
65-39	11904-11905	 	_	
65-40	11905-11909	0.05	_	
65-41	11909-11910	 	_	
65-42	11910-11911	s	_	
65-43	11912-11913	(	_	
65-44	11913-11916	i.e	_	
65-45	11916-11917	.	_	
65-46	11918-11921	the	_	
65-47	11922-11929	stopped	_	
65-48	11930-11934	time	_	
65-49	11934-11935	 	_	
65-50	11935-11936	<	_	
65-51	11936-11937	 	_	
65-52	11937-11941	4.95	_	
65-53	11941-11942	 	_	
65-54	11942-11943	s	_	
65-55	11943-11944	)	_	
65-56	11945-11948	and	_	
65-57	11949-11958	Overshoot	_	
65-58	11959-11962	for	_	
65-59	11963-11966	the	_	
65-60	11967-11972	trial	_	
65-61	11973-11977	with	_	
65-62	11978-11980	TE	_	
65-63	11980-11981	 	_	
65-64	11981-11982	>	_	
65-65	11982-11983	 	_	
65-66	11983-11984	+	_	
65-67	11984-11985	 	_	
65-68	11985-11989	0.05	_	
65-69	11989-11990	 	_	
65-70	11990-11991	s	_	
65-71	11992-11993	(	_	
65-72	11993-11996	i.e	_	
65-73	11996-11997	.	_	
65-74	11998-12001	the	_	
65-75	12002-12009	stopped	_	
65-76	12010-12014	time	_	
65-77	12014-12015	 	_	
65-78	12015-12016	>	_	
65-79	12016-12017	 	_	
65-80	12017-12021	5.05	_	
65-81	12021-12022	 	_	
65-82	12022-12023	s	_	
65-83	12023-12024	)	_	
65-84	12024-12025	,	_	
65-85	12026-12029	and	_	
65-86	12030-12038	averaged	_	
65-87	12039-12042	the	_	
65-88	12043-12045	TE	_	
65-89	12046-12047	s	_	
65-90	12048-12051	for	_	
65-91	12052-12062	Undershoot	_	
65-92	12063-12066	and	_	
65-93	12067-12076	Overshoot	_	
65-94	12077-12083	trials	_	
65-95	12084-12094	separately	_	
65-96	12094-12095	.	_	

#Text=Furthermore, to examine whether the TE correction following Undershoot or Overshoot trials in SCZ was appropriate or not, we compared the performance levels in the SW trials following Undershoot or Overshoot trials between SCZ and HC.
66-1	12096-12107	Furthermore	_	
66-2	12107-12108	,	_	
66-3	12109-12111	to	_	
66-4	12112-12119	examine	_	
66-5	12120-12127	whether	_	
66-6	12128-12131	the	_	
66-7	12132-12134	TE	_	
66-8	12135-12145	correction	_	
66-9	12146-12155	following	_	
66-10	12156-12166	Undershoot	_	
66-11	12167-12169	or	_	
66-12	12170-12179	Overshoot	_	
66-13	12180-12186	trials	_	
66-14	12187-12189	in	_	
66-15	12190-12193	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
66-16	12194-12197	was	_	
66-17	12198-12209	appropriate	_	
66-18	12210-12212	or	_	
66-19	12213-12216	not	_	
66-20	12216-12217	,	_	
66-21	12218-12220	we	_	
66-22	12221-12229	compared	_	
66-23	12230-12233	the	_	
66-24	12234-12245	performance	_	
66-25	12246-12252	levels	_	
66-26	12253-12255	in	_	
66-27	12256-12259	the	_	
66-28	12260-12262	SW	_	
66-29	12263-12269	trials	_	
66-30	12270-12279	following	_	
66-31	12280-12290	Undershoot	_	
66-32	12291-12293	or	_	
66-33	12294-12303	Overshoot	_	
66-34	12304-12310	trials	_	
66-35	12311-12318	between	_	
66-36	12319-12322	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
66-37	12323-12326	and	_	
66-38	12327-12329	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
66-39	12329-12330	.	_	

#Text=The rate of Success, Undershoot and Overshoot SW trials following an Undershoot or Overshoot trial was calculated by averaging the rates from each participant in each group.
67-1	12331-12334	The	_	
67-2	12335-12339	rate	_	
67-3	12340-12342	of	_	
67-4	12343-12350	Success	_	
67-5	12350-12351	,	_	
67-6	12352-12362	Undershoot	_	
67-7	12363-12366	and	_	
67-8	12367-12376	Overshoot	_	
67-9	12377-12379	SW	_	
67-10	12380-12386	trials	_	
67-11	12387-12396	following	_	
67-12	12397-12399	an	_	
67-13	12400-12410	Undershoot	_	
67-14	12411-12413	or	_	
67-15	12414-12423	Overshoot	_	
67-16	12424-12429	trial	_	
67-17	12430-12433	was	_	
67-18	12434-12444	calculated	_	
67-19	12445-12447	by	_	
67-20	12448-12457	averaging	_	
67-21	12458-12461	the	_	
67-22	12462-12467	rates	_	
67-23	12468-12472	from	_	
67-24	12473-12477	each	_	
67-25	12478-12489	participant	_	
67-26	12490-12492	in	_	
67-27	12493-12497	each	_	
67-28	12498-12503	group	_	
67-29	12503-12504	.	_	

#Text=For each participant, we calculated the rates by dividing the number SW trials per type (Success, Undershoot or Overshoot) following an Undershoot or Overshoot trial by the total number of Undershoot or Overshoot trials.
68-1	12505-12508	For	_	
68-2	12509-12513	each	_	
68-3	12514-12525	participant	_	
68-4	12525-12526	,	_	
68-5	12527-12529	we	_	
68-6	12530-12540	calculated	_	
68-7	12541-12544	the	_	
68-8	12545-12550	rates	_	
68-9	12551-12553	by	_	
68-10	12554-12562	dividing	_	
68-11	12563-12566	the	_	
68-12	12567-12573	number	_	
68-13	12574-12576	SW	_	
68-14	12577-12583	trials	_	
68-15	12584-12587	per	_	
68-16	12588-12592	type	_	
68-17	12593-12594	(	_	
68-18	12594-12601	Success	_	
68-19	12601-12602	,	_	
68-20	12603-12613	Undershoot	_	
68-21	12614-12616	or	_	
68-22	12617-12626	Overshoot	_	
68-23	12626-12627	)	_	
68-24	12628-12637	following	_	
68-25	12638-12640	an	_	
68-26	12641-12651	Undershoot	_	
68-27	12652-12654	or	_	
68-28	12655-12664	Overshoot	_	
68-29	12665-12670	trial	_	
68-30	12671-12673	by	_	
68-31	12674-12677	the	_	
68-32	12678-12683	total	_	
68-33	12684-12690	number	_	
68-34	12691-12693	of	_	
68-35	12694-12704	Undershoot	_	
68-36	12705-12707	or	_	
68-37	12708-12717	Overshoot	_	
68-38	12718-12724	trials	_	
68-39	12724-12725	.	_	

#Text=Measurement of intrinsic motivation
#Text=In order to assess each participant's intrinsic motivation for each task, we used the intrinsic motivation inventory (IMI) developed by.
69-1	12726-12737	Measurement	_	
69-2	12738-12740	of	_	
69-3	12741-12750	intrinsic	_	
69-4	12751-12761	motivation	_	
69-5	12762-12764	In	_	
69-6	12765-12770	order	_	
69-7	12771-12773	to	_	
69-8	12774-12780	assess	_	
69-9	12781-12785	each	_	
69-10	12786-12799	participant's	_	
69-11	12800-12809	intrinsic	_	
69-12	12810-12820	motivation	_	
69-13	12821-12824	for	_	
69-14	12825-12829	each	_	
69-15	12830-12834	task	_	
69-16	12834-12835	,	_	
69-17	12836-12838	we	_	
69-18	12839-12843	used	_	
69-19	12844-12847	the	_	
69-20	12848-12857	intrinsic	_	
69-21	12858-12868	motivation	_	
69-22	12869-12878	inventory	_	
69-23	12879-12880	(	_	
69-24	12880-12883	IMI	_	
69-25	12883-12884	)	_	
69-26	12885-12894	developed	_	
69-27	12895-12897	by	_	
69-28	12897-12898	.	_	

#Text=IMI is a self-reported questionnaire, which consists of 21 questions on a seven-point Likert scale for each task.
70-1	12899-12902	IMI	_	
70-2	12903-12905	is	_	
70-3	12906-12907	a	_	
70-4	12908-12921	self-reported	_	
70-5	12922-12935	questionnaire	_	
70-6	12935-12936	,	_	
70-7	12937-12942	which	_	
70-8	12943-12951	consists	_	
70-9	12952-12954	of	_	
70-10	12955-12957	21	_	
70-11	12958-12967	questions	_	
70-12	12968-12970	on	_	
70-13	12971-12972	a	_	
70-14	12973-12984	seven-point	_	
70-15	12985-12991	Likert	_	
70-16	12992-12997	scale	_	
70-17	12998-13001	for	_	
70-18	13002-13006	each	_	
70-19	13007-13011	task	_	
70-20	13011-13012	.	_	

#Text=IMI provides three subscales, “interest and enjoyment”, “choice” and “value”, which are calculated from the corresponding 7 questions.
71-1	13013-13016	IMI	_	
71-2	13017-13025	provides	_	
71-3	13026-13031	three	_	
71-4	13032-13041	subscales	_	
71-5	13041-13042	,	_	
71-6	13043-13044	“	_	
71-7	13044-13052	interest	_	
71-8	13053-13056	and	_	
71-9	13057-13066	enjoyment	_	
71-10	13066-13067	”	_	
71-11	13067-13068	,	_	
71-12	13069-13070	“	_	
71-13	13070-13076	choice	_	
71-14	13076-13077	”	_	
71-15	13078-13081	and	_	
71-16	13082-13083	“	_	
71-17	13083-13088	value	_	
71-18	13088-13089	”	_	
71-19	13089-13090	,	_	
71-20	13091-13096	which	_	
71-21	13097-13100	are	_	
71-22	13101-13111	calculated	_	
71-23	13112-13116	from	_	
71-24	13117-13120	the	_	
71-25	13121-13134	corresponding	_	
71-26	13135-13136	7	_	
71-27	13137-13146	questions	_	
71-28	13146-13147	.	_	

#Text=In this study, subscale scores of “choice” were excluded from the IMI scores as the task was not of free choice.
72-1	13148-13150	In	_	
72-2	13151-13155	this	_	
72-3	13156-13161	study	_	
72-4	13161-13162	,	_	
72-5	13163-13171	subscale	_	
72-6	13172-13178	scores	_	
72-7	13179-13181	of	_	
72-8	13182-13183	“	_	
72-9	13183-13189	choice	_	
72-10	13189-13190	”	_	
72-11	13191-13195	were	_	
72-12	13196-13204	excluded	_	
72-13	13205-13209	from	_	
72-14	13210-13213	the	_	
72-15	13214-13217	IMI	_	
72-16	13218-13224	scores	_	
72-17	13225-13227	as	_	
72-18	13228-13231	the	_	
72-19	13232-13236	task	_	
72-20	13237-13240	was	_	
72-21	13241-13244	not	_	
72-22	13245-13247	of	_	
72-23	13248-13252	free	_	
72-24	13253-13259	choice	_	
72-25	13259-13260	.	_	

#Text=We considered the summed score of “interest and enjoyment” and “value” for SW task as a measure of intrinsic motivation after subtracting the summed score for the control (WS) task.
73-1	13261-13263	We	_	
73-2	13264-13274	considered	_	
73-3	13275-13278	the	_	
73-4	13279-13285	summed	_	
73-5	13286-13291	score	_	
73-6	13292-13294	of	_	
73-7	13295-13296	“	_	
73-8	13296-13304	interest	_	
73-9	13305-13308	and	_	
73-10	13309-13318	enjoyment	_	
73-11	13318-13319	”	_	
73-12	13320-13323	and	_	
73-13	13324-13325	“	_	
73-14	13325-13330	value	_	
73-15	13330-13331	”	_	
73-16	13332-13335	for	_	
73-17	13336-13338	SW	_	
73-18	13339-13343	task	_	
73-19	13344-13346	as	_	
73-20	13347-13348	a	_	
73-21	13349-13356	measure	_	
73-22	13357-13359	of	_	
73-23	13360-13369	intrinsic	_	
73-24	13370-13380	motivation	_	
73-25	13381-13386	after	_	
73-26	13387-13398	subtracting	_	
73-27	13399-13402	the	_	
73-28	13403-13409	summed	_	
73-29	13410-13415	score	_	
73-30	13416-13419	for	_	
73-31	13420-13423	the	_	
73-32	13424-13431	control	_	
73-33	13432-13433	(	_	
73-34	13433-13435	WS	_	
73-35	13435-13436	)	_	
73-36	13437-13441	task	_	
73-37	13441-13442	.	_	

#Text=Scan procedure, MRI data acquisition
#Text=All functional and structural MRI data were collected using a 3-T Verio MRI scanner (Siemens) with the 32-channel head coil at the Integrative Brain Imaging Center, NCNP.
74-1	13443-13447	Scan	_	
74-2	13448-13457	procedure	_	
74-3	13457-13458	,	_	
74-4	13459-13462	MRI	_	
74-5	13463-13467	data	_	
74-6	13468-13479	acquisition	_	
74-7	13480-13483	All	_	
74-8	13484-13494	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[9]	
74-9	13495-13498	and	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[9]	
74-10	13499-13509	structural	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[9]	
74-11	13510-13513	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[9]	
74-12	13514-13518	data	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[9]	
74-13	13519-13523	were	_	
74-14	13524-13533	collected	_	
74-15	13534-13539	using	_	
74-16	13540-13541	a	_	
74-17	13542-13543	3	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-18	13543-13544	-	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-19	13544-13545	T	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-20	13546-13551	Verio	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-21	13552-13555	MRI	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-22	13556-13563	scanner	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-23	13564-13565	(	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-24	13565-13572	Siemens	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-25	13572-13573	)	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[10]	
74-26	13574-13578	with	_	
74-27	13579-13582	the	_	
74-28	13583-13585	32	_	
74-29	13585-13586	-	_	
74-30	13586-13593	channel	_	
74-31	13594-13598	head	_	
74-32	13599-13603	coil	_	
74-33	13604-13606	at	_	
74-34	13607-13610	the	_	
74-35	13611-13622	Integrative	_	
74-36	13623-13628	Brain	_	
74-37	13629-13636	Imaging	_	
74-38	13637-13643	Center	_	
74-39	13643-13644	,	_	
74-40	13645-13649	NCNP	_	
74-41	13649-13650	.	_	

#Text=Firstly, the following parameters were used for high-resolution T1-weighted volumetric 3D (3DT1-weighted) images axially: repetition time (TR)/echo time (TE) = 2300/2.95 ms, 256 × 256 matrix, 9° flip angle, voxel size = 1.1 × 1.1 × 1.2 mm3 and 176 slices without inter-slice gap.
75-1	13651-13658	Firstly	_	
75-2	13658-13659	,	_	
75-3	13660-13663	the	_	
75-4	13664-13673	following	_	
75-5	13674-13684	parameters	_	
75-6	13685-13689	were	_	
75-7	13690-13694	used	_	
75-8	13695-13698	for	_	
75-9	13699-13714	high-resolution	_	
75-10	13715-13717	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
75-11	13717-13718	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
75-12	13718-13726	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[11]	
75-13	13727-13737	volumetric	_	
75-14	13738-13740	3D	_	
75-15	13741-13742	(	_	
75-16	13742-13746	3DT1	_	
75-17	13746-13747	-	_	
75-18	13747-13755	weighted	_	
75-19	13755-13756	)	_	
75-20	13757-13763	images	_	
75-21	13764-13771	axially	_	
75-22	13771-13772	:	_	
75-23	13773-13783	repetition	_	
75-24	13784-13788	time	_	
75-25	13789-13790	(	_	
75-26	13790-13792	TR	_	
75-27	13792-13793	)	_	
75-28	13793-13794	/	_	
75-29	13794-13798	echo	_	
75-30	13799-13803	time	_	
75-31	13804-13805	(	_	
75-32	13805-13807	TE	_	
75-33	13807-13808	)	_	
75-34	13808-13809	 	_	
75-35	13809-13810	=	_	
75-36	13810-13811	 	_	
75-37	13811-13815	2300	_	
75-38	13815-13816	/	_	
75-39	13816-13820	2.95	_	
75-40	13820-13821	 	_	
75-41	13821-13823	ms	_	
75-42	13823-13824	,	_	
75-43	13825-13828	256	_	
75-44	13828-13829	 	_	
75-45	13829-13830	×	_	
75-46	13830-13831	 	_	
75-47	13831-13834	256	_	
75-48	13835-13841	matrix	_	
75-49	13841-13842	,	_	
75-50	13843-13844	9	_	
75-51	13844-13845	°	_	
75-52	13846-13850	flip	_	
75-53	13851-13856	angle	_	
75-54	13856-13857	,	_	
75-55	13858-13863	voxel	_	
75-56	13864-13868	size	_	
75-57	13868-13869	 	_	
75-58	13869-13870	=	_	
75-59	13870-13871	 	_	
75-60	13871-13874	1.1	_	
75-61	13874-13875	 	_	
75-62	13875-13876	×	_	
75-63	13876-13877	 	_	
75-64	13877-13880	1.1	_	
75-65	13880-13881	 	_	
75-66	13881-13882	×	_	
75-67	13882-13883	 	_	
75-68	13883-13886	1.2	_	
75-69	13886-13887	 	_	
75-70	13887-13890	mm3	_	
75-71	13891-13894	and	_	
75-72	13895-13898	176	_	
75-73	13899-13905	slices	_	
75-74	13906-13913	without	_	
75-75	13914-13925	inter-slice	_	
75-76	13926-13929	gap	_	
75-77	13929-13930	.	_	

#Text=Second, functional imaging—gradient echo, T2*-weighted echo-planar images (EPI) with blood oxygenation level-dependent (BOLD) contrast—were acquired during the SW and WS tasks.
76-1	13931-13937	Second	_	
76-2	13937-13938	,	_	
76-3	13939-13949	functional	_	
76-4	13950-13966	imaging—gradient	_	
76-5	13967-13971	echo	_	
76-6	13971-13972	,	_	
76-7	13973-13975	T2	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[12]	
76-8	13975-13976	*	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[12]	
76-9	13976-13977	-	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[12]	
76-10	13977-13985	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging[12]	
76-11	13986-13997	echo-planar	_	
76-12	13998-14004	images	_	
76-13	14005-14006	(	_	
76-14	14006-14009	EPI	_	
76-15	14009-14010	)	_	
76-16	14011-14015	with	_	
76-17	14016-14021	blood	_	
76-18	14022-14033	oxygenation	_	
76-19	14034-14049	level-dependent	_	
76-20	14050-14051	(	_	
76-21	14051-14055	BOLD	_	
76-22	14055-14056	)	_	
76-23	14057-14070	contrast—were	_	
76-24	14071-14079	acquired	_	
76-25	14080-14086	during	_	
76-26	14087-14090	the	_	
76-27	14091-14093	SW	_	
76-28	14094-14097	and	_	
76-29	14098-14100	WS	_	
76-30	14101-14106	tasks	_	
76-31	14106-14107	.	_	

#Text=Forty-two contiguous interleaved transversal slices were acquired in each volume, with a slice thickness of 3 mm and no gap (TR/TE = 2500/25 ms, 90° flip angle, field of view = 192 × 192 mm2, 64 × 64 matrix).
77-1	14108-14117	Forty-two	_	
77-2	14118-14128	contiguous	_	
77-3	14129-14140	interleaved	_	
77-4	14141-14152	transversal	_	
77-5	14153-14159	slices	_	
77-6	14160-14164	were	_	
77-7	14165-14173	acquired	_	
77-8	14174-14176	in	_	
77-9	14177-14181	each	_	
77-10	14182-14188	volume	_	
77-11	14188-14189	,	_	
77-12	14190-14194	with	_	
77-13	14195-14196	a	_	
77-14	14197-14202	slice	_	
77-15	14203-14212	thickness	_	
77-16	14213-14215	of	_	
77-17	14216-14217	3	_	
77-18	14217-14218	 	_	
77-19	14218-14220	mm	_	
77-20	14221-14224	and	_	
77-21	14225-14227	no	_	
77-22	14228-14231	gap	_	
77-23	14232-14233	(	_	
77-24	14233-14235	TR	_	
77-25	14235-14236	/	_	
77-26	14236-14238	TE	_	
77-27	14238-14239	 	_	
77-28	14239-14240	=	_	
77-29	14240-14241	 	_	
77-30	14241-14245	2500	_	
77-31	14245-14246	/	_	
77-32	14246-14248	25	_	
77-33	14248-14249	 	_	
77-34	14249-14251	ms	_	
77-35	14251-14252	,	_	
77-36	14253-14255	90	_	
77-37	14255-14256	°	_	
77-38	14257-14261	flip	_	
77-39	14262-14267	angle	_	
77-40	14267-14268	,	_	
77-41	14269-14274	field	_	
77-42	14275-14277	of	_	
77-43	14278-14282	view	_	
77-44	14282-14283	 	_	
77-45	14283-14284	=	_	
77-46	14284-14285	 	_	
77-47	14285-14288	192	_	
77-48	14288-14289	 	_	
77-49	14289-14290	×	_	
77-50	14290-14291	 	_	
77-51	14291-14294	192	_	
77-52	14294-14295	 	_	
77-53	14295-14298	mm2	_	
77-54	14298-14299	,	_	
77-55	14300-14302	64	_	
77-56	14302-14303	 	_	
77-57	14303-14304	×	_	
77-58	14304-14305	 	_	
77-59	14305-14307	64	_	
77-60	14308-14314	matrix	_	
77-61	14314-14315	)	_	
77-62	14315-14316	.	_	

#Text=Slice orientation was tilted − 30° from the AC–PC line.
78-1	14317-14322	Slice	_	
78-2	14323-14334	orientation	_	
78-3	14335-14338	was	_	
78-4	14339-14345	tilted	_	
78-5	14346-14347	−	_	
78-6	14347-14348	 	_	
78-7	14348-14350	30	_	
78-8	14350-14351	°	_	
78-9	14352-14356	from	_	
78-10	14357-14360	the	_	
78-11	14361-14366	AC–PC	_	
78-12	14367-14371	line	_	
78-13	14371-14372	.	_	

#Text=We discarded the first three images before data processing and used statistical analysis to compensate for the T1 saturation effects.
79-1	14373-14375	We	_	
79-2	14376-14385	discarded	_	
79-3	14386-14389	the	_	
79-4	14390-14395	first	_	
79-5	14396-14401	three	_	
79-6	14402-14408	images	_	
79-7	14409-14415	before	_	
79-8	14416-14420	data	_	
79-9	14421-14431	processing	_	
79-10	14432-14435	and	_	
79-11	14436-14440	used	_	
79-12	14441-14452	statistical	_	
79-13	14453-14461	analysis	_	
79-14	14462-14464	to	_	
79-15	14465-14475	compensate	_	
79-16	14476-14479	for	_	
79-17	14480-14483	the	_	
79-18	14484-14486	T1	_	
79-19	14487-14497	saturation	_	
79-20	14498-14505	effects	_	
79-21	14505-14506	.	_	

#Text=Next, all subjects were instructed to relax, hold still, and fixate the fixation point (cross, visual angle 2°) at the center of the screen during the resting-state fMRI examination. 140 functional images at the same locations as the anatomical slices were acquired by using an EPI sequence with the following parameters: TR/TE = 3000/30 ms, 48 slices, 64 × 64 matrix, 80° flip angle, field of view = 212 × 212 mm2 and voxel size = 3.6 × 3.3 × 3.3 mm3.
80-1	14507-14511	Next	_	
80-2	14511-14512	,	_	
80-3	14513-14516	all	_	
80-4	14517-14525	subjects	_	
80-5	14526-14530	were	_	
80-6	14531-14541	instructed	_	
80-7	14542-14544	to	_	
80-8	14545-14550	relax	_	
80-9	14550-14551	,	_	
80-10	14552-14556	hold	_	
80-11	14557-14562	still	_	
80-12	14562-14563	,	_	
80-13	14564-14567	and	_	
80-14	14568-14574	fixate	_	
80-15	14575-14578	the	_	
80-16	14579-14587	fixation	_	
80-17	14588-14593	point	_	
80-18	14594-14595	(	_	
80-19	14595-14600	cross	_	
80-20	14600-14601	,	_	
80-21	14602-14608	visual	_	
80-22	14609-14614	angle	_	
80-23	14615-14616	2	_	
80-24	14616-14617	°	_	
80-25	14617-14618	)	_	
80-26	14619-14621	at	_	
80-27	14622-14625	the	_	
80-28	14626-14632	center	_	
80-29	14633-14635	of	_	
80-30	14636-14639	the	_	
80-31	14640-14646	screen	_	
80-32	14647-14653	during	_	
80-33	14654-14657	the	_	
80-34	14658-14671	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[13]	
80-35	14672-14676	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[13]	
80-36	14677-14688	examination	_	
80-37	14688-14689	.	_	
80-38	14690-14693	140	_	
80-39	14694-14704	functional	_	
80-40	14705-14711	images	_	
80-41	14712-14714	at	_	
80-42	14715-14718	the	_	
80-43	14719-14723	same	_	
80-44	14724-14733	locations	_	
80-45	14734-14736	as	_	
80-46	14737-14740	the	_	
80-47	14741-14751	anatomical	_	
80-48	14752-14758	slices	_	
80-49	14759-14763	were	_	
80-50	14764-14772	acquired	_	
80-51	14773-14775	by	_	
80-52	14776-14781	using	_	
80-53	14782-14784	an	_	
80-54	14785-14788	EPI	_	
80-55	14789-14797	sequence	_	
80-56	14798-14802	with	_	
80-57	14803-14806	the	_	
80-58	14807-14816	following	_	
80-59	14817-14827	parameters	_	
80-60	14827-14828	:	_	
80-61	14829-14831	TR	_	
80-62	14831-14832	/	_	
80-63	14832-14834	TE	_	
80-64	14834-14835	 	_	
80-65	14835-14836	=	_	
80-66	14836-14837	 	_	
80-67	14837-14841	3000	_	
80-68	14841-14842	/	_	
80-69	14842-14844	30	_	
80-70	14844-14845	 	_	
80-71	14845-14847	ms	_	
80-72	14847-14848	,	_	
80-73	14849-14851	48	_	
80-74	14852-14858	slices	_	
80-75	14858-14859	,	_	
80-76	14860-14862	64	_	
80-77	14862-14863	 	_	
80-78	14863-14864	×	_	
80-79	14864-14865	 	_	
80-80	14865-14867	64	_	
80-81	14868-14874	matrix	_	
80-82	14874-14875	,	_	
80-83	14876-14878	80	_	
80-84	14878-14879	°	_	
80-85	14880-14884	flip	_	
80-86	14885-14890	angle	_	
80-87	14890-14891	,	_	
80-88	14892-14897	field	_	
80-89	14898-14900	of	_	
80-90	14901-14905	view	_	
80-91	14905-14906	 	_	
80-92	14906-14907	=	_	
80-93	14907-14908	 	_	
80-94	14908-14911	212	_	
80-95	14911-14912	 	_	
80-96	14912-14913	×	_	
80-97	14913-14914	 	_	
80-98	14914-14917	212	_	
80-99	14917-14918	 	_	
80-100	14918-14921	mm2	_	
80-101	14922-14925	and	_	
80-102	14926-14931	voxel	_	
80-103	14932-14936	size	_	
80-104	14936-14937	 	_	
80-105	14937-14938	=	_	
80-106	14938-14939	 	_	
80-107	14939-14942	3.6	_	
80-108	14942-14943	 	_	
80-109	14943-14944	×	_	
80-110	14944-14945	 	_	
80-111	14945-14948	3.3	_	
80-112	14948-14949	 	_	
80-113	14949-14950	×	_	
80-114	14950-14951	 	_	
80-115	14951-14954	3.3	_	
80-116	14954-14955	 	_	
80-117	14955-14958	mm3	_	
80-118	14958-14959	.	_	

#Text=The scanning time was 7 min 8 s.
81-1	14960-14963	The	_	
81-2	14964-14972	scanning	_	
81-3	14973-14977	time	_	
81-4	14978-14981	was	_	
81-5	14982-14983	7	_	
81-6	14983-14984	 	_	
81-7	14984-14987	min	_	
81-8	14988-14989	8	_	
81-9	14989-14990	 	_	
81-10	14990-14991	s	_	
81-11	14991-14992	.	_	

#Text=Finally, DTI was performed using the spin echo echo-planar technique (TR/TE = 14,100 /81 ms, 90° flip angle, field of view = 224 × 224 mm2, 114 × 114 matrix, section thickness = 2 mm with no gap).
82-1	14993-15000	Finally	_	
82-2	15000-15001	,	_	
82-3	15002-15005	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging	
82-4	15006-15009	was	_	
82-5	15010-15019	performed	_	
82-6	15020-15025	using	_	
82-7	15026-15029	the	_	
82-8	15030-15034	spin	_	
82-9	15035-15039	echo	_	
82-10	15040-15051	echo-planar	_	
82-11	15052-15061	technique	_	
82-12	15062-15063	(	_	
82-13	15063-15065	TR	_	
82-14	15065-15066	/	_	
82-15	15066-15068	TE	_	
82-16	15068-15069	 	_	
82-17	15069-15070	=	_	
82-18	15070-15071	 	_	
82-19	15071-15077	14,100	_	
82-20	15078-15079	/	_	
82-21	15079-15081	81	_	
82-22	15081-15082	 	_	
82-23	15082-15084	ms	_	
82-24	15084-15085	,	_	
82-25	15086-15088	90	_	
82-26	15088-15089	°	_	
82-27	15090-15094	flip	_	
82-28	15095-15100	angle	_	
82-29	15100-15101	,	_	
82-30	15102-15107	field	_	
82-31	15108-15110	of	_	
82-32	15111-15115	view	_	
82-33	15115-15116	 	_	
82-34	15116-15117	=	_	
82-35	15117-15118	 	_	
82-36	15118-15121	224	_	
82-37	15121-15122	 	_	
82-38	15122-15123	×	_	
82-39	15123-15124	 	_	
82-40	15124-15127	224	_	
82-41	15127-15128	 	_	
82-42	15128-15131	mm2	_	
82-43	15131-15132	,	_	
82-44	15133-15136	114	_	
82-45	15136-15137	 	_	
82-46	15137-15138	×	_	
82-47	15138-15139	 	_	
82-48	15139-15142	114	_	
82-49	15143-15149	matrix	_	
82-50	15149-15150	,	_	
82-51	15151-15158	section	_	
82-52	15159-15168	thickness	_	
82-53	15168-15169	 	_	
82-54	15169-15170	=	_	
82-55	15170-15171	 	_	
82-56	15171-15172	2	_	
82-57	15172-15173	 	_	
82-58	15173-15175	mm	_	
82-59	15176-15180	with	_	
82-60	15181-15183	no	_	
82-61	15184-15187	gap	_	
82-62	15187-15188	)	_	
82-63	15188-15189	.	_	

#Text=Images were obtained with both 30-direction diffusion encoding (b = 1000 s/mm2 for each direction) and no diffusion encoding (b = 0 s/mm2).
83-1	15190-15196	Images	_	
83-2	15197-15201	were	_	
83-3	15202-15210	obtained	_	
83-4	15211-15215	with	_	
83-5	15216-15220	both	_	
83-6	15221-15223	30	_	
83-7	15223-15224	-	_	
83-8	15224-15233	direction	_	
83-9	15234-15243	diffusion	_	
83-10	15244-15252	encoding	_	
83-11	15253-15254	(	_	
83-12	15254-15255	b	_	
83-13	15255-15256	 	_	
83-14	15256-15257	=	_	
83-15	15257-15258	 	_	
83-16	15258-15262	1000	_	
83-17	15262-15263	 	_	
83-18	15263-15264	s	_	
83-19	15264-15265	/	_	
83-20	15265-15268	mm2	_	
83-21	15269-15272	for	_	
83-22	15273-15277	each	_	
83-23	15278-15287	direction	_	
83-24	15287-15288	)	_	
83-25	15289-15292	and	_	
83-26	15293-15295	no	_	
83-27	15296-15305	diffusion	_	
83-28	15306-15314	encoding	_	
83-29	15315-15316	(	_	
83-30	15316-15317	b	_	
83-31	15317-15318	 	_	
83-32	15318-15319	=	_	
83-33	15319-15320	 	_	
83-34	15320-15321	0	_	
83-35	15321-15322	 	_	
83-36	15322-15323	s	_	
83-37	15323-15324	/	_	
83-38	15324-15327	mm2	_	
83-39	15327-15328	)	_	
83-40	15328-15329	.	_	

#Text=A total of 75 axial section images were obtained, covering the entire cerebrum.
84-1	15330-15331	A	_	
84-2	15332-15337	total	_	
84-3	15338-15340	of	_	
84-4	15341-15343	75	_	
84-5	15344-15349	axial	_	
84-6	15350-15357	section	_	
84-7	15358-15364	images	_	
84-8	15365-15369	were	_	
84-9	15370-15378	obtained	_	
84-10	15378-15379	,	_	
84-11	15380-15388	covering	_	
84-12	15389-15392	the	_	
84-13	15393-15399	entire	_	
84-14	15400-15408	cerebrum	_	
84-15	15408-15409	.	_	

#Text=The scanning time was 8 min 1 s.
85-1	15410-15413	The	_	
85-2	15414-15422	scanning	_	
85-3	15423-15427	time	_	
85-4	15428-15431	was	_	
85-5	15432-15433	8	_	
85-6	15433-15434	 	_	
85-7	15434-15437	min	_	
85-8	15438-15439	1	_	
85-9	15439-15440	 	_	
85-10	15440-15441	s	_	
85-11	15441-15442	.	_	

#Text=MRI data from 2 patients were excluded from the analysis because of the excessive motion > 2 mm maximum displacement in x, y or z and > 1.0 degree of angular motion about each axis.
86-1	15443-15446	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
86-2	15447-15451	data	_	
86-3	15452-15456	from	_	
86-4	15457-15458	2	_	
86-5	15459-15467	patients	_	
86-6	15468-15472	were	_	
86-7	15473-15481	excluded	_	
86-8	15482-15486	from	_	
86-9	15487-15490	the	_	
86-10	15491-15499	analysis	_	
86-11	15500-15507	because	_	
86-12	15508-15510	of	_	
86-13	15511-15514	the	_	
86-14	15515-15524	excessive	_	
86-15	15525-15531	motion	_	
86-16	15532-15533	>	_	
86-17	15533-15534	 	_	
86-18	15534-15535	2	_	
86-19	15535-15536	 	_	
86-20	15536-15538	mm	_	
86-21	15539-15546	maximum	_	
86-22	15547-15559	displacement	_	
86-23	15560-15562	in	_	
86-24	15563-15564	x	_	
86-25	15564-15565	,	_	
86-26	15566-15567	y	_	
86-27	15568-15570	or	_	
86-28	15571-15572	z	_	
86-29	15573-15576	and	_	
86-30	15577-15578	>	_	
86-31	15578-15579	 	_	
86-32	15579-15582	1.0	_	
86-33	15583-15589	degree	_	
86-34	15590-15592	of	_	
86-35	15593-15600	angular	_	
86-36	15601-15607	motion	_	
86-37	15608-15613	about	_	
86-38	15614-15618	each	_	
86-39	15619-15623	axis	_	
86-40	15623-15624	.	_	

#Text=FMRI data analysis
#Text=Data were analyzed using Statistical Parametric Mapping (SPM8, Wellcome Department of Imaging Neuroscience, Institute of Neurology, London, UK; http://www.fil.ion.ucl.ac.uk/spm/).
87-1	15625-15629	FMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
87-2	15630-15634	data	_	
87-3	15635-15643	analysis	_	
87-4	15644-15648	Data	_	
87-5	15649-15653	were	_	
87-6	15654-15662	analyzed	_	
87-7	15663-15668	using	_	
87-8	15669-15680	Statistical	_	
87-9	15681-15691	Parametric	_	
87-10	15692-15699	Mapping	_	
87-11	15700-15701	(	_	
87-12	15701-15705	SPM8	_	
87-13	15705-15706	,	_	
87-14	15707-15715	Wellcome	_	
87-15	15716-15726	Department	_	
87-16	15727-15729	of	_	
87-17	15730-15737	Imaging	_	
87-18	15738-15750	Neuroscience	_	
87-19	15750-15751	,	_	
87-20	15752-15761	Institute	_	
87-21	15762-15764	of	_	
87-22	15765-15774	Neurology	_	
87-23	15774-15775	,	_	
87-24	15776-15782	London	_	
87-25	15782-15783	,	_	
87-26	15784-15786	UK	_	
87-27	15786-15787	;	_	
87-28	15788-15792	http	_	
87-29	15792-15793	:	_	
87-30	15793-15794	/	_	
87-31	15794-15795	/	_	
87-32	15795-15816	www.fil.ion.ucl.ac.uk	_	
87-33	15816-15817	/	_	
87-34	15817-15820	spm	_	
87-35	15820-15821	/	_	
87-36	15821-15822	)	_	
87-37	15822-15823	.	_	

#Text=Images were corrected for slice acquisition time within each volume, motion-corrected with realignment to the first volume, spatially normalized to the standard Montreal Neurological Institute (MNI) EPI template, and spatially smoothed using a Gaussian kernel with a full width at half maximum of 8 mm.
88-1	15824-15830	Images	_	
88-2	15831-15835	were	_	
88-3	15836-15845	corrected	_	
88-4	15846-15849	for	_	
88-5	15850-15855	slice	_	
88-6	15856-15867	acquisition	_	
88-7	15868-15872	time	_	
88-8	15873-15879	within	_	
88-9	15880-15884	each	_	
88-10	15885-15891	volume	_	
88-11	15891-15892	,	_	
88-12	15893-15909	motion-corrected	_	
88-13	15910-15914	with	_	
88-14	15915-15926	realignment	_	
88-15	15927-15929	to	_	
88-16	15930-15933	the	_	
88-17	15934-15939	first	_	
88-18	15940-15946	volume	_	
88-19	15946-15947	,	_	
88-20	15948-15957	spatially	_	
88-21	15958-15968	normalized	_	
88-22	15969-15971	to	_	
88-23	15972-15975	the	_	
88-24	15976-15984	standard	_	
88-25	15985-15993	Montreal	_	
88-26	15994-16006	Neurological	_	
88-27	16007-16016	Institute	_	
88-28	16017-16018	(	_	
88-29	16018-16021	MNI	_	
88-30	16021-16022	)	_	
88-31	16023-16026	EPI	_	
88-32	16027-16035	template	_	
88-33	16035-16036	,	_	
88-34	16037-16040	and	_	
88-35	16041-16050	spatially	_	
88-36	16051-16059	smoothed	_	
88-37	16060-16065	using	_	
88-38	16066-16067	a	_	
88-39	16068-16076	Gaussian	_	
88-40	16077-16083	kernel	_	
88-41	16084-16088	with	_	
88-42	16089-16090	a	_	
88-43	16091-16095	full	_	
88-44	16096-16101	width	_	
88-45	16102-16104	at	_	
88-46	16105-16109	half	_	
88-47	16110-16117	maximum	_	
88-48	16118-16120	of	_	
88-49	16121-16122	8	_	
88-50	16122-16123	 	_	
88-51	16123-16125	mm	_	
88-52	16125-16126	.	_	

#Text=For each participant, the BOLD responses across the scanning run were modeled with a general linear model.
89-1	16127-16130	For	_	
89-2	16131-16135	each	_	
89-3	16136-16147	participant	_	
89-4	16147-16148	,	_	
89-5	16149-16152	the	_	
89-6	16153-16157	BOLD	_	
89-7	16158-16167	responses	_	
89-8	16168-16174	across	_	
89-9	16175-16178	the	_	
89-10	16179-16187	scanning	_	
89-11	16188-16191	run	_	
89-12	16192-16196	were	_	
89-13	16197-16204	modeled	_	
89-14	16205-16209	with	_	
89-15	16210-16211	a	_	
89-16	16212-16219	general	_	
89-17	16220-16226	linear	_	
89-18	16227-16232	model	_	
89-19	16232-16233	.	_	

#Text=The model included the following regressors of interest: presentation of SW task cue, presentation of WS task cue, presentation of success feedback in the SW task, presentation of failure feedback in the SW task.
90-1	16234-16237	The	_	
90-2	16238-16243	model	_	
90-3	16244-16252	included	_	
90-4	16253-16256	the	_	
90-5	16257-16266	following	_	
90-6	16267-16277	regressors	_	
90-7	16278-16280	of	_	
90-8	16281-16289	interest	_	
90-9	16289-16290	:	_	
90-10	16291-16303	presentation	_	
90-11	16304-16306	of	_	
90-12	16307-16309	SW	_	
90-13	16310-16314	task	_	
90-14	16315-16318	cue	_	
90-15	16318-16319	,	_	
90-16	16320-16332	presentation	_	
90-17	16333-16335	of	_	
90-18	16336-16338	WS	_	
90-19	16339-16343	task	_	
90-20	16344-16347	cue	_	
90-21	16347-16348	,	_	
90-22	16349-16361	presentation	_	
90-23	16362-16364	of	_	
90-24	16365-16372	success	_	
90-25	16373-16381	feedback	_	
90-26	16382-16384	in	_	
90-27	16385-16388	the	_	
90-28	16389-16391	SW	_	
90-29	16392-16396	task	_	
90-30	16396-16397	,	_	
90-31	16398-16410	presentation	_	
90-32	16411-16413	of	_	
90-33	16414-16421	failure	_	
90-34	16422-16430	feedback	_	
90-35	16431-16433	in	_	
90-36	16434-16437	the	_	
90-37	16438-16440	SW	_	
90-38	16441-16445	task	_	
90-39	16445-16446	.	_	

#Text=The motion parameters, inappropriate trials which participants did not press a button in the SW task or press a button before a SW stopped in the WS task were also included as regressors of no interest.
91-1	16447-16450	The	_	
91-2	16451-16457	motion	_	
91-3	16458-16468	parameters	_	
91-4	16468-16469	,	_	
91-5	16470-16483	inappropriate	_	
91-6	16484-16490	trials	_	
91-7	16491-16496	which	_	
91-8	16497-16509	participants	_	
91-9	16510-16513	did	_	
91-10	16514-16517	not	_	
91-11	16518-16523	press	_	
91-12	16524-16525	a	_	
91-13	16526-16532	button	_	
91-14	16533-16535	in	_	
91-15	16536-16539	the	_	
91-16	16540-16542	SW	_	
91-17	16543-16547	task	_	
91-18	16548-16550	or	_	
91-19	16551-16556	press	_	
91-20	16557-16558	a	_	
91-21	16559-16565	button	_	
91-22	16566-16572	before	_	
91-23	16573-16574	a	_	
91-24	16575-16577	SW	_	
91-25	16578-16585	stopped	_	
91-26	16586-16588	in	_	
91-27	16589-16592	the	_	
91-28	16593-16595	WS	_	
91-29	16596-16600	task	_	
91-30	16601-16605	were	_	
91-31	16606-16610	also	_	
91-32	16611-16619	included	_	
91-33	16620-16622	as	_	
91-34	16623-16633	regressors	_	
91-35	16634-16636	of	_	
91-36	16637-16639	no	_	
91-37	16640-16648	interest	_	
91-38	16648-16649	.	_	

#Text=The regressors (except for the motion parameters) were calculated using a boxcar function convolved with a hemodynamic-response function.
92-1	16650-16653	The	_	
92-2	16654-16664	regressors	_	
92-3	16665-16666	(	_	
92-4	16666-16672	except	_	
92-5	16673-16676	for	_	
92-6	16677-16680	the	_	
92-7	16681-16687	motion	_	
92-8	16688-16698	parameters	_	
92-9	16698-16699	)	_	
92-10	16700-16704	were	_	
92-11	16705-16715	calculated	_	
92-12	16716-16721	using	_	
92-13	16722-16723	a	_	
92-14	16724-16730	boxcar	_	
92-15	16731-16739	function	_	
92-16	16740-16749	convolved	_	
92-17	16750-16754	with	_	
92-18	16755-16756	a	_	
92-19	16757-16777	hemodynamic-response	_	
92-20	16778-16786	function	_	
92-21	16786-16787	.	_	

#Text=The estimates were corrected for temporal autocorrelation by using a first-order autoregressive model.
93-1	16788-16791	The	_	
93-2	16792-16801	estimates	_	
93-3	16802-16806	were	_	
93-4	16807-16816	corrected	_	
93-5	16817-16820	for	_	
93-6	16821-16829	temporal	_	
93-7	16830-16845	autocorrelation	_	
93-8	16846-16848	by	_	
93-9	16849-16854	using	_	
93-10	16855-16856	a	_	
93-11	16857-16868	first-order	_	
93-12	16869-16883	autoregressive	_	
93-13	16884-16889	model	_	
93-14	16889-16890	.	_	

#Text=To investigate cue effects and the feedback effects, our primary focus of interest, two contrast values were calculated: (i) contrast between SW task cue and WS task cue effects (i.e., SW minus WS), and (ii) contrast between success feedback and failure feedback effects (i.e., success minus failure).
94-1	16891-16893	To	_	
94-2	16894-16905	investigate	_	
94-3	16906-16909	cue	_	
94-4	16910-16917	effects	_	
94-5	16918-16921	and	_	
94-6	16922-16925	the	_	
94-7	16926-16934	feedback	_	
94-8	16935-16942	effects	_	
94-9	16942-16943	,	_	
94-10	16944-16947	our	_	
94-11	16948-16955	primary	_	
94-12	16956-16961	focus	_	
94-13	16962-16964	of	_	
94-14	16965-16973	interest	_	
94-15	16973-16974	,	_	
94-16	16975-16978	two	_	
94-17	16979-16987	contrast	_	
94-18	16988-16994	values	_	
94-19	16995-16999	were	_	
94-20	17000-17010	calculated	_	
94-21	17010-17011	:	_	
94-22	17012-17013	(	_	
94-23	17013-17014	i	_	
94-24	17014-17015	)	_	
94-25	17016-17024	contrast	_	
94-26	17025-17032	between	_	
94-27	17033-17035	SW	_	
94-28	17036-17040	task	_	
94-29	17041-17044	cue	_	
94-30	17045-17048	and	_	
94-31	17049-17051	WS	_	
94-32	17052-17056	task	_	
94-33	17057-17060	cue	_	
94-34	17061-17068	effects	_	
94-35	17069-17070	(	_	
94-36	17070-17073	i.e	_	
94-37	17073-17074	.	_	
94-38	17074-17075	,	_	
94-39	17076-17078	SW	_	
94-40	17079-17084	minus	_	
94-41	17085-17087	WS	_	
94-42	17087-17088	)	_	
94-43	17088-17089	,	_	
94-44	17090-17093	and	_	
94-45	17094-17095	(	_	
94-46	17095-17097	ii	_	
94-47	17097-17098	)	_	
94-48	17099-17107	contrast	_	
94-49	17108-17115	between	_	
94-50	17116-17123	success	_	
94-51	17124-17132	feedback	_	
94-52	17133-17136	and	_	
94-53	17137-17144	failure	_	
94-54	17145-17153	feedback	_	
94-55	17154-17161	effects	_	
94-56	17162-17163	(	_	
94-57	17163-17166	i.e	_	
94-58	17166-17167	.	_	
94-59	17167-17168	,	_	
94-60	17169-17176	success	_	
94-61	17177-17182	minus	_	
94-62	17183-17190	failure	_	
94-63	17190-17191	)	_	
94-64	17191-17192	.	_	

#Text=In region of interest (ROI) analysis, we calculated the peaks of clusters that showed significant activation during the cue period (SW-WS) and the feedback period (Success-Failure).
95-1	17193-17195	In	_	
95-2	17196-17202	region	_	
95-3	17203-17205	of	_	
95-4	17206-17214	interest	_	
95-5	17215-17216	(	_	
95-6	17216-17219	ROI	_	
95-7	17219-17220	)	_	
95-8	17221-17229	analysis	_	
95-9	17229-17230	,	_	
95-10	17231-17233	we	_	
95-11	17234-17244	calculated	_	
95-12	17245-17248	the	_	
95-13	17249-17254	peaks	_	
95-14	17255-17257	of	_	
95-15	17258-17266	clusters	_	
95-16	17267-17271	that	_	
95-17	17272-17278	showed	_	
95-18	17279-17290	significant	_	
95-19	17291-17301	activation	_	
95-20	17302-17308	during	_	
95-21	17309-17312	the	_	
95-22	17313-17316	cue	_	
95-23	17317-17323	period	_	
95-24	17324-17325	(	_	
95-25	17325-17330	SW-WS	_	
95-26	17330-17331	)	_	
95-27	17332-17335	and	_	
95-28	17336-17339	the	_	
95-29	17340-17348	feedback	_	
95-30	17349-17355	period	_	
95-31	17356-17357	(	_	
95-32	17357-17372	Success-Failure	_	
95-33	17372-17373	)	_	
95-34	17373-17374	.	_	

#Text=For the analysis of the LPFC and striatum, fMRI data were masked anatomically using the Automated Anatomical Labeling atlas of the WFU (Wake Forest University) Pickatlas toolbox.
96-1	17375-17378	For	_	
96-2	17379-17382	the	_	
96-3	17383-17391	analysis	_	
96-4	17392-17394	of	_	
96-5	17395-17398	the	_	
96-6	17399-17403	LPFC	_	
96-7	17404-17407	and	_	
96-8	17408-17416	striatum	_	
96-9	17416-17417	,	_	
96-10	17418-17422	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
96-11	17423-17427	data	_	
96-12	17428-17432	were	_	
96-13	17433-17439	masked	_	
96-14	17440-17452	anatomically	_	
96-15	17453-17458	using	_	
96-16	17459-17462	the	_	
96-17	17463-17472	Automated	_	
96-18	17473-17483	Anatomical	_	
96-19	17484-17492	Labeling	_	
96-20	17493-17498	atlas	_	
96-21	17499-17501	of	_	
96-22	17502-17505	the	_	
96-23	17506-17509	WFU	_	
96-24	17510-17511	(	_	
96-25	17511-17515	Wake	_	
96-26	17516-17522	Forest	_	
96-27	17523-17533	University	_	
96-28	17533-17534	)	_	
96-29	17535-17544	Pickatlas	_	
96-30	17545-17552	toolbox	_	
96-31	17552-17553	.	_	

#Text=The mask for the LPFC consisted of area 46, and the mask for the striatum consisted of the caudate and putamen.
97-1	17554-17557	The	_	
97-2	17558-17562	mask	_	
97-3	17563-17566	for	_	
97-4	17567-17570	the	_	
97-5	17571-17575	LPFC	_	
97-6	17576-17585	consisted	_	
97-7	17586-17588	of	_	
97-8	17589-17593	area	_	
97-9	17594-17596	46	_	
97-10	17596-17597	,	_	
97-11	17598-17601	and	_	
97-12	17602-17605	the	_	
97-13	17606-17610	mask	_	
97-14	17611-17614	for	_	
97-15	17615-17618	the	_	
97-16	17619-17627	striatum	_	
97-17	17628-17637	consisted	_	
97-18	17638-17640	of	_	
97-19	17641-17644	the	_	
97-20	17645-17652	caudate	_	
97-21	17653-17656	and	_	
97-22	17657-17664	putamen	_	
97-23	17664-17665	.	_	

#Text=Then, the peak activation voxels in the LPFC and the striatum were selected (FWE p < 0.05, one-sample t-test).
98-1	17666-17670	Then	_	
98-2	17670-17671	,	_	
98-3	17672-17675	the	_	
98-4	17676-17680	peak	_	
98-5	17681-17691	activation	_	
98-6	17692-17698	voxels	_	
98-7	17699-17701	in	_	
98-8	17702-17705	the	_	
98-9	17706-17710	LPFC	_	
98-10	17711-17714	and	_	
98-11	17715-17718	the	_	
98-12	17719-17727	striatum	_	
98-13	17728-17732	were	_	
98-14	17733-17741	selected	_	
98-15	17742-17743	(	_	
98-16	17743-17746	FWE	_	
98-17	17747-17748	p	_	
98-18	17748-17749	 	_	
98-19	17749-17750	<	_	
98-20	17750-17751	 	_	
98-21	17751-17755	0.05	_	
98-22	17755-17756	,	_	
98-23	17757-17767	one-sample	_	
98-24	17768-17774	t-test	_	
98-25	17774-17775	)	_	
98-26	17775-17776	.	_	

#Text=However, for the analysis of the cue activation in the striatum, we adopted the beta values of peak voxels which showed a significant difference between SCZ and HC (p < 0.05 FWE cluster correction, two-sample t-test).
99-1	17777-17784	However	_	
99-2	17784-17785	,	_	
99-3	17786-17789	for	_	
99-4	17790-17793	the	_	
99-5	17794-17802	analysis	_	
99-6	17803-17805	of	_	
99-7	17806-17809	the	_	
99-8	17810-17813	cue	_	
99-9	17814-17824	activation	_	
99-10	17825-17827	in	_	
99-11	17828-17831	the	_	
99-12	17832-17840	striatum	_	
99-13	17840-17841	,	_	
99-14	17842-17844	we	_	
99-15	17845-17852	adopted	_	
99-16	17853-17856	the	_	
99-17	17857-17861	beta	_	
99-18	17862-17868	values	_	
99-19	17869-17871	of	_	
99-20	17872-17876	peak	_	
99-21	17877-17883	voxels	_	
99-22	17884-17889	which	_	
99-23	17890-17896	showed	_	
99-24	17897-17898	a	_	
99-25	17899-17910	significant	_	
99-26	17911-17921	difference	_	
99-27	17922-17929	between	_	
99-28	17930-17933	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
99-29	17934-17937	and	_	
99-30	17938-17940	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
99-31	17941-17942	(	_	
99-32	17942-17943	p	_	
99-33	17943-17944	 	_	
99-34	17944-17945	<	_	
99-35	17945-17946	 	_	
99-36	17946-17950	0.05	_	
99-37	17951-17954	FWE	_	
99-38	17955-17962	cluster	_	
99-39	17963-17973	correction	_	
99-40	17973-17974	,	_	
99-41	17975-17985	two-sample	_	
99-42	17986-17992	t-test	_	
99-43	17992-17993	)	_	
99-44	17993-17994	.	_	

#Text=We created small ROIs (6 mm spheres) at the peaks of activation clusters.
100-1	17995-17997	We	_	
100-2	17998-18005	created	_	
100-3	18006-18011	small	_	
100-4	18012-18016	ROIs	_	
100-5	18017-18018	(	_	
100-6	18018-18019	6	_	
100-7	18019-18020	 	_	
100-8	18020-18022	mm	_	
100-9	18023-18030	spheres	_	
100-10	18030-18031	)	_	
100-11	18032-18034	at	_	
100-12	18035-18038	the	_	
100-13	18039-18044	peaks	_	
100-14	18045-18047	of	_	
100-15	18048-18058	activation	_	
100-16	18059-18067	clusters	_	
100-17	18067-18068	.	_	

#Text=Functional connectivity analyses by resting-state fMRI
#Text=The target ROIs consisted of 6-mm radius spheres centered on the LPFC coordination obtained by fMRI data during the task performance and of the striatum cited from the AAL (Automated Anatomical Labeling) template.
101-1	18069-18079	Functional	_	
101-2	18080-18092	connectivity	_	
101-3	18093-18101	analyses	_	
101-4	18102-18104	by	_	
101-5	18105-18118	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[14]	
101-6	18119-18123	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[14]	
101-7	18124-18127	The	_	
101-8	18128-18134	target	_	
101-9	18135-18139	ROIs	_	
101-10	18140-18149	consisted	_	
101-11	18150-18152	of	_	
101-12	18153-18154	6	_	
101-13	18154-18155	-	_	
101-14	18155-18157	mm	_	
101-15	18158-18164	radius	_	
101-16	18165-18172	spheres	_	
101-17	18173-18181	centered	_	
101-18	18182-18184	on	_	
101-19	18185-18188	the	_	
101-20	18189-18193	LPFC	_	
101-21	18194-18206	coordination	_	
101-22	18207-18215	obtained	_	
101-23	18216-18218	by	_	
101-24	18219-18223	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
101-25	18224-18228	data	_	
101-26	18229-18235	during	_	
101-27	18236-18239	the	_	
101-28	18240-18244	task	_	
101-29	18245-18256	performance	_	
101-30	18257-18260	and	_	
101-31	18261-18263	of	_	
101-32	18264-18267	the	_	
101-33	18268-18276	striatum	_	
101-34	18277-18282	cited	_	
101-35	18283-18287	from	_	
101-36	18288-18291	the	_	
101-37	18292-18295	AAL	_	
101-38	18296-18297	(	_	
101-39	18297-18306	Automated	_	
101-40	18307-18317	Anatomical	_	
101-41	18318-18326	Labeling	_	
101-42	18326-18327	)	_	
101-43	18328-18336	template	_	
101-44	18336-18337	.	_	

#Text=Functional connectivity of target ROIs was acquired as follows by using CONN toolbox version 13.b; at first, a signal time-series within the voxel was extracted from each ROI.
102-1	18338-18348	Functional	_	
102-2	18349-18361	connectivity	_	
102-3	18362-18364	of	_	
102-4	18365-18371	target	_	
102-5	18372-18376	ROIs	_	
102-6	18377-18380	was	_	
102-7	18381-18389	acquired	_	
102-8	18390-18392	as	_	
102-9	18393-18400	follows	_	
102-10	18401-18403	by	_	
102-11	18404-18409	using	_	
102-12	18410-18414	CONN	_	
102-13	18415-18422	toolbox	_	
102-14	18423-18430	version	_	
102-15	18431-18433	13	_	
102-16	18433-18434	.	_	
102-17	18434-18435	b	_	
102-18	18435-18436	;	_	
102-19	18437-18439	at	_	
102-20	18440-18445	first	_	
102-21	18445-18446	,	_	
102-22	18447-18448	a	_	
102-23	18449-18455	signal	_	
102-24	18456-18467	time-series	_	
102-25	18468-18474	within	_	
102-26	18475-18478	the	_	
102-27	18479-18484	voxel	_	
102-28	18485-18488	was	_	
102-29	18489-18498	extracted	_	
102-30	18499-18503	from	_	
102-31	18504-18508	each	_	
102-32	18509-18512	ROI	_	
102-33	18512-18513	.	_	

#Text=For the removal of signals of no interest, signals correlated with 6 motion parameters from the realignment procedure and signals derived from the entire White matter mask and CSF mask were regressed out in each participant, by using a general linear model (GLM)-based multiple regression.
103-1	18514-18517	For	_	
103-2	18518-18521	the	_	
103-3	18522-18529	removal	_	
103-4	18530-18532	of	_	
103-5	18533-18540	signals	_	
103-6	18541-18543	of	_	
103-7	18544-18546	no	_	
103-8	18547-18555	interest	_	
103-9	18555-18556	,	_	
103-10	18557-18564	signals	_	
103-11	18565-18575	correlated	_	
103-12	18576-18580	with	_	
103-13	18581-18582	6	_	
103-14	18583-18589	motion	_	
103-15	18590-18600	parameters	_	
103-16	18601-18605	from	_	
103-17	18606-18609	the	_	
103-18	18610-18621	realignment	_	
103-19	18622-18631	procedure	_	
103-20	18632-18635	and	_	
103-21	18636-18643	signals	_	
103-22	18644-18651	derived	_	
103-23	18652-18656	from	_	
103-24	18657-18660	the	_	
103-25	18661-18667	entire	_	
103-26	18668-18673	White	_	
103-27	18674-18680	matter	_	
103-28	18681-18685	mask	_	
103-29	18686-18689	and	_	
103-30	18690-18693	CSF	_	
103-31	18694-18698	mask	_	
103-32	18699-18703	were	_	
103-33	18704-18713	regressed	_	
103-34	18714-18717	out	_	
103-35	18718-18720	in	_	
103-36	18721-18725	each	_	
103-37	18726-18737	participant	_	
103-38	18737-18738	,	_	
103-39	18739-18741	by	_	
103-40	18742-18747	using	_	
103-41	18748-18749	a	_	
103-42	18750-18757	general	_	
103-43	18758-18764	linear	_	
103-44	18765-18770	model	_	
103-45	18771-18772	(	_	
103-46	18772-18775	GLM	_	
103-47	18775-18776	)	_	
103-48	18776-18777	-	_	
103-49	18777-18782	based	_	
103-50	18783-18791	multiple	_	
103-51	18792-18802	regression	_	
103-52	18802-18803	.	_	

#Text=And then linear detrending and despiking was applied to yielded signals to diminish the effect of head motion.
104-1	18804-18807	And	_	
104-2	18808-18812	then	_	
104-3	18813-18819	linear	_	
104-4	18820-18830	detrending	_	
104-5	18831-18834	and	_	
104-6	18835-18844	despiking	_	
104-7	18845-18848	was	_	
104-8	18849-18856	applied	_	
104-9	18857-18859	to	_	
104-10	18860-18867	yielded	_	
104-11	18868-18875	signals	_	
104-12	18876-18878	to	_	
104-13	18879-18887	diminish	_	
104-14	18888-18891	the	_	
104-15	18892-18898	effect	_	
104-16	18899-18901	of	_	
104-17	18902-18906	head	_	
104-18	18907-18913	motion	_	
104-19	18913-18914	.	_	

#Text=After that, confound-removed time course within the voxel was averaged across the voxel of ROIs.
105-1	18915-18920	After	_	
105-2	18921-18925	that	_	
105-3	18925-18926	,	_	
105-4	18927-18943	confound-removed	_	
105-5	18944-18948	time	_	
105-6	18949-18955	course	_	
105-7	18956-18962	within	_	
105-8	18963-18966	the	_	
105-9	18967-18972	voxel	_	
105-10	18973-18976	was	_	
105-11	18977-18985	averaged	_	
105-12	18986-18992	across	_	
105-13	18993-18996	the	_	
105-14	18997-19002	voxel	_	
105-15	19003-19005	of	_	
105-16	19006-19010	ROIs	_	
105-17	19010-19011	.	_	

#Text=Finally, all of the confound-removed time course data underwent a band-pass filtering of 0.01–0.1 Hz.
106-1	19012-19019	Finally	_	
106-2	19019-19020	,	_	
106-3	19021-19024	all	_	
106-4	19025-19027	of	_	
106-5	19028-19031	the	_	
106-6	19032-19048	confound-removed	_	
106-7	19049-19053	time	_	
106-8	19054-19060	course	_	
106-9	19061-19065	data	_	
106-10	19066-19075	underwent	_	
106-11	19076-19077	a	_	
106-12	19078-19087	band-pass	_	
106-13	19088-19097	filtering	_	
106-14	19098-19100	of	_	
106-15	19101-19105	0.01	_	
106-16	19105-19106	–	_	
106-17	19106-19109	0.1	_	
106-18	19109-19110	 	_	
106-19	19110-19112	Hz	_	
106-20	19112-19113	.	_	

#Text=And then, the correlation coefficient of BOLD signal time-course was computed between target ROIs, and Fisher's z-transform was applied for each coefficient, yielding strength of functional connectivity in each subject.
107-1	19114-19117	And	_	
107-2	19118-19122	then	_	
107-3	19122-19123	,	_	
107-4	19124-19127	the	_	
107-5	19128-19139	correlation	_	
107-6	19140-19151	coefficient	_	
107-7	19152-19154	of	_	
107-8	19155-19159	BOLD	_	
107-9	19160-19166	signal	_	
107-10	19167-19178	time-course	_	
107-11	19179-19182	was	_	
107-12	19183-19191	computed	_	
107-13	19192-19199	between	_	
107-14	19200-19206	target	_	
107-15	19207-19211	ROIs	_	
107-16	19211-19212	,	_	
107-17	19213-19216	and	_	
107-18	19217-19225	Fisher's	_	
107-19	19226-19237	z-transform	_	
107-20	19238-19241	was	_	
107-21	19242-19249	applied	_	
107-22	19250-19253	for	_	
107-23	19254-19258	each	_	
107-24	19259-19270	coefficient	_	
107-25	19270-19271	,	_	
107-26	19272-19280	yielding	_	
107-27	19281-19289	strength	_	
107-28	19290-19292	of	_	
107-29	19293-19303	functional	_	
107-30	19304-19316	connectivity	_	
107-31	19317-19319	in	_	
107-32	19320-19324	each	_	
107-33	19325-19332	subject	_	
107-34	19332-19333	.	_	

#Text=Calculation of the FA value by probabilistic tractography
#Text=Each subject's 3DT1-weighted images were first linearly registered to MNI152 standard space using the FLIRT linear registration tool and a 12-degree-of-freedom affine transformation (part of FSL, http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/).
108-1	19334-19345	Calculation	_	
108-2	19346-19348	of	_	
108-3	19349-19352	the	_	
108-4	19353-19355	FA	_	
108-5	19356-19361	value	_	
108-6	19362-19364	by	_	
108-7	19365-19378	probabilistic	_	
108-8	19379-19391	tractography	_	
108-9	19392-19396	Each	_	
108-10	19397-19406	subject's	_	
108-11	19407-19411	3DT1	_	
108-12	19411-19412	-	_	
108-13	19412-19420	weighted	_	
108-14	19421-19427	images	_	
108-15	19428-19432	were	_	
108-16	19433-19438	first	_	
108-17	19439-19447	linearly	_	
108-18	19448-19458	registered	_	
108-19	19459-19461	to	_	
108-20	19462-19468	MNI152	_	
108-21	19469-19477	standard	_	
108-22	19478-19483	space	_	
108-23	19484-19489	using	_	
108-24	19490-19493	the	_	
108-25	19494-19499	FLIRT	_	
108-26	19500-19506	linear	_	
108-27	19507-19519	registration	_	
108-28	19520-19524	tool	_	
108-29	19525-19528	and	_	
108-30	19529-19530	a	_	
108-31	19531-19533	12	_	
108-32	19533-19534	-	_	
108-33	19534-19551	degree-of-freedom	_	
108-34	19552-19558	affine	_	
108-35	19559-19573	transformation	_	
108-36	19574-19575	(	_	
108-37	19575-19579	part	_	
108-38	19580-19582	of	_	
108-39	19583-19586	FSL	_	
108-40	19586-19587	,	_	
108-41	19588-19592	http	_	
108-42	19592-19593	:	_	
108-43	19593-19594	/	_	
108-44	19594-19595	/	_	
108-45	19595-19613	fsl.fmrib.ox.ac.uk	_	
108-46	19613-19614	/	_	
108-47	19614-19617	fsl	_	
108-48	19617-19618	/	_	
108-49	19618-19625	fslwiki	_	
108-50	19625-19626	/	_	
108-51	19626-19627	)	_	
108-52	19627-19628	.	_	

#Text=The linearly transformed 3DT1-weighted images were then used as the input to nonlinearly register each subject's image into MNI152 standard space using FSL's FNIRT nonlinear registration tool.
109-1	19629-19632	The	_	
109-2	19633-19641	linearly	_	
109-3	19642-19653	transformed	_	
109-4	19654-19658	3DT1	_	
109-5	19658-19659	-	_	
109-6	19659-19667	weighted	_	
109-7	19668-19674	images	_	
109-8	19675-19679	were	_	
109-9	19680-19684	then	_	
109-10	19685-19689	used	_	
109-11	19690-19692	as	_	
109-12	19693-19696	the	_	
109-13	19697-19702	input	_	
109-14	19703-19705	to	_	
109-15	19706-19717	nonlinearly	_	
109-16	19718-19726	register	_	
109-17	19727-19731	each	_	
109-18	19732-19741	subject's	_	
109-19	19742-19747	image	_	
109-20	19748-19752	into	_	
109-21	19753-19759	MNI152	_	
109-22	19760-19768	standard	_	
109-23	19769-19774	space	_	
109-24	19775-19780	using	_	
109-25	19781-19786	FSL's	_	
109-26	19787-19792	FNIRT	_	
109-27	19793-19802	nonlinear	_	
109-28	19803-19815	registration	_	
109-29	19816-19820	tool	_	
109-30	19820-19821	.	_	

#Text=All registered images were visually inspected for accurate registration.
110-1	19822-19825	All	_	
110-2	19826-19836	registered	_	
110-3	19837-19843	images	_	
110-4	19844-19848	were	_	
110-5	19849-19857	visually	_	
110-6	19858-19867	inspected	_	
110-7	19868-19871	for	_	
110-8	19872-19880	accurate	_	
110-9	19881-19893	registration	_	
110-10	19893-19894	.	_	

#Text=The striatum seed region for probabilistic tractography was taken from the AAL template, and the LPFC target region for probabilistic tractography was taken from fMRI data obtained during the task performance.
111-1	19895-19898	The	_	
111-2	19899-19907	striatum	_	
111-3	19908-19912	seed	_	
111-4	19913-19919	region	_	
111-5	19920-19923	for	_	
111-6	19924-19937	probabilistic	_	
111-7	19938-19950	tractography	_	
111-8	19951-19954	was	_	
111-9	19955-19960	taken	_	
111-10	19961-19965	from	_	
111-11	19966-19969	the	_	
111-12	19970-19973	AAL	_	
111-13	19974-19982	template	_	
111-14	19982-19983	,	_	
111-15	19984-19987	and	_	
111-16	19988-19991	the	_	
111-17	19992-19996	LPFC	_	
111-18	19997-20003	target	_	
111-19	20004-20010	region	_	
111-20	20011-20014	for	_	
111-21	20015-20028	probabilistic	_	
111-22	20029-20041	tractography	_	
111-23	20042-20045	was	_	
111-24	20046-20051	taken	_	
111-25	20052-20056	from	_	
111-26	20057-20061	fMRI	_	
111-27	20062-20066	data	_	
111-28	20067-20075	obtained	_	
111-29	20076-20082	during	_	
111-30	20083-20086	the	_	
111-31	20087-20091	task	_	
111-32	20092-20103	performance	_	
111-33	20103-20104	.	_	

#Text=An inverse transformation was used to convert these seed and target ROIs in MNI152 standard space back to each subject's native space.
112-1	20105-20107	An	_	
112-2	20108-20115	inverse	_	
112-3	20116-20130	transformation	_	
112-4	20131-20134	was	_	
112-5	20135-20139	used	_	
112-6	20140-20142	to	_	
112-7	20143-20150	convert	_	
112-8	20151-20156	these	_	
112-9	20157-20161	seed	_	
112-10	20162-20165	and	_	
112-11	20166-20172	target	_	
112-12	20173-20177	ROIs	_	
112-13	20178-20180	in	_	
112-14	20181-20187	MNI152	_	
112-15	20188-20196	standard	_	
112-16	20197-20202	space	_	
112-17	20203-20207	back	_	
112-18	20208-20210	to	_	
112-19	20211-20215	each	_	
112-20	20216-20225	subject's	_	
112-21	20226-20232	native	_	
112-22	20233-20238	space	_	
112-23	20238-20239	.	_	

#Text=The raw DTI data were corrected for movement and for eddy current distortions using the FMRIB Diffusion Toolbox (part of FSL).
113-1	20240-20243	The	_	
113-2	20244-20247	raw	_	
113-3	20248-20251	DTI	_	
113-4	20252-20256	data	_	
113-5	20257-20261	were	_	
113-6	20262-20271	corrected	_	
113-7	20272-20275	for	_	
113-8	20276-20284	movement	_	
113-9	20285-20288	and	_	
113-10	20289-20292	for	_	
113-11	20293-20297	eddy	_	
113-12	20298-20305	current	_	
113-13	20306-20317	distortions	_	
113-14	20318-20323	using	_	
113-15	20324-20327	the	_	
113-16	20328-20333	FMRIB	_	
113-17	20334-20343	Diffusion	_	
113-18	20344-20351	Toolbox	_	
113-19	20352-20353	(	_	
113-20	20353-20357	part	_	
113-21	20358-20360	of	_	
113-22	20361-20364	FSL	_	
113-23	20364-20365	)	_	
113-24	20365-20366	.	_	

#Text=The probabilistic tractography was performed between a seed ROI (the striatum) and a target ROI (the LPFC) of the individual brains in native space by sampling 5000 streamline fibers.
114-1	20367-20370	The	_	
114-2	20371-20384	probabilistic	_	
114-3	20385-20397	tractography	_	
114-4	20398-20401	was	_	
114-5	20402-20411	performed	_	
114-6	20412-20419	between	_	
114-7	20420-20421	a	_	
114-8	20422-20426	seed	_	
114-9	20427-20430	ROI	_	
114-10	20431-20432	(	_	
114-11	20432-20435	the	_	
114-12	20436-20444	striatum	_	
114-13	20444-20445	)	_	
114-14	20446-20449	and	_	
114-15	20450-20451	a	_	
114-16	20452-20458	target	_	
114-17	20459-20462	ROI	_	
114-18	20463-20464	(	_	
114-19	20464-20467	the	_	
114-20	20468-20472	LPFC	_	
114-21	20472-20473	)	_	
114-22	20474-20476	of	_	
114-23	20477-20480	the	_	
114-24	20481-20491	individual	_	
114-25	20492-20498	brains	_	
114-26	20499-20501	in	_	
114-27	20502-20508	native	_	
114-28	20509-20514	space	_	
114-29	20515-20517	by	_	
114-30	20518-20526	sampling	_	
114-31	20527-20531	5000	_	
114-32	20532-20542	streamline	_	
114-33	20543-20549	fibers	_	
114-34	20549-20550	.	_	

#Text=Only the top scoring 10% of pathways were retained; these pathways were then considered the most likely pathways connecting the pair of regions.
115-1	20551-20555	Only	_	
115-2	20556-20559	the	_	
115-3	20560-20563	top	_	
115-4	20564-20571	scoring	_	
115-5	20572-20575	10%	_	
115-6	20576-20578	of	_	
115-7	20579-20587	pathways	_	
115-8	20588-20592	were	_	
115-9	20593-20601	retained	_	
115-10	20601-20602	;	_	
115-11	20603-20608	these	_	
115-12	20609-20617	pathways	_	
115-13	20618-20622	were	_	
115-14	20623-20627	then	_	
115-15	20628-20638	considered	_	
115-16	20639-20642	the	_	
115-17	20643-20647	most	_	
115-18	20648-20654	likely	_	
115-19	20655-20663	pathways	_	
115-20	20664-20674	connecting	_	
115-21	20675-20678	the	_	
115-22	20679-20683	pair	_	
115-23	20684-20686	of	_	
115-24	20687-20694	regions	_	
115-25	20694-20695	.	_	

#Text=The probabilistic tractography was visually examined for each subject to verify the trajectory and to check for false-positive streamlines.
116-1	20696-20699	The	_	
116-2	20700-20713	probabilistic	_	
116-3	20714-20726	tractography	_	
116-4	20727-20730	was	_	
116-5	20731-20739	visually	_	
116-6	20740-20748	examined	_	
116-7	20749-20752	for	_	
116-8	20753-20757	each	_	
116-9	20758-20765	subject	_	
116-10	20766-20768	to	_	
116-11	20769-20775	verify	_	
116-12	20776-20779	the	_	
116-13	20780-20790	trajectory	_	
116-14	20791-20794	and	_	
116-15	20795-20797	to	_	
116-16	20798-20803	check	_	
116-17	20804-20807	for	_	
116-18	20808-20822	false-positive	_	
116-19	20823-20834	streamlines	_	
116-20	20834-20835	.	_	

#Text=Fractional anisotropy (FA) was calculated as the mean value within each tract using the fslstats command line tool (part of FSL).
117-1	20836-20846	Fractional	_	
117-2	20847-20857	anisotropy	_	
117-3	20858-20859	(	_	
117-4	20859-20861	FA	_	
117-5	20861-20862	)	_	
117-6	20863-20866	was	_	
117-7	20867-20877	calculated	_	
117-8	20878-20880	as	_	
117-9	20881-20884	the	_	
117-10	20885-20889	mean	_	
117-11	20890-20895	value	_	
117-12	20896-20902	within	_	
117-13	20903-20907	each	_	
117-14	20908-20913	tract	_	
117-15	20914-20919	using	_	
117-16	20920-20923	the	_	
117-17	20924-20932	fslstats	_	
117-18	20933-20940	command	_	
117-19	20941-20945	line	_	
117-20	20946-20950	tool	_	
117-21	20951-20952	(	_	
117-22	20952-20956	part	_	
117-23	20957-20959	of	_	
117-24	20960-20963	FSL	_	
117-25	20963-20964	)	_	
117-26	20964-20965	.	_	

#Text=Path analysis
#Text=In the path analysis, structural equation modeling (SEM) was used to assess the relations among the variables including neural activity and IMI and the behavioral data obtained in this study.
118-1	20966-20970	Path	_	
118-2	20971-20979	analysis	_	
118-3	20980-20982	In	_	
118-4	20983-20986	the	_	
118-5	20987-20991	path	_	
118-6	20992-21000	analysis	_	
118-7	21000-21001	,	_	
118-8	21002-21012	structural	_	
118-9	21013-21021	equation	_	
118-10	21022-21030	modeling	_	
118-11	21031-21032	(	_	
118-12	21032-21035	SEM	_	
118-13	21035-21036	)	_	
118-14	21037-21040	was	_	
118-15	21041-21045	used	_	
118-16	21046-21048	to	_	
118-17	21049-21055	assess	_	
118-18	21056-21059	the	_	
118-19	21060-21069	relations	_	
118-20	21070-21075	among	_	
118-21	21076-21079	the	_	
118-22	21080-21089	variables	_	
118-23	21090-21099	including	_	
118-24	21100-21106	neural	_	
118-25	21107-21115	activity	_	
118-26	21116-21119	and	_	
118-27	21120-21123	IMI	_	
118-28	21124-21127	and	_	
118-29	21128-21131	the	_	
118-30	21132-21142	behavioral	_	
118-31	21143-21147	data	_	
118-32	21148-21156	obtained	_	
118-33	21157-21159	in	_	
118-34	21160-21164	this	_	
118-35	21165-21170	study	_	
118-36	21170-21171	.	_	

#Text=We selected maximum-likelihood with robust standard error (MLR) as the method of estimation.
119-1	21172-21174	We	_	
119-2	21175-21183	selected	_	
119-3	21184-21202	maximum-likelihood	_	
119-4	21203-21207	with	_	
119-5	21208-21214	robust	_	
119-6	21215-21223	standard	_	
119-7	21224-21229	error	_	
119-8	21230-21231	(	_	
119-9	21231-21234	MLR	_	
119-10	21234-21235	)	_	
119-11	21236-21238	as	_	
119-12	21239-21242	the	_	
119-13	21243-21249	method	_	
119-14	21250-21252	of	_	
119-15	21253-21263	estimation	_	
119-16	21263-21264	.	_	

#Text=These analyses were conducted in M-plus v.7.31.
120-1	21265-21270	These	_	
120-2	21271-21279	analyses	_	
120-3	21280-21284	were	_	
120-4	21285-21294	conducted	_	
120-5	21295-21297	in	_	
120-6	21298-21304	M-plus	_	
120-7	21305-21306	v	_	
120-8	21306-21311	.7.31	_	
120-9	21311-21312	.	_	

#Text=To investigate the translational process of motivational information elicited in the striatum into action plans produced in the LPFC, we prioritized the flow of information from the striatum to LPFC in the path analysis.
121-1	21313-21315	To	_	
121-2	21316-21327	investigate	_	
121-3	21328-21331	the	_	
121-4	21332-21345	translational	_	
121-5	21346-21353	process	_	
121-6	21354-21356	of	_	
121-7	21357-21369	motivational	_	
121-8	21370-21381	information	_	
121-9	21382-21390	elicited	_	
121-10	21391-21393	in	_	
121-11	21394-21397	the	_	
121-12	21398-21406	striatum	_	
121-13	21407-21411	into	_	
121-14	21412-21418	action	_	
121-15	21419-21424	plans	_	
121-16	21425-21433	produced	_	
121-17	21434-21436	in	_	
121-18	21437-21440	the	_	
121-19	21441-21445	LPFC	_	
121-20	21445-21446	,	_	
121-21	21447-21449	we	_	
121-22	21450-21461	prioritized	_	
121-23	21462-21465	the	_	
121-24	21466-21470	flow	_	
121-25	21471-21473	of	_	
121-26	21474-21485	information	_	
121-27	21486-21490	from	_	
121-28	21491-21494	the	_	
121-29	21495-21503	striatum	_	
121-30	21504-21506	to	_	
121-31	21507-21511	LPFC	_	
121-32	21512-21514	in	_	
121-33	21515-21518	the	_	
121-34	21519-21523	path	_	
121-35	21524-21532	analysis	_	
121-36	21532-21533	.	_	

#Text=However, we also examined the opposite flow of information from LPFC to the striatum.
122-1	21534-21541	However	_	
122-2	21541-21542	,	_	
122-3	21543-21545	we	_	
122-4	21546-21550	also	_	
122-5	21551-21559	examined	_	
122-6	21560-21563	the	_	
122-7	21564-21572	opposite	_	
122-8	21573-21577	flow	_	
122-9	21578-21580	of	_	
122-10	21581-21592	information	_	
122-11	21593-21597	from	_	
122-12	21598-21602	LPFC	_	
122-13	21603-21605	to	_	
122-14	21606-21609	the	_	
122-15	21610-21618	striatum	_	
122-16	21618-21619	.	_	

#Text=Using four observed variables, we analyzed an unconstrained model and assessed the model’ fit with SCZ and HC data, respectively.
123-1	21620-21625	Using	_	
123-2	21626-21630	four	_	
123-3	21631-21639	observed	_	
123-4	21640-21649	variables	_	
123-5	21649-21650	,	_	
123-6	21651-21653	we	_	
123-7	21654-21662	analyzed	_	
123-8	21663-21665	an	_	
123-9	21666-21679	unconstrained	_	
123-10	21680-21685	model	_	
123-11	21686-21689	and	_	
123-12	21690-21698	assessed	_	
123-13	21699-21702	the	_	
123-14	21703-21708	model	_	
123-15	21708-21709	’	_	
123-16	21710-21713	fit	_	
123-17	21714-21718	with	_	
123-18	21719-21722	SCZ	_	
123-19	21723-21726	and	_	
123-20	21727-21729	HC	_	
123-21	21730-21734	data	_	
123-22	21734-21735	,	_	
123-23	21736-21748	respectively	_	
123-24	21748-21749	.	_	

#Text=Fit was assessed using the χ2 goodness of fit index, Akaike's information criteria (AIC), Bayesian information criteria (BIC), the comparative fit index (CFI), and the standardized root mean square residual (SRMR).
124-1	21750-21753	Fit	_	
124-2	21754-21757	was	_	
124-3	21758-21766	assessed	_	
124-4	21767-21772	using	_	
124-5	21773-21776	the	_	
124-6	21777-21779	χ2	_	
124-7	21780-21788	goodness	_	
124-8	21789-21791	of	_	
124-9	21792-21795	fit	_	
124-10	21796-21801	index	_	
124-11	21801-21802	,	_	
124-12	21803-21811	Akaike's	_	
124-13	21812-21823	information	_	
124-14	21824-21832	criteria	_	
124-15	21833-21834	(	_	
124-16	21834-21837	AIC	_	
124-17	21837-21838	)	_	
124-18	21838-21839	,	_	
124-19	21840-21848	Bayesian	_	
124-20	21849-21860	information	_	
124-21	21861-21869	criteria	_	
124-22	21870-21871	(	_	
124-23	21871-21874	BIC	_	
124-24	21874-21875	)	_	
124-25	21875-21876	,	_	
124-26	21877-21880	the	_	
124-27	21881-21892	comparative	_	
124-28	21893-21896	fit	_	
124-29	21897-21902	index	_	
124-30	21903-21904	(	_	
124-31	21904-21907	CFI	_	
124-32	21907-21908	)	_	
124-33	21908-21909	,	_	
124-34	21910-21913	and	_	
124-35	21914-21917	the	_	
124-36	21918-21930	standardized	_	
124-37	21931-21935	root	_	
124-38	21936-21940	mean	_	
124-39	21941-21947	square	_	
124-40	21948-21956	residual	_	
124-41	21957-21958	(	_	
124-42	21958-21962	SRMR	_	
124-43	21962-21963	)	_	
124-44	21963-21964	.	_	

#Text=Criteria for assessing model fit included: p value of χ2 (df) ≥ 0.05; CFI ≥ 0.95; and SRMR ≤ 0.1.
125-1	21965-21973	Criteria	_	
125-2	21974-21977	for	_	
125-3	21978-21987	assessing	_	
125-4	21988-21993	model	_	
125-5	21994-21997	fit	_	
125-6	21998-22006	included	_	
125-7	22006-22007	:	_	
125-8	22008-22009	p	_	
125-9	22010-22015	value	_	
125-10	22016-22018	of	_	
125-11	22019-22021	χ2	_	
125-12	22022-22023	(	_	
125-13	22023-22025	df	_	
125-14	22025-22026	)	_	
125-15	22026-22027	 	_	
125-16	22027-22028	≥	_	
125-17	22028-22029	 	_	
125-18	22029-22033	0.05	_	
125-19	22033-22034	;	_	
125-20	22035-22038	CFI	_	
125-21	22038-22039	 	_	
125-22	22039-22040	≥	_	
125-23	22040-22041	 	_	
125-24	22041-22045	0.95	_	
125-25	22045-22046	;	_	
125-26	22047-22050	and	_	
125-27	22051-22055	SRMR	_	
125-28	22055-22056	 	_	
125-29	22056-22057	≤	_	
125-30	22057-22058	 	_	
125-31	22058-22061	0.1	_	
125-32	22061-22062	.	_	

#Text=If the estimates of the model were different in SCZ and HC, we performed multiple-group structural equation modeling (MGSEM) to examine the validity.
126-1	22063-22065	If	_	
126-2	22066-22069	the	_	
126-3	22070-22079	estimates	_	
126-4	22080-22082	of	_	
126-5	22083-22086	the	_	
126-6	22087-22092	model	_	
126-7	22093-22097	were	_	
126-8	22098-22107	different	_	
126-9	22108-22110	in	_	
126-10	22111-22114	SCZ	_	
126-11	22115-22118	and	_	
126-12	22119-22121	HC	_	
126-13	22121-22122	,	_	
126-14	22123-22125	we	_	
126-15	22126-22135	performed	_	
126-16	22136-22150	multiple-group	_	
126-17	22151-22161	structural	_	
126-18	22162-22170	equation	_	
126-19	22171-22179	modeling	_	
126-20	22180-22181	(	_	
126-21	22181-22186	MGSEM	_	
126-22	22186-22187	)	_	
126-23	22188-22190	to	_	
126-24	22191-22198	examine	_	
126-25	22199-22202	the	_	
126-26	22203-22211	validity	_	
126-27	22211-22212	.	_	

#Text=Specifically, we compared the fit between two models by examining the change on the model fit indices: the model where loadings samples in the SCZ and HC were constrained to be equal and the other model where they were allowed to differ (unconstrained) using the likelihood ratio test (a 2 difference test).
127-1	22213-22225	Specifically	_	
127-2	22225-22226	,	_	
127-3	22227-22229	we	_	
127-4	22230-22238	compared	_	
127-5	22239-22242	the	_	
127-6	22243-22246	fit	_	
127-7	22247-22254	between	_	
127-8	22255-22258	two	_	
127-9	22259-22265	models	_	
127-10	22266-22268	by	_	
127-11	22269-22278	examining	_	
127-12	22279-22282	the	_	
127-13	22283-22289	change	_	
127-14	22290-22292	on	_	
127-15	22293-22296	the	_	
127-16	22297-22302	model	_	
127-17	22303-22306	fit	_	
127-18	22307-22314	indices	_	
127-19	22314-22315	:	_	
127-20	22316-22319	the	_	
127-21	22320-22325	model	_	
127-22	22326-22331	where	_	
127-23	22332-22340	loadings	_	
127-24	22341-22348	samples	_	
127-25	22349-22351	in	_	
127-26	22352-22355	the	_	
127-27	22356-22359	SCZ	_	
127-28	22360-22363	and	_	
127-29	22364-22366	HC	_	
127-30	22367-22371	were	_	
127-31	22372-22383	constrained	_	
127-32	22384-22386	to	_	
127-33	22387-22389	be	_	
127-34	22390-22395	equal	_	
127-35	22396-22399	and	_	
127-36	22400-22403	the	_	
127-37	22404-22409	other	_	
127-38	22410-22415	model	_	
127-39	22416-22421	where	_	
127-40	22422-22426	they	_	
127-41	22427-22431	were	_	
127-42	22432-22439	allowed	_	
127-43	22440-22442	to	_	
127-44	22443-22449	differ	_	
127-45	22450-22451	(	_	
127-46	22451-22464	unconstrained	_	
127-47	22464-22465	)	_	
127-48	22466-22471	using	_	
127-49	22472-22475	the	_	
127-50	22476-22486	likelihood	_	
127-51	22487-22492	ratio	_	
127-52	22493-22497	test	_	
127-53	22498-22499	(	_	
127-54	22499-22500	a	_	
127-55	22501-22502	2	_	
127-56	22503-22513	difference	_	
127-57	22514-22518	test	_	
127-58	22518-22519	)	_	
127-59	22519-22520	.	_	

#Text=In the present study, we compared the fit between the unconstrained model and the model constrained to be equal to the observed and error variables.
128-1	22521-22523	In	_	
128-2	22524-22527	the	_	
128-3	22528-22535	present	_	
128-4	22536-22541	study	_	
128-5	22541-22542	,	_	
128-6	22543-22545	we	_	
128-7	22546-22554	compared	_	
128-8	22555-22558	the	_	
128-9	22559-22562	fit	_	
128-10	22563-22570	between	_	
128-11	22571-22574	the	_	
128-12	22575-22588	unconstrained	_	
128-13	22589-22594	model	_	
128-14	22595-22598	and	_	
128-15	22599-22602	the	_	
128-16	22603-22608	model	_	
128-17	22609-22620	constrained	_	
128-18	22621-22623	to	_	
128-19	22624-22626	be	_	
128-20	22627-22632	equal	_	
128-21	22633-22635	to	_	
128-22	22636-22639	the	_	
128-23	22640-22648	observed	_	
128-24	22649-22652	and	_	
128-25	22653-22658	error	_	
128-26	22659-22668	variables	_	
128-27	22668-22669	.	_	

#Text=To perform the likelihood ratio test for MLR, we calculated the χ2 value of Satorra-Bentler (M-plus website: https://www.statmodel.com/chidiff.shtml).
129-1	22670-22672	To	_	
129-2	22673-22680	perform	_	
129-3	22681-22684	the	_	
129-4	22685-22695	likelihood	_	
129-5	22696-22701	ratio	_	
129-6	22702-22706	test	_	
129-7	22707-22710	for	_	
129-8	22711-22714	MLR	_	
129-9	22714-22715	,	_	
129-10	22716-22718	we	_	
129-11	22719-22729	calculated	_	
129-12	22730-22733	the	_	
129-13	22734-22736	χ2	_	
129-14	22737-22742	value	_	
129-15	22743-22745	of	_	
129-16	22746-22761	Satorra-Bentler	_	
129-17	22762-22763	(	_	
129-18	22763-22769	M-plus	_	
129-19	22770-22777	website	_	
129-20	22777-22778	:	_	
129-21	22779-22784	https	_	
129-22	22784-22785	:	_	
129-23	22785-22786	/	_	
129-24	22786-22787	/	_	
129-25	22787-22804	www.statmodel.com	_	
129-26	22804-22805	/	_	
129-27	22805-22818	chidiff.shtml	_	
129-28	22818-22819	)	_	
129-29	22819-22820	.	_	

#Text=The Satorra-Bentler scaled chi-square difference test TRd computed as follows;where T0 and T1 are the MLR chi-square values for the nested and comparison model, respectively.
130-1	22821-22824	The	_	
130-2	22825-22840	Satorra-Bentler	_	
130-3	22841-22847	scaled	_	
130-4	22848-22858	chi-square	_	
130-5	22859-22869	difference	_	
130-6	22870-22874	test	_	
130-7	22875-22878	TRd	_	
130-8	22879-22887	computed	_	
130-9	22888-22890	as	_	
130-10	22891-22898	follows	_	
130-11	22898-22899	;	_	
130-12	22899-22904	where	_	
130-13	22905-22907	T0	_	
130-14	22908-22911	and	_	
130-15	22912-22914	T1	_	
130-16	22915-22918	are	_	
130-17	22919-22922	the	_	
130-18	22923-22926	MLR	_	
130-19	22927-22937	chi-square	_	
130-20	22938-22944	values	_	
130-21	22945-22948	for	_	
130-22	22949-22952	the	_	
130-23	22953-22959	nested	_	
130-24	22960-22963	and	_	
130-25	22964-22974	comparison	_	
130-26	22975-22980	model	_	
130-27	22980-22981	,	_	
130-28	22982-22994	respectively	_	
130-29	22994-22995	.	_	

#Text=The difference test scaling correction (cd) was computed as follows;where d0 is the degrees of freedom in the nested model, c0 is the scaling correction factor for the nested model, d1 is the degrees of freedom in the comparison model, and c1 is the scaling correction factor for the comparison model.
131-1	22996-22999	The	_	
131-2	23000-23010	difference	_	
131-3	23011-23015	test	_	
131-4	23016-23023	scaling	_	
131-5	23024-23034	correction	_	
131-6	23035-23036	(	_	
131-7	23036-23038	cd	_	
131-8	23038-23039	)	_	
131-9	23040-23043	was	_	
131-10	23044-23052	computed	_	
131-11	23053-23055	as	_	
131-12	23056-23063	follows	_	
131-13	23063-23064	;	_	
131-14	23064-23069	where	_	
131-15	23070-23072	d0	_	
131-16	23073-23075	is	_	
131-17	23076-23079	the	_	
131-18	23080-23087	degrees	_	
131-19	23088-23090	of	_	
131-20	23091-23098	freedom	_	
131-21	23099-23101	in	_	
131-22	23102-23105	the	_	
131-23	23106-23112	nested	_	
131-24	23113-23118	model	_	
131-25	23118-23119	,	_	
131-26	23120-23122	c0	_	
131-27	23123-23125	is	_	
131-28	23126-23129	the	_	
131-29	23130-23137	scaling	_	
131-30	23138-23148	correction	_	
131-31	23149-23155	factor	_	
131-32	23156-23159	for	_	
131-33	23160-23163	the	_	
131-34	23164-23170	nested	_	
131-35	23171-23176	model	_	
131-36	23176-23177	,	_	
131-37	23178-23180	d1	_	
131-38	23181-23183	is	_	
131-39	23184-23187	the	_	
131-40	23188-23195	degrees	_	
131-41	23196-23198	of	_	
131-42	23199-23206	freedom	_	
131-43	23207-23209	in	_	
131-44	23210-23213	the	_	
131-45	23214-23224	comparison	_	
131-46	23225-23230	model	_	
131-47	23230-23231	,	_	
131-48	23232-23235	and	_	
131-49	23236-23238	c1	_	
131-50	23239-23241	is	_	
131-51	23242-23245	the	_	
131-52	23246-23253	scaling	_	
131-53	23254-23264	correction	_	
131-54	23265-23271	factor	_	
131-55	23272-23275	for	_	
131-56	23276-23279	the	_	
131-57	23280-23290	comparison	_	
131-58	23291-23296	model	_	
131-59	23296-23297	.	_	

#Text=Statistical analysis
#Text=PASW Statistics version 18.0 (SPSS, Chicago, IL, USA) was used for the analysis, and the level of significance was set at 0.05.
132-1	23298-23309	Statistical	_	
132-2	23310-23318	analysis	_	
132-3	23319-23323	PASW	_	
132-4	23324-23334	Statistics	_	
132-5	23335-23342	version	_	
132-6	23343-23347	18.0	_	
132-7	23348-23349	(	_	
132-8	23349-23353	SPSS	_	
132-9	23353-23354	,	_	
132-10	23355-23362	Chicago	_	
132-11	23362-23363	,	_	
132-12	23364-23366	IL	_	
132-13	23366-23367	,	_	
132-14	23368-23371	USA	_	
132-15	23371-23372	)	_	
132-16	23373-23376	was	_	
132-17	23377-23381	used	_	
132-18	23382-23385	for	_	
132-19	23386-23389	the	_	
132-20	23390-23398	analysis	_	
132-21	23398-23399	,	_	
132-22	23400-23403	and	_	
132-23	23404-23407	the	_	
132-24	23408-23413	level	_	
132-25	23414-23416	of	_	
132-26	23417-23429	significance	_	
132-27	23430-23433	was	_	
132-28	23434-23437	set	_	
132-29	23438-23440	at	_	
132-30	23441-23445	0.05	_	
132-31	23445-23446	.	_	

#Text=Mann-Whitney U test was used to explore between-group differences for the demographic and clinical characteristics, the correct trials, the mean RT, and the IMI scores.
133-1	23447-23459	Mann-Whitney	_	
133-2	23460-23461	U	_	
133-3	23462-23466	test	_	
133-4	23467-23470	was	_	
133-5	23471-23475	used	_	
133-6	23476-23478	to	_	
133-7	23479-23486	explore	_	
133-8	23487-23500	between-group	_	
133-9	23501-23512	differences	_	
133-10	23513-23516	for	_	
133-11	23517-23520	the	_	
133-12	23521-23532	demographic	_	
133-13	23533-23536	and	_	
133-14	23537-23545	clinical	_	
133-15	23546-23561	characteristics	_	
133-16	23561-23562	,	_	
133-17	23563-23566	the	_	
133-18	23567-23574	correct	_	
133-19	23575-23581	trials	_	
133-20	23581-23582	,	_	
133-21	23583-23586	the	_	
133-22	23587-23591	mean	_	
133-23	23592-23594	RT	_	
133-24	23594-23595	,	_	
133-25	23596-23599	and	_	
133-26	23600-23603	the	_	
133-27	23604-23607	IMI	_	
133-28	23608-23614	scores	_	
133-29	23614-23615	.	_	

#Text=Two-way mixed ANOVA was used to examine between-group differences for the mean TE, the performance level following Undershoot or Overshoot trials.
134-1	23616-23623	Two-way	_	
134-2	23624-23629	mixed	_	
134-3	23630-23635	ANOVA	_	
134-4	23636-23639	was	_	
134-5	23640-23644	used	_	
134-6	23645-23647	to	_	
134-7	23648-23655	examine	_	
134-8	23656-23669	between-group	_	
134-9	23670-23681	differences	_	
134-10	23682-23685	for	_	
134-11	23686-23689	the	_	
134-12	23690-23694	mean	_	
134-13	23695-23697	TE	_	
134-14	23697-23698	,	_	
134-15	23699-23702	the	_	
134-16	23703-23714	performance	_	
134-17	23715-23720	level	_	
134-18	23721-23730	following	_	
134-19	23731-23741	Undershoot	_	
134-20	23742-23744	or	_	
134-21	23745-23754	Overshoot	_	
134-22	23755-23761	trials	_	
134-23	23761-23762	.	_	

#Text=Pearson's r was calculated for each group to examine the correlation between the performance and the difference of IMI scores in the SW and WS tasks.
135-1	23763-23772	Pearson's	_	
135-2	23773-23774	r	_	
135-3	23775-23778	was	_	
135-4	23779-23789	calculated	_	
135-5	23790-23793	for	_	
135-6	23794-23798	each	_	
135-7	23799-23804	group	_	
135-8	23805-23807	to	_	
135-9	23808-23815	examine	_	
135-10	23816-23819	the	_	
135-11	23820-23831	correlation	_	
135-12	23832-23839	between	_	
135-13	23840-23843	the	_	
135-14	23844-23855	performance	_	
135-15	23856-23859	and	_	
135-16	23860-23863	the	_	
135-17	23864-23874	difference	_	
135-18	23875-23877	of	_	
135-19	23878-23881	IMI	_	
135-20	23882-23888	scores	_	
135-21	23889-23891	in	_	
135-22	23892-23895	the	_	
135-23	23896-23898	SW	_	
135-24	23899-23902	and	_	
135-25	23903-23905	WS	_	
135-26	23906-23911	tasks	_	
135-27	23911-23912	.	_	

#Text=The fMRI data were analyzed as described above in the fMRI data analysis section.
136-1	23913-23916	The	_	
136-2	23917-23921	fMRI	_	
136-3	23922-23926	data	_	
136-4	23927-23931	were	_	
136-5	23932-23940	analyzed	_	
136-6	23941-23943	as	_	
136-7	23944-23953	described	_	
136-8	23954-23959	above	_	
136-9	23960-23962	in	_	
136-10	23963-23966	the	_	
136-11	23967-23971	fMRI	_	
136-12	23972-23976	data	_	
136-13	23977-23985	analysis	_	
136-14	23986-23993	section	_	
136-15	23993-23994	.	_	

#Text=Pearson's r was calculated for each group to examine the correlation between the activation in the striatum or LPFC and the difference of IMI scores between the SW and WS tasks, and the correlation between the activation in the striatum or LPFC and the rate of Success SW trials following Undershoot or Overshoot trials.
137-1	23995-24004	Pearson's	_	
137-2	24005-24006	r	_	
137-3	24007-24010	was	_	
137-4	24011-24021	calculated	_	
137-5	24022-24025	for	_	
137-6	24026-24030	each	_	
137-7	24031-24036	group	_	
137-8	24037-24039	to	_	
137-9	24040-24047	examine	_	
137-10	24048-24051	the	_	
137-11	24052-24063	correlation	_	
137-12	24064-24071	between	_	
137-13	24072-24075	the	_	
137-14	24076-24086	activation	_	
137-15	24087-24089	in	_	
137-16	24090-24093	the	_	
137-17	24094-24102	striatum	_	
137-18	24103-24105	or	_	
137-19	24106-24110	LPFC	_	
137-20	24111-24114	and	_	
137-21	24115-24118	the	_	
137-22	24119-24129	difference	_	
137-23	24130-24132	of	_	
137-24	24133-24136	IMI	_	
137-25	24137-24143	scores	_	
137-26	24144-24151	between	_	
137-27	24152-24155	the	_	
137-28	24156-24158	SW	_	
137-29	24159-24162	and	_	
137-30	24163-24165	WS	_	
137-31	24166-24171	tasks	_	
137-32	24171-24172	,	_	
137-33	24173-24176	and	_	
137-34	24177-24180	the	_	
137-35	24181-24192	correlation	_	
137-36	24193-24200	between	_	
137-37	24201-24204	the	_	
137-38	24205-24215	activation	_	
137-39	24216-24218	in	_	
137-40	24219-24222	the	_	
137-41	24223-24231	striatum	_	
137-42	24232-24234	or	_	
137-43	24235-24239	LPFC	_	
137-44	24240-24243	and	_	
137-45	24244-24247	the	_	
137-46	24248-24252	rate	_	
137-47	24253-24255	of	_	
137-48	24256-24263	Success	_	
137-49	24264-24266	SW	_	
137-50	24267-24273	trials	_	
137-51	24274-24283	following	_	
137-52	24284-24294	Undershoot	_	
137-53	24295-24297	or	_	
137-54	24298-24307	Overshoot	_	
137-55	24308-24314	trials	_	
137-56	24314-24315	.	_	

#Text=In addition, Pearson's r was calculated between the IMI(SW-WS), performance level, error correction, striatum, LPFC β(SW-WS) and Chlorpromazine (CP) equivalent daily dosage of antipsychotics and Positive and Negative Syndrome Scale (PANSS) negative scores.
138-1	24316-24318	In	_	
138-2	24319-24327	addition	_	
138-3	24327-24328	,	_	
138-4	24329-24338	Pearson's	_	
138-5	24339-24340	r	_	
138-6	24341-24344	was	_	
138-7	24345-24355	calculated	_	
138-8	24356-24363	between	_	
138-9	24364-24367	the	_	
138-10	24368-24371	IMI	_	
138-11	24371-24372	(	_	
138-12	24372-24377	SW-WS	_	
138-13	24377-24378	)	_	
138-14	24378-24379	,	_	
138-15	24380-24391	performance	_	
138-16	24392-24397	level	_	
138-17	24397-24398	,	_	
138-18	24399-24404	error	_	
138-19	24405-24415	correction	_	
138-20	24415-24416	,	_	
138-21	24417-24425	striatum	_	
138-22	24425-24426	,	_	
138-23	24427-24431	LPFC	_	
138-24	24432-24433	β	_	
138-25	24433-24434	(	_	
138-26	24434-24439	SW-WS	_	
138-27	24439-24440	)	_	
138-28	24441-24444	and	_	
138-29	24445-24459	Chlorpromazine	_	
138-30	24460-24461	(	_	
138-31	24461-24463	CP	_	
138-32	24463-24464	)	_	
138-33	24465-24475	equivalent	_	
138-34	24476-24481	daily	_	
138-35	24482-24488	dosage	_	
138-36	24489-24491	of	_	
138-37	24492-24506	antipsychotics	_	
138-38	24507-24510	and	_	
138-39	24511-24519	Positive	_	
138-40	24520-24523	and	_	
138-41	24524-24532	Negative	_	
138-42	24533-24541	Syndrome	_	
138-43	24542-24547	Scale	_	
138-44	24548-24549	(	_	
138-45	24549-24554	PANSS	_	
138-46	24554-24555	)	_	
138-47	24556-24564	negative	_	
138-48	24565-24571	scores	_	
138-49	24571-24572	.	_	

#Text=Multiplicity of statistical analyses was corrected using Bonferroni for each test.
139-1	24573-24585	Multiplicity	_	
139-2	24586-24588	of	_	
139-3	24589-24600	statistical	_	
139-4	24601-24609	analyses	_	
139-5	24610-24613	was	_	
139-6	24614-24623	corrected	_	
139-7	24624-24629	using	_	
139-8	24630-24640	Bonferroni	_	
139-9	24641-24644	for	_	
139-10	24645-24649	each	_	
139-11	24650-24654	test	_	
139-12	24654-24655	.	_	

#Text=Results
#Text=Behavioral indices
#Text=Numbers of success trials in the SW task were not significantly different between groups (Fig. 1B, z = 1.58, p = 0.11, Mann-Whitney U test), indicating that SCZ and HC participants performed the SW task equally well.
140-1	24656-24663	Results	_	
140-2	24664-24674	Behavioral	_	
140-3	24675-24682	indices	_	
140-4	24683-24690	Numbers	_	
140-5	24691-24693	of	_	
140-6	24694-24701	success	_	
140-7	24702-24708	trials	_	
140-8	24709-24711	in	_	
140-9	24712-24715	the	_	
140-10	24716-24718	SW	_	
140-11	24719-24723	task	_	
140-12	24724-24728	were	_	
140-13	24729-24732	not	_	
140-14	24733-24746	significantly	_	
140-15	24747-24756	different	_	
140-16	24757-24764	between	_	
140-17	24765-24771	groups	_	
140-18	24772-24773	(	_	
140-19	24773-24776	Fig	_	
140-20	24776-24777	.	_	
140-21	24778-24780	1B	_	
140-22	24780-24781	,	_	
140-23	24782-24783	z	_	
140-24	24783-24784	 	_	
140-25	24784-24785	=	_	
140-26	24785-24786	 	_	
140-27	24786-24790	1.58	_	
140-28	24790-24791	,	_	
140-29	24792-24793	p	_	
140-30	24793-24794	 	_	
140-31	24794-24795	=	_	
140-32	24795-24796	 	_	
140-33	24796-24800	0.11	_	
140-34	24800-24801	,	_	
140-35	24802-24814	Mann-Whitney	_	
140-36	24815-24816	U	_	
140-37	24817-24821	test	_	
140-38	24821-24822	)	_	
140-39	24822-24823	,	_	
140-40	24824-24834	indicating	_	
140-41	24835-24839	that	_	
140-42	24840-24843	SCZ	_	
140-43	24844-24847	and	_	
140-44	24848-24850	HC	_	
140-45	24851-24863	participants	_	
140-46	24864-24873	performed	_	
140-47	24874-24877	the	_	
140-48	24878-24880	SW	_	
140-49	24881-24885	task	_	
140-50	24886-24893	equally	_	
140-51	24894-24898	well	_	
140-52	24898-24899	.	_	

#Text=The reaction times (RTs) in the WS task were not significantly different between groups (Supplementary Table 1), indicating that SCZ were not impaired in simple reaction time.
141-1	24900-24903	The	_	
141-2	24904-24912	reaction	_	
141-3	24913-24918	times	_	
141-4	24919-24920	(	_	
141-5	24920-24923	RTs	_	
141-6	24923-24924	)	_	
141-7	24925-24927	in	_	
141-8	24928-24931	the	_	
141-9	24932-24934	WS	_	
141-10	24935-24939	task	_	
141-11	24940-24944	were	_	
141-12	24945-24948	not	_	
141-13	24949-24962	significantly	_	
141-14	24963-24972	different	_	
141-15	24973-24980	between	_	
141-16	24981-24987	groups	_	
141-17	24988-24989	(	_	
141-18	24989-25002	Supplementary	_	
141-19	25003-25008	Table	_	
141-20	25009-25010	1	_	
141-21	25010-25011	)	_	
141-22	25011-25012	,	_	
141-23	25013-25023	indicating	_	
141-24	25024-25028	that	_	
141-25	25029-25032	SCZ	_	
141-26	25033-25037	were	_	
141-27	25038-25041	not	_	
141-28	25042-25050	impaired	_	
141-29	25051-25053	in	_	
141-30	25054-25060	simple	_	
141-31	25061-25069	reaction	_	
141-32	25070-25074	time	_	
141-33	25074-25075	.	_	

#Text=The TEs in the SW task tended to be faster in SCZ (Supplementary Table 1).
142-1	25076-25079	The	_	
142-2	25080-25083	TEs	_	
142-3	25084-25086	in	_	
142-4	25087-25090	the	_	
142-5	25091-25093	SW	_	
142-6	25094-25098	task	_	
142-7	25099-25105	tended	_	
142-8	25106-25108	to	_	
142-9	25109-25111	be	_	
142-10	25112-25118	faster	_	
142-11	25119-25121	in	_	
142-12	25122-25125	SCZ	_	
142-13	25126-25127	(	_	
142-14	25127-25140	Supplementary	_	
142-15	25141-25146	Table	_	
142-16	25147-25148	1	_	
142-17	25148-25149	)	_	
142-18	25149-25150	.	_	

#Text=Moreover, the task performance was not correlated with the CP equivalent daily dosage of antipsychotics or the PANSS negative scores (Supplementary Table 2).
143-1	25151-25159	Moreover	_	
143-2	25159-25160	,	_	
143-3	25161-25164	the	_	
143-4	25165-25169	task	_	
143-5	25170-25181	performance	_	
143-6	25182-25185	was	_	
143-7	25186-25189	not	_	
143-8	25190-25200	correlated	_	
143-9	25201-25205	with	_	
143-10	25206-25209	the	_	
143-11	25210-25212	CP	_	
143-12	25213-25223	equivalent	_	
143-13	25224-25229	daily	_	
143-14	25230-25236	dosage	_	
143-15	25237-25239	of	_	
143-16	25240-25254	antipsychotics	_	
143-17	25255-25257	or	_	
143-18	25258-25261	the	_	
143-19	25262-25267	PANSS	_	
143-20	25268-25276	negative	_	
143-21	25277-25283	scores	_	
143-22	25284-25285	(	_	
143-23	25285-25298	Supplementary	_	
143-24	25299-25304	Table	_	
143-25	25305-25306	2	_	
143-26	25306-25307	)	_	
143-27	25307-25308	.	_	

#Text=Intrinsic motivational measurement
#Text=The IMI scores for the SW task were significantly higher than those for the WS task in both groups (SCZ: z = 2.04, p = 0.04; HC: z = 3.07, p = 0.002, Wilcoxon signed-rank test), indicating that both groups were more motivated by the SW task than the WS task.
144-1	25309-25318	Intrinsic	_	
144-2	25319-25331	motivational	_	
144-3	25332-25343	measurement	_	
144-4	25344-25347	The	_	
144-5	25348-25351	IMI	_	
144-6	25352-25358	scores	_	
144-7	25359-25362	for	_	
144-8	25363-25366	the	_	
144-9	25367-25369	SW	_	
144-10	25370-25374	task	_	
144-11	25375-25379	were	_	
144-12	25380-25393	significantly	_	
144-13	25394-25400	higher	_	
144-14	25401-25405	than	_	
144-15	25406-25411	those	_	
144-16	25412-25415	for	_	
144-17	25416-25419	the	_	
144-18	25420-25422	WS	_	
144-19	25423-25427	task	_	
144-20	25428-25430	in	_	
144-21	25431-25435	both	_	
144-22	25436-25442	groups	_	
144-23	25443-25444	(	_	
144-24	25444-25447	SCZ	_	
144-25	25447-25448	:	_	
144-26	25449-25450	z	_	
144-27	25450-25451	 	_	
144-28	25451-25452	=	_	
144-29	25452-25453	 	_	
144-30	25453-25457	2.04	_	
144-31	25457-25458	,	_	
144-32	25459-25460	p	_	
144-33	25460-25461	 	_	
144-34	25461-25462	=	_	
144-35	25462-25463	 	_	
144-36	25463-25467	0.04	_	
144-37	25467-25468	;	_	
144-38	25469-25471	HC	_	
144-39	25471-25472	:	_	
144-40	25473-25474	z	_	
144-41	25474-25475	 	_	
144-42	25475-25476	=	_	
144-43	25476-25477	 	_	
144-44	25477-25481	3.07	_	
144-45	25481-25482	,	_	
144-46	25483-25484	p	_	
144-47	25484-25485	 	_	
144-48	25485-25486	=	_	
144-49	25486-25487	 	_	
144-50	25487-25492	0.002	_	
144-51	25492-25493	,	_	
144-52	25494-25502	Wilcoxon	_	
144-53	25503-25514	signed-rank	_	
144-54	25515-25519	test	_	
144-55	25519-25520	)	_	
144-56	25520-25521	,	_	
144-57	25522-25532	indicating	_	
144-58	25533-25537	that	_	
144-59	25538-25542	both	_	
144-60	25543-25549	groups	_	
144-61	25550-25554	were	_	
144-62	25555-25559	more	_	
144-63	25560-25569	motivated	_	
144-64	25570-25572	by	_	
144-65	25573-25576	the	_	
144-66	25577-25579	SW	_	
144-67	25580-25584	task	_	
144-68	25585-25589	than	_	
144-69	25590-25593	the	_	
144-70	25594-25596	WS	_	
144-71	25597-25601	task	_	
144-72	25601-25602	.	_	

#Text=We took the IMI for the SW task subtracted by that for WS task (referred to as IMI(SW-WS)) as a measure of the intrinsic motivation attributed to the components specific to the SW task.
145-1	25603-25605	We	_	
145-2	25606-25610	took	_	
145-3	25611-25614	the	_	
145-4	25615-25618	IMI	_	
145-5	25619-25622	for	_	
145-6	25623-25626	the	_	
145-7	25627-25629	SW	_	
145-8	25630-25634	task	_	
145-9	25635-25645	subtracted	_	
145-10	25646-25648	by	_	
145-11	25649-25653	that	_	
145-12	25654-25657	for	_	
145-13	25658-25660	WS	_	
145-14	25661-25665	task	_	
145-15	25666-25667	(	_	
145-16	25667-25675	referred	_	
145-17	25676-25678	to	_	
145-18	25679-25681	as	_	
145-19	25682-25685	IMI	_	
145-20	25685-25686	(	_	
145-21	25686-25691	SW-WS	_	
145-22	25691-25692	)	_	
145-23	25692-25693	)	_	
145-24	25694-25696	as	_	
145-25	25697-25698	a	_	
145-26	25699-25706	measure	_	
145-27	25707-25709	of	_	
145-28	25710-25713	the	_	
145-29	25714-25723	intrinsic	_	
145-30	25724-25734	motivation	_	
145-31	25735-25745	attributed	_	
145-32	25746-25748	to	_	
145-33	25749-25752	the	_	
145-34	25753-25763	components	_	
145-35	25764-25772	specific	_	
145-36	25773-25775	to	_	
145-37	25776-25779	the	_	
145-38	25780-25782	SW	_	
145-39	25783-25787	task	_	
145-40	25787-25788	.	_	

#Text=The IMI(SW-WS) was significantly lower in the SCZ group (Fig. 1C, z = 2.14, p = 0.03, Mann-Whitney U test).
146-1	25789-25792	The	_	
146-2	25793-25796	IMI	_	
146-3	25796-25797	(	_	
146-4	25797-25802	SW-WS	_	
146-5	25802-25803	)	_	
146-6	25804-25807	was	_	
146-7	25808-25821	significantly	_	
146-8	25822-25827	lower	_	
146-9	25828-25830	in	_	
146-10	25831-25834	the	_	
146-11	25835-25838	SCZ	_	
146-12	25839-25844	group	_	
146-13	25845-25846	(	_	
146-14	25846-25849	Fig	_	
146-15	25849-25850	.	_	
146-16	25851-25853	1C	_	
146-17	25853-25854	,	_	
146-18	25855-25856	z	_	
146-19	25856-25857	 	_	
146-20	25857-25858	=	_	
146-21	25858-25859	 	_	
146-22	25859-25863	2.14	_	
146-23	25863-25864	,	_	
146-24	25865-25866	p	_	
146-25	25866-25867	 	_	
146-26	25867-25868	=	_	
146-27	25868-25869	 	_	
146-28	25869-25873	0.03	_	
146-29	25873-25874	,	_	
146-30	25875-25887	Mann-Whitney	_	
146-31	25888-25889	U	_	
146-32	25890-25894	test	_	
146-33	25894-25895	)	_	
146-34	25895-25896	.	_	

#Text=Since the IMI(SW-WS) were not significantly correlated with the numbers of success trials in either group (Supplementary Fig. 1), the between-group difference was unlikely to be confounded by task performance.
147-1	25897-25902	Since	_	
147-2	25903-25906	the	_	
147-3	25907-25910	IMI	_	
147-4	25910-25911	(	_	
147-5	25911-25916	SW-WS	_	
147-6	25916-25917	)	_	
147-7	25918-25922	were	_	
147-8	25923-25926	not	_	
147-9	25927-25940	significantly	_	
147-10	25941-25951	correlated	_	
147-11	25952-25956	with	_	
147-12	25957-25960	the	_	
147-13	25961-25968	numbers	_	
147-14	25969-25971	of	_	
147-15	25972-25979	success	_	
147-16	25980-25986	trials	_	
147-17	25987-25989	in	_	
147-18	25990-25996	either	_	
147-19	25997-26002	group	_	
147-20	26003-26004	(	_	
147-21	26004-26017	Supplementary	_	
147-22	26018-26021	Fig	_	
147-23	26021-26022	.	_	
147-24	26023-26024	1	_	
147-25	26024-26025	)	_	
147-26	26025-26026	,	_	
147-27	26027-26030	the	_	
147-28	26031-26044	between-group	_	
147-29	26045-26055	difference	_	
147-30	26056-26059	was	_	
147-31	26060-26068	unlikely	_	
147-32	26069-26071	to	_	
147-33	26072-26074	be	_	
147-34	26075-26085	confounded	_	
147-35	26086-26088	by	_	
147-36	26089-26093	task	_	
147-37	26094-26105	performance	_	
147-38	26105-26106	.	_	

#Text=The IMI(SW-WS) was not correlated with the antipsychotic dose or the PANSS negative scores (Supplementary Table 2).
148-1	26107-26110	The	_	
148-2	26111-26114	IMI	_	
148-3	26114-26115	(	_	
148-4	26115-26120	SW-WS	_	
148-5	26120-26121	)	_	
148-6	26122-26125	was	_	
148-7	26126-26129	not	_	
148-8	26130-26140	correlated	_	
148-9	26141-26145	with	_	
148-10	26146-26149	the	_	
148-11	26150-26163	antipsychotic	_	
148-12	26164-26168	dose	_	
148-13	26169-26171	or	_	
148-14	26172-26175	the	_	
148-15	26176-26181	PANSS	_	
148-16	26182-26190	negative	_	
148-17	26191-26197	scores	_	
148-18	26198-26199	(	_	
148-19	26199-26212	Supplementary	_	
148-20	26213-26218	Table	_	
148-21	26219-26220	2	_	
148-22	26220-26221	)	_	
148-23	26221-26222	.	_	

#Text=Error correction in the SW task
#Text=To investigate cognitive control impairment in SCZ, we focused on the error correction.
149-1	26223-26228	Error	_	
149-2	26229-26239	correction	_	
149-3	26240-26242	in	_	
149-4	26243-26246	the	_	
149-5	26247-26249	SW	_	
149-6	26250-26254	task	_	
149-7	26255-26257	To	_	
149-8	26258-26269	investigate	_	
149-9	26270-26279	cognitive	_	
149-10	26280-26287	control	_	
149-11	26288-26298	impairment	_	
149-12	26299-26301	in	_	
149-13	26302-26305	SCZ	_	
149-14	26305-26306	,	_	
149-15	26307-26309	we	_	
149-16	26310-26317	focused	_	
149-17	26318-26320	on	_	
149-18	26321-26324	the	_	
149-19	26325-26330	error	_	
149-20	26331-26341	correction	_	
149-21	26341-26342	.	_	

#Text=Therefore, we classified the erroneous SW trials into two types, Undershoot for trials with timing error (TE) < − 0.05 s and Overshoot for trials with TE > + 0.05 s compared to 5.00 s.
150-1	26343-26352	Therefore	_	
150-2	26352-26353	,	_	
150-3	26354-26356	we	_	
150-4	26357-26367	classified	_	
150-5	26368-26371	the	_	
150-6	26372-26381	erroneous	_	
150-7	26382-26384	SW	_	
150-8	26385-26391	trials	_	
150-9	26392-26396	into	_	
150-10	26397-26400	two	_	
150-11	26401-26406	types	_	
150-12	26406-26407	,	_	
150-13	26408-26418	Undershoot	_	
150-14	26419-26422	for	_	
150-15	26423-26429	trials	_	
150-16	26430-26434	with	_	
150-17	26435-26441	timing	_	
150-18	26442-26447	error	_	
150-19	26448-26449	(	_	
150-20	26449-26451	TE	_	
150-21	26451-26452	)	_	
150-22	26452-26453	 	_	
150-23	26453-26454	<	_	
150-24	26454-26455	 	_	
150-25	26455-26456	−	_	
150-26	26456-26457	 	_	
150-27	26457-26461	0.05	_	
150-28	26461-26462	 	_	
150-29	26462-26463	s	_	
150-30	26464-26467	and	_	
150-31	26468-26477	Overshoot	_	
150-32	26478-26481	for	_	
150-33	26482-26488	trials	_	
150-34	26489-26493	with	_	
150-35	26494-26496	TE	_	
150-36	26496-26497	 	_	
150-37	26497-26498	>	_	
150-38	26498-26499	 	_	
150-39	26499-26500	+	_	
150-40	26500-26501	 	_	
150-41	26501-26505	0.05	_	
150-42	26505-26506	 	_	
150-43	26506-26507	s	_	
150-44	26508-26516	compared	_	
150-45	26517-26519	to	_	
150-46	26520-26524	5.00	_	
150-47	26524-26525	 	_	
150-48	26525-26526	s	_	
150-49	26526-26527	.	_	

#Text=Particularly, after an Undershoot trial, subjects were required to press the button more slowly but regulate the timing so as not to press the button too late for success.
151-1	26528-26540	Particularly	_	
151-2	26540-26541	,	_	
151-3	26542-26547	after	_	
151-4	26548-26550	an	_	
151-5	26551-26561	Undershoot	_	
151-6	26562-26567	trial	_	
151-7	26567-26568	,	_	
151-8	26569-26577	subjects	_	
151-9	26578-26582	were	_	
151-10	26583-26591	required	_	
151-11	26592-26594	to	_	
151-12	26595-26600	press	_	
151-13	26601-26604	the	_	
151-14	26605-26611	button	_	
151-15	26612-26616	more	_	
151-16	26617-26623	slowly	_	
151-17	26624-26627	but	_	
151-18	26628-26636	regulate	_	
151-19	26637-26640	the	_	
151-20	26641-26647	timing	_	
151-21	26648-26650	so	_	
151-22	26651-26653	as	_	
151-23	26654-26657	not	_	
151-24	26658-26660	to	_	
151-25	26661-26666	press	_	
151-26	26667-26670	the	_	
151-27	26671-26677	button	_	
151-28	26678-26681	too	_	
151-29	26682-26686	late	_	
151-30	26687-26690	for	_	
151-31	26691-26698	success	_	
151-32	26698-26699	.	_	

#Text=On the other hand, after an Overshoot trial, subjects were required to press the button faster but regulate the timing so as not to press the button too soon for success.
152-1	26700-26702	On	_	
152-2	26703-26706	the	_	
152-3	26707-26712	other	_	
152-4	26713-26717	hand	_	
152-5	26717-26718	,	_	
152-6	26719-26724	after	_	
152-7	26725-26727	an	_	
152-8	26728-26737	Overshoot	_	
152-9	26738-26743	trial	_	
152-10	26743-26744	,	_	
152-11	26745-26753	subjects	_	
152-12	26754-26758	were	_	
152-13	26759-26767	required	_	
152-14	26768-26770	to	_	
152-15	26771-26776	press	_	
152-16	26777-26780	the	_	
152-17	26781-26787	button	_	
152-18	26788-26794	faster	_	
152-19	26795-26798	but	_	
152-20	26799-26807	regulate	_	
152-21	26808-26811	the	_	
152-22	26812-26818	timing	_	
152-23	26819-26821	so	_	
152-24	26822-26824	as	_	
152-25	26825-26828	not	_	
152-26	26829-26831	to	_	
152-27	26832-26837	press	_	
152-28	26838-26841	the	_	
152-29	26842-26848	button	_	
152-30	26849-26852	too	_	
152-31	26853-26857	soon	_	
152-32	26858-26861	for	_	
152-33	26862-26869	success	_	
152-34	26869-26870	.	_	

#Text=We considered the regulation of button press speed as a type of response inhibition, which is a hallmark of cognitive control.
153-1	26871-26873	We	_	
153-2	26874-26884	considered	_	
153-3	26885-26888	the	_	
153-4	26889-26899	regulation	_	
153-5	26900-26902	of	_	
153-6	26903-26909	button	_	
153-7	26910-26915	press	_	
153-8	26916-26921	speed	_	
153-9	26922-26924	as	_	
153-10	26925-26926	a	_	
153-11	26927-26931	type	_	
153-12	26932-26934	of	_	
153-13	26935-26943	response	_	
153-14	26944-26954	inhibition	_	
153-15	26954-26955	,	_	
153-16	26956-26961	which	_	
153-17	26962-26964	is	_	
153-18	26965-26966	a	_	
153-19	26967-26975	hallmark	_	
153-20	26976-26978	of	_	
153-21	26979-26988	cognitive	_	
153-22	26989-26996	control	_	
153-23	26996-26997	.	_	

#Text=Group differences in cognitive control.
154-1	26998-27003	Group	_	
154-2	27004-27015	differences	_	
154-3	27016-27018	in	_	
154-4	27019-27028	cognitive	_	
154-5	27029-27036	control	_	
154-6	27036-27037	.	_	

#Text=(A) Different types of TEs between groups.
155-1	27038-27039	(	_	
155-2	27039-27040	A	_	
155-3	27040-27041	)	_	
155-4	27042-27051	Different	_	
155-5	27052-27057	types	_	
155-6	27058-27060	of	_	
155-7	27061-27064	TEs	_	
155-8	27065-27072	between	_	
155-9	27073-27079	groups	_	
155-10	27079-27080	.	_	

#Text=There was not a significant main effect of Group (SCZ vs HC) (F(1, 32) = 0.33, p = 0.57), and no interaction between Group and TE (Success vs Undershoot vs Overshoot) (F(2, 64) = 1.60, p = 0.21).
156-1	27081-27086	There	_	
156-2	27087-27090	was	_	
156-3	27091-27094	not	_	
156-4	27095-27096	a	_	
156-5	27097-27108	significant	_	
156-6	27109-27113	main	_	
156-7	27114-27120	effect	_	
156-8	27121-27123	of	_	
156-9	27124-27129	Group	_	
156-10	27130-27131	(	_	
156-11	27131-27134	SCZ	_	
156-12	27135-27137	vs	_	
156-13	27138-27140	HC	_	
156-14	27140-27141	)	_	
156-15	27142-27143	(	_	
156-16	27143-27144	F	_	
156-17	27144-27145	(	_	
156-18	27145-27146	1	_	
156-19	27146-27147	,	_	
156-20	27148-27150	32	_	
156-21	27150-27151	)	_	
156-22	27151-27152	 	_	
156-23	27152-27153	=	_	
156-24	27153-27154	 	_	
156-25	27154-27158	0.33	_	
156-26	27158-27159	,	_	
156-27	27160-27161	p	_	
156-28	27161-27162	 	_	
156-29	27162-27163	=	_	
156-30	27163-27164	 	_	
156-31	27164-27168	0.57	_	
156-32	27168-27169	)	_	
156-33	27169-27170	,	_	
156-34	27171-27174	and	_	
156-35	27175-27177	no	_	
156-36	27178-27189	interaction	_	
156-37	27190-27197	between	_	
156-38	27198-27203	Group	_	
156-39	27204-27207	and	_	
156-40	27208-27210	TE	_	
156-41	27211-27212	(	_	
156-42	27212-27219	Success	_	
156-43	27220-27222	vs	_	
156-44	27223-27233	Undershoot	_	
156-45	27234-27236	vs	_	
156-46	27237-27246	Overshoot	_	
156-47	27246-27247	)	_	
156-48	27248-27249	(	_	
156-49	27249-27250	F	_	
156-50	27250-27251	(	_	
156-51	27251-27252	2	_	
156-52	27252-27253	,	_	
156-53	27254-27256	64	_	
156-54	27256-27257	)	_	
156-55	27257-27258	 	_	
156-56	27258-27259	=	_	
156-57	27259-27260	 	_	
156-58	27260-27264	1.60	_	
156-59	27264-27265	,	_	
156-60	27266-27267	p	_	
156-61	27267-27268	 	_	
156-62	27268-27269	=	_	
156-63	27269-27270	 	_	
156-64	27270-27274	0.21	_	
156-65	27274-27275	)	_	
156-66	27275-27276	.	_	

#Text=(B) We compared the performance level following the Undershoot or Overshoot between SCZ and HC.
157-1	27277-27278	(	_	
157-2	27278-27279	B	_	
157-3	27279-27280	)	_	
157-4	27281-27283	We	_	
157-5	27284-27292	compared	_	
157-6	27293-27296	the	_	
157-7	27297-27308	performance	_	
157-8	27309-27314	level	_	
157-9	27315-27324	following	_	
157-10	27325-27328	the	_	
157-11	27329-27339	Undershoot	_	
157-12	27340-27342	or	_	
157-13	27343-27352	Overshoot	_	
157-14	27353-27360	between	_	
157-15	27361-27364	SCZ	_	
157-16	27365-27368	and	_	
157-17	27369-27371	HC	_	
157-18	27371-27372	.	_	

#Text=In the Post-Overshoot trials, there was a significant main effect of Post-Overshoot (Success vs Undershoot vs Overshoot) (F(2, 62) = 15.35, p < 0.001), and a significant interaction between Post-Overshoot and Group (SCZ vs HC) (F(2, 62) = 5.76, p = 0.01).
158-1	27373-27375	In	_	
158-2	27376-27379	the	_	
158-3	27380-27394	Post-Overshoot	_	
158-4	27395-27401	trials	_	
158-5	27401-27402	,	_	
158-6	27403-27408	there	_	
158-7	27409-27412	was	_	
158-8	27413-27414	a	_	
158-9	27415-27426	significant	_	
158-10	27427-27431	main	_	
158-11	27432-27438	effect	_	
158-12	27439-27441	of	_	
158-13	27442-27456	Post-Overshoot	_	
158-14	27457-27458	(	_	
158-15	27458-27465	Success	_	
158-16	27466-27468	vs	_	
158-17	27469-27479	Undershoot	_	
158-18	27480-27482	vs	_	
158-19	27483-27492	Overshoot	_	
158-20	27492-27493	)	_	
158-21	27494-27495	(	_	
158-22	27495-27496	F	_	
158-23	27496-27497	(	_	
158-24	27497-27498	2	_	
158-25	27498-27499	,	_	
158-26	27500-27502	62	_	
158-27	27502-27503	)	_	
158-28	27503-27504	 	_	
158-29	27504-27505	=	_	
158-30	27505-27506	 	_	
158-31	27506-27511	15.35	_	
158-32	27511-27512	,	_	
158-33	27513-27514	p	_	
158-34	27514-27515	 	_	
158-35	27515-27516	<	_	
158-36	27516-27517	 	_	
158-37	27517-27522	0.001	_	
158-38	27522-27523	)	_	
158-39	27523-27524	,	_	
158-40	27525-27528	and	_	
158-41	27529-27530	a	_	
158-42	27531-27542	significant	_	
158-43	27543-27554	interaction	_	
158-44	27555-27562	between	_	
158-45	27563-27577	Post-Overshoot	_	
158-46	27578-27581	and	_	
158-47	27582-27587	Group	_	
158-48	27588-27589	(	_	
158-49	27589-27592	SCZ	_	
158-50	27593-27595	vs	_	
158-51	27596-27598	HC	_	
158-52	27598-27599	)	_	
158-53	27600-27601	(	_	
158-54	27601-27602	F	_	
158-55	27602-27603	(	_	
158-56	27603-27604	2	_	
158-57	27604-27605	,	_	
158-58	27606-27608	62	_	
158-59	27608-27609	)	_	
158-60	27609-27610	 	_	
158-61	27610-27611	=	_	
158-62	27611-27612	 	_	
158-63	27612-27616	5.76	_	
158-64	27616-27617	,	_	
158-65	27618-27619	p	_	
158-66	27619-27620	 	_	
158-67	27620-27621	=	_	
158-68	27621-27622	 	_	
158-69	27622-27626	0.01	_	
158-70	27626-27627	)	_	
158-71	27627-27628	.	_	

#Text=The secondary analysis for each Post-Overshoot trial revealed a significant main effect of group for Success (F(1, 31) = 6.91, p = 0.013) and Undershoot (F(1, 31) = 7.61, p = 0.010).
159-1	27629-27632	The	_	
159-2	27633-27642	secondary	_	
159-3	27643-27651	analysis	_	
159-4	27652-27655	for	_	
159-5	27656-27660	each	_	
159-6	27661-27675	Post-Overshoot	_	
159-7	27676-27681	trial	_	
159-8	27682-27690	revealed	_	
159-9	27691-27692	a	_	
159-10	27693-27704	significant	_	
159-11	27705-27709	main	_	
159-12	27710-27716	effect	_	
159-13	27717-27719	of	_	
159-14	27720-27725	group	_	
159-15	27726-27729	for	_	
159-16	27730-27737	Success	_	
159-17	27738-27739	(	_	
159-18	27739-27740	F	_	
159-19	27740-27741	(	_	
159-20	27741-27742	1	_	
159-21	27742-27743	,	_	
159-22	27744-27746	31	_	
159-23	27746-27747	)	_	
159-24	27747-27748	 	_	
159-25	27748-27749	=	_	
159-26	27749-27750	 	_	
159-27	27750-27754	6.91	_	
159-28	27754-27755	,	_	
159-29	27756-27757	p	_	
159-30	27757-27758	 	_	
159-31	27758-27759	=	_	
159-32	27759-27760	 	_	
159-33	27760-27765	0.013	_	
159-34	27765-27766	)	_	
159-35	27767-27770	and	_	
159-36	27771-27781	Undershoot	_	
159-37	27782-27783	(	_	
159-38	27783-27784	F	_	
159-39	27784-27785	(	_	
159-40	27785-27786	1	_	
159-41	27786-27787	,	_	
159-42	27788-27790	31	_	
159-43	27790-27791	)	_	
159-44	27791-27792	 	_	
159-45	27792-27793	=	_	
159-46	27793-27794	 	_	
159-47	27794-27798	7.61	_	
159-48	27798-27799	,	_	
159-49	27800-27801	p	_	
159-50	27801-27802	 	_	
159-51	27802-27803	=	_	
159-52	27803-27804	 	_	
159-53	27804-27809	0.010	_	
159-54	27809-27810	)	_	
159-55	27810-27811	.	_	

#Text=On the other hand, for the post-Undershoot trials, although there was a significant main effect of Post-Undershoot (Success vs Undershoot vs Overshoot) (F(2, 66) = 4.33, p = 0.02), there was no significant interaction between Post-Undershoot and Group (SCZ vs HC) (F(2, 66) = 0.99, p = 0.38).
160-1	27812-27814	On	_	
160-2	27815-27818	the	_	
160-3	27819-27824	other	_	
160-4	27825-27829	hand	_	
160-5	27829-27830	,	_	
160-6	27831-27834	for	_	
160-7	27835-27838	the	_	
160-8	27839-27854	post-Undershoot	_	
160-9	27855-27861	trials	_	
160-10	27861-27862	,	_	
160-11	27863-27871	although	_	
160-12	27872-27877	there	_	
160-13	27878-27881	was	_	
160-14	27882-27883	a	_	
160-15	27884-27895	significant	_	
160-16	27896-27900	main	_	
160-17	27901-27907	effect	_	
160-18	27908-27910	of	_	
160-19	27911-27926	Post-Undershoot	_	
160-20	27927-27928	(	_	
160-21	27928-27935	Success	_	
160-22	27936-27938	vs	_	
160-23	27939-27949	Undershoot	_	
160-24	27950-27952	vs	_	
160-25	27953-27962	Overshoot	_	
160-26	27962-27963	)	_	
160-27	27964-27965	(	_	
160-28	27965-27966	F	_	
160-29	27966-27967	(	_	
160-30	27967-27968	2	_	
160-31	27968-27969	,	_	
160-32	27970-27972	66	_	
160-33	27972-27973	)	_	
160-34	27973-27974	 	_	
160-35	27974-27975	=	_	
160-36	27975-27976	 	_	
160-37	27976-27980	4.33	_	
160-38	27980-27981	,	_	
160-39	27982-27983	p	_	
160-40	27983-27984	 	_	
160-41	27984-27985	=	_	
160-42	27985-27986	 	_	
160-43	27986-27990	0.02	_	
160-44	27990-27991	)	_	
160-45	27991-27992	,	_	
160-46	27993-27998	there	_	
160-47	27999-28002	was	_	
160-48	28003-28005	no	_	
160-49	28006-28017	significant	_	
160-50	28018-28029	interaction	_	
160-51	28030-28037	between	_	
160-52	28038-28053	Post-Undershoot	_	
160-53	28054-28057	and	_	
160-54	28058-28063	Group	_	
160-55	28064-28065	(	_	
160-56	28065-28068	SCZ	_	
160-57	28069-28071	vs	_	
160-58	28072-28074	HC	_	
160-59	28074-28075	)	_	
160-60	28076-28077	(	_	
160-61	28077-28078	F	_	
160-62	28078-28079	(	_	
160-63	28079-28080	2	_	
160-64	28080-28081	,	_	
160-65	28082-28084	66	_	
160-66	28084-28085	)	_	
160-67	28085-28086	 	_	
160-68	28086-28087	=	_	
160-69	28087-28088	 	_	
160-70	28088-28092	0.99	_	
160-71	28092-28093	,	_	
160-72	28094-28095	p	_	
160-73	28095-28096	 	_	
160-74	28096-28097	=	_	
160-75	28097-28098	 	_	
160-76	28098-28102	0.38	_	
160-77	28102-28103	)	_	
160-78	28103-28104	.	_	

#Text=Fig. 2
#Text=Firstly, we evaluated the difference in TEs between groups (Fig.2A).
161-1	28105-28108	Fig	_	
161-2	28108-28109	.	_	
161-3	28110-28111	2	_	
161-4	28112-28119	Firstly	_	
161-5	28119-28120	,	_	
161-6	28121-28123	we	_	
161-7	28124-28133	evaluated	_	
161-8	28134-28137	the	_	
161-9	28138-28148	difference	_	
161-10	28149-28151	in	_	
161-11	28152-28155	TEs	_	
161-12	28156-28163	between	_	
161-13	28164-28170	groups	_	
161-14	28171-28172	(	_	
161-15	28172-28175	Fig	_	
161-16	28175-28178	.2A	_	
161-17	28178-28179	)	_	
161-18	28179-28180	.	_	

#Text=There was not a significant main effect of Group (SCZ vs HC) (F(1, 32) = 0.33, p = 0.57), and no interaction between Group and TE (Success vs Undershoot vs Overshoot) (F(2, 64) = 1.60, p = 0.21).
162-1	28181-28186	There	_	
162-2	28187-28190	was	_	
162-3	28191-28194	not	_	
162-4	28195-28196	a	_	
162-5	28197-28208	significant	_	
162-6	28209-28213	main	_	
162-7	28214-28220	effect	_	
162-8	28221-28223	of	_	
162-9	28224-28229	Group	_	
162-10	28230-28231	(	_	
162-11	28231-28234	SCZ	_	
162-12	28235-28237	vs	_	
162-13	28238-28240	HC	_	
162-14	28240-28241	)	_	
162-15	28242-28243	(	_	
162-16	28243-28244	F	_	
162-17	28244-28245	(	_	
162-18	28245-28246	1	_	
162-19	28246-28247	,	_	
162-20	28248-28250	32	_	
162-21	28250-28251	)	_	
162-22	28251-28252	 	_	
162-23	28252-28253	=	_	
162-24	28253-28254	 	_	
162-25	28254-28258	0.33	_	
162-26	28258-28259	,	_	
162-27	28260-28261	p	_	
162-28	28261-28262	 	_	
162-29	28262-28263	=	_	
162-30	28263-28264	 	_	
162-31	28264-28268	0.57	_	
162-32	28268-28269	)	_	
162-33	28269-28270	,	_	
162-34	28271-28274	and	_	
162-35	28275-28277	no	_	
162-36	28278-28289	interaction	_	
162-37	28290-28297	between	_	
162-38	28298-28303	Group	_	
162-39	28304-28307	and	_	
162-40	28308-28310	TE	_	
162-41	28311-28312	(	_	
162-42	28312-28319	Success	_	
162-43	28320-28322	vs	_	
162-44	28323-28333	Undershoot	_	
162-45	28334-28336	vs	_	
162-46	28337-28346	Overshoot	_	
162-47	28346-28347	)	_	
162-48	28348-28349	(	_	
162-49	28349-28350	F	_	
162-50	28350-28351	(	_	
162-51	28351-28352	2	_	
162-52	28352-28353	,	_	
162-53	28354-28356	64	_	
162-54	28356-28357	)	_	
162-55	28357-28358	 	_	
162-56	28358-28359	=	_	
162-57	28359-28360	 	_	
162-58	28360-28364	1.60	_	
162-59	28364-28365	,	_	
162-60	28366-28367	p	_	
162-61	28367-28368	 	_	
162-62	28368-28369	=	_	
162-63	28369-28370	 	_	
162-64	28370-28374	0.21	_	
162-65	28374-28375	)	_	
162-66	28375-28376	.	_	

#Text=This finding indicated that the TEs were not significantly different between groups.
163-1	28377-28381	This	_	
163-2	28382-28389	finding	_	
163-3	28390-28399	indicated	_	
163-4	28400-28404	that	_	
163-5	28405-28408	the	_	
163-6	28409-28412	TEs	_	
163-7	28413-28417	were	_	
163-8	28418-28421	not	_	
163-9	28422-28435	significantly	_	
163-10	28436-28445	different	_	
163-11	28446-28453	between	_	
163-12	28454-28460	groups	_	
163-13	28460-28461	.	_	

#Text=Moreover, to examine whether the correction after an error was appropriate or not in the SCZ group, we compared the performance level following Undershoot or Overshoot between SCZ and HC.
164-1	28462-28470	Moreover	_	
164-2	28470-28471	,	_	
164-3	28472-28474	to	_	
164-4	28475-28482	examine	_	
164-5	28483-28490	whether	_	
164-6	28491-28494	the	_	
164-7	28495-28505	correction	_	
164-8	28506-28511	after	_	
164-9	28512-28514	an	_	
164-10	28515-28520	error	_	
164-11	28521-28524	was	_	
164-12	28525-28536	appropriate	_	
164-13	28537-28539	or	_	
164-14	28540-28543	not	_	
164-15	28544-28546	in	_	
164-16	28547-28550	the	_	
164-17	28551-28554	SCZ	_	
164-18	28555-28560	group	_	
164-19	28560-28561	,	_	
164-20	28562-28564	we	_	
164-21	28565-28573	compared	_	
164-22	28574-28577	the	_	
164-23	28578-28589	performance	_	
164-24	28590-28595	level	_	
164-25	28596-28605	following	_	
164-26	28606-28616	Undershoot	_	
164-27	28617-28619	or	_	
164-28	28620-28629	Overshoot	_	
164-29	28630-28637	between	_	
164-30	28638-28641	SCZ	_	
164-31	28642-28645	and	_	
164-32	28646-28648	HC	_	
164-33	28648-28649	.	_	

#Text=We conducted a two-way mixed ANOVA (Fig. 2B).
165-1	28650-28652	We	_	
165-2	28653-28662	conducted	_	
165-3	28663-28664	a	_	
165-4	28665-28672	two-way	_	
165-5	28673-28678	mixed	_	
165-6	28679-28684	ANOVA	_	
165-7	28685-28686	(	_	
165-8	28686-28689	Fig	_	
165-9	28689-28690	.	_	
165-10	28691-28693	2B	_	
165-11	28693-28694	)	_	
165-12	28694-28695	.	_	

#Text=In the post-Overshoot trials, there was a significant main effect of Post-Overshoot (Success vs Undershoot vs Overshoot) (F(2, 62) = 15.35, p < 0.001), and a significant interaction between Post-Overshoot and Group (SCZ vs HC) (F(2, 62) = 5.76, p = 0.01).
166-1	28696-28698	In	_	
166-2	28699-28702	the	_	
166-3	28703-28717	post-Overshoot	_	
166-4	28718-28724	trials	_	
166-5	28724-28725	,	_	
166-6	28726-28731	there	_	
166-7	28732-28735	was	_	
166-8	28736-28737	a	_	
166-9	28738-28749	significant	_	
166-10	28750-28754	main	_	
166-11	28755-28761	effect	_	
166-12	28762-28764	of	_	
166-13	28765-28779	Post-Overshoot	_	
166-14	28780-28781	(	_	
166-15	28781-28788	Success	_	
166-16	28789-28791	vs	_	
166-17	28792-28802	Undershoot	_	
166-18	28803-28805	vs	_	
166-19	28806-28815	Overshoot	_	
166-20	28815-28816	)	_	
166-21	28817-28818	(	_	
166-22	28818-28819	F	_	
166-23	28819-28820	(	_	
166-24	28820-28821	2	_	
166-25	28821-28822	,	_	
166-26	28823-28825	62	_	
166-27	28825-28826	)	_	
166-28	28826-28827	 	_	
166-29	28827-28828	=	_	
166-30	28828-28829	 	_	
166-31	28829-28834	15.35	_	
166-32	28834-28835	,	_	
166-33	28836-28837	p	_	
166-34	28837-28838	 	_	
166-35	28838-28839	<	_	
166-36	28839-28840	 	_	
166-37	28840-28845	0.001	_	
166-38	28845-28846	)	_	
166-39	28846-28847	,	_	
166-40	28848-28851	and	_	
166-41	28852-28853	a	_	
166-42	28854-28865	significant	_	
166-43	28866-28877	interaction	_	
166-44	28878-28885	between	_	
166-45	28886-28900	Post-Overshoot	_	
166-46	28901-28904	and	_	
166-47	28905-28910	Group	_	
166-48	28911-28912	(	_	
166-49	28912-28915	SCZ	_	
166-50	28916-28918	vs	_	
166-51	28919-28921	HC	_	
166-52	28921-28922	)	_	
166-53	28923-28924	(	_	
166-54	28924-28925	F	_	
166-55	28925-28926	(	_	
166-56	28926-28927	2	_	
166-57	28927-28928	,	_	
166-58	28929-28931	62	_	
166-59	28931-28932	)	_	
166-60	28932-28933	 	_	
166-61	28933-28934	=	_	
166-62	28934-28935	 	_	
166-63	28935-28939	5.76	_	
166-64	28939-28940	,	_	
166-65	28941-28942	p	_	
166-66	28942-28943	 	_	
166-67	28943-28944	=	_	
166-68	28944-28945	 	_	
166-69	28945-28949	0.01	_	
166-70	28949-28950	)	_	
166-71	28950-28951	.	_	

#Text=The secondary analysis for each Post-Overshoot condition revealed a significant main effect of group for Success (F(1, 31) = 6.91, p = 0.013) and Undershoot (F(1, 31) = 7.61, p = 0.010).
167-1	28952-28955	The	_	
167-2	28956-28965	secondary	_	
167-3	28966-28974	analysis	_	
167-4	28975-28978	for	_	
167-5	28979-28983	each	_	
167-6	28984-28998	Post-Overshoot	_	
167-7	28999-29008	condition	_	
167-8	29009-29017	revealed	_	
167-9	29018-29019	a	_	
167-10	29020-29031	significant	_	
167-11	29032-29036	main	_	
167-12	29037-29043	effect	_	
167-13	29044-29046	of	_	
167-14	29047-29052	group	_	
167-15	29053-29056	for	_	
167-16	29057-29064	Success	_	
167-17	29065-29066	(	_	
167-18	29066-29067	F	_	
167-19	29067-29068	(	_	
167-20	29068-29069	1	_	
167-21	29069-29070	,	_	
167-22	29071-29073	31	_	
167-23	29073-29074	)	_	
167-24	29074-29075	 	_	
167-25	29075-29076	=	_	
167-26	29076-29077	 	_	
167-27	29077-29081	6.91	_	
167-28	29081-29082	,	_	
167-29	29083-29084	p	_	
167-30	29084-29085	 	_	
167-31	29085-29086	=	_	
167-32	29086-29087	 	_	
167-33	29087-29092	0.013	_	
167-34	29092-29093	)	_	
167-35	29094-29097	and	_	
167-36	29098-29108	Undershoot	_	
167-37	29109-29110	(	_	
167-38	29110-29111	F	_	
167-39	29111-29112	(	_	
167-40	29112-29113	1	_	
167-41	29113-29114	,	_	
167-42	29115-29117	31	_	
167-43	29117-29118	)	_	
167-44	29118-29119	 	_	
167-45	29119-29120	=	_	
167-46	29120-29121	 	_	
167-47	29121-29125	7.61	_	
167-48	29125-29126	,	_	
167-49	29127-29128	p	_	
167-50	29128-29129	 	_	
167-51	29129-29130	=	_	
167-52	29130-29131	 	_	
167-53	29131-29136	0.010	_	
167-54	29136-29137	)	_	
167-55	29137-29138	.	_	

#Text=On the other hand, for the post-Undershoot trials, although there was a significant main effect of Post-Undershoot (Success vs Undershoot vs Overshoot) (F(2, 66) = 4.33, p = 0.02), there was no significant interaction between Post-Undershoot and Group (SCZ vs HC) (F(2, 66) = 0.99, p = 0.38).
168-1	29139-29141	On	_	
168-2	29142-29145	the	_	
168-3	29146-29151	other	_	
168-4	29152-29156	hand	_	
168-5	29156-29157	,	_	
168-6	29158-29161	for	_	
168-7	29162-29165	the	_	
168-8	29166-29181	post-Undershoot	_	
168-9	29182-29188	trials	_	
168-10	29188-29189	,	_	
168-11	29190-29198	although	_	
168-12	29199-29204	there	_	
168-13	29205-29208	was	_	
168-14	29209-29210	a	_	
168-15	29211-29222	significant	_	
168-16	29223-29227	main	_	
168-17	29228-29234	effect	_	
168-18	29235-29237	of	_	
168-19	29238-29253	Post-Undershoot	_	
168-20	29254-29255	(	_	
168-21	29255-29262	Success	_	
168-22	29263-29265	vs	_	
168-23	29266-29276	Undershoot	_	
168-24	29277-29279	vs	_	
168-25	29280-29289	Overshoot	_	
168-26	29289-29290	)	_	
168-27	29291-29292	(	_	
168-28	29292-29293	F	_	
168-29	29293-29294	(	_	
168-30	29294-29295	2	_	
168-31	29295-29296	,	_	
168-32	29297-29299	66	_	
168-33	29299-29300	)	_	
168-34	29300-29301	 	_	
168-35	29301-29302	=	_	
168-36	29302-29303	 	_	
168-37	29303-29307	4.33	_	
168-38	29307-29308	,	_	
168-39	29309-29310	p	_	
168-40	29310-29311	 	_	
168-41	29311-29312	=	_	
168-42	29312-29313	 	_	
168-43	29313-29317	0.02	_	
168-44	29317-29318	)	_	
168-45	29318-29319	,	_	
168-46	29320-29325	there	_	
168-47	29326-29329	was	_	
168-48	29330-29332	no	_	
168-49	29333-29344	significant	_	
168-50	29345-29356	interaction	_	
168-51	29357-29364	between	_	
168-52	29365-29380	Post-Undershoot	_	
168-53	29381-29384	and	_	
168-54	29385-29390	Group	_	
168-55	29391-29392	(	_	
168-56	29392-29395	SCZ	_	
168-57	29396-29398	vs	_	
168-58	29399-29401	HC	_	
168-59	29401-29402	)	_	
168-60	29403-29404	(	_	
168-61	29404-29405	F	_	
168-62	29405-29406	(	_	
168-63	29406-29407	2	_	
168-64	29407-29408	,	_	
168-65	29409-29411	66	_	
168-66	29411-29412	)	_	
168-67	29412-29413	 	_	
168-68	29413-29414	=	_	
168-69	29414-29415	 	_	
168-70	29415-29419	0.99	_	
168-71	29419-29420	,	_	
168-72	29421-29422	p	_	
168-73	29422-29423	 	_	
168-74	29423-29424	=	_	
168-75	29424-29425	 	_	
168-76	29425-29429	0.38	_	
168-77	29429-29430	)	_	
168-78	29430-29431	.	_	

#Text=These findings indicated that the rate of Success SW trials following Overshoot (Overshoot → Success) in the SCZ group was significantly lower than that in HC, and the rate of Undershoot SW trials following Overshoot (Overshoot → Undershoot) was significantly higher in SCZ participants than in HC, suggesting that SCZ patients showed excessive error correction after Overshoot trials.
169-1	29432-29437	These	_	
169-2	29438-29446	findings	_	
169-3	29447-29456	indicated	_	
169-4	29457-29461	that	_	
169-5	29462-29465	the	_	
169-6	29466-29470	rate	_	
169-7	29471-29473	of	_	
169-8	29474-29481	Success	_	
169-9	29482-29484	SW	_	
169-10	29485-29491	trials	_	
169-11	29492-29501	following	_	
169-12	29502-29511	Overshoot	_	
169-13	29512-29513	(	_	
169-14	29513-29522	Overshoot	_	
169-15	29522-29523	 	_	
169-16	29523-29524	→	_	
169-17	29524-29525	 	_	
169-18	29525-29532	Success	_	
169-19	29532-29533	)	_	
169-20	29534-29536	in	_	
169-21	29537-29540	the	_	
169-22	29541-29544	SCZ	_	
169-23	29545-29550	group	_	
169-24	29551-29554	was	_	
169-25	29555-29568	significantly	_	
169-26	29569-29574	lower	_	
169-27	29575-29579	than	_	
169-28	29580-29584	that	_	
169-29	29585-29587	in	_	
169-30	29588-29590	HC	_	
169-31	29590-29591	,	_	
169-32	29592-29595	and	_	
169-33	29596-29599	the	_	
169-34	29600-29604	rate	_	
169-35	29605-29607	of	_	
169-36	29608-29618	Undershoot	_	
169-37	29619-29621	SW	_	
169-38	29622-29628	trials	_	
169-39	29629-29638	following	_	
169-40	29639-29648	Overshoot	_	
169-41	29649-29650	(	_	
169-42	29650-29659	Overshoot	_	
169-43	29659-29660	 	_	
169-44	29660-29661	→	_	
169-45	29661-29662	 	_	
169-46	29662-29672	Undershoot	_	
169-47	29672-29673	)	_	
169-48	29674-29677	was	_	
169-49	29678-29691	significantly	_	
169-50	29692-29698	higher	_	
169-51	29699-29701	in	_	
169-52	29702-29705	SCZ	_	
169-53	29706-29718	participants	_	
169-54	29719-29723	than	_	
169-55	29724-29726	in	_	
169-56	29727-29729	HC	_	
169-57	29729-29730	,	_	
169-58	29731-29741	suggesting	_	
169-59	29742-29746	that	_	
169-60	29747-29750	SCZ	_	
169-61	29751-29759	patients	_	
169-62	29760-29766	showed	_	
169-63	29767-29776	excessive	_	
169-64	29777-29782	error	_	
169-65	29783-29793	correction	_	
169-66	29794-29799	after	_	
169-67	29800-29809	Overshoot	_	
169-68	29810-29816	trials	_	
169-69	29816-29817	.	_	

#Text=Neither the rate of Overshoot → Success nor of Overshoot → Undershoot was significantly correlated with antipsychotic dose or the PANSS negative scores (Supplementary Table 2).
170-1	29818-29825	Neither	_	
170-2	29826-29829	the	_	
170-3	29830-29834	rate	_	
170-4	29835-29837	of	_	
170-5	29838-29847	Overshoot	_	
170-6	29847-29848	 	_	
170-7	29848-29849	→	_	
170-8	29849-29850	 	_	
170-9	29850-29857	Success	_	
170-10	29858-29861	nor	_	
170-11	29862-29864	of	_	
170-12	29865-29874	Overshoot	_	
170-13	29874-29875	 	_	
170-14	29875-29876	→	_	
170-15	29876-29877	 	_	
170-16	29877-29887	Undershoot	_	
170-17	29888-29891	was	_	
170-18	29892-29905	significantly	_	
170-19	29906-29916	correlated	_	
170-20	29917-29921	with	_	
170-21	29922-29935	antipsychotic	_	
170-22	29936-29940	dose	_	
170-23	29941-29943	or	_	
170-24	29944-29947	the	_	
170-25	29948-29953	PANSS	_	
170-26	29954-29962	negative	_	
170-27	29963-29969	scores	_	
170-28	29970-29971	(	_	
170-29	29971-29984	Supplementary	_	
170-30	29985-29990	Table	_	
170-31	29991-29992	2	_	
170-32	29992-29993	)	_	
170-33	29993-29994	.	_	

#Text=Striatum and LPFC activation during the task cue period
#Text=Striatal and prefrontal activation in SCZ and HC during the task cue period.
171-1	29995-30003	Striatum	_	
171-2	30004-30007	and	_	
171-3	30008-30012	LPFC	_	
171-4	30013-30023	activation	_	
171-5	30024-30030	during	_	
171-6	30031-30034	the	_	
171-7	30035-30039	task	_	
171-8	30040-30043	cue	_	
171-9	30044-30050	period	_	
171-10	30051-30059	Striatal	_	
171-11	30060-30063	and	_	
171-12	30064-30074	prefrontal	_	
171-13	30075-30085	activation	_	
171-14	30086-30088	in	_	
171-15	30089-30092	SCZ	_	
171-16	30093-30096	and	_	
171-17	30097-30099	HC	_	
171-18	30100-30106	during	_	
171-19	30107-30110	the	_	
171-20	30111-30115	task	_	
171-21	30116-30119	cue	_	
171-22	30120-30126	period	_	
171-23	30126-30127	.	_	

#Text=(A) The left (peak at − 12, 23, 4) and right (peak at 9, 17, − 2) striatum activation showing a significant between-group difference in response to the SW cues relative to the WS cues (p < 0.05 FWE cluster correction, two-sample t-test).
172-1	30128-30129	(	_	
172-2	30129-30130	A	_	
172-3	30130-30131	)	_	
172-4	30132-30135	The	_	
172-5	30136-30140	left	_	
172-6	30141-30142	(	_	
172-7	30142-30146	peak	_	
172-8	30147-30149	at	_	
172-9	30150-30151	−	_	
172-10	30151-30152	 	_	
172-11	30152-30154	12	_	
172-12	30154-30155	,	_	
172-13	30156-30158	23	_	
172-14	30158-30159	,	_	
172-15	30160-30161	4	_	
172-16	30161-30162	)	_	
172-17	30163-30166	and	_	
172-18	30167-30172	right	_	
172-19	30173-30174	(	_	
172-20	30174-30178	peak	_	
172-21	30179-30181	at	_	
172-22	30182-30183	9	_	
172-23	30183-30184	,	_	
172-24	30185-30187	17	_	
172-25	30187-30188	,	_	
172-26	30189-30190	−	_	
172-27	30190-30191	 	_	
172-28	30191-30192	2	_	
172-29	30192-30193	)	_	
172-30	30194-30202	striatum	_	
172-31	30203-30213	activation	_	
172-32	30214-30221	showing	_	
172-33	30222-30223	a	_	
172-34	30224-30235	significant	_	
172-35	30236-30249	between-group	_	
172-36	30250-30260	difference	_	
172-37	30261-30263	in	_	
172-38	30264-30272	response	_	
172-39	30273-30275	to	_	
172-40	30276-30279	the	_	
172-41	30280-30282	SW	_	
172-42	30283-30287	cues	_	
172-43	30288-30296	relative	_	
172-44	30297-30299	to	_	
172-45	30300-30303	the	_	
172-46	30304-30306	WS	_	
172-47	30307-30311	cues	_	
172-48	30312-30313	(	_	
172-49	30313-30314	p	_	
172-50	30314-30315	 	_	
172-51	30315-30316	<	_	
172-52	30316-30317	 	_	
172-53	30317-30321	0.05	_	
172-54	30322-30325	FWE	_	
172-55	30326-30333	cluster	_	
172-56	30334-30344	correction	_	
172-57	30344-30345	,	_	
172-58	30346-30356	two-sample	_	
172-59	30357-30363	t-test	_	
172-60	30363-30364	)	_	
172-61	30364-30365	.	_	

#Text=Left: Activation superimposed on coronal view.
173-1	30366-30370	Left	_	
173-2	30370-30371	:	_	
173-3	30372-30382	Activation	_	
173-4	30383-30395	superimposed	_	
173-5	30396-30398	on	_	
173-6	30399-30406	coronal	_	
173-7	30407-30411	view	_	
173-8	30411-30412	.	_	

#Text=Right: Mean contrast values and SEs of the left and right striatum activation.
174-1	30413-30418	Right	_	
174-2	30418-30419	:	_	
174-3	30420-30424	Mean	_	
174-4	30425-30433	contrast	_	
174-5	30434-30440	values	_	
174-6	30441-30444	and	_	
174-7	30445-30448	SEs	_	
174-8	30449-30451	of	_	
174-9	30452-30455	the	_	
174-10	30456-30460	left	_	
174-11	30461-30464	and	_	
174-12	30465-30470	right	_	
174-13	30471-30479	striatum	_	
174-14	30480-30490	activation	_	
174-15	30490-30491	.	_	

#Text=The bilateral striatum activation β(SW-WS) in SCZ was significantly lower than that in HC (Left, t31 = 3.54, p = 0.0013; Right, t31 = 4.05, p = 0.0003, two-sample t-test).
175-1	30492-30495	The	_	
175-2	30496-30505	bilateral	_	
175-3	30506-30514	striatum	_	
175-4	30515-30525	activation	_	
175-5	30526-30527	β	_	
175-6	30527-30528	(	_	
175-7	30528-30533	SW-WS	_	
175-8	30533-30534	)	_	
175-9	30535-30537	in	_	
175-10	30538-30541	SCZ	_	
175-11	30542-30545	was	_	
175-12	30546-30559	significantly	_	
175-13	30560-30565	lower	_	
175-14	30566-30570	than	_	
175-15	30571-30575	that	_	
175-16	30576-30578	in	_	
175-17	30579-30581	HC	_	
175-18	30582-30583	(	_	
175-19	30583-30587	Left	_	
175-20	30587-30588	,	_	
175-21	30589-30592	t31	_	
175-22	30592-30593	 	_	
175-23	30593-30594	=	_	
175-24	30594-30595	 	_	
175-25	30595-30599	3.54	_	
175-26	30599-30600	,	_	
175-27	30601-30602	p	_	
175-28	30602-30603	 	_	
175-29	30603-30604	=	_	
175-30	30604-30605	 	_	
175-31	30605-30611	0.0013	_	
175-32	30611-30612	;	_	
175-33	30613-30618	Right	_	
175-34	30618-30619	,	_	
175-35	30620-30623	t31	_	
175-36	30623-30624	 	_	
175-37	30624-30625	=	_	
175-38	30625-30626	 	_	
175-39	30626-30630	4.05	_	
175-40	30630-30631	,	_	
175-41	30632-30633	p	_	
175-42	30633-30634	 	_	
175-43	30634-30635	=	_	
175-44	30635-30636	 	_	
175-45	30636-30642	0.0003	_	
175-46	30642-30643	,	_	
175-47	30644-30654	two-sample	_	
175-48	30655-30661	t-test	_	
175-49	30661-30662	)	_	
175-50	30662-30663	.	_	

#Text=(B) The left (peak at − 42, 50, 7) and right (peak at 39, 44, 28) prefrontal activation in response to the SW cues relative to the WS cues (FWE, p < 0.05, one-sample t-test).
176-1	30664-30665	(	_	
176-2	30665-30666	B	_	
176-3	30666-30667	)	_	
176-4	30668-30671	The	_	
176-5	30672-30676	left	_	
176-6	30677-30678	(	_	
176-7	30678-30682	peak	_	
176-8	30683-30685	at	_	
176-9	30686-30687	−	_	
176-10	30687-30688	 	_	
176-11	30688-30690	42	_	
176-12	30690-30691	,	_	
176-13	30692-30694	50	_	
176-14	30694-30695	,	_	
176-15	30696-30697	7	_	
176-16	30697-30698	)	_	
176-17	30699-30702	and	_	
176-18	30703-30708	right	_	
176-19	30709-30710	(	_	
176-20	30710-30714	peak	_	
176-21	30715-30717	at	_	
176-22	30718-30720	39	_	
176-23	30720-30721	,	_	
176-24	30722-30724	44	_	
176-25	30724-30725	,	_	
176-26	30726-30728	28	_	
176-27	30728-30729	)	_	
176-28	30730-30740	prefrontal	_	
176-29	30741-30751	activation	_	
176-30	30752-30754	in	_	
176-31	30755-30763	response	_	
176-32	30764-30766	to	_	
176-33	30767-30770	the	_	
176-34	30771-30773	SW	_	
176-35	30774-30778	cues	_	
176-36	30779-30787	relative	_	
176-37	30788-30790	to	_	
176-38	30791-30794	the	_	
176-39	30795-30797	WS	_	
176-40	30798-30802	cues	_	
176-41	30803-30804	(	_	
176-42	30804-30807	FWE	_	
176-43	30807-30808	,	_	
176-44	30809-30810	p	_	
176-45	30810-30811	 	_	
176-46	30811-30812	<	_	
176-47	30812-30813	 	_	
176-48	30813-30817	0.05	_	
176-49	30817-30818	,	_	
176-50	30819-30829	one-sample	_	
176-51	30830-30836	t-test	_	
176-52	30836-30837	)	_	
176-53	30837-30838	.	_	

#Text=Left: activation superimposed on coronal view.
177-1	30839-30843	Left	_	
177-2	30843-30844	:	_	
177-3	30845-30855	activation	_	
177-4	30856-30868	superimposed	_	
177-5	30869-30871	on	_	
177-6	30872-30879	coronal	_	
177-7	30880-30884	view	_	
177-8	30884-30885	.	_	

#Text=Right: mean contrast values and SEs of the left and right prefrontal activation.
178-1	30886-30891	Right	_	
178-2	30891-30892	:	_	
178-3	30893-30897	mean	_	
178-4	30898-30906	contrast	_	
178-5	30907-30913	values	_	
178-6	30914-30917	and	_	
178-7	30918-30921	SEs	_	
178-8	30922-30924	of	_	
178-9	30925-30928	the	_	
178-10	30929-30933	left	_	
178-11	30934-30937	and	_	
178-12	30938-30943	right	_	
178-13	30944-30954	prefrontal	_	
178-14	30955-30965	activation	_	
178-15	30965-30966	.	_	

#Text=The bilateral LPFC activation β(SW-WS) did not show a significant between-group difference (Left, t31 = 0.72, p = 0.48; Right, t31 = 1.95, p = 0.06, two-sample t-test).
179-1	30967-30970	The	_	
179-2	30971-30980	bilateral	_	
179-3	30981-30985	LPFC	_	
179-4	30986-30996	activation	_	
179-5	30997-30998	β	_	
179-6	30998-30999	(	_	
179-7	30999-31004	SW-WS	_	
179-8	31004-31005	)	_	
179-9	31006-31009	did	_	
179-10	31010-31013	not	_	
179-11	31014-31018	show	_	
179-12	31019-31020	a	_	
179-13	31021-31032	significant	_	
179-14	31033-31046	between-group	_	
179-15	31047-31057	difference	_	
179-16	31058-31059	(	_	
179-17	31059-31063	Left	_	
179-18	31063-31064	,	_	
179-19	31065-31068	t31	_	
179-20	31068-31069	 	_	
179-21	31069-31070	=	_	
179-22	31070-31071	 	_	
179-23	31071-31075	0.72	_	
179-24	31075-31076	,	_	
179-25	31077-31078	p	_	
179-26	31078-31079	 	_	
179-27	31079-31080	=	_	
179-28	31080-31081	 	_	
179-29	31081-31085	0.48	_	
179-30	31085-31086	;	_	
179-31	31087-31092	Right	_	
179-32	31092-31093	,	_	
179-33	31094-31097	t31	_	
179-34	31097-31098	 	_	
179-35	31098-31099	=	_	
179-36	31099-31100	 	_	
179-37	31100-31104	1.95	_	
179-38	31104-31105	,	_	
179-39	31106-31107	p	_	
179-40	31107-31108	 	_	
179-41	31108-31109	=	_	
179-42	31109-31110	 	_	
179-43	31110-31114	0.06	_	
179-44	31114-31115	,	_	
179-45	31116-31126	two-sample	_	
179-46	31127-31133	t-test	_	
179-47	31133-31134	)	_	
179-48	31134-31135	.	_	

#Text=(C) Left LPFC (peak at − 42, 50, 7) activation β(SW-WS) in HC was positively and significantly correlated with the IMI(SW-WS) (Fig. 3C, r = 0.62, p = 0.008, correction threshold: p = 0.0125, Pearson), although this was not true for the right LPFC (peak at 39, 44, 28) (r = 0.42, p = 0.09, Pearson).
180-1	31136-31137	(	_	
180-2	31137-31138	C	_	
180-3	31138-31139	)	_	
180-4	31140-31144	Left	_	
180-5	31145-31149	LPFC	_	
180-6	31150-31151	(	_	
180-7	31151-31155	peak	_	
180-8	31156-31158	at	_	
180-9	31159-31160	−	_	
180-10	31160-31161	 	_	
180-11	31161-31163	42	_	
180-12	31163-31164	,	_	
180-13	31165-31167	50	_	
180-14	31167-31168	,	_	
180-15	31169-31170	7	_	
180-16	31170-31171	)	_	
180-17	31172-31182	activation	_	
180-18	31183-31184	β	_	
180-19	31184-31185	(	_	
180-20	31185-31190	SW-WS	_	
180-21	31190-31191	)	_	
180-22	31192-31194	in	_	
180-23	31195-31197	HC	_	
180-24	31198-31201	was	_	
180-25	31202-31212	positively	_	
180-26	31213-31216	and	_	
180-27	31217-31230	significantly	_	
180-28	31231-31241	correlated	_	
180-29	31242-31246	with	_	
180-30	31247-31250	the	_	
180-31	31251-31254	IMI	_	
180-32	31254-31255	(	_	
180-33	31255-31260	SW-WS	_	
180-34	31260-31261	)	_	
180-35	31262-31263	(	_	
180-36	31263-31266	Fig	_	
180-37	31266-31267	.	_	
180-38	31268-31270	3C	_	
180-39	31270-31271	,	_	
180-40	31272-31273	r	_	
180-41	31273-31274	 	_	
180-42	31274-31275	=	_	
180-43	31275-31276	 	_	
180-44	31276-31280	0.62	_	
180-45	31280-31281	,	_	
180-46	31282-31283	p	_	
180-47	31283-31284	 	_	
180-48	31284-31285	=	_	
180-49	31285-31286	 	_	
180-50	31286-31291	0.008	_	
180-51	31291-31292	,	_	
180-52	31293-31303	correction	_	
180-53	31304-31313	threshold	_	
180-54	31313-31314	:	_	
180-55	31315-31316	p	_	
180-56	31316-31317	 	_	
180-57	31317-31318	=	_	
180-58	31318-31319	 	_	
180-59	31319-31325	0.0125	_	
180-60	31325-31326	,	_	
180-61	31327-31334	Pearson	_	
180-62	31334-31335	)	_	
180-63	31335-31336	,	_	
180-64	31337-31345	although	_	
180-65	31346-31350	this	_	
180-66	31351-31354	was	_	
180-67	31355-31358	not	_	
180-68	31359-31363	true	_	
180-69	31364-31367	for	_	
180-70	31368-31371	the	_	
180-71	31372-31377	right	_	
180-72	31378-31382	LPFC	_	
180-73	31383-31384	(	_	
180-74	31384-31388	peak	_	
180-75	31389-31391	at	_	
180-76	31392-31394	39	_	
180-77	31394-31395	,	_	
180-78	31396-31398	44	_	
180-79	31398-31399	,	_	
180-80	31400-31402	28	_	
180-81	31402-31403	)	_	
180-82	31404-31405	(	_	
180-83	31405-31406	r	_	
180-84	31406-31407	 	_	
180-85	31407-31408	=	_	
180-86	31408-31409	 	_	
180-87	31409-31413	0.42	_	
180-88	31413-31414	,	_	
180-89	31415-31416	p	_	
180-90	31416-31417	 	_	
180-91	31417-31418	=	_	
180-92	31418-31419	 	_	
180-93	31419-31423	0.09	_	
180-94	31423-31424	,	_	
180-95	31425-31432	Pearson	_	
180-96	31432-31433	)	_	
180-97	31433-31434	.	_	

#Text=As for SCZ, neither left nor right LPFC activation β(SW-WS) showed a significant correlation with IMI(SW-WS) (left: r = 0.28, p = 0.30; right: r = − 0.17, p = 0.13, Pearson). *: p < 0.0125, n.s.: not significant.
181-1	31435-31437	As	_	
181-2	31438-31441	for	_	
181-3	31442-31445	SCZ	_	
181-4	31445-31446	,	_	
181-5	31447-31454	neither	_	
181-6	31455-31459	left	_	
181-7	31460-31463	nor	_	
181-8	31464-31469	right	_	
181-9	31470-31474	LPFC	_	
181-10	31475-31485	activation	_	
181-11	31486-31487	β	_	
181-12	31487-31488	(	_	
181-13	31488-31493	SW-WS	_	
181-14	31493-31494	)	_	
181-15	31495-31501	showed	_	
181-16	31502-31503	a	_	
181-17	31504-31515	significant	_	
181-18	31516-31527	correlation	_	
181-19	31528-31532	with	_	
181-20	31533-31536	IMI	_	
181-21	31536-31537	(	_	
181-22	31537-31542	SW-WS	_	
181-23	31542-31543	)	_	
181-24	31544-31545	(	_	
181-25	31545-31549	left	_	
181-26	31549-31550	:	_	
181-27	31551-31552	r	_	
181-28	31552-31553	 	_	
181-29	31553-31554	=	_	
181-30	31554-31555	 	_	
181-31	31555-31559	0.28	_	
181-32	31559-31560	,	_	
181-33	31561-31562	p	_	
181-34	31562-31563	 	_	
181-35	31563-31564	=	_	
181-36	31564-31565	 	_	
181-37	31565-31569	0.30	_	
181-38	31569-31570	;	_	
181-39	31571-31576	right	_	
181-40	31576-31577	:	_	
181-41	31578-31579	r	_	
181-42	31579-31580	 	_	
181-43	31580-31581	=	_	
181-44	31581-31582	 	_	
181-45	31582-31583	−	_	
181-46	31583-31584	 	_	
181-47	31584-31588	0.17	_	
181-48	31588-31589	,	_	
181-49	31590-31591	p	_	
181-50	31591-31592	 	_	
181-51	31592-31593	=	_	
181-52	31593-31594	 	_	
181-53	31594-31598	0.13	_	
181-54	31598-31599	,	_	
181-55	31600-31607	Pearson	_	
181-56	31607-31608	)	_	
181-57	31608-31609	.	_	
181-58	31610-31611	*	_	
181-59	31611-31612	:	_	
181-60	31613-31614	p	_	
181-61	31614-31615	 	_	
181-62	31615-31616	<	_	
181-63	31616-31617	 	_	
181-64	31617-31623	0.0125	_	
181-65	31623-31624	,	_	
181-66	31625-31628	n.s	_	
181-67	31628-31629	.	_	
181-68	31629-31630	:	_	
181-69	31631-31634	not	_	
181-70	31635-31646	significant	_	
181-71	31646-31647	.	_	

#Text=Fig. 3
#Text=We observed significant striatum activation in the SW task compared with the WS task during the task cue period in the whole brain analysis (FWE, p < 0.05, one-sample t-test).
182-1	31648-31651	Fig	_	
182-2	31651-31652	.	_	
182-3	31653-31654	3	_	
182-4	31655-31657	We	_	
182-5	31658-31666	observed	_	
182-6	31667-31678	significant	_	
182-7	31679-31687	striatum	_	
182-8	31688-31698	activation	_	
182-9	31699-31701	in	_	
182-10	31702-31705	the	_	
182-11	31706-31708	SW	_	
182-12	31709-31713	task	_	
182-13	31714-31722	compared	_	
182-14	31723-31727	with	_	
182-15	31728-31731	the	_	
182-16	31732-31734	WS	_	
182-17	31735-31739	task	_	
182-18	31740-31746	during	_	
182-19	31747-31750	the	_	
182-20	31751-31755	task	_	
182-21	31756-31759	cue	_	
182-22	31760-31766	period	_	
182-23	31767-31769	in	_	
182-24	31770-31773	the	_	
182-25	31774-31779	whole	_	
182-26	31780-31785	brain	_	
182-27	31786-31794	analysis	_	
182-28	31795-31796	(	_	
182-29	31796-31799	FWE	_	
182-30	31799-31800	,	_	
182-31	31801-31802	p	_	
182-32	31802-31803	 	_	
182-33	31803-31804	<	_	
182-34	31804-31805	 	_	
182-35	31805-31809	0.05	_	
182-36	31809-31810	,	_	
182-37	31811-31821	one-sample	_	
182-38	31822-31828	t-test	_	
182-39	31828-31829	)	_	
182-40	31829-31830	.	_	

#Text=Moreover, a significant between-group difference was observed in the left (peak at − 12, 23, 4) and right (peak at 9, 17, − 2) striatum (Fig.3A, p < 0.05 FWE cluster correction, two-sample t-test).
183-1	31831-31839	Moreover	_	
183-2	31839-31840	,	_	
183-3	31841-31842	a	_	
183-4	31843-31854	significant	_	
183-5	31855-31868	between-group	_	
183-6	31869-31879	difference	_	
183-7	31880-31883	was	_	
183-8	31884-31892	observed	_	
183-9	31893-31895	in	_	
183-10	31896-31899	the	_	
183-11	31900-31904	left	_	
183-12	31905-31906	(	_	
183-13	31906-31910	peak	_	
183-14	31911-31913	at	_	
183-15	31914-31915	−	_	
183-16	31915-31916	 	_	
183-17	31916-31918	12	_	
183-18	31918-31919	,	_	
183-19	31920-31922	23	_	
183-20	31922-31923	,	_	
183-21	31924-31925	4	_	
183-22	31925-31926	)	_	
183-23	31927-31930	and	_	
183-24	31931-31936	right	_	
183-25	31937-31938	(	_	
183-26	31938-31942	peak	_	
183-27	31943-31945	at	_	
183-28	31946-31947	9	_	
183-29	31947-31948	,	_	
183-30	31949-31951	17	_	
183-31	31951-31952	,	_	
183-32	31953-31954	−	_	
183-33	31954-31955	 	_	
183-34	31955-31956	2	_	
183-35	31956-31957	)	_	
183-36	31958-31966	striatum	_	
183-37	31967-31968	(	_	
183-38	31968-31971	Fig	_	
183-39	31971-31974	.3A	_	
183-40	31974-31975	,	_	
183-41	31976-31977	p	_	
183-42	31977-31978	 	_	
183-43	31978-31979	<	_	
183-44	31979-31980	 	_	
183-45	31980-31984	0.05	_	
183-46	31985-31988	FWE	_	
183-47	31989-31996	cluster	_	
183-48	31997-32007	correction	_	
183-49	32007-32008	,	_	
183-50	32009-32019	two-sample	_	
183-51	32020-32026	t-test	_	
183-52	32026-32027	)	_	
183-53	32027-32028	.	_	

#Text=Meanwhile, the bilateral striatum activation β(SW-WS) was not significantly correlated with IMI(SW-WS) in either group (Supplementary Fig. 2).
184-1	32029-32038	Meanwhile	_	
184-2	32038-32039	,	_	
184-3	32040-32043	the	_	
184-4	32044-32053	bilateral	_	
184-5	32054-32062	striatum	_	
184-6	32063-32073	activation	_	
184-7	32074-32075	β	_	
184-8	32075-32076	(	_	
184-9	32076-32081	SW-WS	_	
184-10	32081-32082	)	_	
184-11	32083-32086	was	_	
184-12	32087-32090	not	_	
184-13	32091-32104	significantly	_	
184-14	32105-32115	correlated	_	
184-15	32116-32120	with	_	
184-16	32121-32124	IMI	_	
184-17	32124-32125	(	_	
184-18	32125-32130	SW-WS	_	
184-19	32130-32131	)	_	
184-20	32132-32134	in	_	
184-21	32135-32141	either	_	
184-22	32142-32147	group	_	
184-23	32148-32149	(	_	
184-24	32149-32162	Supplementary	_	
184-25	32163-32166	Fig	_	
184-26	32166-32167	.	_	
184-27	32168-32169	2	_	
184-28	32169-32170	)	_	
184-29	32170-32171	.	_	

#Text=In contrast, we observed significant LPFC activation in response to the SW cues relative to the WS cues (FWE, p < 0.05, one-sample t-test).
185-1	32172-32174	In	_	
185-2	32175-32183	contrast	_	
185-3	32183-32184	,	_	
185-4	32185-32187	we	_	
185-5	32188-32196	observed	_	
185-6	32197-32208	significant	_	
185-7	32209-32213	LPFC	_	
185-8	32214-32224	activation	_	
185-9	32225-32227	in	_	
185-10	32228-32236	response	_	
185-11	32237-32239	to	_	
185-12	32240-32243	the	_	
185-13	32244-32246	SW	_	
185-14	32247-32251	cues	_	
185-15	32252-32260	relative	_	
185-16	32261-32263	to	_	
185-17	32264-32267	the	_	
185-18	32268-32270	WS	_	
185-19	32271-32275	cues	_	
185-20	32276-32277	(	_	
185-21	32277-32280	FWE	_	
185-22	32280-32281	,	_	
185-23	32282-32283	p	_	
185-24	32283-32284	 	_	
185-25	32284-32285	<	_	
185-26	32285-32286	 	_	
185-27	32286-32290	0.05	_	
185-28	32290-32291	,	_	
185-29	32292-32302	one-sample	_	
185-30	32303-32309	t-test	_	
185-31	32309-32310	)	_	
185-32	32310-32311	.	_	

#Text=However, a significant between-group difference was not observed (Fig. 3B, Left, t31 = 0.72, p = 0.48; Right, t31 = 1.95, p = 0.06, two-sample t-test).
186-1	32312-32319	However	_	
186-2	32319-32320	,	_	
186-3	32321-32322	a	_	
186-4	32323-32334	significant	_	
186-5	32335-32348	between-group	_	
186-6	32349-32359	difference	_	
186-7	32360-32363	was	_	
186-8	32364-32367	not	_	
186-9	32368-32376	observed	_	
186-10	32377-32378	(	_	
186-11	32378-32381	Fig	_	
186-12	32381-32382	.	_	
186-13	32383-32385	3B	_	
186-14	32385-32386	,	_	
186-15	32387-32391	Left	_	
186-16	32391-32392	,	_	
186-17	32393-32396	t31	_	
186-18	32396-32397	 	_	
186-19	32397-32398	=	_	
186-20	32398-32399	 	_	
186-21	32399-32403	0.72	_	
186-22	32403-32404	,	_	
186-23	32405-32406	p	_	
186-24	32406-32407	 	_	
186-25	32407-32408	=	_	
186-26	32408-32409	 	_	
186-27	32409-32413	0.48	_	
186-28	32413-32414	;	_	
186-29	32415-32420	Right	_	
186-30	32420-32421	,	_	
186-31	32422-32425	t31	_	
186-32	32425-32426	 	_	
186-33	32426-32427	=	_	
186-34	32427-32428	 	_	
186-35	32428-32432	1.95	_	
186-36	32432-32433	,	_	
186-37	32434-32435	p	_	
186-38	32435-32436	 	_	
186-39	32436-32437	=	_	
186-40	32437-32438	 	_	
186-41	32438-32442	0.06	_	
186-42	32442-32443	,	_	
186-43	32444-32454	two-sample	_	
186-44	32455-32461	t-test	_	
186-45	32461-32462	)	_	
186-46	32462-32463	.	_	

#Text=Left LPFC (peak at − 42, 50, 7) activation β(SW-WS) in HC was positively and significantly correlated with the IMI(SW-WS) (Fig. 3C, r = 0.62, p = 0.008, correction threshold: p = 0.0125, Pearson), although this was not true for the right LPFC (peak at 39, 44, 28) (r = 0.42, p = 0.09, Pearson).
187-1	32464-32468	Left	_	
187-2	32469-32473	LPFC	_	
187-3	32474-32475	(	_	
187-4	32475-32479	peak	_	
187-5	32480-32482	at	_	
187-6	32483-32484	−	_	
187-7	32484-32485	 	_	
187-8	32485-32487	42	_	
187-9	32487-32488	,	_	
187-10	32489-32491	50	_	
187-11	32491-32492	,	_	
187-12	32493-32494	7	_	
187-13	32494-32495	)	_	
187-14	32496-32506	activation	_	
187-15	32507-32508	β	_	
187-16	32508-32509	(	_	
187-17	32509-32514	SW-WS	_	
187-18	32514-32515	)	_	
187-19	32516-32518	in	_	
187-20	32519-32521	HC	_	
187-21	32522-32525	was	_	
187-22	32526-32536	positively	_	
187-23	32537-32540	and	_	
187-24	32541-32554	significantly	_	
187-25	32555-32565	correlated	_	
187-26	32566-32570	with	_	
187-27	32571-32574	the	_	
187-28	32575-32578	IMI	_	
187-29	32578-32579	(	_	
187-30	32579-32584	SW-WS	_	
187-31	32584-32585	)	_	
187-32	32586-32587	(	_	
187-33	32587-32590	Fig	_	
187-34	32590-32591	.	_	
187-35	32592-32594	3C	_	
187-36	32594-32595	,	_	
187-37	32596-32597	r	_	
187-38	32597-32598	 	_	
187-39	32598-32599	=	_	
187-40	32599-32600	 	_	
187-41	32600-32604	0.62	_	
187-42	32604-32605	,	_	
187-43	32606-32607	p	_	
187-44	32607-32608	 	_	
187-45	32608-32609	=	_	
187-46	32609-32610	 	_	
187-47	32610-32615	0.008	_	
187-48	32615-32616	,	_	
187-49	32617-32627	correction	_	
187-50	32628-32637	threshold	_	
187-51	32637-32638	:	_	
187-52	32639-32640	p	_	
187-53	32640-32641	 	_	
187-54	32641-32642	=	_	
187-55	32642-32643	 	_	
187-56	32643-32649	0.0125	_	
187-57	32649-32650	,	_	
187-58	32651-32658	Pearson	_	
187-59	32658-32659	)	_	
187-60	32659-32660	,	_	
187-61	32661-32669	although	_	
187-62	32670-32674	this	_	
187-63	32675-32678	was	_	
187-64	32679-32682	not	_	
187-65	32683-32687	true	_	
187-66	32688-32691	for	_	
187-67	32692-32695	the	_	
187-68	32696-32701	right	_	
187-69	32702-32706	LPFC	_	
187-70	32707-32708	(	_	
187-71	32708-32712	peak	_	
187-72	32713-32715	at	_	
187-73	32716-32718	39	_	
187-74	32718-32719	,	_	
187-75	32720-32722	44	_	
187-76	32722-32723	,	_	
187-77	32724-32726	28	_	
187-78	32726-32727	)	_	
187-79	32728-32729	(	_	
187-80	32729-32730	r	_	
187-81	32730-32731	 	_	
187-82	32731-32732	=	_	
187-83	32732-32733	 	_	
187-84	32733-32737	0.42	_	
187-85	32737-32738	,	_	
187-86	32739-32740	p	_	
187-87	32740-32741	 	_	
187-88	32741-32742	=	_	
187-89	32742-32743	 	_	
187-90	32743-32747	0.09	_	
187-91	32747-32748	,	_	
187-92	32749-32756	Pearson	_	
187-93	32756-32757	)	_	
187-94	32757-32758	.	_	

#Text=As for SCZ, neither left nor right LPFC activation β(SW-WS) showed a significant correlation with IMI(SW-WS) (Fig. 3C).
188-1	32759-32761	As	_	
188-2	32762-32765	for	_	
188-3	32766-32769	SCZ	_	
188-4	32769-32770	,	_	
188-5	32771-32778	neither	_	
188-6	32779-32783	left	_	
188-7	32784-32787	nor	_	
188-8	32788-32793	right	_	
188-9	32794-32798	LPFC	_	
188-10	32799-32809	activation	_	
188-11	32810-32811	β	_	
188-12	32811-32812	(	_	
188-13	32812-32817	SW-WS	_	
188-14	32817-32818	)	_	
188-15	32819-32825	showed	_	
188-16	32826-32827	a	_	
188-17	32828-32839	significant	_	
188-18	32840-32851	correlation	_	
188-19	32852-32856	with	_	
188-20	32857-32860	IMI	_	
188-21	32860-32861	(	_	
188-22	32861-32866	SW-WS	_	
188-23	32866-32867	)	_	
188-24	32868-32869	(	_	
188-25	32869-32872	Fig	_	
188-26	32872-32873	.	_	
188-27	32874-32876	3C	_	
188-28	32876-32877	)	_	
188-29	32877-32878	.	_	

#Text=Moreover, the bilateral striatum and LPFC activity were all not significantly correlated with either antipsychotic dose or the PANSS negative scores (Supplementary Table 2).
189-1	32879-32887	Moreover	_	
189-2	32887-32888	,	_	
189-3	32889-32892	the	_	
189-4	32893-32902	bilateral	_	
189-5	32903-32911	striatum	_	
189-6	32912-32915	and	_	
189-7	32916-32920	LPFC	_	
189-8	32921-32929	activity	_	
189-9	32930-32934	were	_	
189-10	32935-32938	all	_	
189-11	32939-32942	not	_	
189-12	32943-32956	significantly	_	
189-13	32957-32967	correlated	_	
189-14	32968-32972	with	_	
189-15	32973-32979	either	_	
189-16	32980-32993	antipsychotic	_	
189-17	32994-32998	dose	_	
189-18	32999-33001	or	_	
189-19	33002-33005	the	_	
189-20	33006-33011	PANSS	_	
189-21	33012-33020	negative	_	
189-22	33021-33027	scores	_	
189-23	33028-33029	(	_	
189-24	33029-33042	Supplementary	_	
189-25	33043-33048	Table	_	
189-26	33049-33050	2	_	
189-27	33050-33051	)	_	
189-28	33051-33052	.	_	

#Text=Striatum activation during the feedback period
#Text=Striatal activation in SCZ and HC during the feedback period.
190-1	33053-33061	Striatum	_	
190-2	33062-33072	activation	_	
190-3	33073-33079	during	_	
190-4	33080-33083	the	_	
190-5	33084-33092	feedback	_	
190-6	33093-33099	period	_	
190-7	33100-33108	Striatal	_	
190-8	33109-33119	activation	_	
190-9	33120-33122	in	_	
190-10	33123-33126	SCZ	_	
190-11	33127-33130	and	_	
190-12	33131-33133	HC	_	
190-13	33134-33140	during	_	
190-14	33141-33144	the	_	
190-15	33145-33153	feedback	_	
190-16	33154-33160	period	_	
190-17	33160-33161	.	_	

#Text=(A) The left (peak at − 12, 5, − 11) and right (peak at 9, 8, − 8) striatum activation in response to success feedback relative to failure feedback (FWE, p < 0.05, one-sample t-test).
191-1	33162-33163	(	_	
191-2	33163-33164	A	_	
191-3	33164-33165	)	_	
191-4	33166-33169	The	_	
191-5	33170-33174	left	_	
191-6	33175-33176	(	_	
191-7	33176-33180	peak	_	
191-8	33181-33183	at	_	
191-9	33184-33185	−	_	
191-10	33185-33186	 	_	
191-11	33186-33188	12	_	
191-12	33188-33189	,	_	
191-13	33190-33191	5	_	
191-14	33191-33192	,	_	
191-15	33193-33194	−	_	
191-16	33194-33195	 	_	
191-17	33195-33197	11	_	
191-18	33197-33198	)	_	
191-19	33199-33202	and	_	
191-20	33203-33208	right	_	
191-21	33209-33210	(	_	
191-22	33210-33214	peak	_	
191-23	33215-33217	at	_	
191-24	33218-33219	9	_	
191-25	33219-33220	,	_	
191-26	33221-33222	8	_	
191-27	33222-33223	,	_	
191-28	33224-33225	−	_	
191-29	33225-33226	 	_	
191-30	33226-33227	8	_	
191-31	33227-33228	)	_	
191-32	33229-33237	striatum	_	
191-33	33238-33248	activation	_	
191-34	33249-33251	in	_	
191-35	33252-33260	response	_	
191-36	33261-33263	to	_	
191-37	33264-33271	success	_	
191-38	33272-33280	feedback	_	
191-39	33281-33289	relative	_	
191-40	33290-33292	to	_	
191-41	33293-33300	failure	_	
191-42	33301-33309	feedback	_	
191-43	33310-33311	(	_	
191-44	33311-33314	FWE	_	
191-45	33314-33315	,	_	
191-46	33316-33317	p	_	
191-47	33317-33318	 	_	
191-48	33318-33319	<	_	
191-49	33319-33320	 	_	
191-50	33320-33324	0.05	_	
191-51	33324-33325	,	_	
191-52	33326-33336	one-sample	_	
191-53	33337-33343	t-test	_	
191-54	33343-33344	)	_	
191-55	33344-33345	.	_	

#Text=Left: Activation superimposed on the coronal format.
192-1	33346-33350	Left	_	
192-2	33350-33351	:	_	
192-3	33352-33362	Activation	_	
192-4	33363-33375	superimposed	_	
192-5	33376-33378	on	_	
192-6	33379-33382	the	_	
192-7	33383-33390	coronal	_	
192-8	33391-33397	format	_	
192-9	33397-33398	.	_	

#Text=Right: Mean contrast values and SEs of the left and right striatum activation.
193-1	33399-33404	Right	_	
193-2	33404-33405	:	_	
193-3	33406-33410	Mean	_	
193-4	33411-33419	contrast	_	
193-5	33420-33426	values	_	
193-6	33427-33430	and	_	
193-7	33431-33434	SEs	_	
193-8	33435-33437	of	_	
193-9	33438-33441	the	_	
193-10	33442-33446	left	_	
193-11	33447-33450	and	_	
193-12	33451-33456	right	_	
193-13	33457-33465	striatum	_	
193-14	33466-33476	activation	_	
193-15	33476-33477	.	_	

#Text=The bilateral striatum activation β(Success-Failure) did not show a significant between-group difference (Left, t31 = 0.24, p = 0.81; Right, t31 = 0.69, p = 0.50, two-sample t-test).
194-1	33478-33481	The	_	
194-2	33482-33491	bilateral	_	
194-3	33492-33500	striatum	_	
194-4	33501-33511	activation	_	
194-5	33512-33513	β	_	
194-6	33513-33514	(	_	
194-7	33514-33529	Success-Failure	_	
194-8	33529-33530	)	_	
194-9	33531-33534	did	_	
194-10	33535-33538	not	_	
194-11	33539-33543	show	_	
194-12	33544-33545	a	_	
194-13	33546-33557	significant	_	
194-14	33558-33571	between-group	_	
194-15	33572-33582	difference	_	
194-16	33583-33584	(	_	
194-17	33584-33588	Left	_	
194-18	33588-33589	,	_	
194-19	33590-33593	t31	_	
194-20	33593-33594	 	_	
194-21	33594-33595	=	_	
194-22	33595-33596	 	_	
194-23	33596-33600	0.24	_	
194-24	33600-33601	,	_	
194-25	33602-33603	p	_	
194-26	33603-33604	 	_	
194-27	33604-33605	=	_	
194-28	33605-33606	 	_	
194-29	33606-33610	0.81	_	
194-30	33610-33611	;	_	
194-31	33612-33617	Right	_	
194-32	33617-33618	,	_	
194-33	33619-33622	t31	_	
194-34	33622-33623	 	_	
194-35	33623-33624	=	_	
194-36	33624-33625	 	_	
194-37	33625-33629	0.69	_	
194-38	33629-33630	,	_	
194-39	33631-33632	p	_	
194-40	33632-33633	 	_	
194-41	33633-33634	=	_	
194-42	33634-33635	 	_	
194-43	33635-33639	0.50	_	
194-44	33639-33640	,	_	
194-45	33641-33651	two-sample	_	
194-46	33652-33658	t-test	_	
194-47	33658-33659	)	_	
194-48	33659-33660	.	_	

#Text=(B) Striatum activation β(Success-Failure) was not significantly correlated with IMI(SW-WS) in each group (Left: SCZ: r = − 0.31, p = 0.63; HC: r = − 0.24, p = 0.36, Right: SCZ: r = − 0.35, p = 0.32; HC: r = − 0.24, p = 0.35, Pearson). n.s.: not significant.
195-1	33661-33662	(	_	
195-2	33662-33663	B	_	
195-3	33663-33664	)	_	
195-4	33665-33673	Striatum	_	
195-5	33674-33684	activation	_	
195-6	33685-33686	β	_	
195-7	33686-33687	(	_	
195-8	33687-33702	Success-Failure	_	
195-9	33702-33703	)	_	
195-10	33704-33707	was	_	
195-11	33708-33711	not	_	
195-12	33712-33725	significantly	_	
195-13	33726-33736	correlated	_	
195-14	33737-33741	with	_	
195-15	33742-33745	IMI	_	
195-16	33745-33746	(	_	
195-17	33746-33751	SW-WS	_	
195-18	33751-33752	)	_	
195-19	33753-33755	in	_	
195-20	33756-33760	each	_	
195-21	33761-33766	group	_	
195-22	33767-33768	(	_	
195-23	33768-33772	Left	_	
195-24	33772-33773	:	_	
195-25	33774-33777	SCZ	_	
195-26	33777-33778	:	_	
195-27	33779-33780	r	_	
195-28	33780-33781	 	_	
195-29	33781-33782	=	_	
195-30	33782-33783	 	_	
195-31	33783-33784	−	_	
195-32	33784-33785	 	_	
195-33	33785-33789	0.31	_	
195-34	33789-33790	,	_	
195-35	33791-33792	p	_	
195-36	33792-33793	 	_	
195-37	33793-33794	=	_	
195-38	33794-33795	 	_	
195-39	33795-33799	0.63	_	
195-40	33799-33800	;	_	
195-41	33801-33803	HC	_	
195-42	33803-33804	:	_	
195-43	33805-33806	r	_	
195-44	33806-33807	 	_	
195-45	33807-33808	=	_	
195-46	33808-33809	 	_	
195-47	33809-33810	−	_	
195-48	33810-33811	 	_	
195-49	33811-33815	0.24	_	
195-50	33815-33816	,	_	
195-51	33817-33818	p	_	
195-52	33818-33819	 	_	
195-53	33819-33820	=	_	
195-54	33820-33821	 	_	
195-55	33821-33825	0.36	_	
195-56	33825-33826	,	_	
195-57	33827-33832	Right	_	
195-58	33832-33833	:	_	
195-59	33834-33837	SCZ	_	
195-60	33837-33838	:	_	
195-61	33839-33840	r	_	
195-62	33840-33841	 	_	
195-63	33841-33842	=	_	
195-64	33842-33843	 	_	
195-65	33843-33844	−	_	
195-66	33844-33845	 	_	
195-67	33845-33849	0.35	_	
195-68	33849-33850	,	_	
195-69	33851-33852	p	_	
195-70	33852-33853	 	_	
195-71	33853-33854	=	_	
195-72	33854-33855	 	_	
195-73	33855-33859	0.32	_	
195-74	33859-33860	;	_	
195-75	33861-33863	HC	_	
195-76	33863-33864	:	_	
195-77	33865-33866	r	_	
195-78	33866-33867	 	_	
195-79	33867-33868	=	_	
195-80	33868-33869	 	_	
195-81	33869-33870	−	_	
195-82	33870-33871	 	_	
195-83	33871-33875	0.24	_	
195-84	33875-33876	,	_	
195-85	33877-33878	p	_	
195-86	33878-33879	 	_	
195-87	33879-33880	=	_	
195-88	33880-33881	 	_	
195-89	33881-33885	0.35	_	
195-90	33885-33886	,	_	
195-91	33887-33894	Pearson	_	
195-92	33894-33895	)	_	
195-93	33895-33896	.	_	
195-94	33897-33900	n.s	_	
195-95	33900-33901	.	_	
195-96	33901-33902	:	_	
195-97	33903-33906	not	_	
195-98	33907-33918	significant	_	
195-99	33918-33919	.	_	

#Text=Fig. 4
#Text=We measured the neural activity during the feedback period to assess the hedonic response elicited by the success feedback in comparison with the failure trials.
196-1	33920-33923	Fig	_	
196-2	33923-33924	.	_	
196-3	33925-33926	4	_	
196-4	33927-33929	We	_	
196-5	33930-33938	measured	_	
196-6	33939-33942	the	_	
196-7	33943-33949	neural	_	
196-8	33950-33958	activity	_	
196-9	33959-33965	during	_	
196-10	33966-33969	the	_	
196-11	33970-33978	feedback	_	
196-12	33979-33985	period	_	
196-13	33986-33988	to	_	
196-14	33989-33995	assess	_	
196-15	33996-33999	the	_	
196-16	34000-34007	hedonic	_	
196-17	34008-34016	response	_	
196-18	34017-34025	elicited	_	
196-19	34026-34028	by	_	
196-20	34029-34032	the	_	
196-21	34033-34040	success	_	
196-22	34041-34049	feedback	_	
196-23	34050-34052	in	_	
196-24	34053-34063	comparison	_	
196-25	34064-34068	with	_	
196-26	34069-34072	the	_	
196-27	34073-34080	failure	_	
196-28	34081-34087	trials	_	
196-29	34087-34088	.	_	

#Text=We found significant striatal activity in the success trials in comparison with the failure trials bilaterally (FWE, p < 0.05, one-sample t-test) but not a significant between-group difference (Fig. 4A, Left, t31 = 0.24, p = 0.81; Right, t31 = 0.69, p = 0.50, two-sample t-test).
197-1	34089-34091	We	_	
197-2	34092-34097	found	_	
197-3	34098-34109	significant	_	
197-4	34110-34118	striatal	_	
197-5	34119-34127	activity	_	
197-6	34128-34130	in	_	
197-7	34131-34134	the	_	
197-8	34135-34142	success	_	
197-9	34143-34149	trials	_	
197-10	34150-34152	in	_	
197-11	34153-34163	comparison	_	
197-12	34164-34168	with	_	
197-13	34169-34172	the	_	
197-14	34173-34180	failure	_	
197-15	34181-34187	trials	_	
197-16	34188-34199	bilaterally	_	
197-17	34200-34201	(	_	
197-18	34201-34204	FWE	_	
197-19	34204-34205	,	_	
197-20	34206-34207	p	_	
197-21	34207-34208	 	_	
197-22	34208-34209	<	_	
197-23	34209-34210	 	_	
197-24	34210-34214	0.05	_	
197-25	34214-34215	,	_	
197-26	34216-34226	one-sample	_	
197-27	34227-34233	t-test	_	
197-28	34233-34234	)	_	
197-29	34235-34238	but	_	
197-30	34239-34242	not	_	
197-31	34243-34244	a	_	
197-32	34245-34256	significant	_	
197-33	34257-34270	between-group	_	
197-34	34271-34281	difference	_	
197-35	34282-34283	(	_	
197-36	34283-34286	Fig	_	
197-37	34286-34287	.	_	
197-38	34288-34290	4A	_	
197-39	34290-34291	,	_	
197-40	34292-34296	Left	_	
197-41	34296-34297	,	_	
197-42	34298-34301	t31	_	
197-43	34301-34302	 	_	
197-44	34302-34303	=	_	
197-45	34303-34304	 	_	
197-46	34304-34308	0.24	_	
197-47	34308-34309	,	_	
197-48	34310-34311	p	_	
197-49	34311-34312	 	_	
197-50	34312-34313	=	_	
197-51	34313-34314	 	_	
197-52	34314-34318	0.81	_	
197-53	34318-34319	;	_	
197-54	34320-34325	Right	_	
197-55	34325-34326	,	_	
197-56	34327-34330	t31	_	
197-57	34330-34331	 	_	
197-58	34331-34332	=	_	
197-59	34332-34333	 	_	
197-60	34333-34337	0.69	_	
197-61	34337-34338	,	_	
197-62	34339-34340	p	_	
197-63	34340-34341	 	_	
197-64	34341-34342	=	_	
197-65	34342-34343	 	_	
197-66	34343-34347	0.50	_	
197-67	34347-34348	,	_	
197-68	34349-34359	two-sample	_	
197-69	34360-34366	t-test	_	
197-70	34366-34367	)	_	
197-71	34367-34368	.	_	

#Text=Next, we examined the relationship between the striatum activation and IMI scores.
198-1	34369-34373	Next	_	
198-2	34373-34374	,	_	
198-3	34375-34377	we	_	
198-4	34378-34386	examined	_	
198-5	34387-34390	the	_	
198-6	34391-34403	relationship	_	
198-7	34404-34411	between	_	
198-8	34412-34415	the	_	
198-9	34416-34424	striatum	_	
198-10	34425-34435	activation	_	
198-11	34436-34439	and	_	
198-12	34440-34443	IMI	_	
198-13	34444-34450	scores	_	
198-14	34450-34451	.	_	

#Text=Neither the left or right striatum activation β(Success-Failure) was significantly correlated with IMI(SW-WS) in either group (Fig. 4B, Left: SCZ: r = − 0.31, p = 0.63; HC: r = − 0.24, p = 0.36, Right: SCZ: r = − 0.35, p = 0.32; HC: r = − 0.24, p = 0.35, Pearson).
199-1	34452-34459	Neither	_	
199-2	34460-34463	the	_	
199-3	34464-34468	left	_	
199-4	34469-34471	or	_	
199-5	34472-34477	right	_	
199-6	34478-34486	striatum	_	
199-7	34487-34497	activation	_	
199-8	34498-34499	β	_	
199-9	34499-34500	(	_	
199-10	34500-34515	Success-Failure	_	
199-11	34515-34516	)	_	
199-12	34517-34520	was	_	
199-13	34521-34534	significantly	_	
199-14	34535-34545	correlated	_	
199-15	34546-34550	with	_	
199-16	34551-34554	IMI	_	
199-17	34554-34555	(	_	
199-18	34555-34560	SW-WS	_	
199-19	34560-34561	)	_	
199-20	34562-34564	in	_	
199-21	34565-34571	either	_	
199-22	34572-34577	group	_	
199-23	34578-34579	(	_	
199-24	34579-34582	Fig	_	
199-25	34582-34583	.	_	
199-26	34584-34586	4B	_	
199-27	34586-34587	,	_	
199-28	34588-34592	Left	_	
199-29	34592-34593	:	_	
199-30	34594-34597	SCZ	_	
199-31	34597-34598	:	_	
199-32	34599-34600	r	_	
199-33	34600-34601	 	_	
199-34	34601-34602	=	_	
199-35	34602-34603	 	_	
199-36	34603-34604	−	_	
199-37	34604-34605	 	_	
199-38	34605-34609	0.31	_	
199-39	34609-34610	,	_	
199-40	34611-34612	p	_	
199-41	34612-34613	 	_	
199-42	34613-34614	=	_	
199-43	34614-34615	 	_	
199-44	34615-34619	0.63	_	
199-45	34619-34620	;	_	
199-46	34621-34623	HC	_	
199-47	34623-34624	:	_	
199-48	34625-34626	r	_	
199-49	34626-34627	 	_	
199-50	34627-34628	=	_	
199-51	34628-34629	 	_	
199-52	34629-34630	−	_	
199-53	34630-34631	 	_	
199-54	34631-34635	0.24	_	
199-55	34635-34636	,	_	
199-56	34637-34638	p	_	
199-57	34638-34639	 	_	
199-58	34639-34640	=	_	
199-59	34640-34641	 	_	
199-60	34641-34645	0.36	_	
199-61	34645-34646	,	_	
199-62	34647-34652	Right	_	
199-63	34652-34653	:	_	
199-64	34654-34657	SCZ	_	
199-65	34657-34658	:	_	
199-66	34659-34660	r	_	
199-67	34660-34661	 	_	
199-68	34661-34662	=	_	
199-69	34662-34663	 	_	
199-70	34663-34664	−	_	
199-71	34664-34665	 	_	
199-72	34665-34669	0.35	_	
199-73	34669-34670	,	_	
199-74	34671-34672	p	_	
199-75	34672-34673	 	_	
199-76	34673-34674	=	_	
199-77	34674-34675	 	_	
199-78	34675-34679	0.32	_	
199-79	34679-34680	;	_	
199-80	34681-34683	HC	_	
199-81	34683-34684	:	_	
199-82	34685-34686	r	_	
199-83	34686-34687	 	_	
199-84	34687-34688	=	_	
199-85	34688-34689	 	_	
199-86	34689-34690	−	_	
199-87	34690-34691	 	_	
199-88	34691-34695	0.24	_	
199-89	34695-34696	,	_	
199-90	34697-34698	p	_	
199-91	34698-34699	 	_	
199-92	34699-34700	=	_	
199-93	34700-34701	 	_	
199-94	34701-34705	0.35	_	
199-95	34705-34706	,	_	
199-96	34707-34714	Pearson	_	
199-97	34714-34715	)	_	
199-98	34715-34716	.	_	

#Text=In addition, the bilateral striatum activation β(SW-WS) in SCZ was not significantly correlated with antipsychotic dose (left: r = 0.01, p = 0.92; right: r = 0.16, p = 0.55, Pearson), the PANSS negative score (left: r = 0.16, p = 0.55; right: r = 0.23, p = 0.38, Pearson).
200-1	34717-34719	In	_	
200-2	34720-34728	addition	_	
200-3	34728-34729	,	_	
200-4	34730-34733	the	_	
200-5	34734-34743	bilateral	_	
200-6	34744-34752	striatum	_	
200-7	34753-34763	activation	_	
200-8	34764-34765	β	_	
200-9	34765-34766	(	_	
200-10	34766-34771	SW-WS	_	
200-11	34771-34772	)	_	
200-12	34773-34775	in	_	
200-13	34776-34779	SCZ	_	
200-14	34780-34783	was	_	
200-15	34784-34787	not	_	
200-16	34788-34801	significantly	_	
200-17	34802-34812	correlated	_	
200-18	34813-34817	with	_	
200-19	34818-34831	antipsychotic	_	
200-20	34832-34836	dose	_	
200-21	34837-34838	(	_	
200-22	34838-34842	left	_	
200-23	34842-34843	:	_	
200-24	34844-34845	r	_	
200-25	34845-34846	 	_	
200-26	34846-34847	=	_	
200-27	34847-34848	 	_	
200-28	34848-34852	0.01	_	
200-29	34852-34853	,	_	
200-30	34854-34855	p	_	
200-31	34855-34856	 	_	
200-32	34856-34857	=	_	
200-33	34857-34858	 	_	
200-34	34858-34862	0.92	_	
200-35	34862-34863	;	_	
200-36	34864-34869	right	_	
200-37	34869-34870	:	_	
200-38	34871-34872	r	_	
200-39	34872-34873	 	_	
200-40	34873-34874	=	_	
200-41	34874-34875	 	_	
200-42	34875-34879	0.16	_	
200-43	34879-34880	,	_	
200-44	34881-34882	p	_	
200-45	34882-34883	 	_	
200-46	34883-34884	=	_	
200-47	34884-34885	 	_	
200-48	34885-34889	0.55	_	
200-49	34889-34890	,	_	
200-50	34891-34898	Pearson	_	
200-51	34898-34899	)	_	
200-52	34899-34900	,	_	
200-53	34901-34904	the	_	
200-54	34905-34910	PANSS	_	
200-55	34911-34919	negative	_	
200-56	34920-34925	score	_	
200-57	34926-34927	(	_	
200-58	34927-34931	left	_	
200-59	34931-34932	:	_	
200-60	34933-34934	r	_	
200-61	34934-34935	 	_	
200-62	34935-34936	=	_	
200-63	34936-34937	 	_	
200-64	34937-34941	0.16	_	
200-65	34941-34942	,	_	
200-66	34943-34944	p	_	
200-67	34944-34945	 	_	
200-68	34945-34946	=	_	
200-69	34946-34947	 	_	
200-70	34947-34951	0.55	_	
200-71	34951-34952	;	_	
200-72	34953-34958	right	_	
200-73	34958-34959	:	_	
200-74	34960-34961	r	_	
200-75	34961-34962	 	_	
200-76	34962-34963	=	_	
200-77	34963-34964	 	_	
200-78	34964-34968	0.23	_	
200-79	34968-34969	,	_	
200-80	34970-34971	p	_	
200-81	34971-34972	 	_	
200-82	34972-34973	=	_	
200-83	34973-34974	 	_	
200-84	34974-34978	0.38	_	
200-85	34978-34979	,	_	
200-86	34980-34987	Pearson	_	
200-87	34987-34988	)	_	
200-88	34988-34989	.	_	

#Text=Relationship between LPFC activity and cognitive control
#Text=The reduced rate of Overshoot → Success in the SCZ group suggests that cognitive control of actions after Overshoot trials was impaired in this group, so we analyzed the relationship between it and LPFC activation as well as IMI(SW-WS).
201-1	34990-35002	Relationship	_	
201-2	35003-35010	between	_	
201-3	35011-35015	LPFC	_	
201-4	35016-35024	activity	_	
201-5	35025-35028	and	_	
201-6	35029-35038	cognitive	_	
201-7	35039-35046	control	_	
201-8	35047-35050	The	_	
201-9	35051-35058	reduced	_	
201-10	35059-35063	rate	_	
201-11	35064-35066	of	_	
201-12	35067-35076	Overshoot	_	
201-13	35076-35077	 	_	
201-14	35077-35078	→	_	
201-15	35078-35079	 	_	
201-16	35079-35086	Success	_	
201-17	35087-35089	in	_	
201-18	35090-35093	the	_	
201-19	35094-35097	SCZ	_	
201-20	35098-35103	group	_	
201-21	35104-35112	suggests	_	
201-22	35113-35117	that	_	
201-23	35118-35127	cognitive	_	
201-24	35128-35135	control	_	
201-25	35136-35138	of	_	
201-26	35139-35146	actions	_	
201-27	35147-35152	after	_	
201-28	35153-35162	Overshoot	_	
201-29	35163-35169	trials	_	
201-30	35170-35173	was	_	
201-31	35174-35182	impaired	_	
201-32	35183-35185	in	_	
201-33	35186-35190	this	_	
201-34	35191-35196	group	_	
201-35	35196-35197	,	_	
201-36	35198-35200	so	_	
201-37	35201-35203	we	_	
201-38	35204-35212	analyzed	_	
201-39	35213-35216	the	_	
201-40	35217-35229	relationship	_	
201-41	35230-35237	between	_	
201-42	35238-35240	it	_	
201-43	35241-35244	and	_	
201-44	35245-35249	LPFC	_	
201-45	35250-35260	activation	_	
201-46	35261-35263	as	_	
201-47	35264-35268	well	_	
201-48	35269-35271	as	_	
201-49	35272-35275	IMI	_	
201-50	35275-35276	(	_	
201-51	35276-35281	SW-WS	_	
201-52	35281-35282	)	_	
201-53	35282-35283	.	_	

#Text=There was a significant correlation between left LPFC and IMI(SW-WS), so we focused on the left LPFC for further analysis.
202-1	35284-35289	There	_	
202-2	35290-35293	was	_	
202-3	35294-35295	a	_	
202-4	35296-35307	significant	_	
202-5	35308-35319	correlation	_	
202-6	35320-35327	between	_	
202-7	35328-35332	left	_	
202-8	35333-35337	LPFC	_	
202-9	35338-35341	and	_	
202-10	35342-35345	IMI	_	
202-11	35345-35346	(	_	
202-12	35346-35351	SW-WS	_	
202-13	35351-35352	)	_	
202-14	35352-35353	,	_	
202-15	35354-35356	so	_	
202-16	35357-35359	we	_	
202-17	35360-35367	focused	_	
202-18	35368-35370	on	_	
202-19	35371-35374	the	_	
202-20	35375-35379	left	_	
202-21	35380-35384	LPFC	_	
202-22	35385-35388	for	_	
202-23	35389-35396	further	_	
202-24	35397-35405	analysis	_	
202-25	35405-35406	.	_	

#Text=Correlation between the activation in LPFC and the rate of success SW trial following Overshoot (Overshoot → Success).
203-1	35407-35418	Correlation	_	
203-2	35419-35426	between	_	
203-3	35427-35430	the	_	
203-4	35431-35441	activation	_	
203-5	35442-35444	in	_	
203-6	35445-35449	LPFC	_	
203-7	35450-35453	and	_	
203-8	35454-35457	the	_	
203-9	35458-35462	rate	_	
203-10	35463-35465	of	_	
203-11	35466-35473	success	_	
203-12	35474-35476	SW	_	
203-13	35477-35482	trial	_	
203-14	35483-35492	following	_	
203-15	35493-35502	Overshoot	_	
203-16	35503-35504	(	_	
203-17	35504-35513	Overshoot	_	
203-18	35513-35514	 	_	
203-19	35514-35515	→	_	
203-20	35515-35516	 	_	
203-21	35516-35523	Success	_	
203-22	35523-35524	)	_	
203-23	35524-35525	.	_	

#Text=In the HC group, there was a trend for significant correlation between left LPFC activation and the rate (Overshoot → Success) (r = 0.52, p = 0.04, correction threshold: p = 0.025, Pearson).
204-1	35526-35528	In	_	
204-2	35529-35532	the	_	
204-3	35533-35535	HC	_	
204-4	35536-35541	group	_	
204-5	35541-35542	,	_	
204-6	35543-35548	there	_	
204-7	35549-35552	was	_	
204-8	35553-35554	a	_	
204-9	35555-35560	trend	_	
204-10	35561-35564	for	_	
204-11	35565-35576	significant	_	
204-12	35577-35588	correlation	_	
204-13	35589-35596	between	_	
204-14	35597-35601	left	_	
204-15	35602-35606	LPFC	_	
204-16	35607-35617	activation	_	
204-17	35618-35621	and	_	
204-18	35622-35625	the	_	
204-19	35626-35630	rate	_	
204-20	35631-35632	(	_	
204-21	35632-35641	Overshoot	_	
204-22	35641-35642	 	_	
204-23	35642-35643	→	_	
204-24	35643-35644	 	_	
204-25	35644-35651	Success	_	
204-26	35651-35652	)	_	
204-27	35653-35654	(	_	
204-28	35654-35655	r	_	
204-29	35655-35656	 	_	
204-30	35656-35657	=	_	
204-31	35657-35658	 	_	
204-32	35658-35662	0.52	_	
204-33	35662-35663	,	_	
204-34	35664-35665	p	_	
204-35	35665-35666	 	_	
204-36	35666-35667	=	_	
204-37	35667-35668	 	_	
204-38	35668-35672	0.04	_	
204-39	35672-35673	,	_	
204-40	35674-35684	correction	_	
204-41	35685-35694	threshold	_	
204-42	35694-35695	:	_	
204-43	35696-35697	p	_	
204-44	35697-35698	 	_	
204-45	35698-35699	=	_	
204-46	35699-35700	 	_	
204-47	35700-35705	0.025	_	
204-48	35705-35706	,	_	
204-49	35707-35714	Pearson	_	
204-50	35714-35715	)	_	
204-51	35715-35716	.	_	

#Text=In SCZ, there was no significant correlation among them.
205-1	35717-35719	In	_	
205-2	35720-35723	SCZ	_	
205-3	35723-35724	,	_	
205-4	35725-35730	there	_	
205-5	35731-35734	was	_	
205-6	35735-35737	no	_	
205-7	35738-35749	significant	_	
205-8	35750-35761	correlation	_	
205-9	35762-35767	among	_	
205-10	35768-35772	them	_	
205-11	35772-35773	.	_	

#Text=(SCZ, r = − 0.12, p = 0.56, Pearson). †: p < 0.05, n.s.: not significant.
206-1	35774-35775	(	_	
206-2	35775-35778	SCZ	_	
206-3	35778-35779	,	_	
206-4	35780-35781	r	_	
206-5	35781-35782	 	_	
206-6	35782-35783	=	_	
206-7	35783-35784	 	_	
206-8	35784-35785	−	_	
206-9	35785-35786	 	_	
206-10	35786-35790	0.12	_	
206-11	35790-35791	,	_	
206-12	35792-35793	p	_	
206-13	35793-35794	 	_	
206-14	35794-35795	=	_	
206-15	35795-35796	 	_	
206-16	35796-35800	0.56	_	
206-17	35800-35801	,	_	
206-18	35802-35809	Pearson	_	
206-19	35809-35810	)	_	
206-20	35810-35811	.	_	
206-21	35812-35813	†	_	
206-22	35813-35814	:	_	
206-23	35815-35816	p	_	
206-24	35816-35817	 	_	
206-25	35817-35818	<	_	
206-26	35818-35819	 	_	
206-27	35819-35823	0.05	_	
206-28	35823-35824	,	_	
206-29	35825-35828	n.s	_	
206-30	35828-35829	.	_	
206-31	35829-35830	:	_	
206-32	35831-35834	not	_	
206-33	35835-35846	significant	_	
206-34	35846-35847	.	_	

#Text=Fig. 5
#Text=In the HC group, there was a trend for significant correlation between left LPFC activation and the rate (Overshoot → Success) (r = 0.52, p = 0.04, correction threshold: p = 0.025, Pearson) but not in SCZ (Fig. 5).
207-1	35848-35851	Fig	_	
207-2	35851-35852	.	_	
207-3	35853-35854	5	_	
207-4	35855-35857	In	_	
207-5	35858-35861	the	_	
207-6	35862-35864	HC	_	
207-7	35865-35870	group	_	
207-8	35870-35871	,	_	
207-9	35872-35877	there	_	
207-10	35878-35881	was	_	
207-11	35882-35883	a	_	
207-12	35884-35889	trend	_	
207-13	35890-35893	for	_	
207-14	35894-35905	significant	_	
207-15	35906-35917	correlation	_	
207-16	35918-35925	between	_	
207-17	35926-35930	left	_	
207-18	35931-35935	LPFC	_	
207-19	35936-35946	activation	_	
207-20	35947-35950	and	_	
207-21	35951-35954	the	_	
207-22	35955-35959	rate	_	
207-23	35960-35961	(	_	
207-24	35961-35970	Overshoot	_	
207-25	35970-35971	 	_	
207-26	35971-35972	→	_	
207-27	35972-35973	 	_	
207-28	35973-35980	Success	_	
207-29	35980-35981	)	_	
207-30	35982-35983	(	_	
207-31	35983-35984	r	_	
207-32	35984-35985	 	_	
207-33	35985-35986	=	_	
207-34	35986-35987	 	_	
207-35	35987-35991	0.52	_	
207-36	35991-35992	,	_	
207-37	35993-35994	p	_	
207-38	35994-35995	 	_	
207-39	35995-35996	=	_	
207-40	35996-35997	 	_	
207-41	35997-36001	0.04	_	
207-42	36001-36002	,	_	
207-43	36003-36013	correction	_	
207-44	36014-36023	threshold	_	
207-45	36023-36024	:	_	
207-46	36025-36026	p	_	
207-47	36026-36027	 	_	
207-48	36027-36028	=	_	
207-49	36028-36029	 	_	
207-50	36029-36034	0.025	_	
207-51	36034-36035	,	_	
207-52	36036-36043	Pearson	_	
207-53	36043-36044	)	_	
207-54	36045-36048	but	_	
207-55	36049-36052	not	_	
207-56	36053-36055	in	_	
207-57	36056-36059	SCZ	_	
207-58	36060-36061	(	_	
207-59	36061-36064	Fig	_	
207-60	36064-36065	.	_	
207-61	36066-36067	5	_	
207-62	36067-36068	)	_	
207-63	36068-36069	.	_	

#Text=In addition, in HC, the rate of Overshoot → Success trials was significantly correlated with IMI(SW-WS) but not in SCZ (HC, r = 0.61, p = 0.024; SCZ, r = 0.05, p = 0.86, correction threshold: p = 0.025, Pearson).
208-1	36070-36072	In	_	
208-2	36073-36081	addition	_	
208-3	36081-36082	,	_	
208-4	36083-36085	in	_	
208-5	36086-36088	HC	_	
208-6	36088-36089	,	_	
208-7	36090-36093	the	_	
208-8	36094-36098	rate	_	
208-9	36099-36101	of	_	
208-10	36102-36111	Overshoot	_	
208-11	36111-36112	 	_	
208-12	36112-36113	→	_	
208-13	36113-36114	 	_	
208-14	36114-36121	Success	_	
208-15	36122-36128	trials	_	
208-16	36129-36132	was	_	
208-17	36133-36146	significantly	_	
208-18	36147-36157	correlated	_	
208-19	36158-36162	with	_	
208-20	36163-36166	IMI	_	
208-21	36166-36167	(	_	
208-22	36167-36172	SW-WS	_	
208-23	36172-36173	)	_	
208-24	36174-36177	but	_	
208-25	36178-36181	not	_	
208-26	36182-36184	in	_	
208-27	36185-36188	SCZ	_	
208-28	36189-36190	(	_	
208-29	36190-36192	HC	_	
208-30	36192-36193	,	_	
208-31	36194-36195	r	_	
208-32	36195-36196	 	_	
208-33	36196-36197	=	_	
208-34	36197-36198	 	_	
208-35	36198-36202	0.61	_	
208-36	36202-36203	,	_	
208-37	36204-36205	p	_	
208-38	36205-36206	 	_	
208-39	36206-36207	=	_	
208-40	36207-36208	 	_	
208-41	36208-36213	0.024	_	
208-42	36213-36214	;	_	
208-43	36215-36218	SCZ	_	
208-44	36218-36219	,	_	
208-45	36220-36221	r	_	
208-46	36221-36222	 	_	
208-47	36222-36223	=	_	
208-48	36223-36224	 	_	
208-49	36224-36228	0.05	_	
208-50	36228-36229	,	_	
208-51	36230-36231	p	_	
208-52	36231-36232	 	_	
208-53	36232-36233	=	_	
208-54	36233-36234	 	_	
208-55	36234-36238	0.86	_	
208-56	36238-36239	,	_	
208-57	36240-36250	correction	_	
208-58	36251-36260	threshold	_	
208-59	36260-36261	:	_	
208-60	36262-36263	p	_	
208-61	36263-36264	 	_	
208-62	36264-36265	=	_	
208-63	36265-36266	 	_	
208-64	36266-36271	0.025	_	
208-65	36271-36272	,	_	
208-66	36273-36280	Pearson	_	
208-67	36280-36281	)	_	
208-68	36281-36282	.	_	

#Text=These results suggest that activity in the left LPFC, which was correlated with intrinsic motivation, is associated with a context updating process after Overshoot trials in HC but not in SCZ participants.
209-1	36283-36288	These	_	
209-2	36289-36296	results	_	
209-3	36297-36304	suggest	_	
209-4	36305-36309	that	_	
209-5	36310-36318	activity	_	
209-6	36319-36321	in	_	
209-7	36322-36325	the	_	
209-8	36326-36330	left	_	
209-9	36331-36335	LPFC	_	
209-10	36335-36336	,	_	
209-11	36337-36342	which	_	
209-12	36343-36346	was	_	
209-13	36347-36357	correlated	_	
209-14	36358-36362	with	_	
209-15	36363-36372	intrinsic	_	
209-16	36373-36383	motivation	_	
209-17	36383-36384	,	_	
209-18	36385-36387	is	_	
209-19	36388-36398	associated	_	
209-20	36399-36403	with	_	
209-21	36404-36405	a	_	
209-22	36406-36413	context	_	
209-23	36414-36422	updating	_	
209-24	36423-36430	process	_	
209-25	36431-36436	after	_	
209-26	36437-36446	Overshoot	_	
209-27	36447-36453	trials	_	
209-28	36454-36456	in	_	
209-29	36457-36459	HC	_	
209-30	36460-36463	but	_	
209-31	36464-36467	not	_	
209-32	36468-36470	in	_	
209-33	36471-36474	SCZ	_	
209-34	36475-36487	participants	_	
209-35	36487-36488	.	_	

#Text=Functional correlation between LPFC and striatum
#Text=We suspected that the difference in function of the frontostriatal loop components was important for the difference in IMI scores and cognitive control between groups, so we examined the relationships between the LPFC and striatum.
210-1	36489-36499	Functional	_	
210-2	36500-36511	correlation	_	
210-3	36512-36519	between	_	
210-4	36520-36524	LPFC	_	
210-5	36525-36528	and	_	
210-6	36529-36537	striatum	_	
210-7	36538-36540	We	_	
210-8	36541-36550	suspected	_	
210-9	36551-36555	that	_	
210-10	36556-36559	the	_	
210-11	36560-36570	difference	_	
210-12	36571-36573	in	_	
210-13	36574-36582	function	_	
210-14	36583-36585	of	_	
210-15	36586-36589	the	_	
210-16	36590-36604	frontostriatal	_	
210-17	36605-36609	loop	_	
210-18	36610-36620	components	_	
210-19	36621-36624	was	_	
210-20	36625-36634	important	_	
210-21	36635-36638	for	_	
210-22	36639-36642	the	_	
210-23	36643-36653	difference	_	
210-24	36654-36656	in	_	
210-25	36657-36660	IMI	_	
210-26	36661-36667	scores	_	
210-27	36668-36671	and	_	
210-28	36672-36681	cognitive	_	
210-29	36682-36689	control	_	
210-30	36690-36697	between	_	
210-31	36698-36704	groups	_	
210-32	36704-36705	,	_	
210-33	36706-36708	so	_	
210-34	36709-36711	we	_	
210-35	36712-36720	examined	_	
210-36	36721-36724	the	_	
210-37	36725-36738	relationships	_	
210-38	36739-36746	between	_	
210-39	36747-36750	the	_	
210-40	36751-36755	LPFC	_	
210-41	36756-36759	and	_	
210-42	36760-36768	striatum	_	
210-43	36768-36769	.	_	

#Text=Correlation between LPFC and striatum activity, functional connectivity and fractional anisotropy.
211-1	36770-36781	Correlation	_	
211-2	36782-36789	between	_	
211-3	36790-36794	LPFC	_	
211-4	36795-36798	and	_	
211-5	36799-36807	striatum	_	
211-6	36808-36816	activity	_	
211-7	36816-36817	,	_	
211-8	36818-36828	functional	_	
211-9	36829-36841	connectivity	_	
211-10	36842-36845	and	_	
211-11	36846-36856	fractional	_	
211-12	36857-36867	anisotropy	_	
211-13	36867-36868	.	_	

#Text=(A) The activity in the left LPFC β(SW-WS) was significantly correlated with activity in the left striatum β(SW-WS) in both groups (SCZ: r = 0.66, p = 0.001; HC: r = 0.50, p = 0.017, correction threshold: p = 0.025, Pearson).
212-1	36869-36870	(	_	
212-2	36870-36871	A	_	
212-3	36871-36872	)	_	
212-4	36873-36876	The	_	
212-5	36877-36885	activity	_	
212-6	36886-36888	in	_	
212-7	36889-36892	the	_	
212-8	36893-36897	left	_	
212-9	36898-36902	LPFC	_	
212-10	36903-36904	β	_	
212-11	36904-36905	(	_	
212-12	36905-36910	SW-WS	_	
212-13	36910-36911	)	_	
212-14	36912-36915	was	_	
212-15	36916-36929	significantly	_	
212-16	36930-36940	correlated	_	
212-17	36941-36945	with	_	
212-18	36946-36954	activity	_	
212-19	36955-36957	in	_	
212-20	36958-36961	the	_	
212-21	36962-36966	left	_	
212-22	36967-36975	striatum	_	
212-23	36976-36977	β	_	
212-24	36977-36978	(	_	
212-25	36978-36983	SW-WS	_	
212-26	36983-36984	)	_	
212-27	36985-36987	in	_	
212-28	36988-36992	both	_	
212-29	36993-36999	groups	_	
212-30	37000-37001	(	_	
212-31	37001-37004	SCZ	_	
212-32	37004-37005	:	_	
212-33	37006-37007	r	_	
212-34	37007-37008	 	_	
212-35	37008-37009	=	_	
212-36	37009-37010	 	_	
212-37	37010-37014	0.66	_	
212-38	37014-37015	,	_	
212-39	37016-37017	p	_	
212-40	37017-37018	 	_	
212-41	37018-37019	=	_	
212-42	37019-37020	 	_	
212-43	37020-37025	0.001	_	
212-44	37025-37026	;	_	
212-45	37027-37029	HC	_	
212-46	37029-37030	:	_	
212-47	37031-37032	r	_	
212-48	37032-37033	 	_	
212-49	37033-37034	=	_	
212-50	37034-37035	 	_	
212-51	37035-37039	0.50	_	
212-52	37039-37040	,	_	
212-53	37041-37042	p	_	
212-54	37042-37043	 	_	
212-55	37043-37044	=	_	
212-56	37044-37045	 	_	
212-57	37045-37050	0.017	_	
212-58	37050-37051	,	_	
212-59	37052-37062	correction	_	
212-60	37063-37072	threshold	_	
212-61	37072-37073	:	_	
212-62	37074-37075	p	_	
212-63	37075-37076	 	_	
212-64	37076-37077	=	_	
212-65	37077-37078	 	_	
212-66	37078-37083	0.025	_	
212-67	37083-37084	,	_	
212-68	37085-37092	Pearson	_	
212-69	37092-37093	)	_	
212-70	37093-37094	.	_	

#Text=The difference of the correlation coefficients in both groups was not significant (p = 0.54). *: p < 0.025.
213-1	37095-37098	The	_	
213-2	37099-37109	difference	_	
213-3	37110-37112	of	_	
213-4	37113-37116	the	_	
213-5	37117-37128	correlation	_	
213-6	37129-37141	coefficients	_	
213-7	37142-37144	in	_	
213-8	37145-37149	both	_	
213-9	37150-37156	groups	_	
213-10	37157-37160	was	_	
213-11	37161-37164	not	_	
213-12	37165-37176	significant	_	
213-13	37177-37178	(	_	
213-14	37178-37179	p	_	
213-15	37179-37180	 	_	
213-16	37180-37181	=	_	
213-17	37181-37182	 	_	
213-18	37182-37186	0.54	_	
213-19	37186-37187	)	_	
213-20	37187-37188	.	_	
213-21	37189-37190	*	_	
213-22	37190-37191	:	_	
213-23	37192-37193	p	_	
213-24	37193-37194	 	_	
213-25	37194-37195	<	_	
213-26	37195-37196	 	_	
213-27	37196-37201	0.025	_	
213-28	37201-37202	.	_	

#Text=(B) The functional connectivity in left LPFC- left striatum using resting-state fMRI was not significantly different (SCZ: 0.06 ± 0.05, HC: 0.07 ± 0.03, z = 0.36, p = 0.72, Mann-Whitney U test, error bar: SEM).
214-1	37203-37204	(	_	
214-2	37204-37205	B	_	
214-3	37205-37206	)	_	
214-4	37207-37210	The	_	
214-5	37211-37221	functional	_	
214-6	37222-37234	connectivity	_	
214-7	37235-37237	in	_	
214-8	37238-37242	left	_	
214-9	37243-37247	LPFC	_	
214-10	37247-37248	-	_	
214-11	37249-37253	left	_	
214-12	37254-37262	striatum	_	
214-13	37263-37268	using	_	
214-14	37269-37282	resting-state	_	
214-15	37283-37287	fMRI	_	
214-16	37288-37291	was	_	
214-17	37292-37295	not	_	
214-18	37296-37309	significantly	_	
214-19	37310-37319	different	_	
214-20	37320-37321	(	_	
214-21	37321-37324	SCZ	_	
214-22	37324-37325	:	_	
214-23	37326-37330	0.06	_	
214-24	37330-37331	 	_	
214-25	37331-37332	±	_	
214-26	37332-37333	 	_	
214-27	37333-37337	0.05	_	
214-28	37337-37338	,	_	
214-29	37339-37341	HC	_	
214-30	37341-37342	:	_	
214-31	37343-37347	0.07	_	
214-32	37347-37348	 	_	
214-33	37348-37349	±	_	
214-34	37349-37350	 	_	
214-35	37350-37354	0.03	_	
214-36	37354-37355	,	_	
214-37	37356-37357	z	_	
214-38	37357-37358	 	_	
214-39	37358-37359	=	_	
214-40	37359-37360	 	_	
214-41	37360-37364	0.36	_	
214-42	37364-37365	,	_	
214-43	37366-37367	p	_	
214-44	37367-37368	 	_	
214-45	37368-37369	=	_	
214-46	37369-37370	 	_	
214-47	37370-37374	0.72	_	
214-48	37374-37375	,	_	
214-49	37376-37388	Mann-Whitney	_	
214-50	37389-37390	U	_	
214-51	37391-37395	test	_	
214-52	37395-37396	,	_	
214-53	37397-37402	error	_	
214-54	37403-37406	bar	_	
214-55	37406-37407	:	_	
214-56	37408-37411	SEM	_	
214-57	37411-37412	)	_	
214-58	37412-37413	.	_	

#Text=(C) FA (fractional anisotropy) in left LPFC- left striatum pathway was not significantly different between the groups (SCZ: 0.47, HC: 0.44, z = 1.31, p = 0.19, Mann-Whitney U test).
215-1	37414-37415	(	_	
215-2	37415-37416	C	_	
215-3	37416-37417	)	_	
215-4	37418-37420	FA	_	
215-5	37421-37422	(	_	
215-6	37422-37432	fractional	_	
215-7	37433-37443	anisotropy	_	
215-8	37443-37444	)	_	
215-9	37445-37447	in	_	
215-10	37448-37452	left	_	
215-11	37453-37457	LPFC	_	
215-12	37457-37458	-	_	
215-13	37459-37463	left	_	
215-14	37464-37472	striatum	_	
215-15	37473-37480	pathway	_	
215-16	37481-37484	was	_	
215-17	37485-37488	not	_	
215-18	37489-37502	significantly	_	
215-19	37503-37512	different	_	
215-20	37513-37520	between	_	
215-21	37521-37524	the	_	
215-22	37525-37531	groups	_	
215-23	37532-37533	(	_	
215-24	37533-37536	SCZ	_	
215-25	37536-37537	:	_	
215-26	37538-37542	0.47	_	
215-27	37542-37543	,	_	
215-28	37544-37546	HC	_	
215-29	37546-37547	:	_	
215-30	37548-37552	0.44	_	
215-31	37552-37553	,	_	
215-32	37554-37555	z	_	
215-33	37555-37556	 	_	
215-34	37556-37557	=	_	
215-35	37557-37558	 	_	
215-36	37558-37562	1.31	_	
215-37	37562-37563	,	_	
215-38	37564-37565	p	_	
215-39	37565-37566	 	_	
215-40	37566-37567	=	_	
215-41	37567-37568	 	_	
215-42	37568-37572	0.19	_	
215-43	37572-37573	,	_	
215-44	37574-37586	Mann-Whitney	_	
215-45	37587-37588	U	_	
215-46	37589-37593	test	_	
215-47	37593-37594	)	_	
215-48	37594-37595	.	_	

#Text=Fig. 6
#Text=The activity in the left LPFC β(SW-WS) was significantly correlated with the activity in the left striatum β(SW-WS) in both groups (Fig. 6A, SCZ: r = 0.66, p = 0.001, HC: r = 0.50, p = 0.017, correction threshold: p = 0.025, Pearson).
216-1	37596-37599	Fig	_	
216-2	37599-37600	.	_	
216-3	37601-37602	6	_	
216-4	37603-37606	The	_	
216-5	37607-37615	activity	_	
216-6	37616-37618	in	_	
216-7	37619-37622	the	_	
216-8	37623-37627	left	_	
216-9	37628-37632	LPFC	_	
216-10	37633-37634	β	_	
216-11	37634-37635	(	_	
216-12	37635-37640	SW-WS	_	
216-13	37640-37641	)	_	
216-14	37642-37645	was	_	
216-15	37646-37659	significantly	_	
216-16	37660-37670	correlated	_	
216-17	37671-37675	with	_	
216-18	37676-37679	the	_	
216-19	37680-37688	activity	_	
216-20	37689-37691	in	_	
216-21	37692-37695	the	_	
216-22	37696-37700	left	_	
216-23	37701-37709	striatum	_	
216-24	37710-37711	β	_	
216-25	37711-37712	(	_	
216-26	37712-37717	SW-WS	_	
216-27	37717-37718	)	_	
216-28	37719-37721	in	_	
216-29	37722-37726	both	_	
216-30	37727-37733	groups	_	
216-31	37734-37735	(	_	
216-32	37735-37738	Fig	_	
216-33	37738-37739	.	_	
216-34	37740-37742	6A	_	
216-35	37742-37743	,	_	
216-36	37744-37747	SCZ	_	
216-37	37747-37748	:	_	
216-38	37749-37750	r	_	
216-39	37750-37751	 	_	
216-40	37751-37752	=	_	
216-41	37752-37753	 	_	
216-42	37753-37757	0.66	_	
216-43	37757-37758	,	_	
216-44	37759-37760	p	_	
216-45	37760-37761	 	_	
216-46	37761-37762	=	_	
216-47	37762-37763	 	_	
216-48	37763-37768	0.001	_	
216-49	37768-37769	,	_	
216-50	37770-37772	HC	_	
216-51	37772-37773	:	_	
216-52	37774-37775	r	_	
216-53	37775-37776	 	_	
216-54	37776-37777	=	_	
216-55	37777-37778	 	_	
216-56	37778-37782	0.50	_	
216-57	37782-37783	,	_	
216-58	37784-37785	p	_	
216-59	37785-37786	 	_	
216-60	37786-37787	=	_	
216-61	37787-37788	 	_	
216-62	37788-37793	0.017	_	
216-63	37793-37794	,	_	
216-64	37795-37805	correction	_	
216-65	37806-37815	threshold	_	
216-66	37815-37816	:	_	
216-67	37817-37818	p	_	
216-68	37818-37819	 	_	
216-69	37819-37820	=	_	
216-70	37820-37821	 	_	
216-71	37821-37826	0.025	_	
216-72	37826-37827	,	_	
216-73	37828-37835	Pearson	_	
216-74	37835-37836	)	_	
216-75	37836-37837	.	_	

#Text=We further examined the functional connectivity during rest and a structural abnormality between the LPFC and striatum.
217-1	37838-37840	We	_	
217-2	37841-37848	further	_	
217-3	37849-37857	examined	_	
217-4	37858-37861	the	_	
217-5	37862-37872	functional	_	
217-6	37873-37885	connectivity	_	
217-7	37886-37892	during	_	
217-8	37893-37897	rest	_	
217-9	37898-37901	and	_	
217-10	37902-37903	a	_	
217-11	37904-37914	structural	_	
217-12	37915-37926	abnormality	_	
217-13	37927-37934	between	_	
217-14	37935-37938	the	_	
217-15	37939-37943	LPFC	_	
217-16	37944-37947	and	_	
217-17	37948-37956	striatum	_	
217-18	37956-37957	.	_	

#Text=Neither the resting-state functional connectivity nor the fractional anisotropy (FA) values were significantly different between groups (Fig. 6B and C).
218-1	37958-37965	Neither	_	
218-2	37966-37969	the	_	
218-3	37970-37983	resting-state	_	
218-4	37984-37994	functional	_	
218-5	37995-38007	connectivity	_	
218-6	38008-38011	nor	_	
218-7	38012-38015	the	_	
218-8	38016-38026	fractional	_	
218-9	38027-38037	anisotropy	_	
218-10	38038-38039	(	_	
218-11	38039-38041	FA	_	
218-12	38041-38042	)	_	
218-13	38043-38049	values	_	
218-14	38050-38054	were	_	
218-15	38055-38068	significantly	_	
218-16	38069-38078	different	_	
218-17	38079-38086	between	_	
218-18	38087-38093	groups	_	
218-19	38094-38095	(	_	
218-20	38095-38098	Fig	_	
218-21	38098-38099	.	_	
218-22	38100-38102	6B	_	
218-23	38103-38106	and	_	
218-24	38107-38108	C	_	
218-25	38108-38109	)	_	
218-26	38109-38110	.	_	

#Text=These results suggest that the LPFC-striatum connectivity was not impaired in the SCZ patients either functionally or structurally.
219-1	38111-38116	These	_	
219-2	38117-38124	results	_	
219-3	38125-38132	suggest	_	
219-4	38133-38137	that	_	
219-5	38138-38141	the	_	
219-6	38142-38155	LPFC-striatum	_	
219-7	38156-38168	connectivity	_	
219-8	38169-38172	was	_	
219-9	38173-38176	not	_	
219-10	38177-38185	impaired	_	
219-11	38186-38188	in	_	
219-12	38189-38192	the	_	
219-13	38193-38196	SCZ	_	
219-14	38197-38205	patients	_	
219-15	38206-38212	either	_	
219-16	38213-38225	functionally	_	
219-17	38226-38228	or	_	
219-18	38229-38241	structurally	_	
219-19	38241-38242	.	_	

#Text=Path analysis
#Text=To assess the relations among IMI(SW-WS), the striatum β(SW-WS), the LPFC β (SW-WS), and the rate of Overshoot → Success trials, we analyzed an unconstrained model by structural equation modeling and assessed the model fit indices in each group.
220-1	38243-38247	Path	_	
220-2	38248-38256	analysis	_	
220-3	38257-38259	To	_	
220-4	38260-38266	assess	_	
220-5	38267-38270	the	_	
220-6	38271-38280	relations	_	
220-7	38281-38286	among	_	
220-8	38287-38290	IMI	_	
220-9	38290-38291	(	_	
220-10	38291-38296	SW-WS	_	
220-11	38296-38297	)	_	
220-12	38297-38298	,	_	
220-13	38299-38302	the	_	
220-14	38303-38311	striatum	_	
220-15	38312-38313	β	_	
220-16	38313-38314	(	_	
220-17	38314-38319	SW-WS	_	
220-18	38319-38320	)	_	
220-19	38320-38321	,	_	
220-20	38322-38325	the	_	
220-21	38326-38330	LPFC	_	
220-22	38331-38332	β	_	
220-23	38333-38334	(	_	
220-24	38334-38339	SW-WS	_	
220-25	38339-38340	)	_	
220-26	38340-38341	,	_	
220-27	38342-38345	and	_	
220-28	38346-38349	the	_	
220-29	38350-38354	rate	_	
220-30	38355-38357	of	_	
220-31	38358-38367	Overshoot	_	
220-32	38367-38368	 	_	
220-33	38368-38369	→	_	
220-34	38369-38370	 	_	
220-35	38370-38377	Success	_	
220-36	38378-38384	trials	_	
220-37	38384-38385	,	_	
220-38	38386-38388	we	_	
220-39	38389-38397	analyzed	_	
220-40	38398-38400	an	_	
220-41	38401-38414	unconstrained	_	
220-42	38415-38420	model	_	
220-43	38421-38423	by	_	
220-44	38424-38434	structural	_	
220-45	38435-38443	equation	_	
220-46	38444-38452	modeling	_	
220-47	38453-38456	and	_	
220-48	38457-38465	assessed	_	
220-49	38466-38469	the	_	
220-50	38470-38475	model	_	
220-51	38476-38479	fit	_	
220-52	38480-38487	indices	_	
220-53	38488-38490	in	_	
220-54	38491-38495	each	_	
220-55	38496-38501	group	_	
220-56	38501-38502	.	_	

#Text=As one of our primary aims was to explore the neural correlates of intrinsic motivation, which was indicated by the significant correlation between the IMI(SW-WS) and the left LPFC β(SW-WS), we decided to focus on the left side.
221-1	38503-38505	As	_	
221-2	38506-38509	one	_	
221-3	38510-38512	of	_	
221-4	38513-38516	our	_	
221-5	38517-38524	primary	_	
221-6	38525-38529	aims	_	
221-7	38530-38533	was	_	
221-8	38534-38536	to	_	
221-9	38537-38544	explore	_	
221-10	38545-38548	the	_	
221-11	38549-38555	neural	_	
221-12	38556-38566	correlates	_	
221-13	38567-38569	of	_	
221-14	38570-38579	intrinsic	_	
221-15	38580-38590	motivation	_	
221-16	38590-38591	,	_	
221-17	38592-38597	which	_	
221-18	38598-38601	was	_	
221-19	38602-38611	indicated	_	
221-20	38612-38614	by	_	
221-21	38615-38618	the	_	
221-22	38619-38630	significant	_	
221-23	38631-38642	correlation	_	
221-24	38643-38650	between	_	
221-25	38651-38654	the	_	
221-26	38655-38658	IMI	_	
221-27	38658-38659	(	_	
221-28	38659-38664	SW-WS	_	
221-29	38664-38665	)	_	
221-30	38666-38669	and	_	
221-31	38670-38673	the	_	
221-32	38674-38678	left	_	
221-33	38679-38683	LPFC	_	
221-34	38684-38685	β	_	
221-35	38685-38686	(	_	
221-36	38686-38691	SW-WS	_	
221-37	38691-38692	)	_	
221-38	38692-38693	,	_	
221-39	38694-38696	we	_	
221-40	38697-38704	decided	_	
221-41	38705-38707	to	_	
221-42	38708-38713	focus	_	
221-43	38714-38716	on	_	
221-44	38717-38720	the	_	
221-45	38721-38725	left	_	
221-46	38726-38730	side	_	
221-47	38730-38731	.	_	

#Text=Path diagrams in SCZ and HC model the results obtained from the unconstrained model by multiple-group structural equation modeling.
222-1	38732-38736	Path	_	
222-2	38737-38745	diagrams	_	
222-3	38746-38748	in	_	
222-4	38749-38752	SCZ	_	
222-5	38753-38756	and	_	
222-6	38757-38759	HC	_	
222-7	38760-38765	model	_	
222-8	38766-38769	the	_	
222-9	38770-38777	results	_	
222-10	38778-38786	obtained	_	
222-11	38787-38791	from	_	
222-12	38792-38795	the	_	
222-13	38796-38809	unconstrained	_	
222-14	38810-38815	model	_	
222-15	38816-38818	by	_	
222-16	38819-38833	multiple-group	_	
222-17	38834-38844	structural	_	
222-18	38845-38853	equation	_	
222-19	38854-38862	modeling	_	
222-20	38862-38863	.	_	

#Text=Path coefficients indicate the standardized model results. *: p < 0.05.
223-1	38864-38868	Path	_	
223-2	38869-38881	coefficients	_	
223-3	38882-38890	indicate	_	
223-4	38891-38894	the	_	
223-5	38895-38907	standardized	_	
223-6	38908-38913	model	_	
223-7	38914-38921	results	_	
223-8	38921-38922	.	_	
223-9	38923-38924	*	_	
223-10	38924-38925	:	_	
223-11	38926-38927	p	_	
223-12	38927-38928	 	_	
223-13	38928-38929	<	_	
223-14	38929-38930	 	_	
223-15	38930-38934	0.05	_	
223-16	38934-38935	.	_	

#Text=Fig. 7
#Text=All path coefficients were significant in HC but not in SCZ (Fig. 7).
224-1	38936-38939	Fig	_	
224-2	38939-38940	.	_	
224-3	38941-38942	7	_	
224-4	38943-38946	All	_	
224-5	38947-38951	path	_	
224-6	38952-38964	coefficients	_	
224-7	38965-38969	were	_	
224-8	38970-38981	significant	_	
224-9	38982-38984	in	_	
224-10	38985-38987	HC	_	
224-11	38988-38991	but	_	
224-12	38992-38995	not	_	
224-13	38996-38998	in	_	
224-14	38999-39002	SCZ	_	
224-15	39003-39004	(	_	
224-16	39004-39007	Fig	_	
224-17	39007-39008	.	_	
224-18	39009-39010	7	_	
224-19	39010-39011	)	_	
224-20	39011-39012	.	_	

#Text=As the path coefficients in both groups were different, we statistically tested the differences using multiple-group structural equation modeling to examine the validity.
225-1	39013-39015	As	_	
225-2	39016-39019	the	_	
225-3	39020-39024	path	_	
225-4	39025-39037	coefficients	_	
225-5	39038-39040	in	_	
225-6	39041-39045	both	_	
225-7	39046-39052	groups	_	
225-8	39053-39057	were	_	
225-9	39058-39067	different	_	
225-10	39067-39068	,	_	
225-11	39069-39071	we	_	
225-12	39072-39085	statistically	_	
225-13	39086-39092	tested	_	
225-14	39093-39096	the	_	
225-15	39097-39108	differences	_	
225-16	39109-39114	using	_	
225-17	39115-39129	multiple-group	_	
225-18	39130-39140	structural	_	
225-19	39141-39149	equation	_	
225-20	39150-39158	modeling	_	
225-21	39159-39161	to	_	
225-22	39162-39169	examine	_	
225-23	39170-39173	the	_	
225-24	39174-39182	validity	_	
225-25	39182-39183	.	_	

#Text=All model fit indices in the constrained model were lower than those in the unconstrained model (Supplementary Table 3).
226-1	39184-39187	All	_	
226-2	39188-39193	model	_	
226-3	39194-39197	fit	_	
226-4	39198-39205	indices	_	
226-5	39206-39208	in	_	
226-6	39209-39212	the	_	
226-7	39213-39224	constrained	_	
226-8	39225-39230	model	_	
226-9	39231-39235	were	_	
226-10	39236-39241	lower	_	
226-11	39242-39246	than	_	
226-12	39247-39252	those	_	
226-13	39253-39255	in	_	
226-14	39256-39259	the	_	
226-15	39260-39273	unconstrained	_	
226-16	39274-39279	model	_	
226-17	39280-39281	(	_	
226-18	39281-39294	Supplementary	_	
226-19	39295-39300	Table	_	
226-20	39301-39302	3	_	
226-21	39302-39303	)	_	
226-22	39303-39304	.	_	

#Text=These results indicate that the unconstrained model is reasonable and suggest that the left LPFC receives the motivational signal and moderates the action based on this signal in HC but not in SCZ.
227-1	39305-39310	These	_	
227-2	39311-39318	results	_	
227-3	39319-39327	indicate	_	
227-4	39328-39332	that	_	
227-5	39333-39336	the	_	
227-6	39337-39350	unconstrained	_	
227-7	39351-39356	model	_	
227-8	39357-39359	is	_	
227-9	39360-39370	reasonable	_	
227-10	39371-39374	and	_	
227-11	39375-39382	suggest	_	
227-12	39383-39387	that	_	
227-13	39388-39391	the	_	
227-14	39392-39396	left	_	
227-15	39397-39401	LPFC	_	
227-16	39402-39410	receives	_	
227-17	39411-39414	the	_	
227-18	39415-39427	motivational	_	
227-19	39428-39434	signal	_	
227-20	39435-39438	and	_	
227-21	39439-39448	moderates	_	
227-22	39449-39452	the	_	
227-23	39453-39459	action	_	
227-24	39460-39465	based	_	
227-25	39466-39468	on	_	
227-26	39469-39473	this	_	
227-27	39474-39480	signal	_	
227-28	39481-39483	in	_	
227-29	39484-39486	HC	_	
227-30	39487-39490	but	_	
227-31	39491-39494	not	_	
227-32	39495-39497	in	_	
227-33	39498-39501	SCZ	_	
227-34	39501-39502	.	_	

#Text=Discussion
#Text=IMI scores and activation in the striatum during the task cue period
#Text=The significant between-group difference in IMI(SW-WS) indicates that intrinsic motivation specific to the SW task in the SCZ group was lower than that in HC.
228-1	39503-39513	Discussion	_	
228-2	39514-39517	IMI	_	
228-3	39518-39524	scores	_	
228-4	39525-39528	and	_	
228-5	39529-39539	activation	_	
228-6	39540-39542	in	_	
228-7	39543-39546	the	_	
228-8	39547-39555	striatum	_	
228-9	39556-39562	during	_	
228-10	39563-39566	the	_	
228-11	39567-39571	task	_	
228-12	39572-39575	cue	_	
228-13	39576-39582	period	_	
228-14	39583-39586	The	_	
228-15	39587-39598	significant	_	
228-16	39599-39612	between-group	_	
228-17	39613-39623	difference	_	
228-18	39624-39626	in	_	
228-19	39627-39630	IMI	_	
228-20	39630-39631	(	_	
228-21	39631-39636	SW-WS	_	
228-22	39636-39637	)	_	
228-23	39638-39647	indicates	_	
228-24	39648-39652	that	_	
228-25	39653-39662	intrinsic	_	
228-26	39663-39673	motivation	_	
228-27	39674-39682	specific	_	
228-28	39683-39685	to	_	
228-29	39686-39689	the	_	
228-30	39690-39692	SW	_	
228-31	39693-39697	task	_	
228-32	39698-39700	in	_	
228-33	39701-39704	the	_	
228-34	39705-39708	SCZ	_	
228-35	39709-39714	group	_	
228-36	39715-39718	was	_	
228-37	39719-39724	lower	_	
228-38	39725-39729	than	_	
228-39	39730-39734	that	_	
228-40	39735-39737	in	_	
228-41	39738-39740	HC	_	
228-42	39740-39741	.	_	

#Text=Correspondingly, the striatal activation β(SW-WS) was significantly lower in SCZ than in HC.
229-1	39742-39757	Correspondingly	_	
229-2	39757-39758	,	_	
229-3	39759-39762	the	_	
229-4	39763-39771	striatal	_	
229-5	39772-39782	activation	_	
229-6	39783-39784	β	_	
229-7	39784-39785	(	_	
229-8	39785-39790	SW-WS	_	
229-9	39790-39791	)	_	
229-10	39792-39795	was	_	
229-11	39796-39809	significantly	_	
229-12	39810-39815	lower	_	
229-13	39816-39818	in	_	
229-14	39819-39822	SCZ	_	
229-15	39823-39827	than	_	
229-16	39828-39830	in	_	
229-17	39831-39833	HC	_	
229-18	39833-39834	.	_	

#Text=The lowered activation in the striatum may reflect reduced intrinsic motivation in the SW task in SCZ, since striatal activation has been suggested to encode anticipatory motivation.
230-1	39835-39838	The	_	
230-2	39839-39846	lowered	_	
230-3	39847-39857	activation	_	
230-4	39858-39860	in	_	
230-5	39861-39864	the	_	
230-6	39865-39873	striatum	_	
230-7	39874-39877	may	_	
230-8	39878-39885	reflect	_	
230-9	39886-39893	reduced	_	
230-10	39894-39903	intrinsic	_	
230-11	39904-39914	motivation	_	
230-12	39915-39917	in	_	
230-13	39918-39921	the	_	
230-14	39922-39924	SW	_	
230-15	39925-39929	task	_	
230-16	39930-39932	in	_	
230-17	39933-39936	SCZ	_	
230-18	39936-39937	,	_	
230-19	39938-39943	since	_	
230-20	39944-39952	striatal	_	
230-21	39953-39963	activation	_	
230-22	39964-39967	has	_	
230-23	39968-39972	been	_	
230-24	39973-39982	suggested	_	
230-25	39983-39985	to	_	
230-26	39986-39992	encode	_	
230-27	39993-40005	anticipatory	_	
230-28	40006-40016	motivation	_	
230-29	40016-40017	.	_	

#Text=Consistent with our finding, Radula reported in their meta-analysis that SCZ patients showed a significant hypo-activation in bilateral ventral striatum during reward anticipation, which was not moderated by current antipsychotic drug use.
231-1	40018-40028	Consistent	_	
231-2	40029-40033	with	_	
231-3	40034-40037	our	_	
231-4	40038-40045	finding	_	
231-5	40045-40046	,	_	
231-6	40047-40053	Radula	_	
231-7	40054-40062	reported	_	
231-8	40063-40065	in	_	
231-9	40066-40071	their	_	
231-10	40072-40085	meta-analysis	_	
231-11	40086-40090	that	_	
231-12	40091-40094	SCZ	_	
231-13	40095-40103	patients	_	
231-14	40104-40110	showed	_	
231-15	40111-40112	a	_	
231-16	40113-40124	significant	_	
231-17	40125-40140	hypo-activation	_	
231-18	40141-40143	in	_	
231-19	40144-40153	bilateral	_	
231-20	40154-40161	ventral	_	
231-21	40162-40170	striatum	_	
231-22	40171-40177	during	_	
231-23	40178-40184	reward	_	
231-24	40185-40197	anticipation	_	
231-25	40197-40198	,	_	
231-26	40199-40204	which	_	
231-27	40205-40208	was	_	
231-28	40209-40212	not	_	
231-29	40213-40222	moderated	_	
231-30	40223-40225	by	_	
231-31	40226-40233	current	_	
231-32	40234-40247	antipsychotic	_	
231-33	40248-40252	drug	_	
231-34	40253-40256	use	_	
231-35	40256-40257	.	_	

#Text=Considering the strong dopaminergic (DA) projections to the striatum and the idea that the DA system is involved in “wanting” or desire for success, the reduced striatal activation may suggest a deficit in the process of “wanting” or expecting a success in the SW task.
232-1	40258-40269	Considering	_	
232-2	40270-40273	the	_	
232-3	40274-40280	strong	_	
232-4	40281-40293	dopaminergic	_	
232-5	40294-40295	(	_	
232-6	40295-40297	DA	_	
232-7	40297-40298	)	_	
232-8	40299-40310	projections	_	
232-9	40311-40313	to	_	
232-10	40314-40317	the	_	
232-11	40318-40326	striatum	_	
232-12	40327-40330	and	_	
232-13	40331-40334	the	_	
232-14	40335-40339	idea	_	
232-15	40340-40344	that	_	
232-16	40345-40348	the	_	
232-17	40349-40351	DA	_	
232-18	40352-40358	system	_	
232-19	40359-40361	is	_	
232-20	40362-40370	involved	_	
232-21	40371-40373	in	_	
232-22	40374-40375	“	_	
232-23	40375-40382	wanting	_	
232-24	40382-40383	”	_	
232-25	40384-40386	or	_	
232-26	40387-40393	desire	_	
232-27	40394-40397	for	_	
232-28	40398-40405	success	_	
232-29	40405-40406	,	_	
232-30	40407-40410	the	_	
232-31	40411-40418	reduced	_	
232-32	40419-40427	striatal	_	
232-33	40428-40438	activation	_	
232-34	40439-40442	may	_	
232-35	40443-40450	suggest	_	
232-36	40451-40452	a	_	
232-37	40453-40460	deficit	_	
232-38	40461-40463	in	_	
232-39	40464-40467	the	_	
232-40	40468-40475	process	_	
232-41	40476-40478	of	_	
232-42	40479-40480	“	_	
232-43	40480-40487	wanting	_	
232-44	40487-40488	”	_	
232-45	40489-40491	or	_	
232-46	40492-40501	expecting	_	
232-47	40502-40503	a	_	
232-48	40504-40511	success	_	
232-49	40512-40514	in	_	
232-50	40515-40518	the	_	
232-51	40519-40521	SW	_	
232-52	40522-40526	task	_	
232-53	40526-40527	.	_	

#Text=IMI scores and the activation in LPFC during the task cue period
#Text=The striatal activation was not significantly correlated with IMI in either group, which was contrary to our expectation.
233-1	40528-40531	IMI	_	
233-2	40532-40538	scores	_	
233-3	40539-40542	and	_	
233-4	40543-40546	the	_	
233-5	40547-40557	activation	_	
233-6	40558-40560	in	_	
233-7	40561-40565	LPFC	_	
233-8	40566-40572	during	_	
233-9	40573-40576	the	_	
233-10	40577-40581	task	_	
233-11	40582-40585	cue	_	
233-12	40586-40592	period	_	
233-13	40593-40596	The	_	
233-14	40597-40605	striatal	_	
233-15	40606-40616	activation	_	
233-16	40617-40620	was	_	
233-17	40621-40624	not	_	
233-18	40625-40638	significantly	_	
233-19	40639-40649	correlated	_	
233-20	40650-40654	with	_	
233-21	40655-40658	IMI	_	
233-22	40659-40661	in	_	
233-23	40662-40668	either	_	
233-24	40669-40674	group	_	
233-25	40674-40675	,	_	
233-26	40676-40681	which	_	
233-27	40682-40685	was	_	
233-28	40686-40694	contrary	_	
233-29	40695-40697	to	_	
233-30	40698-40701	our	_	
233-31	40702-40713	expectation	_	
233-32	40713-40714	.	_	

#Text=This may be partly due to an inherent property of the IMI.
234-1	40715-40719	This	_	
234-2	40720-40723	may	_	
234-3	40724-40726	be	_	
234-4	40727-40733	partly	_	
234-5	40734-40737	due	_	
234-6	40738-40740	to	_	
234-7	40741-40743	an	_	
234-8	40744-40752	inherent	_	
234-9	40753-40761	property	_	
234-10	40762-40764	of	_	
234-11	40765-40768	the	_	
234-12	40769-40772	IMI	_	
234-13	40772-40773	.	_	

#Text=Because IMI is a self-reported questionnaire, the participants' answers might weight the self-monitored aspects of their motivation more and reflect the intrinsic motivation itself just indirectly.
235-1	40774-40781	Because	_	
235-2	40782-40785	IMI	_	
235-3	40786-40788	is	_	
235-4	40789-40790	a	_	
235-5	40791-40804	self-reported	_	
235-6	40805-40818	questionnaire	_	
235-7	40818-40819	,	_	
235-8	40820-40823	the	_	
235-9	40824-40836	participants	_	
235-10	40836-40837	'	_	
235-11	40838-40845	answers	_	
235-12	40846-40851	might	_	
235-13	40852-40858	weight	_	
235-14	40859-40862	the	_	
235-15	40863-40877	self-monitored	_	
235-16	40878-40885	aspects	_	
235-17	40886-40888	of	_	
235-18	40889-40894	their	_	
235-19	40895-40905	motivation	_	
235-20	40906-40910	more	_	
235-21	40911-40914	and	_	
235-22	40915-40922	reflect	_	
235-23	40923-40926	the	_	
235-24	40927-40936	intrinsic	_	
235-25	40937-40947	motivation	_	
235-26	40948-40954	itself	_	
235-27	40955-40959	just	_	
235-28	40960-40970	indirectly	_	
235-29	40970-40971	.	_	

#Text=This idea is supported by our finding that the left LPFC activation was significantly positively correlated with IMI in HC.
236-1	40972-40976	This	_	
236-2	40977-40981	idea	_	
236-3	40982-40984	is	_	
236-4	40985-40994	supported	_	
236-5	40995-40997	by	_	
236-6	40998-41001	our	_	
236-7	41002-41009	finding	_	
236-8	41010-41014	that	_	
236-9	41015-41018	the	_	
236-10	41019-41023	left	_	
236-11	41024-41028	LPFC	_	
236-12	41029-41039	activation	_	
236-13	41040-41043	was	_	
236-14	41044-41057	significantly	_	
236-15	41058-41068	positively	_	
236-16	41069-41079	correlated	_	
236-17	41080-41084	with	_	
236-18	41085-41088	IMI	_	
236-19	41089-41091	in	_	
236-20	41092-41094	HC	_	
236-21	41094-41095	.	_	

#Text=This suggests that IMI may be useful to detect a cognitively monitored aspect of intrinsic motivation, while a free-choice behavior is more useful for detecting intrinsic motivation directly.
237-1	41096-41100	This	_	
237-2	41101-41109	suggests	_	
237-3	41110-41114	that	_	
237-4	41115-41118	IMI	_	
237-5	41119-41122	may	_	
237-6	41123-41125	be	_	
237-7	41126-41132	useful	_	
237-8	41133-41135	to	_	
237-9	41136-41142	detect	_	
237-10	41143-41144	a	_	
237-11	41145-41156	cognitively	_	
237-12	41157-41166	monitored	_	
237-13	41167-41173	aspect	_	
237-14	41174-41176	of	_	
237-15	41177-41186	intrinsic	_	
237-16	41187-41197	motivation	_	
237-17	41197-41198	,	_	
237-18	41199-41204	while	_	
237-19	41205-41206	a	_	
237-20	41207-41218	free-choice	_	
237-21	41219-41227	behavior	_	
237-22	41228-41230	is	_	
237-23	41231-41235	more	_	
237-24	41236-41242	useful	_	
237-25	41243-41246	for	_	
237-26	41247-41256	detecting	_	
237-27	41257-41266	intrinsic	_	
237-28	41267-41277	motivation	_	
237-29	41278-41286	directly	_	
237-30	41286-41287	.	_	

#Text=Our finding that the LPFC is involved in intrinsic motivation measured by IMI is consistent with our previous study using a free-choice behavior.
238-1	41288-41291	Our	_	
238-2	41292-41299	finding	_	
238-3	41300-41304	that	_	
238-4	41305-41308	the	_	
238-5	41309-41313	LPFC	_	
238-6	41314-41316	is	_	
238-7	41317-41325	involved	_	
238-8	41326-41328	in	_	
238-9	41329-41338	intrinsic	_	
238-10	41339-41349	motivation	_	
238-11	41350-41358	measured	_	
238-12	41359-41361	by	_	
238-13	41362-41365	IMI	_	
238-14	41366-41368	is	_	
238-15	41369-41379	consistent	_	
238-16	41380-41384	with	_	
238-17	41385-41388	our	_	
238-18	41389-41397	previous	_	
238-19	41398-41403	study	_	
238-20	41404-41409	using	_	
238-21	41410-41411	a	_	
238-22	41412-41423	free-choice	_	
238-23	41424-41432	behavior	_	
238-24	41432-41433	.	_	

#Text=Importantly, the significant correlation observed in HC between the IMI and the LPFC activation was not obtained in the SCZ group, suggesting that the cognitively monitored aspect of intrinsic motivation is not appropriately processed in SCZ.
239-1	41434-41445	Importantly	_	
239-2	41445-41446	,	_	
239-3	41447-41450	the	_	
239-4	41451-41462	significant	_	
239-5	41463-41474	correlation	_	
239-6	41475-41483	observed	_	
239-7	41484-41486	in	_	
239-8	41487-41489	HC	_	
239-9	41490-41497	between	_	
239-10	41498-41501	the	_	
239-11	41502-41505	IMI	_	
239-12	41506-41509	and	_	
239-13	41510-41513	the	_	
239-14	41514-41518	LPFC	_	
239-15	41519-41529	activation	_	
239-16	41530-41533	was	_	
239-17	41534-41537	not	_	
239-18	41538-41546	obtained	_	
239-19	41547-41549	in	_	
239-20	41550-41553	the	_	
239-21	41554-41557	SCZ	_	
239-22	41558-41563	group	_	
239-23	41563-41564	,	_	
239-24	41565-41575	suggesting	_	
239-25	41576-41580	that	_	
239-26	41581-41584	the	_	
239-27	41585-41596	cognitively	_	
239-28	41597-41606	monitored	_	
239-29	41607-41613	aspect	_	
239-30	41614-41616	of	_	
239-31	41617-41626	intrinsic	_	
239-32	41627-41637	motivation	_	
239-33	41638-41640	is	_	
239-34	41641-41644	not	_	
239-35	41645-41658	appropriately	_	
239-36	41659-41668	processed	_	
239-37	41669-41671	in	_	
239-38	41672-41675	SCZ	_	
239-39	41675-41676	.	_	

#Text=Error correction after Undershoot and Overshoot trials
#Text=The abnormal performance observed in SCZ participants in our study is unlikely due to time perception deficits known in SCZ, since the accuracy and the mean TE in the SW task were normal in SCZ.
240-1	41677-41682	Error	_	
240-2	41683-41693	correction	_	
240-3	41694-41699	after	_	
240-4	41700-41710	Undershoot	_	
240-5	41711-41714	and	_	
240-6	41715-41724	Overshoot	_	
240-7	41725-41731	trials	_	
240-8	41732-41735	The	_	
240-9	41736-41744	abnormal	_	
240-10	41745-41756	performance	_	
240-11	41757-41765	observed	_	
240-12	41766-41768	in	_	
240-13	41769-41772	SCZ	_	
240-14	41773-41785	participants	_	
240-15	41786-41788	in	_	
240-16	41789-41792	our	_	
240-17	41793-41798	study	_	
240-18	41799-41801	is	_	
240-19	41802-41810	unlikely	_	
240-20	41811-41814	due	_	
240-21	41815-41817	to	_	
240-22	41818-41822	time	_	
240-23	41823-41833	perception	_	
240-24	41834-41842	deficits	_	
240-25	41843-41848	known	_	
240-26	41849-41851	in	_	
240-27	41852-41855	SCZ	_	
240-28	41855-41856	,	_	
240-29	41857-41862	since	_	
240-30	41863-41866	the	_	
240-31	41867-41875	accuracy	_	
240-32	41876-41879	and	_	
240-33	41880-41883	the	_	
240-34	41884-41888	mean	_	
240-35	41889-41891	TE	_	
240-36	41892-41894	in	_	
240-37	41895-41898	the	_	
240-38	41899-41901	SW	_	
240-39	41902-41906	task	_	
240-40	41907-41911	were	_	
240-41	41912-41918	normal	_	
240-42	41919-41921	in	_	
240-43	41922-41925	SCZ	_	
240-44	41925-41926	.	_	

#Text=We focused on the relationship between the participants' performance after error and the LPFC activation, because the cognitive control for context updating in the PFC is recruited after error.
241-1	41927-41929	We	_	
241-2	41930-41937	focused	_	
241-3	41938-41940	on	_	
241-4	41941-41944	the	_	
241-5	41945-41957	relationship	_	
241-6	41958-41965	between	_	
241-7	41966-41969	the	_	
241-8	41970-41982	participants	_	
241-9	41982-41983	'	_	
241-10	41984-41995	performance	_	
241-11	41996-42001	after	_	
241-12	42002-42007	error	_	
241-13	42008-42011	and	_	
241-14	42012-42015	the	_	
241-15	42016-42020	LPFC	_	
241-16	42021-42031	activation	_	
241-17	42031-42032	,	_	
241-18	42033-42040	because	_	
241-19	42041-42044	the	_	
241-20	42045-42054	cognitive	_	
241-21	42055-42062	control	_	
241-22	42063-42066	for	_	
241-23	42067-42074	context	_	
241-24	42075-42083	updating	_	
241-25	42084-42086	in	_	
241-26	42087-42090	the	_	
241-27	42091-42094	PFC	_	
241-28	42095-42097	is	_	
241-29	42098-42107	recruited	_	
241-30	42108-42113	after	_	
241-31	42114-42119	error	_	
241-32	42119-42120	.	_	

#Text=The monitoring aspect of intrinsic motivation may also be processed in the LPFC and affect some processes of cognitive control.
242-1	42121-42124	The	_	
242-2	42125-42135	monitoring	_	
242-3	42136-42142	aspect	_	
242-4	42143-42145	of	_	
242-5	42146-42155	intrinsic	_	
242-6	42156-42166	motivation	_	
242-7	42167-42170	may	_	
242-8	42171-42175	also	_	
242-9	42176-42178	be	_	
242-10	42179-42188	processed	_	
242-11	42189-42191	in	_	
242-12	42192-42195	the	_	
242-13	42196-42200	LPFC	_	
242-14	42201-42204	and	_	
242-15	42205-42211	affect	_	
242-16	42212-42216	some	_	
242-17	42217-42226	processes	_	
242-18	42227-42229	of	_	
242-19	42230-42239	cognitive	_	
242-20	42240-42247	control	_	
242-21	42247-42248	.	_	

#Text=Actually, the rate of Overshoot → Success was significantly positively correlated with the LPFC activation in HC as the IMI scores were.
243-1	42249-42257	Actually	_	
243-2	42257-42258	,	_	
243-3	42259-42262	the	_	
243-4	42263-42267	rate	_	
243-5	42268-42270	of	_	
243-6	42271-42280	Overshoot	_	
243-7	42280-42281	 	_	
243-8	42281-42282	→	_	
243-9	42282-42283	 	_	
243-10	42283-42290	Success	_	
243-11	42291-42294	was	_	
243-12	42295-42308	significantly	_	
243-13	42309-42319	positively	_	
243-14	42320-42330	correlated	_	
243-15	42331-42335	with	_	
243-16	42336-42339	the	_	
243-17	42340-42344	LPFC	_	
243-18	42345-42355	activation	_	
243-19	42356-42358	in	_	
243-20	42359-42361	HC	_	
243-21	42362-42364	as	_	
243-22	42365-42368	the	_	
243-23	42369-42372	IMI	_	
243-24	42373-42379	scores	_	
243-25	42380-42384	were	_	
243-26	42384-42385	.	_	

#Text=These correlations were no more significant in SCZ.
244-1	42386-42391	These	_	
244-2	42392-42404	correlations	_	
244-3	42405-42409	were	_	
244-4	42410-42412	no	_	
244-5	42413-42417	more	_	
244-6	42418-42429	significant	_	
244-7	42430-42432	in	_	
244-8	42433-42436	SCZ	_	
244-9	42436-42437	.	_	

#Text=These results suggest that SCZ failed to correctly control the timing of button press in the SW task following Overshoot, which may be induced by the functional impairment of LPFC in cognitively controlling intrinsic motivation to obtain goal-directed behavior.
245-1	42438-42443	These	_	
245-2	42444-42451	results	_	
245-3	42452-42459	suggest	_	
245-4	42460-42464	that	_	
245-5	42465-42468	SCZ	_	
245-6	42469-42475	failed	_	
245-7	42476-42478	to	_	
245-8	42479-42488	correctly	_	
245-9	42489-42496	control	_	
245-10	42497-42500	the	_	
245-11	42501-42507	timing	_	
245-12	42508-42510	of	_	
245-13	42511-42517	button	_	
245-14	42518-42523	press	_	
245-15	42524-42526	in	_	
245-16	42527-42530	the	_	
245-17	42531-42533	SW	_	
245-18	42534-42538	task	_	
245-19	42539-42548	following	_	
245-20	42549-42558	Overshoot	_	
245-21	42558-42559	,	_	
245-22	42560-42565	which	_	
245-23	42566-42569	may	_	
245-24	42570-42572	be	_	
245-25	42573-42580	induced	_	
245-26	42581-42583	by	_	
245-27	42584-42587	the	_	
245-28	42588-42598	functional	_	
245-29	42599-42609	impairment	_	
245-30	42610-42612	of	_	
245-31	42613-42617	LPFC	_	
245-32	42618-42620	in	_	
245-33	42621-42632	cognitively	_	
245-34	42633-42644	controlling	_	
245-35	42645-42654	intrinsic	_	
245-36	42655-42665	motivation	_	
245-37	42666-42668	to	_	
245-38	42669-42675	obtain	_	
245-39	42676-42689	goal-directed	_	
245-40	42690-42698	behavior	_	
245-41	42698-42699	.	_	

#Text=It was interesting that LPFC activation was associated with the error correction specifically after Overshoot.
246-1	42700-42702	It	_	
246-2	42703-42706	was	_	
246-3	42707-42718	interesting	_	
246-4	42719-42723	that	_	
246-5	42724-42728	LPFC	_	
246-6	42729-42739	activation	_	
246-7	42740-42743	was	_	
246-8	42744-42754	associated	_	
246-9	42755-42759	with	_	
246-10	42760-42763	the	_	
246-11	42764-42769	error	_	
246-12	42770-42780	correction	_	
246-13	42781-42793	specifically	_	
246-14	42794-42799	after	_	
246-15	42800-42809	Overshoot	_	
246-16	42809-42810	.	_	

#Text=It may be related to the fact that motivation would simply push forward action execution if not for explicit cognitive control, and cognitive control is recruited when an inappropriate excessive behavior has to be suppressed.
247-1	42811-42813	It	_	
247-2	42814-42817	may	_	
247-3	42818-42820	be	_	
247-4	42821-42828	related	_	
247-5	42829-42831	to	_	
247-6	42832-42835	the	_	
247-7	42836-42840	fact	_	
247-8	42841-42845	that	_	
247-9	42846-42856	motivation	_	
247-10	42857-42862	would	_	
247-11	42863-42869	simply	_	
247-12	42870-42874	push	_	
247-13	42875-42882	forward	_	
247-14	42883-42889	action	_	
247-15	42890-42899	execution	_	
247-16	42900-42902	if	_	
247-17	42903-42906	not	_	
247-18	42907-42910	for	_	
247-19	42911-42919	explicit	_	
247-20	42920-42929	cognitive	_	
247-21	42930-42937	control	_	
247-22	42937-42938	,	_	
247-23	42939-42942	and	_	
247-24	42943-42952	cognitive	_	
247-25	42953-42960	control	_	
247-26	42961-42963	is	_	
247-27	42964-42973	recruited	_	
247-28	42974-42978	when	_	
247-29	42979-42981	an	_	
247-30	42982-42995	inappropriate	_	
247-31	42996-43005	excessive	_	
247-32	43006-43014	behavior	_	
247-33	43015-43018	has	_	
247-34	43019-43021	to	_	
247-35	43022-43024	be	_	
247-36	43025-43035	suppressed	_	
247-37	43035-43036	.	_	

#Text=In our SW task, subjects need to press the button faster in the SW trials following an Overshoot to achieve success.
248-1	43037-43039	In	_	
248-2	43040-43043	our	_	
248-3	43044-43046	SW	_	
248-4	43047-43051	task	_	
248-5	43051-43052	,	_	
248-6	43053-43061	subjects	_	
248-7	43062-43066	need	_	
248-8	43067-43069	to	_	
248-9	43070-43075	press	_	
248-10	43076-43079	the	_	
248-11	43080-43086	button	_	
248-12	43087-43093	faster	_	
248-13	43094-43096	in	_	
248-14	43097-43100	the	_	
248-15	43101-43103	SW	_	
248-16	43104-43110	trials	_	
248-17	43111-43120	following	_	
248-18	43121-43123	an	_	
248-19	43124-43133	Overshoot	_	
248-20	43134-43136	to	_	
248-21	43137-43144	achieve	_	
248-22	43145-43152	success	_	
248-23	43152-43153	.	_	

#Text=Since Overshoot errors may cause an excessively fast response in the following trial, the response should be adequately regulated.
249-1	43154-43159	Since	_	
249-2	43160-43169	Overshoot	_	
249-3	43170-43176	errors	_	
249-4	43177-43180	may	_	
249-5	43181-43186	cause	_	
249-6	43187-43189	an	_	
249-7	43190-43201	excessively	_	
249-8	43202-43206	fast	_	
249-9	43207-43215	response	_	
249-10	43216-43218	in	_	
249-11	43219-43222	the	_	
249-12	43223-43232	following	_	
249-13	43233-43238	trial	_	
249-14	43238-43239	,	_	
249-15	43240-43243	the	_	
249-16	43244-43252	response	_	
249-17	43253-43259	should	_	
249-18	43260-43262	be	_	
249-19	43263-43273	adequately	_	
249-20	43274-43283	regulated	_	
249-21	43283-43284	.	_	

#Text=The motivation signal from the striatum could reach the LPFC probably via the thalamus, and cognitive control might have worked to adequately regulate the motivation signal to obtain goal-directed behavior in HC.
250-1	43285-43288	The	_	
250-2	43289-43299	motivation	_	
250-3	43300-43306	signal	_	
250-4	43307-43311	from	_	
250-5	43312-43315	the	_	
250-6	43316-43324	striatum	_	
250-7	43325-43330	could	_	
250-8	43331-43336	reach	_	
250-9	43337-43340	the	_	
250-10	43341-43345	LPFC	_	
250-11	43346-43354	probably	_	
250-12	43355-43358	via	_	
250-13	43359-43362	the	_	
250-14	43363-43371	thalamus	_	
250-15	43371-43372	,	_	
250-16	43373-43376	and	_	
250-17	43377-43386	cognitive	_	
250-18	43387-43394	control	_	
250-19	43395-43400	might	_	
250-20	43401-43405	have	_	
250-21	43406-43412	worked	_	
250-22	43413-43415	to	_	
250-23	43416-43426	adequately	_	
250-24	43427-43435	regulate	_	
250-25	43436-43439	the	_	
250-26	43440-43450	motivation	_	
250-27	43451-43457	signal	_	
250-28	43458-43460	to	_	
250-29	43461-43467	obtain	_	
250-30	43468-43481	goal-directed	_	
250-31	43482-43490	behavior	_	
250-32	43491-43493	in	_	
250-33	43494-43496	HC	_	
250-34	43496-43497	.	_	

#Text=In SCZ, this adequate regulation of motivation signal in LPFC seemed to be deteriorated so that the rate of Overshoot → Success trials was lower in the SCZ group than in HC.
251-1	43498-43500	In	_	
251-2	43501-43504	SCZ	_	
251-3	43504-43505	,	_	
251-4	43506-43510	this	_	
251-5	43511-43519	adequate	_	
251-6	43520-43530	regulation	_	
251-7	43531-43533	of	_	
251-8	43534-43544	motivation	_	
251-9	43545-43551	signal	_	
251-10	43552-43554	in	_	
251-11	43555-43559	LPFC	_	
251-12	43560-43566	seemed	_	
251-13	43567-43569	to	_	
251-14	43570-43572	be	_	
251-15	43573-43585	deteriorated	_	
251-16	43586-43588	so	_	
251-17	43589-43593	that	_	
251-18	43594-43597	the	_	
251-19	43598-43602	rate	_	
251-20	43603-43605	of	_	
251-21	43606-43615	Overshoot	_	
251-22	43615-43616	 	_	
251-23	43616-43617	→	_	
251-24	43617-43618	 	_	
251-25	43618-43625	Success	_	
251-26	43626-43632	trials	_	
251-27	43633-43636	was	_	
251-28	43637-43642	lower	_	
251-29	43643-43645	in	_	
251-30	43646-43649	the	_	
251-31	43650-43653	SCZ	_	
251-32	43654-43659	group	_	
251-33	43660-43664	than	_	
251-34	43665-43667	in	_	
251-35	43668-43670	HC	_	
251-36	43670-43671	.	_	

#Text=Actually, the rate of Overshoot → Undershoot was significantly higher in SCZ than in HC, suggesting a dysregulation of the drive to accelerate the timing in SCZ (Fig. 2B).
252-1	43672-43680	Actually	_	
252-2	43680-43681	,	_	
252-3	43682-43685	the	_	
252-4	43686-43690	rate	_	
252-5	43691-43693	of	_	
252-6	43694-43703	Overshoot	_	
252-7	43703-43704	 	_	
252-8	43704-43705	→	_	
252-9	43705-43706	 	_	
252-10	43706-43716	Undershoot	_	
252-11	43717-43720	was	_	
252-12	43721-43734	significantly	_	
252-13	43735-43741	higher	_	
252-14	43742-43744	in	_	
252-15	43745-43748	SCZ	_	
252-16	43749-43753	than	_	
252-17	43754-43756	in	_	
252-18	43757-43759	HC	_	
252-19	43759-43760	,	_	
252-20	43761-43771	suggesting	_	
252-21	43772-43773	a	_	
252-22	43774-43787	dysregulation	_	
252-23	43788-43790	of	_	
252-24	43791-43794	the	_	
252-25	43795-43800	drive	_	
252-26	43801-43803	to	_	
252-27	43804-43814	accelerate	_	
252-28	43815-43818	the	_	
252-29	43819-43825	timing	_	
252-30	43826-43828	in	_	
252-31	43829-43832	SCZ	_	
252-32	43833-43834	(	_	
252-33	43834-43837	Fig	_	
252-34	43837-43838	.	_	
252-35	43839-43841	2B	_	
252-36	43841-43842	)	_	
252-37	43842-43843	.	_	

#Text=The regulation of motivation signal by cognitive control might be different in the SW trials following an Undershoot, since a slower response should have been intended there.
253-1	43844-43847	The	_	
253-2	43848-43858	regulation	_	
253-3	43859-43861	of	_	
253-4	43862-43872	motivation	_	
253-5	43873-43879	signal	_	
253-6	43880-43882	by	_	
253-7	43883-43892	cognitive	_	
253-8	43893-43900	control	_	
253-9	43901-43906	might	_	
253-10	43907-43909	be	_	
253-11	43910-43919	different	_	
253-12	43920-43922	in	_	
253-13	43923-43926	the	_	
253-14	43927-43929	SW	_	
253-15	43930-43936	trials	_	
253-16	43937-43946	following	_	
253-17	43947-43949	an	_	
253-18	43950-43960	Undershoot	_	
253-19	43960-43961	,	_	
253-20	43962-43967	since	_	
253-21	43968-43969	a	_	
253-22	43970-43976	slower	_	
253-23	43977-43985	response	_	
253-24	43986-43992	should	_	
253-25	43993-43997	have	_	
253-26	43998-44002	been	_	
253-27	44003-44011	intended	_	
253-28	44012-44017	there	_	
253-29	44017-44018	.	_	

#Text=Actually, the rate of Undershoot → Success was not significantly different between groups.
254-1	44019-44027	Actually	_	
254-2	44027-44028	,	_	
254-3	44029-44032	the	_	
254-4	44033-44037	rate	_	
254-5	44038-44040	of	_	
254-6	44041-44051	Undershoot	_	
254-7	44051-44052	 	_	
254-8	44052-44053	→	_	
254-9	44053-44054	 	_	
254-10	44054-44061	Success	_	
254-11	44062-44065	was	_	
254-12	44066-44069	not	_	
254-13	44070-44083	significantly	_	
254-14	44084-44093	different	_	
254-15	44094-44101	between	_	
254-16	44102-44108	groups	_	
254-17	44108-44109	.	_	

#Text=This finding is in part consistent with a previous study in which trial-and-error adjustment of response time was required for patients with SCZ and HC to maximize reward.
255-1	44110-44114	This	_	
255-2	44115-44122	finding	_	
255-3	44123-44125	is	_	
255-4	44126-44128	in	_	
255-5	44129-44133	part	_	
255-6	44134-44144	consistent	_	
255-7	44145-44149	with	_	
255-8	44150-44151	a	_	
255-9	44152-44160	previous	_	
255-10	44161-44166	study	_	
255-11	44167-44169	in	_	
255-12	44170-44175	which	_	
255-13	44176-44191	trial-and-error	_	
255-14	44192-44202	adjustment	_	
255-15	44203-44205	of	_	
255-16	44206-44214	response	_	
255-17	44215-44219	time	_	
255-18	44220-44223	was	_	
255-19	44224-44232	required	_	
255-20	44233-44236	for	_	
255-21	44237-44245	patients	_	
255-22	44246-44250	with	_	
255-23	44251-44254	SCZ	_	
255-24	44255-44258	and	_	
255-25	44259-44261	HC	_	
255-26	44262-44264	to	_	
255-27	44265-44273	maximize	_	
255-28	44274-44280	reward	_	
255-29	44280-44281	.	_	

#Text=Compared with HC, the patients with SCZ showed impairment in the learning of faster responses, but not in the learning of slower responses.
256-1	44282-44290	Compared	_	
256-2	44291-44295	with	_	
256-3	44296-44298	HC	_	
256-4	44298-44299	,	_	
256-5	44300-44303	the	_	
256-6	44304-44312	patients	_	
256-7	44313-44317	with	_	
256-8	44318-44321	SCZ	_	
256-9	44322-44328	showed	_	
256-10	44329-44339	impairment	_	
256-11	44340-44342	in	_	
256-12	44343-44346	the	_	
256-13	44347-44355	learning	_	
256-14	44356-44358	of	_	
256-15	44359-44365	faster	_	
256-16	44366-44375	responses	_	
256-17	44375-44376	,	_	
256-18	44377-44380	but	_	
256-19	44381-44384	not	_	
256-20	44385-44387	in	_	
256-21	44388-44391	the	_	
256-22	44392-44400	learning	_	
256-23	44401-44403	of	_	
256-24	44404-44410	slower	_	
256-25	44411-44420	responses	_	
256-26	44420-44421	.	_	

#Text=Despite the differences in the task design and reward dependency, these two studies jointly indicate that the adjustment to accelerate behavioral responses may be impaired in SCZ, accounting for the differences in the accuracy between the adjustment of Overshoot errors and that of Undershoot errors.
257-1	44422-44429	Despite	_	
257-2	44430-44433	the	_	
257-3	44434-44445	differences	_	
257-4	44446-44448	in	_	
257-5	44449-44452	the	_	
257-6	44453-44457	task	_	
257-7	44458-44464	design	_	
257-8	44465-44468	and	_	
257-9	44469-44475	reward	_	
257-10	44476-44486	dependency	_	
257-11	44486-44487	,	_	
257-12	44488-44493	these	_	
257-13	44494-44497	two	_	
257-14	44498-44505	studies	_	
257-15	44506-44513	jointly	_	
257-16	44514-44522	indicate	_	
257-17	44523-44527	that	_	
257-18	44528-44531	the	_	
257-19	44532-44542	adjustment	_	
257-20	44543-44545	to	_	
257-21	44546-44556	accelerate	_	
257-22	44557-44567	behavioral	_	
257-23	44568-44577	responses	_	
257-24	44578-44581	may	_	
257-25	44582-44584	be	_	
257-26	44585-44593	impaired	_	
257-27	44594-44596	in	_	
257-28	44597-44600	SCZ	_	
257-29	44600-44601	,	_	
257-30	44602-44612	accounting	_	
257-31	44613-44616	for	_	
257-32	44617-44620	the	_	
257-33	44621-44632	differences	_	
257-34	44633-44635	in	_	
257-35	44636-44639	the	_	
257-36	44640-44648	accuracy	_	
257-37	44649-44656	between	_	
257-38	44657-44660	the	_	
257-39	44661-44671	adjustment	_	
257-40	44672-44674	of	_	
257-41	44675-44684	Overshoot	_	
257-42	44685-44691	errors	_	
257-43	44692-44695	and	_	
257-44	44696-44700	that	_	
257-45	44701-44703	of	_	
257-46	44704-44714	Undershoot	_	
257-47	44715-44721	errors	_	
257-48	44721-44722	.	_	

#Text=Prefrontal-striatal interaction and cognitive control impairment in SCZ
#Text= pointed out that it is important to elucidate whether the cognitive control impairments associated with altered LPFC function reflect problems in translating reward information into goal representations.
258-1	44723-44742	Prefrontal-striatal	_	
258-2	44743-44754	interaction	_	
258-3	44755-44758	and	_	
258-4	44759-44768	cognitive	_	
258-5	44769-44776	control	_	
258-6	44777-44787	impairment	_	
258-7	44788-44790	in	_	
258-8	44791-44794	SCZ	_	
258-9	44796-44803	pointed	_	
258-10	44804-44807	out	_	
258-11	44808-44812	that	_	
258-12	44813-44815	it	_	
258-13	44816-44818	is	_	
258-14	44819-44828	important	_	
258-15	44829-44831	to	_	
258-16	44832-44841	elucidate	_	
258-17	44842-44849	whether	_	
258-18	44850-44853	the	_	
258-19	44854-44863	cognitive	_	
258-20	44864-44871	control	_	
258-21	44872-44883	impairments	_	
258-22	44884-44894	associated	_	
258-23	44895-44899	with	_	
258-24	44900-44907	altered	_	
258-25	44908-44912	LPFC	_	
258-26	44913-44921	function	_	
258-27	44922-44929	reflect	_	
258-28	44930-44938	problems	_	
258-29	44939-44941	in	_	
258-30	44942-44953	translating	_	
258-31	44954-44960	reward	_	
258-32	44961-44972	information	_	
258-33	44973-44977	into	_	
258-34	44978-44982	goal	_	
258-35	44983-44998	representations	_	
258-36	44998-44999	.	_	

#Text=They also reported a potentially important role for prefrontal-striatal interactions in mediating impairment between motivation and goal-directed behavior in SCZ.
259-1	45000-45004	They	_	
259-2	45005-45009	also	_	
259-3	45010-45018	reported	_	
259-4	45019-45020	a	_	
259-5	45021-45032	potentially	_	
259-6	45033-45042	important	_	
259-7	45043-45047	role	_	
259-8	45048-45051	for	_	
259-9	45052-45071	prefrontal-striatal	_	
259-10	45072-45084	interactions	_	
259-11	45085-45087	in	_	
259-12	45088-45097	mediating	_	
259-13	45098-45108	impairment	_	
259-14	45109-45116	between	_	
259-15	45117-45127	motivation	_	
259-16	45128-45131	and	_	
259-17	45132-45145	goal-directed	_	
259-18	45146-45154	behavior	_	
259-19	45155-45157	in	_	
259-20	45158-45161	SCZ	_	
259-21	45161-45162	.	_	

#Text=However, there have been few direct tests of it.
260-1	45163-45170	However	_	
260-2	45170-45171	,	_	
260-3	45172-45177	there	_	
260-4	45178-45182	have	_	
260-5	45183-45187	been	_	
260-6	45188-45191	few	_	
260-7	45192-45198	direct	_	
260-8	45199-45204	tests	_	
260-9	45205-45207	of	_	
260-10	45208-45210	it	_	
260-11	45210-45211	.	_	

#Text=The present findings suggest that functional or structural connectivity is not impaired generally but the LPFC function in cognitive control of intrinsic motivation moderated by the striatum is impaired in SCZ.
261-1	45212-45215	The	_	
261-2	45216-45223	present	_	
261-3	45224-45232	findings	_	
261-4	45233-45240	suggest	_	
261-5	45241-45245	that	_	
261-6	45246-45256	functional	_	
261-7	45257-45259	or	_	
261-8	45260-45270	structural	_	
261-9	45271-45283	connectivity	_	
261-10	45284-45286	is	_	
261-11	45287-45290	not	_	
261-12	45291-45299	impaired	_	
261-13	45300-45309	generally	_	
261-14	45310-45313	but	_	
261-15	45314-45317	the	_	
261-16	45318-45322	LPFC	_	
261-17	45323-45331	function	_	
261-18	45332-45334	in	_	
261-19	45335-45344	cognitive	_	
261-20	45345-45352	control	_	
261-21	45353-45355	of	_	
261-22	45356-45365	intrinsic	_	
261-23	45366-45376	motivation	_	
261-24	45377-45386	moderated	_	
261-25	45387-45389	by	_	
261-26	45390-45393	the	_	
261-27	45394-45402	striatum	_	
261-28	45403-45405	is	_	
261-29	45406-45414	impaired	_	
261-30	45415-45417	in	_	
261-31	45418-45421	SCZ	_	
261-32	45421-45422	.	_	

#Text=This idea was clearly supported by the path analysis that suggested that the left LPFC received the motivation signal from the striatum and adequately regulated action accelerated by the Overshoot errors in HC but this process was impaired in SCZ (Fig. 7).
262-1	45423-45427	This	_	
262-2	45428-45432	idea	_	
262-3	45433-45436	was	_	
262-4	45437-45444	clearly	_	
262-5	45445-45454	supported	_	
262-6	45455-45457	by	_	
262-7	45458-45461	the	_	
262-8	45462-45466	path	_	
262-9	45467-45475	analysis	_	
262-10	45476-45480	that	_	
262-11	45481-45490	suggested	_	
262-12	45491-45495	that	_	
262-13	45496-45499	the	_	
262-14	45500-45504	left	_	
262-15	45505-45509	LPFC	_	
262-16	45510-45518	received	_	
262-17	45519-45522	the	_	
262-18	45523-45533	motivation	_	
262-19	45534-45540	signal	_	
262-20	45541-45545	from	_	
262-21	45546-45549	the	_	
262-22	45550-45558	striatum	_	
262-23	45559-45562	and	_	
262-24	45563-45573	adequately	_	
262-25	45574-45583	regulated	_	
262-26	45584-45590	action	_	
262-27	45591-45602	accelerated	_	
262-28	45603-45605	by	_	
262-29	45606-45609	the	_	
262-30	45610-45619	Overshoot	_	
262-31	45620-45626	errors	_	
262-32	45627-45629	in	_	
262-33	45630-45632	HC	_	
262-34	45633-45636	but	_	
262-35	45637-45641	this	_	
262-36	45642-45649	process	_	
262-37	45650-45653	was	_	
262-38	45654-45662	impaired	_	
262-39	45663-45665	in	_	
262-40	45666-45669	SCZ	_	
262-41	45670-45671	(	_	
262-42	45671-45674	Fig	_	
262-43	45674-45675	.	_	
262-44	45676-45677	7	_	
262-45	45677-45678	)	_	
262-46	45678-45679	.	_	

#Text=In addition, avolition is a reduced motivation to initiate or persist in goal-directed behavior.
263-1	45680-45682	In	_	
263-2	45683-45691	addition	_	
263-3	45691-45692	,	_	
263-4	45693-45702	avolition	_	
263-5	45703-45705	is	_	
263-6	45706-45707	a	_	
263-7	45708-45715	reduced	_	
263-8	45716-45726	motivation	_	
263-9	45727-45729	to	_	
263-10	45730-45738	initiate	_	
263-11	45739-45741	or	_	
263-12	45742-45749	persist	_	
263-13	45750-45752	in	_	
263-14	45753-45766	goal-directed	_	
263-15	45767-45775	behavior	_	
263-16	45775-45776	.	_	

#Text=It comprises a part of experiential negative symptoms along with anhedonia, which are defined in terms of motivation.
264-1	45777-45779	It	_	
264-2	45780-45789	comprises	_	
264-3	45790-45791	a	_	
264-4	45792-45796	part	_	
264-5	45797-45799	of	_	
264-6	45800-45812	experiential	_	
264-7	45813-45821	negative	_	
264-8	45822-45830	symptoms	_	
264-9	45831-45836	along	_	
264-10	45837-45841	with	_	
264-11	45842-45851	anhedonia	_	
264-12	45851-45852	,	_	
264-13	45853-45858	which	_	
264-14	45859-45862	are	_	
264-15	45863-45870	defined	_	
264-16	45871-45873	in	_	
264-17	45874-45879	terms	_	
264-18	45880-45882	of	_	
264-19	45883-45893	motivation	_	
264-20	45893-45894	.	_	

#Text=In the present study, as we indeed found some evidence for increased avolition but not for anhedonia in SCZ, we assume that the activity in the LPFC contributed to both volition and cognitive control.
265-1	45895-45897	In	_	
265-2	45898-45901	the	_	
265-3	45902-45909	present	_	
265-4	45910-45915	study	_	
265-5	45915-45916	,	_	
265-6	45917-45919	as	_	
265-7	45920-45922	we	_	
265-8	45923-45929	indeed	_	
265-9	45930-45935	found	_	
265-10	45936-45940	some	_	
265-11	45941-45949	evidence	_	
265-12	45950-45953	for	_	
265-13	45954-45963	increased	_	
265-14	45964-45973	avolition	_	
265-15	45974-45977	but	_	
265-16	45978-45981	not	_	
265-17	45982-45985	for	_	
265-18	45986-45995	anhedonia	_	
265-19	45996-45998	in	_	
265-20	45999-46002	SCZ	_	
265-21	46002-46003	,	_	
265-22	46004-46006	we	_	
265-23	46007-46013	assume	_	
265-24	46014-46018	that	_	
265-25	46019-46022	the	_	
265-26	46023-46031	activity	_	
265-27	46032-46034	in	_	
265-28	46035-46038	the	_	
265-29	46039-46043	LPFC	_	
265-30	46044-46055	contributed	_	
265-31	46056-46058	to	_	
265-32	46059-46063	both	_	
265-33	46064-46072	volition	_	
265-34	46073-46076	and	_	
265-35	46077-46086	cognitive	_	
265-36	46087-46094	control	_	
265-37	46094-46095	.	_	

#Text=Activation in the striatum during the feedback period
#Text=The striatum activation during the feedback period was not significantly different between groups, suggesting that the hedonic aspects of intrinsic motivation such as pleasure in the outcome (Success-Failure) obtained in the SW task were similar in SCZ and HC.
266-1	46096-46106	Activation	_	
266-2	46107-46109	in	_	
266-3	46110-46113	the	_	
266-4	46114-46122	striatum	_	
266-5	46123-46129	during	_	
266-6	46130-46133	the	_	
266-7	46134-46142	feedback	_	
266-8	46143-46149	period	_	
266-9	46150-46153	The	_	
266-10	46154-46162	striatum	_	
266-11	46163-46173	activation	_	
266-12	46174-46180	during	_	
266-13	46181-46184	the	_	
266-14	46185-46193	feedback	_	
266-15	46194-46200	period	_	
266-16	46201-46204	was	_	
266-17	46205-46208	not	_	
266-18	46209-46222	significantly	_	
266-19	46223-46232	different	_	
266-20	46233-46240	between	_	
266-21	46241-46247	groups	_	
266-22	46247-46248	,	_	
266-23	46249-46259	suggesting	_	
266-24	46260-46264	that	_	
266-25	46265-46268	the	_	
266-26	46269-46276	hedonic	_	
266-27	46277-46284	aspects	_	
266-28	46285-46287	of	_	
266-29	46288-46297	intrinsic	_	
266-30	46298-46308	motivation	_	
266-31	46309-46313	such	_	
266-32	46314-46316	as	_	
266-33	46317-46325	pleasure	_	
266-34	46326-46328	in	_	
266-35	46329-46332	the	_	
266-36	46333-46340	outcome	_	
266-37	46341-46342	(	_	
266-38	46342-46357	Success-Failure	_	
266-39	46357-46358	)	_	
266-40	46359-46367	obtained	_	
266-41	46368-46370	in	_	
266-42	46371-46374	the	_	
266-43	46375-46377	SW	_	
266-44	46378-46382	task	_	
266-45	46383-46387	were	_	
266-46	46388-46395	similar	_	
266-47	46396-46398	in	_	
266-48	46399-46402	SCZ	_	
266-49	46403-46406	and	_	
266-50	46407-46409	HC	_	
266-51	46409-46410	.	_	

#Text=If the striatum activation during the feedback period reflects the emotional response to feedback stimuli, it may well explain the lack of correlation between the striatum activation (Success-Failure) and the IMI(SW-WS) during the feedback period in either group, because IMI(SW-WS) is assumed to reflect the cognitively monitored aspects of intrinsic motivation.
267-1	46411-46413	If	_	
267-2	46414-46417	the	_	
267-3	46418-46426	striatum	_	
267-4	46427-46437	activation	_	
267-5	46438-46444	during	_	
267-6	46445-46448	the	_	
267-7	46449-46457	feedback	_	
267-8	46458-46464	period	_	
267-9	46465-46473	reflects	_	
267-10	46474-46477	the	_	
267-11	46478-46487	emotional	_	
267-12	46488-46496	response	_	
267-13	46497-46499	to	_	
267-14	46500-46508	feedback	_	
267-15	46509-46516	stimuli	_	
267-16	46516-46517	,	_	
267-17	46518-46520	it	_	
267-18	46521-46524	may	_	
267-19	46525-46529	well	_	
267-20	46530-46537	explain	_	
267-21	46538-46541	the	_	
267-22	46542-46546	lack	_	
267-23	46547-46549	of	_	
267-24	46550-46561	correlation	_	
267-25	46562-46569	between	_	
267-26	46570-46573	the	_	
267-27	46574-46582	striatum	_	
267-28	46583-46593	activation	_	
267-29	46594-46595	(	_	
267-30	46595-46610	Success-Failure	_	
267-31	46610-46611	)	_	
267-32	46612-46615	and	_	
267-33	46616-46619	the	_	
267-34	46620-46623	IMI	_	
267-35	46623-46624	(	_	
267-36	46624-46629	SW-WS	_	
267-37	46629-46630	)	_	
267-38	46631-46637	during	_	
267-39	46638-46641	the	_	
267-40	46642-46650	feedback	_	
267-41	46651-46657	period	_	
267-42	46658-46660	in	_	
267-43	46661-46667	either	_	
267-44	46668-46673	group	_	
267-45	46673-46674	,	_	
267-46	46675-46682	because	_	
267-47	46683-46686	IMI	_	
267-48	46686-46687	(	_	
267-49	46687-46692	SW-WS	_	
267-50	46692-46693	)	_	
267-51	46694-46696	is	_	
267-52	46697-46704	assumed	_	
267-53	46705-46707	to	_	
267-54	46708-46715	reflect	_	
267-55	46716-46719	the	_	
267-56	46720-46731	cognitively	_	
267-57	46732-46741	monitored	_	
267-58	46742-46749	aspects	_	
267-59	46750-46752	of	_	
267-60	46753-46762	intrinsic	_	
267-61	46763-46773	motivation	_	
267-62	46773-46774	.	_	

#Text=Moreover, this striatum β(Success-Failure) may suggest that SCZ patients retain the function of ‘hedonics or liking’ formed by the opioid and GABA system in the nucleus accumbens shell and its projections to the ventral pallidum, which reflects the ability of the organism to enjoy the stimulus or event that provides pleasure or reward.
268-1	46775-46783	Moreover	_	
268-2	46783-46784	,	_	
268-3	46785-46789	this	_	
268-4	46790-46798	striatum	_	
268-5	46799-46800	β	_	
268-6	46800-46801	(	_	
268-7	46801-46816	Success-Failure	_	
268-8	46816-46817	)	_	
268-9	46818-46821	may	_	
268-10	46822-46829	suggest	_	
268-11	46830-46834	that	_	
268-12	46835-46838	SCZ	_	
268-13	46839-46847	patients	_	
268-14	46848-46854	retain	_	
268-15	46855-46858	the	_	
268-16	46859-46867	function	_	
268-17	46868-46870	of	_	
268-18	46871-46872	‘	_	
268-19	46872-46880	hedonics	_	
268-20	46881-46883	or	_	
268-21	46884-46890	liking	_	
268-22	46890-46891	’	_	
268-23	46892-46898	formed	_	
268-24	46899-46901	by	_	
268-25	46902-46905	the	_	
268-26	46906-46912	opioid	_	
268-27	46913-46916	and	_	
268-28	46917-46921	GABA	_	
268-29	46922-46928	system	_	
268-30	46929-46931	in	_	
268-31	46932-46935	the	_	
268-32	46936-46943	nucleus	_	
268-33	46944-46953	accumbens	_	
268-34	46954-46959	shell	_	
268-35	46960-46963	and	_	
268-36	46964-46967	its	_	
268-37	46968-46979	projections	_	
268-38	46980-46982	to	_	
268-39	46983-46986	the	_	
268-40	46987-46994	ventral	_	
268-41	46995-47003	pallidum	_	
268-42	47003-47004	,	_	
268-43	47005-47010	which	_	
268-44	47011-47019	reflects	_	
268-45	47020-47023	the	_	
268-46	47024-47031	ability	_	
268-47	47032-47034	of	_	
268-48	47035-47038	the	_	
268-49	47039-47047	organism	_	
268-50	47048-47050	to	_	
268-51	47051-47056	enjoy	_	
268-52	47057-47060	the	_	
268-53	47061-47069	stimulus	_	
268-54	47070-47072	or	_	
268-55	47073-47078	event	_	
268-56	47079-47083	that	_	
268-57	47084-47092	provides	_	
268-58	47093-47101	pleasure	_	
268-59	47102-47104	or	_	
268-60	47105-47111	reward	_	
268-61	47111-47112	.	_	

#Text=Of course, because this striatum activity observed during the feedback period in the SW task may also reflect the reinforcement of the behavior based on the outcome formed by the DA system, we think it is difficult to strictly dissociate these two functions.
269-1	47113-47115	Of	_	
269-2	47116-47122	course	_	
269-3	47122-47123	,	_	
269-4	47124-47131	because	_	
269-5	47132-47136	this	_	
269-6	47137-47145	striatum	_	
269-7	47146-47154	activity	_	
269-8	47155-47163	observed	_	
269-9	47164-47170	during	_	
269-10	47171-47174	the	_	
269-11	47175-47183	feedback	_	
269-12	47184-47190	period	_	
269-13	47191-47193	in	_	
269-14	47194-47197	the	_	
269-15	47198-47200	SW	_	
269-16	47201-47205	task	_	
269-17	47206-47209	may	_	
269-18	47210-47214	also	_	
269-19	47215-47222	reflect	_	
269-20	47223-47226	the	_	
269-21	47227-47240	reinforcement	_	
269-22	47241-47243	of	_	
269-23	47244-47247	the	_	
269-24	47248-47256	behavior	_	
269-25	47257-47262	based	_	
269-26	47263-47265	on	_	
269-27	47266-47269	the	_	
269-28	47270-47277	outcome	_	
269-29	47278-47284	formed	_	
269-30	47285-47287	by	_	
269-31	47288-47291	the	_	
269-32	47292-47294	DA	_	
269-33	47295-47301	system	_	
269-34	47301-47302	,	_	
269-35	47303-47305	we	_	
269-36	47306-47311	think	_	
269-37	47312-47314	it	_	
269-38	47315-47317	is	_	
269-39	47318-47327	difficult	_	
269-40	47328-47330	to	_	
269-41	47331-47339	strictly	_	
269-42	47340-47350	dissociate	_	
269-43	47351-47356	these	_	
269-44	47357-47360	two	_	
269-45	47361-47370	functions	_	
269-46	47370-47371	.	_	

#Text=All in all, this finding supports the view that patients with SCZ exhibit a hedonic response as reported in recent studies.
270-1	47372-47375	All	_	
270-2	47376-47378	in	_	
270-3	47379-47382	all	_	
270-4	47382-47383	,	_	
270-5	47384-47388	this	_	
270-6	47389-47396	finding	_	
270-7	47397-47405	supports	_	
270-8	47406-47409	the	_	
270-9	47410-47414	view	_	
270-10	47415-47419	that	_	
270-11	47420-47428	patients	_	
270-12	47429-47433	with	_	
270-13	47434-47437	SCZ	_	
270-14	47438-47445	exhibit	_	
270-15	47446-47447	a	_	
270-16	47448-47455	hedonic	_	
270-17	47456-47464	response	_	
270-18	47465-47467	as	_	
270-19	47468-47476	reported	_	
270-20	47477-47479	in	_	
270-21	47480-47486	recent	_	
270-22	47487-47494	studies	_	
270-23	47494-47495	.	_	

#Text=Limitations
#Text=The patients who participated in the study were clinically stable and possibly treatment responsive considering the relatively short duration of illness.
271-1	47496-47507	Limitations	_	
271-2	47508-47511	The	_	
271-3	47512-47520	patients	_	
271-4	47521-47524	who	_	
271-5	47525-47537	participated	_	
271-6	47538-47540	in	_	
271-7	47541-47544	the	_	
271-8	47545-47550	study	_	
271-9	47551-47555	were	_	
271-10	47556-47566	clinically	_	
271-11	47567-47573	stable	_	
271-12	47574-47577	and	_	
271-13	47578-47586	possibly	_	
271-14	47587-47596	treatment	_	
271-15	47597-47607	responsive	_	
271-16	47608-47619	considering	_	
271-17	47620-47623	the	_	
271-18	47624-47634	relatively	_	
271-19	47635-47640	short	_	
271-20	47641-47649	duration	_	
271-21	47650-47652	of	_	
271-22	47653-47660	illness	_	
271-23	47660-47661	.	_	

#Text=Therefore, it should be taken with care that the patient populations are not representative of schizophrenia as a whole but more likely to represent those who are in the stage of rehabilitation.
272-1	47662-47671	Therefore	_	
272-2	47671-47672	,	_	
272-3	47673-47675	it	_	
272-4	47676-47682	should	_	
272-5	47683-47685	be	_	
272-6	47686-47691	taken	_	
272-7	47692-47696	with	_	
272-8	47697-47701	care	_	
272-9	47702-47706	that	_	
272-10	47707-47710	the	_	
272-11	47711-47718	patient	_	
272-12	47719-47730	populations	_	
272-13	47731-47734	are	_	
272-14	47735-47738	not	_	
272-15	47739-47753	representative	_	
272-16	47754-47756	of	_	
272-17	47757-47770	schizophrenia	_	
272-18	47771-47773	as	_	
272-19	47774-47775	a	_	
272-20	47776-47781	whole	_	
272-21	47782-47785	but	_	
272-22	47786-47790	more	_	
272-23	47791-47797	likely	_	
272-24	47798-47800	to	_	
272-25	47801-47810	represent	_	
272-26	47811-47816	those	_	
272-27	47817-47820	who	_	
272-28	47821-47824	are	_	
272-29	47825-47827	in	_	
272-30	47828-47831	the	_	
272-31	47832-47837	stage	_	
272-32	47838-47840	of	_	
272-33	47841-47855	rehabilitation	_	
272-34	47855-47856	.	_	

#Text=As the main aim of our study was to explore the neural mechanism of intrinsic motivation, which is a key element in psychiatric rehabilitation, we regard the patient characteristics were well suited to the object of the present study.
273-1	47857-47859	As	_	
273-2	47860-47863	the	_	
273-3	47864-47868	main	_	
273-4	47869-47872	aim	_	
273-5	47873-47875	of	_	
273-6	47876-47879	our	_	
273-7	47880-47885	study	_	
273-8	47886-47889	was	_	
273-9	47890-47892	to	_	
273-10	47893-47900	explore	_	
273-11	47901-47904	the	_	
273-12	47905-47911	neural	_	
273-13	47912-47921	mechanism	_	
273-14	47922-47924	of	_	
273-15	47925-47934	intrinsic	_	
273-16	47935-47945	motivation	_	
273-17	47945-47946	,	_	
273-18	47947-47952	which	_	
273-19	47953-47955	is	_	
273-20	47956-47957	a	_	
273-21	47958-47961	key	_	
273-22	47962-47969	element	_	
273-23	47970-47972	in	_	
273-24	47973-47984	psychiatric	_	
273-25	47985-47999	rehabilitation	_	
273-26	47999-48000	,	_	
273-27	48001-48003	we	_	
273-28	48004-48010	regard	_	
273-29	48011-48014	the	_	
273-30	48015-48022	patient	_	
273-31	48023-48038	characteristics	_	
273-32	48039-48043	were	_	
273-33	48044-48048	well	_	
273-34	48049-48055	suited	_	
273-35	48056-48058	to	_	
273-36	48059-48062	the	_	
273-37	48063-48069	object	_	
273-38	48070-48072	of	_	
273-39	48073-48076	the	_	
273-40	48077-48084	present	_	
273-41	48085-48090	study	_	
273-42	48090-48091	.	_	

#Text=As these clinical characteristics could have different effects on intrinsic motivation, a greater sample size with various clinical characteristics may enable us to investigate the effect in the general population of people with schizophrenia.
274-1	48092-48094	As	_	
274-2	48095-48100	these	_	
274-3	48101-48109	clinical	_	
274-4	48110-48125	characteristics	_	
274-5	48126-48131	could	_	
274-6	48132-48136	have	_	
274-7	48137-48146	different	_	
274-8	48147-48154	effects	_	
274-9	48155-48157	on	_	
274-10	48158-48167	intrinsic	_	
274-11	48168-48178	motivation	_	
274-12	48178-48179	,	_	
274-13	48180-48181	a	_	
274-14	48182-48189	greater	_	
274-15	48190-48196	sample	_	
274-16	48197-48201	size	_	
274-17	48202-48206	with	_	
274-18	48207-48214	various	_	
274-19	48215-48223	clinical	_	
274-20	48224-48239	characteristics	_	
274-21	48240-48243	may	_	
274-22	48244-48250	enable	_	
274-23	48251-48253	us	_	
274-24	48254-48256	to	_	
274-25	48257-48268	investigate	_	
274-26	48269-48272	the	_	
274-27	48273-48279	effect	_	
274-28	48280-48282	in	_	
274-29	48283-48286	the	_	
274-30	48287-48294	general	_	
274-31	48295-48305	population	_	
274-32	48306-48308	of	_	
274-33	48309-48315	people	_	
274-34	48316-48320	with	_	
274-35	48321-48334	schizophrenia	_	
274-36	48334-48335	.	_	

#Text=In addition, it may be also important to examine additional information such as family socioeconomic status or parental education.
275-1	48336-48338	In	_	
275-2	48339-48347	addition	_	
275-3	48347-48348	,	_	
275-4	48349-48351	it	_	
275-5	48352-48355	may	_	
275-6	48356-48358	be	_	
275-7	48359-48363	also	_	
275-8	48364-48373	important	_	
275-9	48374-48376	to	_	
275-10	48377-48384	examine	_	
275-11	48385-48395	additional	_	
275-12	48396-48407	information	_	
275-13	48408-48412	such	_	
275-14	48413-48415	as	_	
275-15	48416-48422	family	_	
275-16	48423-48436	socioeconomic	_	
275-17	48437-48443	status	_	
275-18	48444-48446	or	_	
275-19	48447-48455	parental	_	
275-20	48456-48465	education	_	
275-21	48465-48466	.	_	

#Text=Moreover, we used the IMI-SR (schizophrenia) because the main aim of our study was to investigate the neural substrates of intrinsic motivation in SCZ.
276-1	48467-48475	Moreover	_	
276-2	48475-48476	,	_	
276-3	48477-48479	we	_	
276-4	48480-48484	used	_	
276-5	48485-48488	the	_	
276-6	48489-48495	IMI-SR	_	
276-7	48496-48497	(	_	
276-8	48497-48510	schizophrenia	_	
276-9	48510-48511	)	_	
276-10	48512-48519	because	_	
276-11	48520-48523	the	_	
276-12	48524-48528	main	_	
276-13	48529-48532	aim	_	
276-14	48533-48535	of	_	
276-15	48536-48539	our	_	
276-16	48540-48545	study	_	
276-17	48546-48549	was	_	
276-18	48550-48552	to	_	
276-19	48553-48564	investigate	_	
276-20	48565-48568	the	_	
276-21	48569-48575	neural	_	
276-22	48576-48586	substrates	_	
276-23	48587-48589	of	_	
276-24	48590-48599	intrinsic	_	
276-25	48600-48610	motivation	_	
276-26	48611-48613	in	_	
276-27	48614-48617	SCZ	_	
276-28	48617-48618	.	_	

#Text=The IMI-SR was developed from an original scale that contained as many as 54 items in 6 subscales so as to increase its relevance and utility for psychiatric patients.
277-1	48619-48622	The	_	
277-2	48623-48629	IMI-SR	_	
277-3	48630-48633	was	_	
277-4	48634-48643	developed	_	
277-5	48644-48648	from	_	
277-6	48649-48651	an	_	
277-7	48652-48660	original	_	
277-8	48661-48666	scale	_	
277-9	48667-48671	that	_	
277-10	48672-48681	contained	_	
277-11	48682-48684	as	_	
277-12	48685-48689	many	_	
277-13	48690-48692	as	_	
277-14	48693-48695	54	_	
277-15	48696-48701	items	_	
277-16	48702-48704	in	_	
277-17	48705-48706	6	_	
277-18	48707-48716	subscales	_	
277-19	48717-48719	so	_	
277-20	48720-48722	as	_	
277-21	48723-48725	to	_	
277-22	48726-48734	increase	_	
277-23	48735-48738	its	_	
277-24	48739-48748	relevance	_	
277-25	48749-48752	and	_	
277-26	48753-48760	utility	_	
277-27	48761-48764	for	_	
277-28	48765-48776	psychiatric	_	
277-29	48777-48785	patients	_	
277-30	48785-48786	.	_	

#Text=However, the IMI-SR has not been validated in healthy populations.
278-1	48787-48794	However	_	
278-2	48794-48795	,	_	
278-3	48796-48799	the	_	
278-4	48800-48806	IMI-SR	_	
278-5	48807-48810	has	_	
278-6	48811-48814	not	_	
278-7	48815-48819	been	_	
278-8	48820-48829	validated	_	
278-9	48830-48832	in	_	
278-10	48833-48840	healthy	_	
278-11	48841-48852	populations	_	
278-12	48852-48853	.	_	

#Text=In the present study, the base score for either the SW or WS task was smaller in HC compared to SCZ, which may have occurred due to a difference in attitude bias toward the task.
279-1	48854-48856	In	_	
279-2	48857-48860	the	_	
279-3	48861-48868	present	_	
279-4	48869-48874	study	_	
279-5	48874-48875	,	_	
279-6	48876-48879	the	_	
279-7	48880-48884	base	_	
279-8	48885-48890	score	_	
279-9	48891-48894	for	_	
279-10	48895-48901	either	_	
279-11	48902-48905	the	_	
279-12	48906-48908	SW	_	
279-13	48909-48911	or	_	
279-14	48912-48914	WS	_	
279-15	48915-48919	task	_	
279-16	48920-48923	was	_	
279-17	48924-48931	smaller	_	
279-18	48932-48934	in	_	
279-19	48935-48937	HC	_	
279-20	48938-48946	compared	_	
279-21	48947-48949	to	_	
279-22	48950-48953	SCZ	_	
279-23	48953-48954	,	_	
279-24	48955-48960	which	_	
279-25	48961-48964	may	_	
279-26	48965-48969	have	_	
279-27	48970-48978	occurred	_	
279-28	48979-48982	due	_	
279-29	48983-48985	to	_	
279-30	48986-48987	a	_	
279-31	48988-48998	difference	_	
279-32	48999-49001	in	_	
279-33	49002-49010	attitude	_	
279-34	49011-49015	bias	_	
279-35	49016-49022	toward	_	
279-36	49023-49026	the	_	
279-37	49027-49031	task	_	
279-38	49031-49032	.	_	

#Text=More specifically the patients may have perceived both tasks as more interesting and valuable than the HC because the patients acknowledged that they were being tested.
280-1	49033-49037	More	_	
280-2	49038-49050	specifically	_	
280-3	49051-49054	the	_	
280-4	49055-49063	patients	_	
280-5	49064-49067	may	_	
280-6	49068-49072	have	_	
280-7	49073-49082	perceived	_	
280-8	49083-49087	both	_	
280-9	49088-49093	tasks	_	
280-10	49094-49096	as	_	
280-11	49097-49101	more	_	
280-12	49102-49113	interesting	_	
280-13	49114-49117	and	_	
280-14	49118-49126	valuable	_	
280-15	49127-49131	than	_	
280-16	49132-49135	the	_	
280-17	49136-49138	HC	_	
280-18	49139-49146	because	_	
280-19	49147-49150	the	_	
280-20	49151-49159	patients	_	
280-21	49160-49172	acknowledged	_	
280-22	49173-49177	that	_	
280-23	49178-49182	they	_	
280-24	49183-49187	were	_	
280-25	49188-49193	being	_	
280-26	49194-49200	tested	_	
280-27	49200-49201	.	_	

#Text=Conclusions
#Text=We found lower intrinsic motivation in SCZ than in HC and that the LPFC mechanism to signal appropriate cognitive control, which is influenced by intrinsic motivation for the SW task moderated by the striatum, is impaired in SCZ.
281-1	49202-49213	Conclusions	_	
281-2	49214-49216	We	_	
281-3	49217-49222	found	_	
281-4	49223-49228	lower	_	
281-5	49229-49238	intrinsic	_	
281-6	49239-49249	motivation	_	
281-7	49250-49252	in	_	
281-8	49253-49256	SCZ	_	
281-9	49257-49261	than	_	
281-10	49262-49264	in	_	
281-11	49265-49267	HC	_	
281-12	49268-49271	and	_	
281-13	49272-49276	that	_	
281-14	49277-49280	the	_	
281-15	49281-49285	LPFC	_	
281-16	49286-49295	mechanism	_	
281-17	49296-49298	to	_	
281-18	49299-49305	signal	_	
281-19	49306-49317	appropriate	_	
281-20	49318-49327	cognitive	_	
281-21	49328-49335	control	_	
281-22	49335-49336	,	_	
281-23	49337-49342	which	_	
281-24	49343-49345	is	_	
281-25	49346-49356	influenced	_	
281-26	49357-49359	by	_	
281-27	49360-49369	intrinsic	_	
281-28	49370-49380	motivation	_	
281-29	49381-49384	for	_	
281-30	49385-49388	the	_	
281-31	49389-49391	SW	_	
281-32	49392-49396	task	_	
281-33	49397-49406	moderated	_	
281-34	49407-49409	by	_	
281-35	49410-49413	the	_	
281-36	49414-49422	striatum	_	
281-37	49422-49423	,	_	
281-38	49424-49426	is	_	
281-39	49427-49435	impaired	_	
281-40	49436-49438	in	_	
281-41	49439-49442	SCZ	_	
281-42	49442-49443	.	_	

#Text=This finding indicates that in SCZ the neural activity in LPFC is not working effectively as a mediator linking intrinsic motivation to cognitive control of action plans as it is in HC.
282-1	49444-49448	This	_	
282-2	49449-49456	finding	_	
282-3	49457-49466	indicates	_	
282-4	49467-49471	that	_	
282-5	49472-49474	in	_	
282-6	49475-49478	SCZ	_	
282-7	49479-49482	the	_	
282-8	49483-49489	neural	_	
282-9	49490-49498	activity	_	
282-10	49499-49501	in	_	
282-11	49502-49506	LPFC	_	
282-12	49507-49509	is	_	
282-13	49510-49513	not	_	
282-14	49514-49521	working	_	
282-15	49522-49533	effectively	_	
282-16	49534-49536	as	_	
282-17	49537-49538	a	_	
282-18	49539-49547	mediator	_	
282-19	49548-49555	linking	_	
282-20	49556-49565	intrinsic	_	
282-21	49566-49576	motivation	_	
282-22	49577-49579	to	_	
282-23	49580-49589	cognitive	_	
282-24	49590-49597	control	_	
282-25	49598-49600	of	_	
282-26	49601-49607	action	_	
282-27	49608-49613	plans	_	
282-28	49614-49616	as	_	
282-29	49617-49619	it	_	
282-30	49620-49622	is	_	
282-31	49623-49625	in	_	
282-32	49626-49628	HC	_	
282-33	49628-49629	.	_	

#Text=It might be improved by cognitive rehabilitation for better social functioning through possibly enhancing the frontal activity.
283-1	49630-49632	It	_	
283-2	49633-49638	might	_	
283-3	49639-49641	be	_	
283-4	49642-49650	improved	_	
283-5	49651-49653	by	_	
283-6	49654-49663	cognitive	_	
283-7	49664-49678	rehabilitation	_	
283-8	49679-49682	for	_	
283-9	49683-49689	better	_	
283-10	49690-49696	social	_	
283-11	49697-49708	functioning	_	
283-12	49709-49716	through	_	
283-13	49717-49725	possibly	_	
283-14	49726-49735	enhancing	_	
283-15	49736-49739	the	_	
283-16	49740-49747	frontal	_	
283-17	49748-49756	activity	_	
283-18	49756-49757	.	_	

#Text=Further studies are required to understand whether and how the LPFC functional impairments in SCZ are related to the mechanisms of social functioning improvement by cognitive rehabilitation.
284-1	49758-49765	Further	_	
284-2	49766-49773	studies	_	
284-3	49774-49777	are	_	
284-4	49778-49786	required	_	
284-5	49787-49789	to	_	
284-6	49790-49800	understand	_	
284-7	49801-49808	whether	_	
284-8	49809-49812	and	_	
284-9	49813-49816	how	_	
284-10	49817-49820	the	_	
284-11	49821-49825	LPFC	_	
284-12	49826-49836	functional	_	
284-13	49837-49848	impairments	_	
284-14	49849-49851	in	_	
284-15	49852-49855	SCZ	_	
284-16	49856-49859	are	_	
284-17	49860-49867	related	_	
284-18	49868-49870	to	_	
284-19	49871-49874	the	_	
284-20	49875-49885	mechanisms	_	
284-21	49886-49888	of	_	
284-22	49889-49895	social	_	
284-23	49896-49907	functioning	_	
284-24	49908-49919	improvement	_	
284-25	49920-49922	by	_	
284-26	49923-49932	cognitive	_	
284-27	49933-49947	rehabilitation	_	
284-28	49947-49948	.	_	

#Text=References
#Text=Parallel organization of functionally segregated circuits linking basal ganglia and cortex
#Text=Duration of illness and duration of untreated illness in relation to drug response in psychiatric disorders
#Text=
#Text=Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions
#Text=The structure of negative symptoms within schizophrenia: implications for assessment
#Text=
#Text=Motivation and cognitive control: from behavior to neural mechanism
#Text=Biosocial pathways to functional outcome in schizophrenia
#Text=Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study
#Text=Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task
#Text=Anterior cingulate cortex, error detection, and the online monitoring of performance
#Text=Intrinsic motivation and learning in a schizophrenia spectrum sample
#Text=Intrinsic motivation inventory: an adapted measure for schizophrenia research
#Text=Measuring motivation in schizophrenia: is a general state of motivation necessary for task-specific motivation?
285-1	49949-49959	References	_	
285-2	49960-49968	Parallel	_	
285-3	49969-49981	organization	_	
285-4	49982-49984	of	_	
285-5	49985-49997	functionally	_	
285-6	49998-50008	segregated	_	
285-7	50009-50017	circuits	_	
285-8	50018-50025	linking	_	
285-9	50026-50031	basal	_	
285-10	50032-50039	ganglia	_	
285-11	50040-50043	and	_	
285-12	50044-50050	cortex	_	
285-13	50051-50059	Duration	_	
285-14	50060-50062	of	_	
285-15	50063-50070	illness	_	
285-16	50071-50074	and	_	
285-17	50075-50083	duration	_	
285-18	50084-50086	of	_	
285-19	50087-50096	untreated	_	
285-20	50097-50104	illness	_	
285-21	50105-50107	in	_	
285-22	50108-50116	relation	_	
285-23	50117-50119	to	_	
285-24	50120-50124	drug	_	
285-25	50125-50133	response	_	
285-26	50134-50136	in	_	
285-27	50137-50148	psychiatric	_	
285-28	50149-50158	disorders	_	
285-29	50160-50164	Goal	_	
285-30	50165-50180	representations	_	
285-31	50181-50184	and	_	
285-32	50185-50197	motivational	_	
285-33	50198-50203	drive	_	
285-34	50204-50206	in	_	
285-35	50207-50220	schizophrenia	_	
285-36	50220-50221	:	_	
285-37	50222-50225	the	_	
285-38	50226-50230	role	_	
285-39	50231-50233	of	_	
285-40	50234-50253	prefrontal-striatal	_	
285-41	50254-50266	interactions	_	
285-42	50267-50270	The	_	
285-43	50271-50280	structure	_	
285-44	50281-50283	of	_	
285-45	50284-50292	negative	_	
285-46	50293-50301	symptoms	_	
285-47	50302-50308	within	_	
285-48	50309-50322	schizophrenia	_	
285-49	50322-50323	:	_	
285-50	50324-50336	implications	_	
285-51	50337-50340	for	_	
285-52	50341-50351	assessment	_	
285-53	50353-50363	Motivation	_	
285-54	50364-50367	and	_	
285-55	50368-50377	cognitive	_	
285-56	50378-50385	control	_	
285-57	50385-50386	:	_	
285-58	50387-50391	from	_	
285-59	50392-50400	behavior	_	
285-60	50401-50403	to	_	
285-61	50404-50410	neural	_	
285-62	50411-50420	mechanism	_	
285-63	50421-50430	Biosocial	_	
285-64	50431-50439	pathways	_	
285-65	50440-50442	to	_	
285-66	50443-50453	functional	_	
285-67	50454-50461	outcome	_	
285-68	50462-50464	in	_	
285-69	50465-50478	schizophrenia	_	
285-70	50479-50488	Prominent	_	
285-71	50489-50497	clinical	_	
285-72	50498-50507	dimension	_	
285-73	50507-50508	,	_	
285-74	50509-50517	duration	_	
285-75	50518-50520	of	_	
285-76	50521-50528	illness	_	
285-77	50529-50532	and	_	
285-78	50533-50542	treatment	_	
285-79	50543-50551	response	_	
285-80	50552-50554	in	_	
285-81	50555-50568	schizophrenia	_	
285-82	50568-50569	:	_	
285-83	50570-50571	a	_	
285-84	50572-50584	naturalistic	_	
285-85	50585-50590	study	_	
285-86	50591-50597	Timing	_	
285-87	50598-50610	dysfunctions	_	
285-88	50611-50613	in	_	
285-89	50614-50627	schizophrenia	_	
285-90	50628-50630	as	_	
285-91	50631-50639	measured	_	
285-92	50640-50642	by	_	
285-93	50643-50644	a	_	
285-94	50645-50655	repetitive	_	
285-95	50656-50662	finger	_	
285-96	50663-50670	tapping	_	
285-97	50671-50675	task	_	
285-98	50676-50684	Anterior	_	
285-99	50685-50694	cingulate	_	
285-100	50695-50701	cortex	_	
285-101	50701-50702	,	_	
285-102	50703-50708	error	_	
285-103	50709-50718	detection	_	
285-104	50718-50719	,	_	
285-105	50720-50723	and	_	
285-106	50724-50727	the	_	
285-107	50728-50734	online	_	
285-108	50735-50745	monitoring	_	
285-109	50746-50748	of	_	
285-110	50749-50760	performance	_	
285-111	50761-50770	Intrinsic	_	
285-112	50771-50781	motivation	_	
285-113	50782-50785	and	_	
285-114	50786-50794	learning	_	
285-115	50795-50797	in	_	
285-116	50798-50799	a	_	
285-117	50800-50813	schizophrenia	_	
285-118	50814-50822	spectrum	_	
285-119	50823-50829	sample	_	
285-120	50830-50839	Intrinsic	_	
285-121	50840-50850	motivation	_	
285-122	50851-50860	inventory	_	
285-123	50860-50861	:	_	
285-124	50862-50864	an	_	
285-125	50865-50872	adapted	_	
285-126	50873-50880	measure	_	
285-127	50881-50884	for	_	
285-128	50885-50898	schizophrenia	_	
285-129	50899-50907	research	_	
285-130	50908-50917	Measuring	_	
285-131	50918-50928	motivation	_	
285-132	50929-50931	in	_	
285-133	50932-50945	schizophrenia	_	
285-134	50945-50946	:	_	
285-135	50947-50949	is	_	
285-136	50950-50951	a	_	
285-137	50952-50959	general	_	
285-138	50960-50965	state	_	
285-139	50966-50968	of	_	
285-140	50969-50979	motivation	_	
285-141	50980-50989	necessary	_	
285-142	50990-50993	for	_	
285-143	50994-51007	task-specific	_	
285-144	51008-51018	motivation	_	
285-145	51018-51019	?	_	

#Text=Explicit time deficit in schizophrenia: systematic review and meta-analysis indicate it is primary and not domain specific
#Text=Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies
#Text=
#Text=A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation
#Text=Optimized EPI for fMRI studies of the orbitofrontal cortex
#Text=Executive functions
#Text=Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing
#Text=
#Text=Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia
#Text=The basal ganglia: learning new tricks and loving it
#Text=What are the functional consequences of neurocognitive deficits in schizophrenia?
286-1	51020-51028	Explicit	_	
286-2	51029-51033	time	_	
286-3	51034-51041	deficit	_	
286-4	51042-51044	in	_	
286-5	51045-51058	schizophrenia	_	
286-6	51058-51059	:	_	
286-7	51060-51070	systematic	_	
286-8	51071-51077	review	_	
286-9	51078-51081	and	_	
286-10	51082-51095	meta-analysis	_	
286-11	51096-51104	indicate	_	
286-12	51105-51107	it	_	
286-13	51108-51110	is	_	
286-14	51111-51118	primary	_	
286-15	51119-51122	and	_	
286-16	51123-51126	not	_	
286-17	51127-51133	domain	_	
286-18	51134-51142	specific	_	
286-19	51143-51152	Emotional	_	
286-20	51153-51163	experience	_	
286-21	51164-51166	in	_	
286-22	51167-51175	patients	_	
286-23	51176-51180	with	_	
286-24	51181-51194	schizophrenia	_	
286-25	51195-51204	revisited	_	
286-26	51204-51205	:	_	
286-27	51206-51219	meta-analysis	_	
286-28	51220-51222	of	_	
286-29	51223-51233	laboratory	_	
286-30	51234-51241	studies	_	
286-31	51243-51244	A	_	
286-32	51245-51258	meta-analytic	_	
286-33	51259-51265	review	_	
286-34	51266-51268	of	_	
286-35	51269-51280	experiments	_	
286-36	51281-51290	examining	_	
286-37	51291-51294	the	_	
286-38	51295-51302	effects	_	
286-39	51303-51305	of	_	
286-40	51306-51315	extrinsic	_	
286-41	51316-51323	rewards	_	
286-42	51324-51326	on	_	
286-43	51327-51336	intrinsic	_	
286-44	51337-51347	motivation	_	
286-45	51348-51357	Optimized	_	
286-46	51358-51361	EPI	_	
286-47	51362-51365	for	_	
286-48	51366-51370	fMRI	_	
286-49	51371-51378	studies	_	
286-50	51379-51381	of	_	
286-51	51382-51385	the	_	
286-52	51386-51399	orbitofrontal	_	
286-53	51400-51406	cortex	_	
286-54	51407-51416	Executive	_	
286-55	51417-51426	functions	_	
286-56	51427-51436	Transient	_	
286-57	51437-51451	overexpression	_	
286-58	51452-51454	of	_	
286-59	51455-51463	striatal	_	
286-60	51464-51466	D2	_	
286-61	51467-51476	receptors	_	
286-62	51477-51484	impairs	_	
286-63	51485-51492	operant	_	
286-64	51493-51503	motivation	_	
286-65	51504-51507	and	_	
286-66	51508-51516	interval	_	
286-67	51517-51523	timing	_	
286-68	51525-51535	Motivation	_	
286-69	51536-51539	and	_	
286-70	51540-51543	its	_	
286-71	51544-51556	relationship	_	
286-72	51557-51559	to	_	
286-73	51560-51574	neurocognition	_	
286-74	51574-51575	,	_	
286-75	51576-51582	social	_	
286-76	51583-51592	cognition	_	
286-77	51592-51593	,	_	
286-78	51594-51597	and	_	
286-79	51598-51608	functional	_	
286-80	51609-51616	outcome	_	
286-81	51617-51619	in	_	
286-82	51620-51633	schizophrenia	_	
286-83	51634-51637	The	_	
286-84	51638-51643	basal	_	
286-85	51644-51651	ganglia	_	
286-86	51651-51652	:	_	
286-87	51653-51661	learning	_	
286-88	51662-51665	new	_	
286-89	51666-51672	tricks	_	
286-90	51673-51676	and	_	
286-91	51677-51683	loving	_	
286-92	51684-51686	it	_	
286-93	51687-51691	What	_	
286-94	51692-51695	are	_	
286-95	51696-51699	the	_	
286-96	51700-51710	functional	_	
286-97	51711-51723	consequences	_	
286-98	51724-51726	of	_	
286-99	51727-51741	neurocognitive	_	
286-100	51742-51750	deficits	_	
286-101	51751-51753	in	_	
286-102	51754-51767	schizophrenia	_	
286-103	51767-51768	?	_	

#Text=Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?
287-1	51769-51783	Neurocognitive	_	
287-2	51784-51792	deficits	_	
287-3	51793-51796	and	_	
287-4	51797-51807	functional	_	
287-5	51808-51815	outcome	_	
287-6	51816-51818	in	_	
287-7	51819-51832	schizophrenia	_	
287-8	51832-51833	:	_	
287-9	51834-51837	are	_	
287-10	51838-51840	we	_	
287-11	51841-51850	measuring	_	
287-12	51851-51854	the	_	
287-13	51855-51856	“	_	
287-14	51856-51861	right	_	
287-15	51862-51867	stuff	_	
287-16	51867-51868	”	_	
287-17	51868-51869	?	_	

#Text=Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
#Text=The reward circuit: linking primate anatomy and human imaging
#Text=Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior
#Text=Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics
#Text=
#Text=Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia
#Text=On the factorial and construct validity of the intrinsic motivation inventory: conceptual and operational concerns
#Text=Psychometric properties of the Intrinsic Motivation Inventory in a competitive sport setting: a confirmatory factor analysis
#Text=A meta-analysis of cognitive remediation in schizophrenia
#Text=Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research
#Text=Basal ganglia and cerebellar loops: motor and cognitive circuits
#Text=The prefrontal cortex and cognitive control
#Text=An integrative theory of prefrontal cortex function
#Text=Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia
#Text=Neural basis of the undermining effect of monetary reward on intrinsic motivation
#Text=
#Text=Schizophrenia patients are more emotionally active than is assumed based on their behavior
#Text=How the brain translates money into force: a neuroimaging study of subliminal motivation
#Text=Intrinsic motivation and the effects of self-consciousness, self-awareness, and ego-involvement: an investigation of internally controlling styles
#Text=A pilot study on the effects of cognitive remediation on hemodynamic responses in the prefrontal cortices of patients with schizophrenia: a multi-channel near-infrared spectroscopy study
#Text=Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis
#Text=Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine
#Text=Multiple dopamine functions at different time courses
#Text=Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia
#Text=A review of reward processing and motivational impairment in schizophrenia
#Text=Intrinsic motivation and metacognition as predictors of learning potential in patients with remitted schizophrenia
#Text=Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia
#Text=Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review
#Text=Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
#Text=Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises
#Text=Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks
#Text=Supporting autonomy to motivate patients with diabetes for glucose control
#Text=A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes
#Text=Supplementary data
#Text=Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.nicl.2017.07.003.
288-1	51870-51881	Approaching	_	
288-2	51882-51883	a	_	
288-3	51884-51893	consensus	_	
288-4	51894-51903	cognitive	_	
288-5	51904-51911	battery	_	
288-6	51912-51915	for	_	
288-7	51916-51924	clinical	_	
288-8	51925-51931	trials	_	
288-9	51932-51934	in	_	
288-10	51935-51948	schizophrenia	_	
288-11	51948-51949	:	_	
288-12	51950-51953	the	_	
288-13	51954-51966	NIMH-MATRICS	_	
288-14	51967-51977	conference	_	
288-15	51978-51980	to	_	
288-16	51981-51987	select	_	
288-17	51988-51997	cognitive	_	
288-18	51998-52005	domains	_	
288-19	52006-52009	and	_	
288-20	52010-52014	test	_	
288-21	52015-52023	criteria	_	
288-22	52024-52027	The	_	
288-23	52028-52034	reward	_	
288-24	52035-52042	circuit	_	
288-25	52042-52043	:	_	
288-26	52044-52051	linking	_	
288-27	52052-52059	primate	_	
288-28	52060-52067	anatomy	_	
288-29	52068-52071	and	_	
288-30	52072-52077	human	_	
288-31	52078-52085	imaging	_	
288-32	52086-52094	Patients	_	
288-33	52095-52099	with	_	
288-34	52100-52113	schizophrenia	_	
288-35	52114-52125	demonstrate	_	
288-36	52126-52138	dissociation	_	
288-37	52139-52146	between	_	
288-38	52147-52156	affective	_	
288-39	52157-52167	experience	_	
288-40	52168-52171	and	_	
288-41	52172-52181	motivated	_	
288-42	52182-52190	behavior	_	
288-43	52191-52202	Dysfunction	_	
288-44	52203-52205	of	_	
288-45	52206-52213	ventral	_	
288-46	52214-52222	striatal	_	
288-47	52223-52229	reward	_	
288-48	52230-52240	prediction	_	
288-49	52241-52243	in	_	
288-50	52244-52257	schizophrenic	_	
288-51	52258-52266	patients	_	
288-52	52267-52274	treated	_	
288-53	52275-52279	with	_	
288-54	52280-52287	typical	_	
288-55	52287-52288	,	_	
288-56	52289-52292	not	_	
288-57	52293-52301	atypical	_	
288-58	52301-52302	,	_	
288-59	52303-52315	neuroleptics	_	
288-60	52317-52324	Looking	_	
288-61	52325-52327	at	_	
288-62	52328-52331	the	_	
288-63	52332-52337	other	_	
288-64	52338-52342	side	_	
288-65	52343-52345	of	_	
288-66	52346-52349	the	_	
288-67	52350-52354	coin	_	
288-68	52354-52355	:	_	
288-69	52356-52357	a	_	
288-70	52358-52371	meta-analysis	_	
288-71	52372-52374	of	_	
288-72	52375-52388	self-reported	_	
288-73	52389-52398	emotional	_	
288-74	52399-52406	arousal	_	
288-75	52407-52409	in	_	
288-76	52410-52416	people	_	
288-77	52417-52421	with	_	
288-78	52422-52435	schizophrenia	_	
288-79	52436-52438	On	_	
288-80	52439-52442	the	_	
288-81	52443-52452	factorial	_	
288-82	52453-52456	and	_	
288-83	52457-52466	construct	_	
288-84	52467-52475	validity	_	
288-85	52476-52478	of	_	
288-86	52479-52482	the	_	
288-87	52483-52492	intrinsic	_	
288-88	52493-52503	motivation	_	
288-89	52504-52513	inventory	_	
288-90	52513-52514	:	_	
288-91	52515-52525	conceptual	_	
288-92	52526-52529	and	_	
288-93	52530-52541	operational	_	
288-94	52542-52550	concerns	_	
288-95	52551-52563	Psychometric	_	
288-96	52564-52574	properties	_	
288-97	52575-52577	of	_	
288-98	52578-52581	the	_	
288-99	52582-52591	Intrinsic	_	
288-100	52592-52602	Motivation	_	
288-101	52603-52612	Inventory	_	
288-102	52613-52615	in	_	
288-103	52616-52617	a	_	
288-104	52618-52629	competitive	_	
288-105	52630-52635	sport	_	
288-106	52636-52643	setting	_	
288-107	52643-52644	:	_	
288-108	52645-52646	a	_	
288-109	52647-52659	confirmatory	_	
288-110	52660-52666	factor	_	
288-111	52667-52675	analysis	_	
288-112	52676-52677	A	_	
288-113	52678-52691	meta-analysis	_	
288-114	52692-52694	of	_	
288-115	52695-52704	cognitive	_	
288-116	52705-52716	remediation	_	
288-117	52717-52719	in	_	
288-118	52720-52733	schizophrenia	_	
288-119	52734-52743	Avolition	_	
288-120	52744-52747	and	_	
288-121	52748-52758	expressive	_	
288-122	52759-52767	deficits	_	
288-123	52768-52775	capture	_	
288-124	52776-52784	negative	_	
288-125	52785-52792	symptom	_	
288-126	52793-52806	phenomenology	_	
288-127	52806-52807	:	_	
288-128	52808-52820	implications	_	
288-129	52821-52824	for	_	
288-130	52825-52828	DSM	_	
288-131	52828-52829	-	_	
288-132	52829-52830	5	_	
288-133	52831-52834	and	_	
288-134	52835-52848	schizophrenia	_	
288-135	52849-52857	research	_	
288-136	52858-52863	Basal	_	
288-137	52864-52871	ganglia	_	
288-138	52872-52875	and	_	
288-139	52876-52886	cerebellar	_	
288-140	52887-52892	loops	_	
288-141	52892-52893	:	_	
288-142	52894-52899	motor	_	
288-143	52900-52903	and	_	
288-144	52904-52913	cognitive	_	
288-145	52914-52922	circuits	_	
288-146	52923-52926	The	_	
288-147	52927-52937	prefrontal	_	
288-148	52938-52944	cortex	_	
288-149	52945-52948	and	_	
288-150	52949-52958	cognitive	_	
288-151	52959-52966	control	_	
288-152	52967-52969	An	_	
288-153	52970-52981	integrative	_	
288-154	52982-52988	theory	_	
288-155	52989-52991	of	_	
288-156	52992-53002	prefrontal	_	
288-157	53003-53009	cortex	_	
288-158	53010-53018	function	_	
288-159	53019-53032	Meta-analysis	_	
288-160	53033-53035	of	_	
288-161	53036-53038	41	_	
288-162	53039-53049	functional	_	
288-163	53050-53062	neuroimaging	_	
288-164	53063-53070	studies	_	
288-165	53071-53073	of	_	
288-166	53074-53083	executive	_	
288-167	53084-53092	function	_	
288-168	53093-53095	in	_	
288-169	53096-53109	schizophrenia	_	
288-170	53110-53116	Neural	_	
288-171	53117-53122	basis	_	
288-172	53123-53125	of	_	
288-173	53126-53129	the	_	
288-174	53130-53141	undermining	_	
288-175	53142-53148	effect	_	
288-176	53149-53151	of	_	
288-177	53152-53160	monetary	_	
288-178	53161-53167	reward	_	
288-179	53168-53170	on	_	
288-180	53171-53180	intrinsic	_	
288-181	53181-53191	motivation	_	
288-182	53193-53206	Schizophrenia	_	
288-183	53207-53215	patients	_	
288-184	53216-53219	are	_	
288-185	53220-53224	more	_	
288-186	53225-53236	emotionally	_	
288-187	53237-53243	active	_	
288-188	53244-53248	than	_	
288-189	53249-53251	is	_	
288-190	53252-53259	assumed	_	
288-191	53260-53265	based	_	
288-192	53266-53268	on	_	
288-193	53269-53274	their	_	
288-194	53275-53283	behavior	_	
288-195	53284-53287	How	_	
288-196	53288-53291	the	_	
288-197	53292-53297	brain	_	
288-198	53298-53308	translates	_	
288-199	53309-53314	money	_	
288-200	53315-53319	into	_	
288-201	53320-53325	force	_	
288-202	53325-53326	:	_	
288-203	53327-53328	a	_	
288-204	53329-53341	neuroimaging	_	
288-205	53342-53347	study	_	
288-206	53348-53350	of	_	
288-207	53351-53361	subliminal	_	
288-208	53362-53372	motivation	_	
288-209	53373-53382	Intrinsic	_	
288-210	53383-53393	motivation	_	
288-211	53394-53397	and	_	
288-212	53398-53401	the	_	
288-213	53402-53409	effects	_	
288-214	53410-53412	of	_	
288-215	53413-53431	self-consciousness	_	
288-216	53431-53432	,	_	
288-217	53433-53447	self-awareness	_	
288-218	53447-53448	,	_	
288-219	53449-53452	and	_	
288-220	53453-53468	ego-involvement	_	
288-221	53468-53469	:	_	
288-222	53470-53472	an	_	
288-223	53473-53486	investigation	_	
288-224	53487-53489	of	_	
288-225	53490-53500	internally	_	
288-226	53501-53512	controlling	_	
288-227	53513-53519	styles	_	
288-228	53520-53521	A	_	
288-229	53522-53527	pilot	_	
288-230	53528-53533	study	_	
288-231	53534-53536	on	_	
288-232	53537-53540	the	_	
288-233	53541-53548	effects	_	
288-234	53549-53551	of	_	
288-235	53552-53561	cognitive	_	
288-236	53562-53573	remediation	_	
288-237	53574-53576	on	_	
288-238	53577-53588	hemodynamic	_	
288-239	53589-53598	responses	_	
288-240	53599-53601	in	_	
288-241	53602-53605	the	_	
288-242	53606-53616	prefrontal	_	
288-243	53617-53625	cortices	_	
288-244	53626-53628	of	_	
288-245	53629-53637	patients	_	
288-246	53638-53642	with	_	
288-247	53643-53656	schizophrenia	_	
288-248	53656-53657	:	_	
288-249	53658-53659	a	_	
288-250	53660-53673	multi-channel	_	
288-251	53674-53687	near-infrared	_	
288-252	53688-53700	spectroscopy	_	
288-253	53701-53706	study	_	
288-254	53707-53714	Ventral	_	
288-255	53715-53723	striatal	_	
288-256	53724-53734	activation	_	
288-257	53735-53741	during	_	
288-258	53742-53748	reward	_	
288-259	53749-53759	processing	_	
288-260	53760-53762	in	_	
288-261	53763-53772	psychosis	_	
288-262	53772-53773	:	_	
288-263	53774-53775	a	_	
288-264	53776-53791	neurofunctional	_	
288-265	53792-53805	meta-analysis	_	
288-266	53806-53812	Reward	_	
288-267	53813-53819	system	_	
288-268	53820-53830	activation	_	
288-269	53831-53833	in	_	
288-270	53834-53847	schizophrenic	_	
288-271	53848-53856	patients	_	
288-272	53857-53865	switched	_	
288-273	53866-53870	from	_	
288-274	53871-53878	typical	_	
288-275	53879-53891	neuroleptics	_	
288-276	53892-53894	to	_	
288-277	53895-53905	olanzapine	_	
288-278	53906-53914	Multiple	_	
288-279	53915-53923	dopamine	_	
288-280	53924-53933	functions	_	
288-281	53934-53936	at	_	
288-282	53937-53946	different	_	
288-283	53947-53951	time	_	
288-284	53952-53959	courses	_	
288-285	53960-53968	Deficits	_	
288-286	53969-53971	in	_	
288-287	53972-53980	positive	_	
288-288	53981-53994	reinforcement	_	
288-289	53995-54003	learning	_	
288-290	54004-54007	and	_	
288-291	54008-54026	uncertainty-driven	_	
288-292	54027-54038	exploration	_	
288-293	54039-54042	are	_	
288-294	54043-54053	associated	_	
288-295	54054-54058	with	_	
288-296	54059-54067	distinct	_	
288-297	54068-54075	aspects	_	
288-298	54076-54078	of	_	
288-299	54079-54087	negative	_	
288-300	54088-54096	symptoms	_	
288-301	54097-54099	in	_	
288-302	54100-54113	schizophrenia	_	
288-303	54114-54115	A	_	
288-304	54116-54122	review	_	
288-305	54123-54125	of	_	
288-306	54126-54132	reward	_	
288-307	54133-54143	processing	_	
288-308	54144-54147	and	_	
288-309	54148-54160	motivational	_	
288-310	54161-54171	impairment	_	
288-311	54172-54174	in	_	
288-312	54175-54188	schizophrenia	_	
288-313	54189-54198	Intrinsic	_	
288-314	54199-54209	motivation	_	
288-315	54210-54213	and	_	
288-316	54214-54227	metacognition	_	
288-317	54228-54230	as	_	
288-318	54231-54241	predictors	_	
288-319	54242-54244	of	_	
288-320	54245-54253	learning	_	
288-321	54254-54263	potential	_	
288-322	54264-54266	in	_	
288-323	54267-54275	patients	_	
288-324	54276-54280	with	_	
288-325	54281-54289	remitted	_	
288-326	54290-54303	schizophrenia	_	
288-327	54304-54317	Meta-analysis	_	
288-328	54318-54320	of	_	
288-329	54321-54331	functional	_	
288-330	54332-54344	neuroimaging	_	
288-331	54345-54352	studies	_	
288-332	54353-54355	of	_	
288-333	54356-54363	emotion	_	
288-334	54364-54374	perception	_	
288-335	54375-54378	and	_	
288-336	54379-54389	experience	_	
288-337	54390-54392	in	_	
288-338	54393-54406	schizophrenia	_	
288-339	54407-54419	Neurobiology	_	
288-340	54420-54422	of	_	
288-341	54423-54432	cognitive	_	
288-342	54433-54444	remediation	_	
288-343	54445-54452	therapy	_	
288-344	54453-54456	for	_	
288-345	54457-54470	schizophrenia	_	
288-346	54470-54471	:	_	
288-347	54472-54473	a	_	
288-348	54474-54484	systematic	_	
288-349	54485-54491	review	_	
288-350	54492-54501	Automated	_	
288-351	54502-54512	anatomical	_	
288-352	54513-54521	labeling	_	
288-353	54522-54524	of	_	
288-354	54525-54536	activations	_	
288-355	54537-54539	in	_	
288-356	54540-54543	SPM	_	
288-357	54544-54549	using	_	
288-358	54550-54551	a	_	
288-359	54552-54563	macroscopic	_	
288-360	54564-54574	anatomical	_	
288-361	54575-54587	parcellation	_	
288-362	54588-54590	of	_	
288-363	54591-54594	the	_	
288-364	54595-54598	MNI	_	
288-365	54599-54602	MRI	_	
288-366	54603-54617	single-subject	_	
288-367	54618-54623	brain	_	
288-368	54624-54635	Preliminary	_	
288-369	54636-54644	evidence	_	
288-370	54645-54647	of	_	
288-371	54648-54656	improved	_	
288-372	54657-54663	verbal	_	
288-373	54664-54671	working	_	
288-374	54672-54678	memory	_	
288-375	54679-54690	performance	_	
288-376	54691-54694	and	_	
288-377	54695-54708	normalization	_	
288-378	54709-54711	of	_	
288-379	54712-54724	task-related	_	
288-380	54725-54732	frontal	_	
288-381	54733-54737	lobe	_	
288-382	54738-54748	activation	_	
288-383	54749-54751	in	_	
288-384	54752-54765	schizophrenia	_	
288-385	54766-54775	following	_	
288-386	54776-54785	cognitive	_	
288-387	54786-54795	exercises	_	
288-388	54796-54800	Conn	_	
288-389	54800-54801	:	_	
288-390	54802-54803	a	_	
288-391	54804-54814	functional	_	
288-392	54815-54827	connectivity	_	
288-393	54828-54835	toolbox	_	
288-394	54836-54839	for	_	
288-395	54840-54850	correlated	_	
288-396	54851-54854	and	_	
288-397	54855-54869	anticorrelated	_	
288-398	54870-54875	brain	_	
288-399	54876-54884	networks	_	
288-400	54885-54895	Supporting	_	
288-401	54896-54904	autonomy	_	
288-402	54905-54907	to	_	
288-403	54908-54916	motivate	_	
288-404	54917-54925	patients	_	
288-405	54926-54930	with	_	
288-406	54931-54939	diabetes	_	
288-407	54940-54943	for	_	
288-408	54944-54951	glucose	_	
288-409	54952-54959	control	_	
288-410	54960-54961	A	_	
288-411	54962-54975	meta-analysis	_	
288-412	54976-54978	of	_	
288-413	54979-54988	cognitive	_	
288-414	54989-55000	remediation	_	
288-415	55001-55004	for	_	
288-416	55005-55018	schizophrenia	_	
288-417	55018-55019	:	_	
288-418	55020-55031	methodology	_	
288-419	55032-55035	and	_	
288-420	55036-55042	effect	_	
288-421	55043-55048	sizes	_	
288-422	55049-55062	Supplementary	_	
288-423	55063-55067	data	_	
288-424	55068-55081	Supplementary	_	
288-425	55082-55086	data	_	
288-426	55087-55089	to	_	
288-427	55090-55094	this	_	
288-428	55095-55102	article	_	
288-429	55103-55106	can	_	
288-430	55107-55109	be	_	
288-431	55110-55115	found	_	
288-432	55116-55122	online	_	
288-433	55123-55125	at	_	
288-434	55126-55130	http	_	
288-435	55130-55131	:	_	
288-436	55131-55132	/	_	
288-437	55132-55133	/	_	
288-438	55133-55143	dx.doi.org	_	
288-439	55143-55144	/	_	
288-440	55144-55151	10.1016	_	
288-441	55151-55152	/	_	
288-442	55152-55158	j.nicl	_	
288-443	55158-55170	.2017.07.003	_	
288-444	55170-55171	.	_	
